
<html lang="en"     class="pb-page"  data-request-id="0549b821-5559-458e-9e0f-55b619b86bd1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.1c00802;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-13;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain" /></meta><meta name="dc.Creator" content="Nan  Zheng" /></meta><meta name="dc.Creator" content="Sean B.  Christensen" /></meta><meta name="dc.Creator" content="Cheryl  Dowell" /></meta><meta name="dc.Creator" content="Landa  Purushottam" /></meta><meta name="dc.Creator" content="Jack J.  Skalicky" /></meta><meta name="dc.Creator" content="J. Michael  McIntosh" /></meta><meta name="dc.Creator" content="Danny Hung-Chieh  Chou" /></meta><meta name="dc.Description" content="α9-Containing nicotinic acetylcholine receptors (nAChRs) are key targets for the treatment of neuropathic pain. α-Conotoxin RgIA4 is a peptide antagonist of human α9α10 nAChRs with high selectivity..." /></meta><meta name="Description" content="α9-Containing nicotinic acetylcholine receptors (nAChRs) are key targets for the treatment of neuropathic pain. α-Conotoxin RgIA4 is a peptide antagonist of human α9α10 nAChRs with high selectivity..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 23, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00802" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00802" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00802" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00802" /></link>
        
    
    

<title>Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00802" /></meta><meta property="og:title" content="Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0009.jpeg" /></meta><meta property="og:description" content="α9-Containing nicotinic acetylcholine receptors (nAChRs) are key targets for the treatment of neuropathic pain. α-Conotoxin RgIA4 is a peptide antagonist of human α9α10 nAChRs with high selectivity. However, structural rearrangement reveals a potential liability for clinical applications. We herein report our designer RgIA analogues stabilized by methylene thioacetal as nonopioid analgesic agents. We demonstrate that replacing disulfide loop I [CysI–CysIII] with methylene thioacetal in the RgIA skeleton results in activity loss, whereas substitution of loop II [CysII–CysIV] can be accommodated. The lead molecule, RgIA-5524, exhibits highly selective inhibition of α9α10 nAChRs with an IC50 of 0.9 nM and much reduced degradation in human serum. In vivo studies showed that RgIA-5524 relieves chemotherapy-induced neuropathic pain in wild type but not α9 knockout mouse models, demonstrating that α9-containing nAChRs are necessary for the therapeutic effects. This work highlights the application of methylene thioacetal as a disulfide surrogate in conotoxin-based, disulfide-rich peptide drugs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00802"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00802">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00802&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00802&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00802&amp;href=/doi/10.1021/acs.jmedchem.1c00802" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 9513-9524</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00799" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00831" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Nan Zheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nan Zheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nan++Zheng">Nan Zheng</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-2833-4374" title="Orcid link">https://orcid.org/0000-0002-2833-4374</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sean B. Christensen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sean B. Christensen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Science, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sean+B.++Christensen">Sean B. Christensen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cheryl Dowell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cheryl Dowell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Science, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cheryl++Dowell">Cheryl Dowell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Landa Purushottam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Landa Purushottam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Division of Endocrinology and Diabetes, Stanford University, Stanford, California 94305, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Landa++Purushottam">Landa Purushottam</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jack J. Skalicky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jack J. Skalicky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jack+J.++Skalicky">Jack J. Skalicky</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">J. Michael McIntosh</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. Michael McIntosh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Biological Science, University of Utah, Salt Lake City, Utah 84112, United States</div><div class="loa-info-affiliations-info">George E. Whalen Veterans Affairs Medical Center, Salt Lake City, Utah 84108, United States</div><div class="loa-info-affiliations-info">Department of Psychiatry, University of Utah, Salt Lake City, Utah 84112, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a5c4d0d1cdcad7d6c8c6cccbd1cad6cd8bc8cccec0e5c2c8c4ccc98bc6cac8"><span class="__cf_email__" data-cfemail="bcddc9c8d4d3cecfd1dfd5d2c8d3cfd492d1d5d7d9fcdbd1ddd5d092dfd3d1">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+Michael++McIntosh">J. Michael McIntosh</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Danny Hung-Chieh Chou</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Danny Hung-Chieh Chou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Division of Endocrinology and Diabetes, Stanford University, Stanford, California 94305, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#88ece9e6e6f1ebe0e7fdc8fbfce9e6eee7faeca6edecfd"><span class="__cf_email__" data-cfemail="76121718180f151e190336050217181019041258131203">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Danny+Hung-Chieh++Chou">Danny Hung-Chieh Chou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-9110-614X" title="Orcid link">https://orcid.org/0000-0001-9110-614X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00802&amp;href=/doi/10.1021%2Facs.jmedchem.1c00802" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 9513–9524</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 23, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 May 2021</li><li><span class="item_label"><b>Published</b> online</span>23 June 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00802" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00802</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9513%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNan%2BZheng%252C%2BSean%2BB.%2BChristensen%252C%2BCheryl%2BDowell%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D13%26contentID%3Dacs.jmedchem.1c00802%26title%3DDiscovery%2Bof%2BMethylene%2BThioacetal-Incorporated%2B%25CE%25B1-RgIA%2BAnalogues%2Bas%2BPotent%2Band%2BStable%2BAntagonists%2Bof%2Bthe%2BHuman%2B%25CE%25B19%25CE%25B110%2BNicotinic%2BAcetylcholine%2BReceptor%2Bfor%2Bthe%2BTreatment%2Bof%2BNeuropathic%2BPain%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9524%26publicationDate%3DJuly%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00802"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">564</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00802" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nan&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;B. Christensen&quot;},{&quot;first_name&quot;:&quot;Cheryl&quot;,&quot;last_name&quot;:&quot;Dowell&quot;},{&quot;first_name&quot;:&quot;Landa&quot;,&quot;last_name&quot;:&quot;Purushottam&quot;},{&quot;first_name&quot;:&quot;Jack&quot;,&quot;last_name&quot;:&quot;J. Skalicky&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Michael McIntosh&quot;},{&quot;first_name&quot;:&quot;Danny&quot;,&quot;last_name&quot;:&quot;Hung-Chieh Chou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;9513-9524&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00802&quot;},&quot;abstract&quot;:&quot;α9-Containing nicotinic acetylcholine receptors (nAChRs) are key targets for the treatment of neuropathic pain. α-Conotoxin RgIA4 is a peptide antagonist of human α9α10 nAChRs with high selectivity. However, structural rearrangement reveals a potential liability for clinical applications. We herein report our designer RgIA analogues stabilized by methylene thioacetal as nonopioid analgesic agents. We demonstrate that replacing disulfide loop I [CysI–CysIII] with methylene thioacetal in the RgIA skeleton results in activity loss, whereas substitution of loop II [CysII–CysIV] can be accommodated. The lead molecule, RgIA-5524, exhibits highly selective inhibition of α9α10 nAChRs with an IC50 of 0.9 nM and much reduced degradation in human serum. In vivo studies showed that RgIA-5524 relieves chemotherapy-induced neuropathic pain in wild type but not α9 knockout mouse models, demonstrating that α9-containing nAChRs are necessary for the therapeutic effects. This work highlights the application of methylene thioac&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00802&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00802" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00802&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00802" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00802&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00802" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00802&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00802&amp;href=/doi/10.1021/acs.jmedchem.1c00802" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00802" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00802" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00802%26sid%3Dliteratum%253Aachs%26pmid%3D34161094%26genre%3Darticle%26aulast%3DZheng%26date%3D2021%26atitle%3DDiscovery%2Bof%2BMethylene%2BThioacetal-Incorporated%2B%25CE%25B1-RgIA%2BAnalogues%2Bas%2BPotent%2Band%2BStable%2BAntagonists%2Bof%2Bthe%2BHuman%2B%25CE%25B19%25CE%25B110%2BNicotinic%2BAcetylcholine%2BReceptor%2Bfor%2Bthe%2BTreatment%2Bof%2BNeuropathic%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D13%26spage%3D9513%26epage%3D9524%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">α9-Containing nicotinic acetylcholine receptors (nAChRs) are key targets for the treatment of neuropathic pain. α-Conotoxin RgIA4 is a peptide antagonist of human α9α10 nAChRs with high selectivity. However, structural rearrangement reveals a potential liability for clinical applications. We herein report our designer RgIA analogues stabilized by methylene thioacetal as nonopioid analgesic agents. We demonstrate that replacing disulfide loop I [Cys<sup>I</sup>–Cys<sup>III</sup>] with methylene thioacetal in the RgIA skeleton results in activity loss, whereas substitution of loop II [Cys<sup>II</sup>–Cys<sup>IV</sup>] can be accommodated. The lead molecule, RgIA-5524, exhibits highly selective inhibition of α9α10 nAChRs with an IC<sub>50</sub> of 0.9 nM and much reduced degradation in human serum. <i>In vivo</i> studies showed that RgIA-5524 relieves chemotherapy-induced neuropathic pain in wild type but not α9 knockout mouse models, demonstrating that α9-containing nAChRs are necessary for the therapeutic effects. This work highlights the application of methylene thioacetal as a disulfide surrogate in conotoxin-based, disulfide-rich peptide drugs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neuropathic pain is a highly prevalent but poorly managed health issue which largely lacks adequate medications and in-depth understanding of its molecular mechanisms.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Opioids are first-line drugs for the treatment of moderate to severe neuropathic pain; however, the broad and less-regulated clinical application of these drugs has resulted in a critical public health emergency, the opioid epidemic crisis.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> To tackle this issue, new medications that can act through alternative molecular mechanisms with diminished side effects and toxicity are urgently needed. Intense research efforts have been devoted to the discovery of lead compounds that can target pain-related ion channels and receptors including NMDAR, Ca<sub>v</sub>2.2, Na<sub>v</sub>1.7, and TRPV1.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6−10)</a> Nicotinic acetylcholine receptors (nAChRs), distributed throughout both peripheral and central nervous systems, are a group of transmembrane ligand-gated cationic channels that mediate fast synaptic transmission and are involved in a wide range of nervous system disorders including neuropathic pain, Parkinson’s disease, schizophrenia, and alcohol and drug addiction.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Different nAChR subunits including α, β, γ, δ, and ε associate in various combinations within these homo- or heteropentameric receptors, leading to a complex variety of nAChR subtypes with distinct pharmacological and biophysical functions.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> The nAChRs have previously been targeted for analgesic drug discovery albeit with progress being hindered by a narrow therapeutic window and side effects caused by indiscriminate subtype targeting.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Recent studies indicate that antagonists of α9-containing nAChRs are analgesic in animal models of neuropathic pain, which makes this receptor a potential new target for nonopioid analgesic medication research.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a></div><div class="NLM_p">Nature provides a practical means to discover drugs for the treatment of refractory diseases.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> The first FDA-approved conotoxin-based drug, ω-conotoxin MVIIA (ziconotide), is clinically used in the treatment of chronic pain.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> α-Conotoxins (CTxs), derived from the venom of predatory marine snails, are peptides that are active at nAChR subtypes.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> Recent studies identified α-CTxs including RgIA, Vc1.1, and PeIA as promising candidates for nonopioid analgesic development (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A,B).<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29">(25−29)</a> RgIA exhibits high potency and selectivity on rodent α9α10 nAChRs but has low activity at the human variant. Based on the original sequence of RgIA, the second generation candidate RgIA4 was developed which exhibits high potency for both human and rodent α9α10 nAChRs.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33">(30−33)</a> Structurally, CTxs rely on highly conserved cysteine frameworks to maintain rigid structures, which are crucial for receptor recognition, potency, and selectivity.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Unfortunately, like other disulfide-rich peptides, RgIA4 is susceptible to disulfide-scrambling in reducing physiological environments that can lead to concomitant alternation of three-dimensional structures, aggregation, decreased therapeutic efficacy, and increased immunogenic side effects. Designer disulfide mimetics can prevent disulfide bond scrambling and therefore represent powerful tools in disulfide-rich peptide drug discovery.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Strategies including dicarba, saturated dicarba, alkyne, thioether, ether, diselenide (Sec), penicillamine-cysteine (Pen-Cys) hybrid, and triazole bridge replacement have been extensively applied in CTx modifications (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C).<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46">(35−46)</a> However, such strategies lack broad applicability owing to incompatibility of the mimetic moiety with bioactivity and toxicity. Head-to-tail backbone cyclization is another investigated strategy to improve peptide stability through prevention of degradation as it stabilized the structure and reduced proteolysis susceptibility.<a onclick="showRef(event, 'ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50">(47−50)</a> Nevertheless, the application of this method to RgIA resulted in obvious potency drop on α9α10 nAChR binding affinity.<a onclick="showRef(event, 'ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53 ref54">(51−54)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Amino acid sequence alignments of α-Ctx RgIA, ImI, Vc1.1, PeIA, MII, and PnIA. Disulfide connectivity is Cys<sup>I</sup>–Cys<sup>III</sup> (loop I) and Cys<sup>II</sup>–Cys<sup>IV</sup> (loop II). # = C-terminal amide; ̂ = C-terminal carboxylate acid. (B) Binding surface of RgIA bound to the α9 nAChR subunit crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HY7">6HY7</a>). Key binding residues (Ser4, Asp5, Arg7, and Arg9) are labeled in black font and shown as stick representation with oxygen, nitrogen, and sulfur atoms in red, blue, and yellow, respectively. (C) Chemical structures of native disulfide and developed disulfide mimetics. Pen = <span class="smallcaps smallerCapital">l</span>-penicillamine. (D) Chemical syntheses of methylene thioacetal RgIA analogues in this study. All linear peptides were synthesized through Fmoc-SPPS on the automated synthesizer. Fully folded peptides were obtained <i>via</i> a two-step procedure. Reaction conditions (a) TCEP·HCl, K<sub>2</sub>CO<sub>3</sub>, and H<sub>2</sub>O and then Et<sub>3</sub>N, CH<sub>2</sub>I<sub>2</sub>, and THF. (b) I<sub>2</sub>, AcOH, and H<sub>2</sub>O.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By inserting a minimal functional carbon unit (CH<sub>2</sub>) into native disulfide, the unreducible methylene thioacetal is an efficient disulfide surrogate, which has been introduced into some bioactive peptides and proteins to improve their biophysical properties.<a onclick="showRef(event, 'ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58">(55−58)</a> Compared to the previous approaches requiring the use of unnatural amino acids and metallic catalysts, the methylene thioacetal bond is directly derived from two natural cysteines under simple basic conditions, which is a major advancement for future therapeutic development. In this study, we applied the strategic replacement of native disulfide with methylene thioacetal to stabilize the globular active conformation of RgIA analogues. The best candidate RgIA-5524 exhibited high potency (IC<sub>50</sub> = 0.9 nM) on human α9α10 nAChRs with superb selectivity against other pain-related ion channels and receptors.</div><div class="NLM_p last">There is an ongoing controversy regarding the therapeutic mechanism of action of α-CTxs, with a number of studies suggesting that stimulation of GABA<sub>B</sub> receptors is necessary yet others indicating that blockade of α9 nAChRs is key.<a onclick="showRef(event, 'ref30 ref59 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref30 ref59 ref60 ref61 ref62">(30,59−62)</a> The present study, utilizing wild-type and knockout (KO) mice, demonstrates not only that a selective α9α10 nAChR antagonist is analgesic but also that the presence of the α9-nAChR subunit is required for analgesic activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemical Synthesis and Characterization of RgIA Methylene Thioacetal Analogues</h3><div class="NLM_p last">The chemical synthesis of RgIA analogues was achieved using 9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase peptide synthesis (SPPS) on 2-chlorotrityl chloride (2-CTC) resin followed by two-step and regioselective intramolecular bond formation reactions (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). The correct scaffold folding is Cys<sup>I</sup>–Cys<sup>III</sup>, Cys<sup>II</sup>–Cys<sup>IV</sup>, or its corresponding methylene thioacetal replacement with the same connectivity. Bonds were explicitly formed in the order (1) methylene thioacetal formation on free Cys after trityl (Trt) removal through cleavage, (2) disulfide bond formation <i>via in situ</i> oxidative acetamidomethyl (Acm) deprotection-coupling process, and (3) repeating methylene thioacetal formation to generate the <i>bis</i>-methylene thioacetal replaced analogue. In detail, after cleavage of the assembled peptide chain from 2-CTC resin, the Trt protections were removed and the target methylene thioacetal bond was formed by treatment with diiodomethane in the presence of tris(2-carboxyethyl)phosphine hydrochloride (TCEP·HCl), potassium carbonate, and trimethylamine (Et<sub>3</sub>N).<a onclick="showRef(event, 'ref54 ref58'); return false;" href="javascript:void(0);" class="ref ref54 ref58">(54,58)</a> This key-step conversion can be conducted in as large as the 300 mg scale in one batch, which enables large preparation of target peptides for further studies. The second disulfide bridge was formed after Acm deprotection by the treatment of excess iodine in 25% aqueous acetic acid (AcOH) to yield fully folded peptides. RgIA and RgIA4 were synthesized according to previous reports.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> All peptides were purified as ≥95% purity indicated by reversed-phase high-performance liquid chromatography (RP-HPLC), and final products were analyzed by ESI-MS before NMR studies and biological assays (Figure S1, Table S1, and LC chromatography is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_004.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> <i>In Vitro</i> Biological Evaluation of RgIA Methylene Thioacetal Analogues</h3><div class="NLM_p">The bioactivities of all synthesized analogues were tested by two-electrode-voltage-clamp (TEVC) electrophysiology on human α9α10 nAChRs heterlogously expressed in <i>Xenopus laevis</i> oocytes (cRNA injection ratio 1:1). To determine the compatibility of methylene thioacetal as a disulfide surrogate in the RgIA series, we synthesized and tested a suite of analogues with different methylene thioacetal replacements. IC<sub>50</sub> values determined by concentration–response analysis (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A. By comparison, native RgIA inhibits ACh-evoked currents mediated by human α9α10 nAChRs with an IC<sub>50</sub> value of 510 nM due to the low affinity for the human receptor.<a onclick="showRef(event, 'ref33 ref63'); return false;" href="javascript:void(0);" class="ref ref33 ref63">(33,63)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Amino acid sequences and potencies of synthesized methylene thioacetal RgIA analogues on hα9α10 nAChRs. <sup><i>a</i></sup>Bond connectivity is C<sup>I</sup>–C<sup>III</sup> (loop I) and C<sup>II</sup>–C<sup>IV</sup> (loop II) or their corresponding methylene thioacetal surrogates X<sup>I</sup>–X<sup>III</sup> and X<sup>II</sup>–X<sup>IV</sup>. X represents methylene thioacetal replacement; ̂ represents C-terminal carboxylic acid; Cit = <span class="smallcaps smallerCapital">l</span>-citrulline; iY = L-3-iodo-tyrosine; bA = β-alanine; bhY = <span class="smallcaps smallerCapital">l</span>-β-homotyrosine. <sup><i>b</i></sup>Calculated from concentration–response curves. Numbers in parenthesis are 95% confidence intervals. (B) Concentration–response analysis for inhibition of human α9α10 nAChR by synthesized peptides on blocking ACh-induced current on human nAChR currents expressed in <i>X. laevis</i> oocytes. (C) IC<sub>50</sub> for inhibition of nAChR subtypes by RgIA-5524 and RgIA-5533 on blocking ACh-induced current on human nAChR currents expressed in <i>X. laevis</i> oocytes. (D) Concentration–response analysis for inhibition of hα9α10 <i>vs</i> hα7 nAChR by RgIA-5524 and RgIA-5533. Data points represent the mean ± SEM from three to four independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Differential effects were produced when methylene thioacetal was introduced to the sequence of a modified RgIA analogue, RgIA4. Specifically, RgIA-5533, which had the loop II [Cys<sup>II</sup>–Cys<sup>IV</sup>] disulfide exchanged for methylene thioacetal, had low nanomolar potency (IC<sub>50</sub> = 6.1 nM). In contrast, as for analogue RgIA-5617, with the methylene thioacetal functionality moved to loop I [Cys<sup>I</sup>–Cys<sup>III</sup>], there was a tremendous decrease in potency (IC<sub>50</sub> = 880 nM). Activity was further eliminated when both disulfides were replaced in RgIA-5618 (IC<sub>50</sub> > 10 μM). These data show that the loop II disulfide [Cys<sup>II</sup>–Cys<sup>IV</sup>] in RgIA is amenable to modification with methylene thioacetal, whereas substitution at the other position [Cys<sup>I</sup>–Cys<sup>III</sup>] abolishes activity for human α9α10 nAChRs. Our results are consistent with the pioneering research of dicarba-modified analogues of RgIA in which both the trans/cis isomers of [Cys<sup>II</sup>–Cys<sup>IV</sup>]-dicarba RgIA maintained some (albeit much reduced) activity for the α9α10 nAChR, whereas the [Cys<sup>I</sup>–Cys<sup>III</sup>]-dicarba analogues were totally inactive.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Similarly, the importance of the [Cys<sup>I</sup>–Cys<sup>III</sup>] disulfide on the structure and activity was also demonstrated in another α-4/3-CTx ImI by analyzing disulfide-deficient analogues.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63,64)</a> We then modified RgIA-5533 with mutants based on RgIA5 and a noncanonical amino acid, β-homotyrosine (bhTyr), to afford the most potent analogue RgIA-5524 with an IC<sub>50</sub> value of 0.9 nM.<a onclick="showRef(event, 'ref30 ref46'); return false;" href="javascript:void(0);" class="ref ref30 ref46">(30,46)</a> Single residue mutation of bhTyr with β-Alanine (bAla) yielded an analogue, RgIA-5573, which was less potent (IC<sub>50</sub> = 2.9 nM), indicating the importance of a phenolic moiety at residue position 13, consistent with our recent research of critical residues in RgIA.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p last">We next investigated the subtype selectivity of RgIA-5533 and RgIA-5524. TEVC electrophysiology showed that both analogues failed to inhibit a wide range of nAChR subtypes at 10 μM (IC<sub>50</sub> > 10 μM), including α1β1δε, α2β2, α2β4, α3β2, α3β4 α4β2, α4β4, α6/α3β2β3, and α6/α3β4 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_004.pdf" class="ext-link">S2</a>). Concentration–response analysis indicated that RgIA-5533 had low activity (IC<sub>50</sub> > 10 μM) on hα7 nAChRs and RgIA-5524 exhibited nanomolar activity (IC<sub>50</sub> = 186 nM) which is greater than 200-fold higher than the IC<sub>50</sub> for hα9α10 nAChRs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). To further assess the binding affinity of RgIA-5524 on hα7 nAChRs, we carried out a competition binding assay using [<sup>125</sup>I]α-bungarotoxin (α-Btx). RgIA-5524 produced only 41% inhibition at 10 μM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), consistent with its low potency in functional assays on the hα7 nAChR subtype.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> <i>In Vivo</i> Pain-Relieving Efficacy of RgIA-5524</h3><div class="NLM_p">Chemotherapy-induced neuropathic pain is a major dose-limiting side effect of platin-based drugs.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(65)</a> Currently, the pathophysiology of oxaliplatin-induced neuropathic pain remains poorly investigated and there are no approved drugs for the prevention of this dose-limiting adverse outcome. The <i>in vivo</i> analgesic activity of RgIA-5524 was assessed using a model of oxaliplatin-induced peripheral neuropathic pain in mice. Cold allodynia is a disabling side effect of oxaliplatin. The magnitude and time course of this side effect are dose-dependent. Repeated daily injections of RgIA-5524 prevented the development of neuropathic pain caused by chemotherapy. Oxaliplatin (i.p. 3.5 mg/kg, 5 days each week) created substantial cold allodynia by day 21 of treatment as indicated by significantly reduced paw withdrawal latency on the cold plate. In contrast, oxaliplatin-treated mice that received 40 μg/kg of RgIA-5524 did not develop allodynia (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vivo</i> pain-relieving effects of RgIA-5524 in chronic chemotherapy-induced neuropathic pain. RgIA-5524 relieves pain induced by repeated oxaliplatin dosing. Mice were injected once per day, 5 days per week with the chemotherapeutic agent oxaliplatin (3.5 mg/kg, i.p.) over a three-week period. On the days of oxaliplatin injection, mice also received either saline or RgIA-5524 (40 μg/kg). Once per week, 24 h after last RgIA-5524 injection, mice were assessed for cold allodynia using a cold plate as described in the Experimental Section. Allodynia reached statistical significance by day 21 and was effectively reversed by RgIA-5524. Statistical evaluations of the data were performed by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. Data are expressed as means ± SEM, <i>n</i> = eight mice per group. <sup>xxx</sup><i>P</i> < 0.001 for a significant difference from Ox/Sal <i>vs</i> Sal/Sal-treated mice; ***<i>P</i> < 0.001 for a significant difference from Ox/Sal <i>vs</i> Ox/RgIA-5524-treated mice. Ox, oxaliplatin; Sal, 0.9% saline; s, seconds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next performed the single-injection oxaliplatin treatment study in both wild-type and α9 KO mice. The results show that RgIA-5524 was effective in reversing the acute cold allodynia 5 days after oxaliplatin treatment (s.c. 5.0 and 10.0 mg/kg) as indicated by significant differences between the WT group of Sal/Sal <i>versus</i> Ox/Sal and Ox/RgIA-5524 <i>versus</i> Ox/Sal (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,C). However, this effect did not occur in the α9 KO mice group, where no significance was observed between the α9 KO group of Ox/RgIA-5524 <i>versus</i> Ox/Sal (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B,D). This KO experiment demonstrated that the blockade of α9α10 nAChR by RgIA-5524 enabled the prevention or attenuation of chemotherapy-induced neuropathic pain. It is of interest to note that in the single-dose oxaliplatin model, the latency of response to cold is the same in α9 KO and w.t. animals. This indicates that germline α9 knockout mice differ in the development of allodynia compared to adult mice in which the function of the α9 gene is conditionally silenced by an antagonist.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. α9 nAChR subunit is required for analgesic effects of RgIA-5524. (A, B) On day 1, a single dose of oxaliplatin 5 mg/kg i.p. was given along with either RgIA 5524 (40 μg/kg, s.c.) or 0.9% saline. Mice were assessed for cold allodynia on day 5. RgIA-5524 prevented the development of allodynia in (A) wild-type mice but not in (B) α9-subunit null mice (<i>n</i> = 12 mice/group). (C,D) On day 1, mice were administered a higher dose of oxaliplatin (10 mg/kg i.p.) and either RgIA-5524 (40 μg/kg s.c.) or saline. Oxaliplatin-induced cold allodynia was prevented by the single dose of RgIA-5524 administered on day 1 in (C) wild-type mice but not in (D) α9-subunit null mice (n = 8 mice/group). Statistical evaluations of the data were performed by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. All results are expressed as means ± SEM. *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 for a significant difference from Sal/Sal-treated mice. <sup>o</sup><i>P</i> <0.05, <sup>oo</sup><i>P</i> <0.01, and <sup>ooo</sup><i>P</i> < 0.001 for a significant difference from oxaliplatin/RgIA-5524-treated mice. Ox, oxaliplatin; Sal, 0.9% saline; s, seconds; α9<sup>–/–</sup>, α9 knockout mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> <i>In Vitro</i> Pharmacological, Toxicity, and Metabolism Assays of RgIA-5524</h3><div class="NLM_p">We further demonstrated that the most potent analogue RgIA-5524 was a promising nonopioid analgesic candidate <i>via</i> a broad suite of <i>in vitro</i> pharmacology assays. First, we tested RgIA-5524 on a wide range of various pain-associated receptors and ion channels. As summarized in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, at the 10 μM level, RgIA-5524 showed low or no activity (<50% inhibition) on these potential targets including opioid receptors, NMDAR, BZD, OCT receptors, and various voltage-gated ion channels (Na<sup>+</sup>, K<sup>+</sup>, and Ca<sup>2+</sup>). Testing RgIA-5524 on the N-type Ca<sup>2+</sup> channel showed low potency with only 58.4% inhibition at 10 μM, whereas further concentration–response analysis demonstrated only micromolar affinity, too low to account for the analgesic activity. Utilizing a cellular dielectric spectroscopy assay, we also demonstrated that RgIA-5524 failed to display any concentration-dependent agonist or antagonist effects at GABA<sub>B1b</sub> receptors, which has been a postulated mechanism for RgIA analgesia (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,D,E).<a onclick="showRef(event, 'ref59 ref66'); return false;" href="javascript:void(0);" class="ref ref59 ref66">(59,65)</a> Taken together with the above mentioned <i>in vivo</i> α9 KO mice study, the results firmly demonstrate that antagonizing α9-containing nAChRs is the dominant mechanism of the observed RgIA-5524 analgesic effects.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Binding activity of RgIA-5524 on other pain-related ion channels and receptors at 10 μM. <sup><i>a</i></sup>Each experiment was conducted with duplicate wells. Binding was calculated as % inhibition of the binding of a radioactively labeled ligand specific for each target, and the enzyme inhibition effect was calculated as % inhibition of control enzyme activity. A secondary, concentration–response analysis was conducted when the primary screening assay indicated ≥50% inhibition. <sup><i>b</i></sup>Nicotinic neuronal type. <sup><i>c</i></sup>Strychnine-sensitive. <sup><i>d</i></sup>Strychnine-insensitive; AR, adenosine receptor; AT, angiotensin; BK<sub>2</sub>, bradykinin receptor; CB, cannabinoid receptor; CCK, cholecystokinin receptor; CRF, corticotropin-releasing factor; D, dopamine; ET, endothelin receptor; GABA, γ-aminobutyric acid; GAL, galanin receptor; mGluR, metabotropic glutamate receptor; GlyR, glycine receptor (strychnine-sensitive); H, histamine receptor; CysLT, cysteinyl leukotriene; M, muscarinic acetylcholine receptor; NK, neurokinin receptor; DOP, δ-opioid receptor; KOP, κ-opioid receptor; MOP, μ-opioid receptor; NOP, nociceptin/orphanin FQ receptor; GR, glucocorticoid receptor; ER, estrogen receptor; AR, androgen receptor; PAFR, platelet-activating factor receptor; TRH1, thyrotropin-releasing hormone; VPAC, vasoactive intestinal peptide receptor; V, vasopressin receptor; LTCC, L-type Ca<sup>2+</sup> channel; NTCC, N-type Ca<sup>2+</sup> channel; BZD, benzodiazepine; PCP, phencyclidine. (B) Functional activity of RgIA-5524 on GABA<sub>B</sub> receptors and the hERG K<sup>+</sup> channel. <sup><i>e</i></sup>Two separate experiments were conducted with duplicate wells for the IC<sub>50</sub> and EC<sub>50</sub> studies. Cellular agonist and antagonist effects were calculated as % of control response and % inhibition to a known reference agonist or antagonist, respectively; <sup><i>f</i></sup>Measured at 100 μM RgIA-5524. (C) Enzyme and uptake assays of RgIA-5524. <sup><i>g</i></sup>Each experiment was conducted with duplicate wells. The antagonist effect was calculated as % inhibition to the measured component. TXA<sub>2</sub> synthetase, thromboxane A2 synthetase; constitutive NOS, constitutive NO synthase; MAO, monoamine oxidase. Concentration–response analysis of the (D) agonist and (E) antagonist effect of RgIA-5524 on GABA<sub>B</sub> receptors. (F) Concentration–response analysis of RgIA-5524 on the hERG K<sup>+</sup> channel measured by tail current inhibition. (G) Inhibition of CYP enzyme isoforms by RgIA-5524 at 100 nM and 10 μM. Duplicated experiments were conducted for each concentration, and data are expressed as means ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Drug-induced cardiotoxicity has become one of the major reasons leading to drug withdrawal in the past decades, which is closely related to the blockade of the human ether-a-go-go-related gene (hERG) K<sup>+</sup> channel.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(66)</a> No evidence for cardiovascular liability was indicated from an automated-whole cell patch-clamp assay in which RgIA-5524 caused <25% inhibition at a high concentration of 100 μM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,F). Meanwhile, RgIA-5524 was inactive in a set of enzyme and uptake assays including acetylcholinesterase and MAO, which are potentially important in several neurodegenerative disorders (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). Finally, we assessed the potential of RgIA-5524 to influence drug–drug interactions; no inhibition was observed against a wide panel of CYP enzyme isoforms at 10 μM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>G).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> NMR Spectroscopy and Structural Analysis</h3><div class="NLM_p">NMR studies of the modified analogues were performed to compare and contrast the structural features. Analogues including RgIA-5533, RgIA-5617, and RgIA-5524 were analyzed by homonuclear 2D <sup>1</sup>H NMR spectroscopy including TOCSY, NOESY, COSY, and HSQC. Together with our previous study of RgIA4,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(69)</a> assignments on all residues except for N-terminal Gly<sup>1</sup> primary amine were achieved (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_004.pdf" class="ext-link">Supporting Information</a>). In all molecules studied, Pro<sup>6</sup> was identified as <i>trans</i> conformation by strong NOEs observed from Asp<sup>5</sup> Hα to Pro<sup>6</sup> Hδ. Hα secondary-shift analysis was used to assess any changes in the secondary structure elements. In general, secondary Hα shift confirmed that RgIA-5533, 5524, and 5617 all maintained the globular conformations. Subtle changes were observed in the critical residues including Asp<sup>5</sup>-Pro<sup>6</sup>-Arg<sup>7</sup> and Arg/Cit<sup>9</sup>-Tyr/iTyr<sup>10</sup>-Gln/Arg<sup>11</sup> segments. No obvious differences among the potent analogue RgIA-5533, RgIA-5524, or inactive RgIA-5617 compared with that of native disulfides bonded RgIA and RgIA4 were observed from Hα secondary chemical shifts. Slight deviations existed at C-termini of individual peptides primarily due to terminal flexibility (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Overlay of the secondary chemical shifts of RgIA (black), RgIA4 (gray), RgIA-5617 (pink), RgIA-5533 (green), and RgIA-5524 (blue). The <i>x</i>-axis shows the peptide sequences with the substituted residue for the mutant at residues 4, 9, 10, 13, and 14 calculated based on their corresponding standard chemical shifts. Representative NMR structures and distance measurements (Å) between Cα in two intramolecular bridges. (B) RgIA bound to the hα9 nAChR subunit crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HY7">6HY7</a>); representative NMR solution structures of (C) RgIA (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JUQ">2JUQ</a>), (D) RgIA4, (E) RgIA-5533, (F) RgIA-5617, and (G) RgIA-5524. Structures are shown as stick representation with atom oxygen, nitrogen, sulfur, and iodine colored in red, blue, yellow, and purple, respectively. Cα distances were measured using PyMOL program.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Three-dimensional NMR solution structures of these analogues were calculated using CYANA 3.0 with atom distance and dihedral angle restraints generated from g11-NOESY and NOESY (200 ms) spectra. Backbone dihedral angle restraints including φ, ψ, and χ1 were predicted using the TALOS program based on the Hα, Cα, Cβ, and amide hydrogen (HN) chemical shifts. The 20 lowest energy state ensembles were obtained with low RMSD (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_004.pdf" class="ext-link">Supporting Information</a>). Together with previously reported structures of RgIA (NMR solution structure PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JUQ">2JUQ</a><a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(67)</a> and cocrystal extract PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HY7">6HY7</a><a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(68)</a>) and RgIA4,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(69)</a> the “closest to mean” energy states were chosen to represent each peptide and are shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B–G with average Cα distance of cysteine pairs measured using PyMOL program. All methylene thioacetal-modified peptides maintained globular conformations closely resembling that of RgIA and RgIA4. The most significant difference between RgIA-5617 and the potent analogues (RgIA4, RgIA-5533, and 5524) were the Cα distances of cysteine pairs. Both the Cα distances of the two cysteine pairs in RgIA-5617 are apparently shortened (average of 4.8 and 4.7 Å in cysteine loop I and loop II, receptively) compared with the other molecules (average of 5.4–6.1 Å). One potential reason for the potency loss of analogues RgIA-5617 and RgIA-5618 is that the insertion of the CH<sub>2</sub> group in loop I disulfide [Cys<sup>I</sup>–Cys<sup>III</sup>] forced a conformation “shrink” in these loop I-modified analogues to accommodate the dihedral and torsional angle changes, which reduced their binding affinities. On the other hand, it has also been proposed by MD stimulation that the loop I disulfide in RgIA analogues might provide stacking interaction toward the receptor by directly contacting with the C-loop disulfide of the nAChR surface.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Therefore, methylene thioacetal replacement at this loop could cause potency loss by interfering with this binding site, which could be another contributing factor despite their minor secondary structure perturbations.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vitro</i> Stability Assays</h3><div class="NLM_p">Generally, disulfide-folded peptides and proteins have rigid structures which result in relatively enhanced stability against proteases. However, free reducing thiols in human serum can interfere with the disulfide connectivity of cysteine-rich peptides by scrambling and thus lead to enzymatic degradation and potency loss.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(70)</a> To determine how methylene thioacetal influenced the metabolic stability of RgIA4, <i>in vitro</i> human serum stability assay of RgIA-5524 and RgIA-5533 was performed. Peptides (0.1 mg/mL in the 90% human serum AB type) were continuously incubated in human serum at 37 °C for 24 h, and the amount of remaining peptide was determined by RP-HPLC at time points 0, 1, 2, 4, 8, and 24 h postincubation. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, RgIA4 scrambled rapidly into its isomer RgIA4[1,4] and ended up with less than 25% of the globular RgIA4, which is consistent with our previous observations.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(69)</a> RgIA-5533 was significantly more stable than RgIA4 where above 70% of the peptide was intact even after 24 h of incubation. RgIA-5524 was slightly less stable compared with RgIA-5533 possibly due to its higher arginine-rich sequence which can be cleaved by trypsin (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). More importantly, complete disulfide scrambling inhibition was achieved when methylene thioacetal was introduced. We also assessed the stability of RgIA-5524 against RgIA4 in the presence of reduced glutathione (GSH) at physiological pH. Similar to human serum degradation results, single methylene thioacetal replacement in RgIA-5524 was able to largely suppress disulfide scrambling (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). The concentration of RgIA4 was rapidly reduced to less than 50% of the initial level; after 8 h, the concentration remained nearly constant which may represent equilibration between isomers under such reducing conditions.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Overall, RgIA-5524 exhibited significantly improved stability which makes it a more attractive and promising candidate for further development.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. RgIA-5524 shows greatly improved stability compared with RgIA4. (A) Complete disulfide scrambling prevention was observed indicated by HPLC traces at certain time points post peptide incubation in 90% human serum at 37 °C. The front peak in the left panel is the scrambled ribbon isomer RgIA4[1,4]. (B) Stability assay of RgIA-5524 and RgIA-5533 <i>vs</i> RgIA4 in human serum. Peptides were incubated in the 90% human serum AB type (0.1 mg/mL) at 37 °C. (C) Reductive stability assay of RgIA-5524 <i>vs</i> RgIA4. Peptide samples were dissolved at 0.1 mg/mL in the presence of reduced GSH (10 equiv.) in pH 7.4 PBS and incubated at 37 °C. Statistical evaluations of the data were performed by Student’s <i>t</i> (unpaired) test. All results are expressed as means ± SD (<i>n</i> = 3), **<i>P</i> < 0.01, ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We report the design, synthesis, and pharmacological characterization of a suite of α-CTx RgIA analogues with the native disulfide bonds replaced by methylene thioacetal, which provided stabilized ligands targeting human α9α10 nAChRs as potential nonopioid-based analgesic agents for the treatment of neuropathic pain. We identified RgIA-5524 as a highly selective and potent candidate which relieved chemotherapy-induced neuropathic pain <i>via</i> blocking of α9-containing nAChRs. Notably, RgIA-5524 demonstrated enhanced stability and complete disulfide scrambling suppression. This works also highlighted the power of methylene thioacetal as a native disulfide surrogate in disulfide-rich peptide stabilization. RgIA-5524 thus represents an advanced template for the development of peptidic nonopioid analgesics.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Materials</h3><div class="NLM_p last"><i>Chemicals</i>. All chemicals were purchased and used directly without further purification. Fmoc-protected amino acids and reagents were purchased from Chemimpex, Thermal Fischer, and Sigma-Aldrich. <i>Oocytes</i>. <i>X. leavis</i> frog oocytes used for two-electrode voltage clamp experiments were purchased from Xenopus One. <i>Mice</i>. CBA/CaJ inbred strain mice (2–3 weeks, male) used for <i>in vivo</i> assays were obtained from Jackson Laboratory.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Conotoxin Analogue Synthesis</h3><div class="NLM_p last"><i>SPSS</i>. Linear peptides were synthesized using automated Fmoc-SPPS chemistry on the synthesizer (Syzo I) as previously described using 2-CTC resin.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(69)</a><i>Cleavage and Purification</i>. Peptides were cleaved off from resin by treatment with a cocktail buffer (TFA/H<sub>2</sub>O/TIPS/EDT = 95:2:2:1, 3.0 mL/0.1 mmol) for 2.5 h. The obtained peptide-TFA solution was then filtered <i>via</i> plastic filter and precipitated out into cold ether (40 mL) and cooled at −20 °C for 30 min before being pelleted by centrifugation. The crude peptide was washed with cold ether (30 mL) to remove residual TFA and dried in vacuum. The crude product was then purified by RP-HPLC performed on the Jupiter 5 μ C18 300 Å (250 × 10 mm) column at 3.0 mL/min with a H<sub>2</sub>O/ACN gradient containing 0.1% TFA from 5 to 45% ACN over 40 min on an Agilent 1260 HPLC system. The purified fractions containing the targeted product were collected and lyophilized using a freeze dryer (Labconco). <i>LC/MS Analysis</i>. Characterization of peptides was performed by LC/MS on a Phenomenex Gemini C18 3.0 μm (110 Å 150 × 3 mm) column at 0.4 mL/min flow speed with a H<sub>2</sub>O/ACN gradient containing 0.1% formic acid on an Agilent 1260 Quadrupole LC/MS system. HPLC purification fractions, purity check for final products, and stability assays were also analyzed by LC/MS. <i>Methylene Thioacetal Formation.</i> The reaction was carried out using a protocol reported by Cramer.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The purified linear peptide was dissolved in dd H<sub>2</sub>O (6.4 mM) and treated with a premixed TCEP<sup>.</sup>HCl (2.0 eq.) and K<sub>2</sub>CO<sub>3</sub> (4.0 equiv) in H<sub>2</sub>O (19.0 mM). The mixture was gently stirred at room temperature for 2 h. Then, Et<sub>3</sub>N (10.0 equiv 380 mM in THF) was added to the mixture followed by CH<sub>2</sub>I<sub>2</sub> (6.0 equiv 230 mM dissolved in THF). This mixture was allowed to react at room temperature until a complete conversion of the linear peptide in about 6 h (note: longer reaction time may lead to a broad peak on RP-HPLC which is probably caused by amino acid racemization; 5% DMSO could be added in large-scale preparation). <i>I</i><sub><i>2</i></sub><i>-Mediated Disulfide Formation.</i> To the stirred <i>bis</i>-Acm-protected peptide solution in AcOH (aq. 25%, 1.0 mM) was added I<sub>2</sub> (10.0 eq.) in AcOH (5.0 mg/mL). The reaction was stirred at room temperature for 10 min and monitored by LC–MS. The excess I<sub>2</sub> was quenched by adding 1.0 M solution of ascorbic acid until colorless, and the mixture was then purified by RP-HPLC to afford peptides. All fully folded peptides were identified as ≥95% purity by RP-HPLC before NMR analysis and biological assays. <i>Peptide Characterization.</i> Molecular weights were measured by ESI-MS [M + H]<sup>+</sup> and [M + 2H]<sup>2+</sup>, RgIA-5617: calcd, 1705.6 853.3; found, 1705.4 853.4; RgIA-5533: calcd, 1705.6 853.3; found, 1705.4 853.4; RgIA-5618, calcd, 1719.7 860.4; found, 1719.6 860.4; RgIA-5524, calcd, 937.9; found, 937.5. MALDI-TOF [M + H]<sup>+</sup> calcd 1873.5886; found, 1873.5533; RgIA-5573, calcd, 1768.8 884.9; found, 1768.5 884.9.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> TEVC Recording</h3><div class="NLM_p last">We followed a standard method as previously described.<a onclick="showRef(event, 'ref30 ref69'); return false;" href="javascript:void(0);" class="ref ref30 ref69">(30,68)</a> Briefly, <i>X. laevis</i> oocytes were used to express cloned human nAChR subtypes heterologously. For all of nAChRs, oocytes were injected with a 1:1 ratio (15–25 ng in equal parts) of each subunit cRNA. For the homologous human α7 nAChRs, oocytes were injected with 50 ng of α7-encoding cRNA. Recordings were performed 1–3 days postinjection. Oocytes were voltage-clamped at a membrane potential of −70 mV in a 30 μL oocyte chamber which was gravity-perfused at a flow rate of ∼2 mL/min with ND-96 buffer containing 0.1 mg/mL BSA. A 1 s ACh (100 μM for all subtypes, with the exception of 200 μM for α7 and 10 μM for the muscle subtype) pulse per minute was applied to establish a baseline. Then, ND96 solution containing the various concentrations of test peptides was switched and the ACh responses were measured until a steady state reached. All recordings were generated at room temperature and repeated as three to six independent experiments. Data analyses were performed with GraphPad Prism software, and values including the resulting IC<sub>50</sub> were calculated using a nonlinear regression sigmoidal dose–response.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>In Vitro</i> Pharmacology Assays</h3><div class="NLM_p last">Generally, RgIA-5524 was initially tested in quadruplicate at a default concentration of 10 μM in primary assays. A secondary assay was performed to determine a concentration–response curve when RgIA-5524 blocked higher than 50% of the radioligand binding. <i>Competition Binding and Enzyme Assays</i>. Synthetic RgIA-5524 was tested in binding assays by Eurofins Cerep, Pharma Discovery Service, Celle l’Evescault, France. RgIA-5524 was tested at the Dept. of Veterans Affairs Medical Center Research Service (R&D-22) in Portland, OR on serotonin, dopamine and opioid receptors, as well as biogenic amine transporters. Cell membrane homogenates were incubated with the radioligand in the absence or presence of RgIA-5524. Nonspecific binding was determined in the presence of a specific agonist or antagonist at the target. Following incubation, the samples were filtered rapidly under vacuum through glass fiber filters presoaked in a buffer and rinsed several times with an ice-cold buffer using a 48-sample or 96-sample cell harvester. The filters were then counted for radioactivity in a scintillation counter using a scintillation cocktail. <i>hERG K</i><sup><i>+</i></sup><i>Channel Inhibition Assay</i>. Automated whole-cell patch clamp (Qpatch 16) on human hERG-transfected CHO–K1 cells was used to record outward potassium currents. After whole cell configuration was achieved at 22 °C, the cell was held at −80 mV. A 50 ms pulse to −40 mV was delivered to measure the leaking current. Then, the cell is depolarized to +20 mV for 2 s followed by a 1 s pulse to −40 mV to reveal the hERG K<sup>+</sup> tail current. This paradigm is delivered every 5 s to monitor current amplitude. The exocellular solution is applied first followed by RgIA-5524 solution sequentially on the same cell. E-4031 was tested as the reference ligand. <i>Functional Study of RgIA-5524 at GABA</i><sub><i>B1b</i></sub><i>Receptors (performed by Eurofins Cerep, France)</i>. RBL cells expressing human GABAB<sub>1b</sub> receptors were suspended in DMEM buffer and then distributed in microplates. Fluo4 NW mixed with probenicid in HBSS buffer complemented with 20 mM Hepes (pH 7.4) was then added into each well and equilibrated with the cells for 60 min at 37 °C and then 15 min at 22 °C. For testing of the agonist effect, the assay plates were positioned in a microplate reader, which was used for the addition of HBSS buffer (basal control), the reference agonist 3-APMPA at 100 μM (stimulated control) or various concentrations (EC<sub>50</sub> determination), or RgIA-5524. For testing of the antagonist effect, HBSS, CGP55845A at various concentrations (reference antagonist), or RgIA-5524 was added; then, 5 min later, 3000 nM 3-APMPA (agonist reference compound, EC<sub>80</sub>) or HBSS buffer (basal control) was added. For both agonist and antagonist assays, the changes in fluorescence intensity, which varies proportionally to the free cytosolic Ca<sup>2+</sup> ion concentration, was calculated as % of control response. <i>CYP Enzyme Isoform Inhibition Assays</i>. RgIA-5524 is preincubated with the NADPH-generating system in PBS 7.4 for 5 min in a 37 °C dry incubator. The reaction is initiated by adding a mixture of a CYP enzyme isoform, a substrate, and BSA. The fluorescence in each well is read before and after the incubation period. The percent inhibition is calculated by subtracting the percent of control.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>In Vivo</i> Antinociceptive Activity Evaluation</h3><div class="NLM_p last"><i>Neuropathic Pain Model</i>. All experimental procedures on animals were performed in accordance with the NIH guidelines for the care and use of laboratory animals and were performed under Institutional Animal Care and Use Committees’ (IACUC) approved protocols at the University of Utah. All efforts were made to minimize suffering. Male CBA/CaJ mice (2–3 months old) were injected with oxaliplatin. For the chronic administration group, oxaliplatin was administered i.p., at 3.5 mg/kg 5 days per week over a period of 21 days. For acute administration groups, either 5.0 mg/kg oxaliplatin or 10.0 mg/kg oxaliplatin was given as a single dose. 0.9% saline was used as vehicle control. <i>Cold Plate Test.</i> A cold plate test was performed using a hot/cold plate (IITC Life Science). Mice were allowed to acclimatize to the testing chamber until investigative behavior subsided. Then, the plate temperature lowered from room temperature using a linear ramp (10 °C/min). The time and temperature of the first pain-related behavior (lifting and licking of the hind paw) were recorded. Raters were blind to drug and mouse genotype. Statistical evaluations of the data were performed by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. All results are expressed as means ± SEM (<i>n</i> = 8–12).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Structural Analysis</h3><div class="NLM_p last"><i>NMR Spectroscopy</i>. Peptide samples (prepared at a concentration of 2.0 mM dissolved in a 10% D<sub>2</sub>O-containing buffer pH 3.5 with 20 mM Na<sub>2</sub>HPO<sub>4</sub>, 50 mM NaCl, 50 μM NaN<sub>3</sub>, and 0.1 mM EDTA, uncorrected for isotope effects) were recorded at 298 K on an Inova 600 MHz spectrometer. Secondary structure determination was achieved using TOCSY (80 ms), NOESY (200 ms), g11-NOESY, gCOSY, and HSQC. Excitation sculpting schemes were used for water suppression. Spectra were analyzed using NMRPipe and SPARKY. <i>Structure Calculations</i>. Three-dimensional structures were calculated from the two-dimensional spectra using CYANA 3.0 with backbone dihedral angle constrains predicted using TALOS program. Noncanonical amino acids (<span class="smallcaps smallerCapital">l</span>-citrulline, <span class="smallcaps smallerCapital">l</span>-3-iodo-tyrosine, <span class="smallcaps smallerCapital">l</span>-<i>S</i>-methylene-cysteine, and <span class="smallcaps smallerCapital">l</span>-β-homotyrosine) were built based on their corresponding natural amino acids using CYANA 3.0 as previously described.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(68)</a> The 20 lowest-energy ensembles out of the total 200 calculated structures were chosen for further analysis of the Cα distance measurement. Molecular representations were prepared using PyMOL program.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Stability Assays</h3><div class="NLM_p last">Testing peptides were dissolved in PBS 7.4 at a concentration of 1.0 mg/mL for stock solution and were further diluted with either human serum (AB type, Sigma-Aldrich) or PBS 7.4-containing reduced glutathione (10 equiv) to a final testing peptide concentration of 0.1 mg/mL. Then, the diluted solutions were incubated at 37 °C, and portions of the mixture were taken up at predetermined time points for RP-HPLC analysis. Serum protein was removed by denaturation with the addition of an equal volume of ACN, cooled on ice for 10 min, and followed by centrifugation at 13,000<i>g</i> for 10 min. The supernatant was collected and analyzed by RP-HPLC. The stability at each time point was calculated as the area of the treated peptide peaks (220 nm) on RP-HPLC as the percentage of the area of the 0 h-treated peptides. Each experiment was performed in triplicate. Data were analyzed by Student’s <i>t</i> (unpaired) test. <i>P</i> values were **<i>P</i> < 0.01 and ***<i>P</i> < 0.001 for a significant difference at each time point.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00802" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00802?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00802</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Twenty lowest energy states’ ensemble of NMR solution structures for RgIA-5533 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_001.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Twenty lowest energy states’ ensemble of NMR solution structures for RgIA-5617 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Twenty lowest energy states’ ensemble of NMR solution structures for RgIA-5524 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Supporting figures and tables; LC-chromatogram and MS spectrum for purified peptides; NMR chemical shift assignments; NMR solution structure ensemble; and NMR spectra of compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_004.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_001.pdb">jm1c00802_si_001.pdb (294.24 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_002.pdb">jm1c00802_si_002.pdb (256.29 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_003.pdb">jm1c00802_si_003.pdb (256.29 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_004.pdf">jm1c00802_si_004.pdf (1.32 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00802" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Michael McIntosh</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Science, University of Utah, Salt Lake City, Utah 84112, United States</span>; 
    <span class="hlFld-Affiliation affiliation">George
E. Whalen Veterans Affairs Medical Center, Salt Lake City, Utah 84108, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Psychiatry, University of Utah, Salt Lake City, Utah 84112, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#741501001c1b060719171d1a001b071c5a191d1f11341319151d185a171b19"><span class="__cf_email__" data-cfemail="f29387869a9d80819f919b9c869d819adc9f9b9997b2959f939b9edc919d9f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danny Hung-Chieh Chou</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Division of Endocrinology and Diabetes, Stanford University, Stanford, California 94305, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-9110-614X" title="Orcid link">https://orcid.org/0000-0001-9110-614X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#593d383737203a31362c192a2d38373f362b3d773c3d2c"><span class="__cf_email__" data-cfemail="6a0e0b0404130902051f2a191e0b040c05180e440f0e1f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nan Zheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Utah, Salt Lake City, Utah 84112, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-2833-4374" title="Orcid link">https://orcid.org/0000-0002-2833-4374</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean B. Christensen</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Science, University of Utah, Salt Lake City, Utah 84112, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheryl Dowell</span> - <span class="hlFld-Affiliation affiliation">School
of Biological Science, University of Utah, Salt Lake City, Utah 84112, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Landa Purushottam</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Division of Endocrinology and Diabetes, Stanford University, Stanford, California 94305, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jack J. Skalicky</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Utah, Salt Lake City, Utah 84112, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>N.Z. and S.B.C. contributed equally to this manuscript N.Z., J.M.M., and D.H.-C.C conceived and designed the experiments; N.Z. and L.P. conducted the syntheses and purification of analogues; S.B.C. performed the animal experiments; C.D. performed the TEVC electrophysiology; N.Z. and L.P. performed the stability assays; N.Z. and J.J.S. performed the NMR studies and structural calculations; N.Z., S.B.C., C.D., J.J.S., J.M.M., and D.H.-C.C. analyzed data; N.Z., J. M.M., and D.H.-C.C. wrote and revised the manuscript. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Patent application has been filed by the University of Utah for peptides described herein. N. Z., J. M. M. and D. H.-C. C are listed as inventors.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to acknowledge the support of Dr. David White and NIDA’s Addiction Treatment Discovery Program for data provided for use in this manuscript. We thank Prof. Eric Schmidt and Alan Blakely for helpful discussions. This research was supported financially by the Office of the Assistant Secretary of Defense for Health Affairs under award no. W81XWH-17-1-0413 (to J.M.M and D.H.-C.C.), National Institutes of Health GM136430 (to J.M.M.), and National Institute of General Medical Science GM125001 (to D.H.-C.C.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">Acm</td><td class="NLM_def"><p class="first last">acetamidomethyl</p></td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">CTxs</td><td class="NLM_def"><p class="first last">conotoxins</p></td></tr><tr><td class="NLM_term">2-CTC</td><td class="NLM_def"><p class="first last">2-chlorotrityl chloride</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EDT</td><td class="NLM_def"><p class="first last">1,2-ethanedithiol</p></td></tr><tr><td class="NLM_term">ESI-MS</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">FA</td><td class="NLM_def"><p class="first last">formic acid</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-benzotriazole-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">nAChRs</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptors</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">Ox</td><td class="NLM_def"><p class="first last">oxaliplatin</p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reversed-phase high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">Sal</td><td class="NLM_def"><p class="first last">saline</p></td></tr><tr><td class="NLM_term">s.c.</td><td class="NLM_def"><p class="first last">subcutaneous injection</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid-phase peptide synthesis</p></td></tr><tr><td class="NLM_term">TCEP<sup>.</sup>HCl</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine hydrochloride</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TIPS</td><td class="NLM_def"><p class="first last">triisopropylsilane</p></td></tr><tr><td class="NLM_term">Trt</td><td class="NLM_def"><p class="first last">trityl</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colloca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhassira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickenson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarnitsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccleston, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, S. N.</span></span> <span> </span><span class="NLM_article-title">Neuropathic pain</span>. <i>Nat. Rev. Dis. Primers.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17002</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2017.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fnrdp.2017.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28205574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A280%3ADC%252BC1c3nsFWqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=17002&author=L.+Collocaauthor=T.+Ludmanauthor=D.+Bouhassiraauthor=R.+Baronauthor=A.+H.+Dickensonauthor=D.+Yarnitskyauthor=R.+Freemanauthor=A.+Truiniauthor=N.+Attalauthor=N.+B.+Finnerupauthor=C.+Ecclestonauthor=E.+Kalsoauthor=D.+L.+Bennettauthor=R.+H.+Dworkinauthor=S.+N.+Raja&title=Neuropathic+pain&doi=10.1038%2Fnrdp.2017.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain</span></div><div class="casAuthors">Colloca Luana; Ludman Taylor; Bouhassira Didier; Baron Ralf; Dickenson Anthony H; Yarnitsky David; Freeman Roy; Truini Andrea; Attal Nadine; Finnerup Nanna B; Eccleston Christopher; Eccleston Christopher; Kalso Eija; Bennett David L; Dworkin Robert H; Raja Srinivasa N</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7-10% of the general population.  Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the ageing global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy.  Indeed, imbalances between excitatory and inhibitory somatosensory signalling, alterations in ion channels and variability in the way that pain messages are modulated in the central nervous system all have been implicated in neuropathic pain.  The burden of chronic neuropathic pain seems to be related to the complexity of neuropathic symptoms, poor outcomes and difficult treatment decisions.  Importantly, quality of life is impaired in patients with neuropathic pain owing to increased drug prescriptions and visits to health care providers, as well as the morbidity from the pain itself and the inciting disease.  Despite challenges, progress in the understanding of the pathophysiology of neuropathic pain is spurring the development of new diagnostic procedures and personalized interventions, which emphasize the need for a multidisciplinary approach to the management of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtG6bfcFGVpLJzI8owOhpDfW6udTcc2ebUIL24HoTSaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3nsFWqsQ%253D%253D&md5=003498925636e0a417267ad96d446782</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2017.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2017.2%26sid%3Dliteratum%253Aachs%26aulast%3DColloca%26aufirst%3DL.%26aulast%3DLudman%26aufirst%3DT.%26aulast%3DBouhassira%26aufirst%3DD.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26aulast%3DYarnitsky%26aufirst%3DD.%26aulast%3DFreeman%26aufirst%3DR.%26aulast%3DTruini%26aufirst%3DA.%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DEccleston%26aufirst%3DC.%26aulast%3DKalso%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26atitle%3DNeuropathic%2520pain%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers.%26date%3D2017%26volume%3D3%26spage%3D17002%26doi%3D10.1038%2Fnrdp.2017.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murnion, B. P.</span></span> <span> </span><span class="NLM_article-title">Neuropathic Pain: Current Definition and Review of Drug Treatment</span>. <i>Aust. Prescr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.18773/austprescr.2018.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.18773%2Faustprescr.2018.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=29921999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A280%3ADC%252BC1Mbpt1Knsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=60-63&author=B.+P.+Murnion&title=Neuropathic+Pain%3A+Current+Definition+and+Review+of+Drug+Treatment&doi=10.18773%2Faustprescr.2018.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain: current definition and review of drug treatment</span></div><div class="casAuthors">Murnion Bridin P</div><div class="citationInfo"><span class="NLM_cas:title">Australian prescriber</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">60-63</span>
        ISSN:<span class="NLM_cas:issn">0312-8008</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtGXiLlyciwZZoeNcnHOQ9fW6udTcc2ebUIL24HoTSaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mbpt1Knsg%253D%253D&md5=542c0155bcea11e8420f9906d4a7ca03</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.18773%2Faustprescr.2018.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18773%252Faustprescr.2018.022%26sid%3Dliteratum%253Aachs%26aulast%3DMurnion%26aufirst%3DB.%2BP.%26atitle%3DNeuropathic%2520Pain%253A%2520Current%2520Definition%2520and%2520Review%2520of%2520Drug%2520Treatment%26jtitle%3DAust.%2520Prescr.%26date%3D2018%26volume%3D41%26spage%3D60%26epage%3D63%26doi%3D10.18773%2Faustprescr.2018.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brady, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Back, S. E.</span></span> <span> </span><span class="NLM_article-title">Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update</span>. <i>Am. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1176/appi.ajp.2015.15020262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1176%2Fappi.ajp.2015.15020262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=26337039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A280%3ADC%252BC287ptVensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=18-26&author=K.+T.+Bradyauthor=J.+L.+McCauleyauthor=S.+E.+Back&title=Prescription+Opioid+Misuse%2C+Abuse%2C+and+Treatment+in+the+United+States%3A+An+Update&doi=10.1176%2Fappi.ajp.2015.15020262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update</span></div><div class="casAuthors">Brady Kathleen T; McCauley Jenna L; Back Sudie E</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Prescription opioid abuse and dependence have escalated rapidly in the United States over the past 20 years, leading to high rates of overdose deaths and a dramatic increase in the number of people seeking treatment for opioid dependence.  The authors review the scope of the abuse and overdose epidemic, prescription practices, and the assessment, treatment, and prevention of prescription opioid misuse and dependence.  METHOD:  The authors provide an overview of the literature from 2006 to the present, with the twin goals of highlighting advances in prevention and treatment and identifying remaining gaps in the science.  RESULTS:  A number of policy and educational initiatives at the state and federal government level have been undertaken in the past 5 years to help providers and consumers, respectively, prescribe and use opioids more responsibly.  Initial reports suggest that diversion and abuse levels have begun to plateau, likely as a result of these initiatives.  While there is a large body of research suggesting that opioid substitution coupled with psychosocial interventions is the best treatment option for heroin dependence, there is limited research focusing specifically on the treatment of prescription opioid dependence.  In particular, the treatment of chronic pain in individuals with prescription opioid use disorders is underexplored.  CONCLUSIONS:  While policy and educational initiatives appear to be effective in decreasing prescription opioid abuse and misuse, research focusing on the development and evaluation of treatments specific to prescription opioid dependence and its common comorbidities (e.g., chronic pain, depression) is critically needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvfVgf-x3X7NHxxy173TfNfW6udTcc2eZEHKxG2Emvg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ptVensw%253D%253D&md5=ab766e00ee16e8a1ceaf763c59128d9d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2015.15020262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2015.15020262%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DK.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BL.%26aulast%3DBack%26aufirst%3DS.%2BE.%26atitle%3DPrescription%2520Opioid%2520Misuse%252C%2520Abuse%252C%2520and%2520Treatment%2520in%2520the%2520United%2520States%253A%2520An%2520Update%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2016%26volume%3D173%26spage%3D18%26epage%3D26%26doi%3D10.1176%2Fappi.ajp.2015.15020262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burke, D. S.</span></span> <span> </span><span class="NLM_article-title">Forecasting the Opioid Epidemic</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">529</span>, <span class="refDoi"> DOI: 10.1126/science.aal2943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1126%2Fscience.aal2943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=27811241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCmsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2016&pages=529&author=D.+S.+Burke&title=Forecasting+the+Opioid+Epidemic&doi=10.1126%2Fscience.aal2943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Forecasting the opioid epidemic</span></div><div class="casAuthors">Burke, Donald S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">6312</span>),
    <span class="NLM_cas:pages">529</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXwaOiXEwDCLVg90H21EOLACvtfcHk0lhm_FQ1Jr9fHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCmsr%252FM&md5=883cf8ce5827e2e45af8d71235298696</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.aal2943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aal2943%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DD.%2BS.%26atitle%3DForecasting%2520the%2520Opioid%2520Epidemic%26jtitle%3DScience%26date%3D2016%26volume%3D354%26spage%3D529%26doi%3D10.1126%2Fscience.aal2943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span> <span> </span><span class="NLM_article-title">The Opioid Epidemic: Crisis and Solutions</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-010617-052534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1146%2Fannurev-pharmtox-010617-052534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28968188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsF2hurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2018&pages=143-159&author=P.+Skolnick&title=The+Opioid+Epidemic%3A+Crisis+and+Solutions&doi=10.1146%2Fannurev-pharmtox-010617-052534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Opioid Epidemic: Crisis and Solutions</span></div><div class="casAuthors">Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-159</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">The widespread abuse of prescription opioids and a dramatic increase in the availability of illicit opioids have created what is commonly referred to as the opioid epidemic.  The magnitude of this epidemic is startling: About 4% of the adult US population misuses prescription opioids, and in 2015, more than 33,000 deaths were attributable to overdose with licit and illicit opioids.  Increasing the availability of medication-assisted treatments (such as buprenorphine and naltrexone), the use of abuse-deterrent formulations, and the adoption of US Centers for Disease Control and Prevention prescribing guidelines all constitute short-term approaches to quell this epidemic.  However, with more than 125 million Americans suffering from either acute or chronic pain, the development of effective alternatives to opioids, enabled at least in part by a fuller understanding of the neurobiol. bases of pain, offers the best long-term soln. for controlling and ultimately eradicating this epidemic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfFMgljpaLo7Vg90H21EOLACvtfcHk0lhm_FQ1Jr9fHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2hurzP&md5=af8d4dfe44cab36c82163e4e06e9ac61</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010617-052534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010617-052534%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DThe%2520Opioid%2520Epidemic%253A%2520Crisis%2520and%2520Solutions%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2018%26volume%3D58%26spage%3D143%26epage%3D159%26doi%3D10.1146%2Fannurev-pharmtox-010617-052534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1016/j.nurt.2009.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.nurt.2009.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=19789073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=693-702&author=L.-J.+Wuauthor=M.+Zhuo&title=Targeting+the+NMDA+Receptor+Subunit+NR2B+for+the+Treatment+of+Neuropathic+Pain&doi=10.1016%2Fj.nurt.2009.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain</span></div><div class="casAuthors">Wu, Long-Jun; Zhuo, Min</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-702</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1933-7213</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain is generally defined as a chronic pain state resulting from peripheral or central nerve injury, or both.  An effective treatment for neuropathic pain is still lacking.  The NMDA receptor, one type of the ionotropic glutamate receptors, is known to be important for triggering long-lasting changes in synapses.  NMDA receptor-dependent synaptic plasticity plays roles not only in physiol. functions such as learning and memory, but also in unwanted pathol. conditions such as chronic pain.  This review addresses recent progress on NMDA receptors in neuropathic pain, with particular emphasis on the NR2B-subunit-contg. receptors.  The expression and function of NMDA receptors in synaptic plasticity in the pain transmission pathway from dorsal root ganglia to the anterior cingulate cortex is reviewed, and preclin. and clin. investigations of selective NMDA receptor in neuropathic pain are discussed.  The NMDA receptors, in particular NR2B-contg. NMDA receptors, serve as promising targets for treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJj_EcDQHnR7Vg90H21EOLACvtfcHk0lhm_FQ1Jr9fHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKqu7g%253D&md5=b68285897a56e8c4e2b02233cf2c8de7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.nurt.2009.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nurt.2009.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.-J.%26aulast%3DZhuo%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520NMDA%2520Receptor%2520Subunit%2520NR2B%2520for%2520the%2520Treatment%2520of%2520Neuropathic%2520Pain%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D693%26epage%3D702%26doi%3D10.1016%2Fj.nurt.2009.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidders, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skerratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Ion Channels as Therapeutic Targets: A Drug Discovery Perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1021/jm3011433</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3011433" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=593-624&author=S.+K.+Bagalauthor=A.+D.+Brownauthor=P.+J.+Coxauthor=K.+Omotoauthor=R.+M.+Owenauthor=D.+C.+Prydeauthor=B.+Siddersauthor=S.+E.+Skerrattauthor=E.+B.+Stevensauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Ion+Channels+as+Therapeutic+Targets%3A+A+Drug+Discovery+Perspective&doi=10.1021%2Fjm3011433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ion Channels as Therapeutic Targets: A Drug Discovery Perspective</span></div><div class="casAuthors">Bagal, Sharan K.; Brown, Alan D.; Cox, Peter J.; Omoto, Kiyoyuki; Owen, Robert M.; Pryde, David C.; Sidders, Benjamin; Skerratt, Sarah E.; Stevens, Edward B.; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">593-624</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Ion channels are membrane proteins expressed in almost all living cells.  The sequencing of the human genome has identified more than 400 putative ion channels, but only a fraction of these have been cloned and functionally tested.  The widespread tissue distribution of ion channels, coupled with the plethora of physiol. consequences of their opening and closing, makes ion-channel-targeted drug discovery highly compelling.  However, despite some important drugs in clin. use today, as a class, ion channels remain underexploited in drug discovery and many existing drugs are poorly selective with significant toxicities or suboptimal efficacy.  This Perspective seeks to review the ion channel family, its structural and functional features, and the diseases that are known to be modulated by members of the family.  In particular, we will explore the structure and properties of known ligands and consider the future prospects for drug discovery in this challenging but high potential area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4sRMpezV_yLVg90H21EOLACvtfcHk0liqiKsiuebUuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsbbN&md5=aa6f69a2a48003055d10bd75d4575ee4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm3011433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3011433%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DOwen%26aufirst%3DR.%2BM.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DSidders%26aufirst%3DB.%26aulast%3DSkerratt%26aufirst%3DS.%2BE.%26aulast%3DStevens%26aufirst%3DE.%2BB.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DIon%2520Channels%2520as%2520Therapeutic%2520Targets%253A%2520A%2520Drug%2520Discovery%2520Perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D593%26epage%3D624%26doi%3D10.1021%2Fjm3011433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de%0ALera+Ruizauthor=R.+L.+Kraus&title=Voltage-Gated+Sodium+Channels%3A+Structure%2C+Function%2C+Pharmacology%2C+and+Clinical+Indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0liqiKsiuebUuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-Gated%2520Sodium%2520Channels%253A%2520Structure%252C%2520Function%252C%2520Pharmacology%252C%2520and%2520Clinical%2520Indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajouhesh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckley, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delwig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Bois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, J. C.</span></span> <span> </span><span class="NLM_article-title">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8695</span>– <span class="NLM_lpage">8710</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01906</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8695-8710&author=J.+V.+Mulcahyauthor=H.+Pajouheshauthor=J.+T.+Beckleyauthor=A.+Delwigauthor=J.+Du+Boisauthor=J.+C.+Hunter&title=Challenges+and+Opportunities+for+Therapeutics+Targeting+the+Voltage-Gated+Sodium+Channel+Isoform+NaV1.7&doi=10.1021%2Facs.jmedchem.8b01906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7</span></div><div class="casAuthors">Mulcahy, John V.; Pajouhesh, Hassan; Beckley, Jacob T.; Delwig, Anton; Du Bois, J.; Hunter, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8695-8710</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium ion channel subtype 1.7 (NaV1.7) is a high interest target for the discovery of non-opioid analgesics.  Compelling evidence from human genetic data, particularly the finding that persons lacking functional NaV1.7 are insensitive to pain, has spurred considerable effort to develop selective inhibitors of this Na+ ion channel target as analgesic medicines.  Recent clin. setbacks and disappointing performance of preclin. compds. in animal pain models, however, have led to skepticism around the potential of selective NaV1.7 inhibitors as human therapeutics.  In this Perspective, we discuss the attributes and limitations of recently disclosed investigational drugs targeting NaV1.7, and review evidence that, by better understanding the requirements for selectivity and target engagement, the opportunity to deliver effective analgesic medicines targeting NaV1.7 endures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLRid0FL5Uk7Vg90H21EOLACvtfcHk0lih3ybmOpBr5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFCiurw%253D&md5=414a1a2ba5f68684ae8a6fbba812b1f5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01906%26sid%3Dliteratum%253Aachs%26aulast%3DMulcahy%26aufirst%3DJ.%2BV.%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DBeckley%26aufirst%3DJ.%2BT.%26aulast%3DDelwig%26aufirst%3DA.%26aulast%3DDu%2BBois%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DChallenges%2520and%2520Opportunities%2520for%2520Therapeutics%2520Targeting%2520the%2520Voltage-Gated%2520Sodium%2520Channel%2520Isoform%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8695%26epage%3D8710%26doi%3D10.1021%2Facs.jmedchem.8b01906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortright, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eid, S. R.</span></span> <span> </span><span class="NLM_article-title">The Vanilloid Receptor TRPV1: 10 Years from Channel Cloning to Antagonist Proof-of-Concept</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1038/nrd2280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fnrd2280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=17464295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslyiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=357-372&author=A.+Szallasiauthor=D.+N.+Cortrightauthor=C.+A.+Blumauthor=S.+R.+Eid&title=The+Vanilloid+Receptor+TRPV1%3A+10+Years+from+Channel+Cloning+to+Antagonist+Proof-of-Concept&doi=10.1038%2Fnrd2280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept</span></div><div class="casAuthors">Szallasi, Arpad; Cortright, Daniel N.; Blum, Charles A.; Eid, Samer R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-372</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The clin. use of TRPV1 (transient receptor potential vanilloid subfamily, member 1; also known as VR1) antagonists is based on the concept that endogenous agonists acting on TRPV1 might provide a major contribution to certain pain conditions.  Indeed, a no. of small-mol. TRPV1 antagonists are already undergoing Phase I/II clin. trials for the indications of chronic inflammatory pain and migraine.  Moreover, animal models suggest a therapeutic value for TRPV1 antagonists in the treatment of other types of pain, including pain from cancer.  We argue that TRPV1 antagonists alone or in conjunction with other analgesics will improve the quality of life of people with migraine, chronic intractable pain secondary to cancer, AIDS or diabetes.  Moreover, emerging data indicate that TRPV1 antagonists could also be useful in treating disorders other than pain, such as urinary urge incontinence, chronic cough and irritable bowel syndrome.  The lack of effective drugs for treating many of these conditions highlights the need for further investigation into the therapeutic potential of TRPV1 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUDqlPg9Oh7Vg90H21EOLACvtfcHk0lih3ybmOpBr5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslyiu7Y%253D&md5=6ddc7988d2b5924320b46cd89196b9d8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd2280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2280%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26aulast%3DCortright%26aufirst%3DD.%2BN.%26aulast%3DBlum%26aufirst%3DC.%2BA.%26aulast%3DEid%26aufirst%3DS.%2BR.%26atitle%3DThe%2520Vanilloid%2520Receptor%2520TRPV1%253A%252010%2520Years%2520from%2520Channel%2520Cloning%2520to%2520Antagonist%2520Proof-of-Concept%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2007%26volume%3D6%26spage%3D357%26epage%3D372%26doi%3D10.1038%2Fnrd2280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, E. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, E. F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkondon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, S. W.</span></span> <span> </span><span class="NLM_article-title">Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1152/physrev.00015.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1152%2Fphysrev.00015.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=19126755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Cqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=73-120&author=E.+X.+Albuquerqueauthor=E.+F.+R.+Pereiraauthor=M.+Alkondonauthor=S.+W.+Rogers&title=Mammalian+Nicotinic+Acetylcholine+Receptors%3A+From+Structure+to+Function&doi=10.1152%2Fphysrev.00015.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian nicotinic acetylcholine receptors: from structure to function</span></div><div class="casAuthors">Albuquerque, Edson X.; Pereira, Edna F. R.; Alkondon, Manickavasagom; Rogers, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-120</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The classical studies of nicotine by Langley at the turn of the 20th century introduced the concept of a "receptive substance," from which the idea of a "receptor" came to light.  Subsequent studies aided by the Torpedo elec. organ, a rich source of muscle-type nicotinic receptors (nAChRs), and the discovery of α-bungarotoxin, a snake toxin that binds pseudo-irreversibly to the muscle nAChR, resulted in the muscle nAChR being the best characterized ligand-gated ion channel hitherto.  With the advancement of functional and genetic studies in the late 1980s, the existence of nAChRs in the mammalian brain was confirmed and the realization that the numerous nAChR subtypes contribute to the psychoactive properties of nicotine and other drugs of abuse and to the neuropathol. of various diseases, including Alzheimer's, Parkinson's, and schizophrenia, has since emerged.  This review provides a comprehensive overview of these findings and the more recent revelations of the impact that the rich diversity in function and expression of this receptor family has on neuronal and nonneuronal cells throughout the body.  Despite these numerous developments, our understanding of the contributions of specific neuronal nAChR subtypes to the many facets of physiol. throughout the body remains in its infancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5h0p4UKbZkbVg90H21EOLACvtfcHk0lhDlC2YUtAwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Cqtrw%253D&md5=aa33a8cc5ac9736725840588b9fc191c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00015.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00015.2008%26sid%3Dliteratum%253Aachs%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DPereira%26aufirst%3DE.%2BF.%2BR.%26aulast%3DAlkondon%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DS.%2BW.%26atitle%3DMammalian%2520Nicotinic%2520Acetylcholine%2520Receptors%253A%2520From%2520Structure%2520to%2520Function%26jtitle%3DPhysiol.%2520Rev.%26date%3D2009%26volume%3D89%26spage%3D73%26epage%3D120%26doi%3D10.1152%2Fphysrev.00015.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lester, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lummis, S. C. R.</span></span> <span> </span><span class="NLM_article-title">The Structural Basis of Function in Cys-loop Receptors</span>. <i>Q. Rev. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1017/s0033583510000168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1017%2FS0033583510000168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=20849671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGitbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2010&pages=449-499&author=A.+J.+Thompsonauthor=H.+A.+Lesterauthor=S.+C.+R.+Lummis&title=The+Structural+Basis+of+Function+in+Cys-loop+Receptors&doi=10.1017%2Fs0033583510000168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The structural basis of function in Cys-loop receptors</span></div><div class="casAuthors">Thompson, Andrew J.; Lester, Henry A.; Lummis, Sarah C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Quarterly Reviews of Biophysics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-499</span>CODEN:
                <span class="NLM_cas:coden">QURBAW</span>;
        ISSN:<span class="NLM_cas:issn">0033-5835</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  Cys-loop receptors are membrane-spanning neurotransmitter-gated ion channels that are responsible for fast excitatory and inhibitory transmission in the peripheral and central nervous systems.  The best studied members of the Cys-loop family are nACh, 5-HT3, GABAA and glycine receptors.  All these receptors share a common structure of five subunits, pseudo-sym. arranged to form a rosette with a central ion-conducting pore.  Some are cation selective (e.g. nACh and 5-HT3) and some are anion selective (e.g. GABAA and glycine).  Each receptor has an extracellular domain (ECD) that contains the ligand-binding sites, a transmembrane domain (TMD) that allows ions to pass across the membrane, and an intracellular domain (ICD) that plays a role in channel conductance and receptor modulation.  Cys-loop receptors are the targets for many currently used clin. relevant drugs (e.g. benzodiazepines and anesthetics).  Understanding the mol. mechanisms of these receptors could therefore provide the catalyst for further development in this field, as well as promoting the development of exptl. techniques for other areas of neuro-science.In this review, we present our current understanding of Cys-loop receptor structure and function.  The ECD has been extensively studied.  Research in this area has been stimulated in recent years by the publication of high-resoln. structures of nACh receptors and related proteins, which have permitted the creation of many Cys loop receptor homol. models of this region.  Here, using the 5-HT3 receptor as a typical member of the family, we describe how homol. modeling and ligand docking can provide useful but not definitive information about ligand interactions.  We briefly consider some of the many Cys-loop receptors modulators.  We discuss the current understanding of the structure of the TMD, and how this links to the ECD to allow channel gating, and consider the roles of the ICD, whose structure is poorly understood.  We also describe some of the current methods that are beginning to reveal the differences between different receptor states, and may ultimately show structural details of transitions between them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVJDk3Q9tLCbVg90H21EOLACvtfcHk0lhDlC2YUtAwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGitbfL&md5=4cc49b8ab933a4a53af023c525b64578</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1017%2FS0033583510000168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0033583510000168%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DLummis%26aufirst%3DS.%2BC.%2BR.%26atitle%3DThe%2520Structural%2520Basis%2520of%2520Function%2520in%2520Cys-loop%2520Receptors%26jtitle%3DQ.%2520Rev.%2520Biophys.%26date%3D2010%26volume%3D43%26spage%3D449%26epage%3D499%26doi%3D10.1017%2Fs0033583510000168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anand, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span> <span> </span><span class="NLM_article-title">Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes have a Pentameric Quaternary Structure</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">11192</span>– <span class="NLM_lpage">11198</span>, <span class="refDoi"> DOI: 10.1016/s0021-9258(18)99147-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2FS0021-9258%2818%2999147-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=2040627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADyaK3MXks1Ort74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=11192-11198&author=R.+Anandauthor=W.+G.+Conroyauthor=R.+Schoepferauthor=P.+Whitingauthor=J.+Lindstrom&title=Neuronal+Nicotinic+Acetylcholine+Receptors+Expressed+in+Xenopus+Oocytes+have+a+Pentameric+Quaternary+Structure&doi=10.1016%2Fs0021-9258%2818%2999147-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure</span></div><div class="casAuthors">Anand, Rene; Conroy, William G.; Schoepfer, Ralf; Whiting, Paul; Lindstrom, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">11192-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The subunit stoichiometry of chicken neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes was detd. by quantitation of the amt. of radioactivity in individual subunits of [35S]methionine-labeled receptors.  The chicken neuronal nicotinic acetylcholine receptor appears to be a pentamer of 2α4 acetylcholine-binding subunits and 3β2 structural subunits.  These expressed receptors bind L-[3H]nicotine with high affinity, are transposed to the surface of the oocyte outer membrane, and cosediment on sucrose gradients with acetylcholine receptors isolated from chicken brain.  By using this unique and generally applicable method of detg. subunit stoichiometry of receptors expressed in oocytes, the expected (α1)2β1γδ stoichiometry was obtained for muscle-type acetylcholine receptors assembled from coexpression of either Torpedo α1 or human α1 subunits, with Torpedo β1, γ, and δ subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqZD5fdhaDBbVg90H21EOLACvtfcHk0lhDlC2YUtAwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXks1Ort74%253D&md5=9dd5b2c1e749ffa366b85e75b9381ba6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2999147-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252999147-7%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DConroy%26aufirst%3DW.%2BG.%26aulast%3DSchoepfer%26aufirst%3DR.%26aulast%3DWhiting%26aufirst%3DP.%26aulast%3DLindstrom%26aufirst%3DJ.%26atitle%3DNeuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%2520Expressed%2520in%2520Xenopus%2520Oocytes%2520have%2520a%2520Pentameric%2520Quaternary%2520Structure%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D11192%26epage%3D11198%26doi%3D10.1016%2Fs0021-9258%2818%2999147-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umana, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGehee, D. S.</span></span> <span> </span><span class="NLM_article-title">Neuronal Nicotinic Receptors as Analgesic Targets: It’s a Winding Road</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1208</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2013.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.bcp.2013.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=23948066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGrurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=1208-1214&author=I.+C.+Umanaauthor=C.+A.+Danieleauthor=D.+S.+McGehee&title=Neuronal+Nicotinic+Receptors+as+Analgesic+Targets%3A+It%E2%80%99s+a+Winding+Road&doi=10.1016%2Fj.bcp.2013.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors as analgesic targets: It's a winding road</span></div><div class="casAuthors">Umana, Iboro C.; Daniele, Claire A.; McGehee, Daniel S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1208-1214</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Along with their well known role in nicotine addiction and autonomic physiol., neuronal nicotinic receptors (nAChRs) also have profound analgesic effects in animal models and humans.  This is not a new idea, even in the early 1500s, soon after tobacco was introduced to the new world, its proponents listed pain relief among the beneficial properties of smoking.  In recent years, analgesics that target specific nAChR subtypes have shown highly efficacious antinociceptive properties in acute and chronic pain models.  To date, the side effects of these drugs have precluded their advancement to the clinic.  This review summarizes the recent efforts to identify novel analgesics that target nAChRs, and outlines some of the key neural substrates that contribute to these physiol. effects.  There remain many unanswered mechanistic questions in this field, and there are still compelling reasons to explore neuronal nAChRs as targets for the relief of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotPcztI6nLt7Vg90H21EOLACvtfcHk0lia9PAmtMQqag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGrurzJ&md5=23c9429a6a857df03ee6ce9b67e7928e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DUmana%26aufirst%3DI.%2BC.%26aulast%3DDaniele%26aufirst%3DC.%2BA.%26aulast%3DMcGehee%26aufirst%3DD.%2BS.%26atitle%3DNeuronal%2520Nicotinic%2520Receptors%2520as%2520Analgesic%2520Targets%253A%2520It%25E2%2580%2599s%2520a%2520Winding%2520Road%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26spage%3D1208%26epage%3D1214%26doi%3D10.1016%2Fj.bcp.2013.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincler, M.</span></span> <span> </span><span class="NLM_article-title">Neuronal Nicotinic Receptors as Targets for Novel Analgesics</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1191</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1517/13543784.14.10.1191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1517%2F13543784.14.10.1191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=16185161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVehsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1191-1198&author=M.+Vincler&title=Neuronal+Nicotinic+Receptors+as+Targets+for+Novel+Analgesics&doi=10.1517%2F13543784.14.10.1191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors as targets for novel analgesics</span></div><div class="casAuthors">Vincler, Michelle</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1191-1198</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The potential use of nicotinic acetylcholine receptor agonists has been the subject of a no. of recent reviews.  Despite the promises of better things to come, few new compds. have been identified that circumvent the issues hindering the widespread use of the previously described nicotinic analgesics, mainly a narrow therapeutic window between analgesic efficacy and toxicity, and a lack of knowledge of native nicotinic acetylcholine receptor expression.  However, several recent developments have potentially opened new windows of opportunity in the use of nicotinic agents for analgesia.  A small no. of labs. have reported that peripheral nerve injury alters the pharmacol. of nicotinic receptors, resulting in a leftward shift of analgesic potency but not of toxicity.  Another important development in the pathophysiol. of neuropathic pain is the reliance of nerve injury-induced behavioral hypersensitivity on both peripheral and central neural immune interactions.  Finally, the reported neuroprotective effects of nicotine following spinal cord injury may provide an opportunity for the development of selective nicotinic agonists that are capable of attenuating chronic pain.  The current review will attempt to highlight these recent developments and outline key findings that demonstrate further opportunity for the development of nicotinic agonists as novel analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOi3sjgoNqS7Vg90H21EOLACvtfcHk0lia9PAmtMQqag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVehsLbP&md5=ad045b7017465e4aeaeb7a015f2744d9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.10.1191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.10.1191%26sid%3Dliteratum%253Aachs%26aulast%3DVincler%26aufirst%3DM.%26atitle%3DNeuronal%2520Nicotinic%2520Receptors%2520as%2520Targets%2520for%2520Novel%2520Analgesics%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1191%26epage%3D1198%26doi%3D10.1517%2F13543784.14.10.1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Absalom, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chebib, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elgoyhen, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincler, M.</span></span> <span> </span><span class="NLM_article-title">Alpha9 nicotinic acetylcholine receptors and the treatment of pain</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.bcp.2009.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=19477168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSmsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=693-702&author=J.+M.+McIntoshauthor=N.+Absalomauthor=M.+Chebibauthor=A.+B.+Elgoyhenauthor=M.+Vincler&title=Alpha9+nicotinic+acetylcholine+receptors+and+the+treatment+of+pain&doi=10.1016%2Fj.bcp.2009.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Alpha9 nicotinic acetylcholine receptors and the treatment of pain</span></div><div class="casAuthors">McIntosh, J. Michael; Absalom, Nathan; Chebib, Mary; Elgoyhen, Ana Belen; Vincler, Michelle</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">693-702</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronic pain is a vexing worldwide problem that causes substantial disability and consumes significant medical resources.  Although there are numerous analgesic medications, these work through a small set of mol. mechanisms.  Even when these medications are used in combination, substantial amts. of pain often remain.  It is therefore highly desirable to develop treatments that work through distinct mechanisms of action.  While agonists of nicotinic acetylcholine receptors (nAChRs) have been intensively studied, new data suggest a role for selective antagonists of nAChRs. α-Conotoxins are small peptides used offensively by carnivorous marine snails known as Conus.  A subset of these peptides known as α-conotoxins RgIA and Vc1.1 produces both acute and long lasting analgesia.  In addn., these peptides appear to accelerate the recovery of function after nerve injury, possibly through immune mediated mechanisms.  Pharmacol. anal. indicates that RgIA and Vc1.1 are selective antagonists of α9α10 nAChRs.  A recent study also reported that these α9α10 antagonists are also potent GABA-B agonists.  In the current study, we were unable to detect RgIA or Vc1.1 binding to or action on cloned GABA-B receptors expressed in HEK cells or Xenopus oocytes.  We review the background, findings and implications of use of compds. that act on α9* nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_JL-Oz_qm7Vg90H21EOLACvtfcHk0liPMu-NmmMKYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSmsLjP&md5=6c280aabb216d07a17a6f066686a215f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DAbsalom%26aufirst%3DN.%26aulast%3DChebib%26aufirst%3DM.%26aulast%3DElgoyhen%26aufirst%3DA.%2BB.%26aulast%3DVincler%26aufirst%3DM.%26atitle%3DAlpha9%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520the%2520treatment%2520of%2520pain%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D693%26epage%3D702%26doi%3D10.1016%2Fj.bcp.2009.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">α9-containing nicotinic acetylcholine receptors and the modulation of pain</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">1927</span>, <span class="refDoi"> DOI: 10.1111/bph.13931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1111%2Fbph.13931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28662295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1CjsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=1915-1927&author=A.+J.+Honeauthor=D.+Serventauthor=J.+M.+McIntosh&title=%CE%B19-containing+nicotinic+acetylcholine+receptors+and+the+modulation+of+pain&doi=10.1111%2Fbph.13931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">α9-containing nicotinic acetylcholine receptors and the modulation of pain</span></div><div class="casAuthors">Hone, Arik J.; Servent, Denis; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1915-1927</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Neuropathic pain is a complex and debilitating syndrome for which there are few effective pharmacol. treatments.  Opioid-based medications are initially effective for acute pain, but tolerance to their analgesic effects quickly develops, and long-term use often leads to phys. dependence and addiction.  Furthermore, neuropathic pain is generally resistant to non-steroidal anti-inflammatory drugs.  Other classes of medications including antidepressants, antiepileptics and voltage-gated calcium channel inhibitors are only partially effective in most patients, may be assocd. with significant side effects and have few disease-modifying effects on the underlying pathol.  Medications that act through new mechanisms of action, and particularly ones that have disease-modifying properties, would be highly desirable.  In the last decade, a potential new target for the treatment of neuropathic pain has emerged: the α9-contg. nicotinic acetylcholine receptor (nAChR).  Recent studies indicate that antagonists of α9-contg. nAChRs are analgesic in animal models of neuropathic pain.  These nerve injury models include chronic constriction injury, partial sciatic nerve ligation, streptozotocin-induced diabetic neuropathy and chemotherapeutic-induced neuropathy.  This review details the history and state of the field regarding the role that α9-contg. nAChRs may play in neuropathic pain.  An alternative hypothesis that α-conotoxins exert their therapeutic effect through blocking N-type calcium channels via activation of GABAB receptors is also reviewed.  Understanding how antagonists of α9-contg. nAChRs exert their therapeutic effects may ultimately result in the development of medications that not only treat but also prevent the development of neuropathic pain states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3vMYRgMOCarVg90H21EOLACvtfcHk0liPMu-NmmMKYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1CjsrnI&md5=fee4ba72b136e684770c221feefbf4b1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fbph.13931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13931%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DServent%26aufirst%3DD.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3D%25CE%25B19-containing%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520the%2520modulation%2520of%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D1915%26epage%3D1927%26doi%3D10.1111%2Fbph.13931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor</span>. <i>Pharmacol. Therapeut.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>222</i></span>,  <span class="NLM_fpage">107792</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2020.107792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.pharmthera.2020.107792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=33309557" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2021&pages=107792&author=X.+Liauthor=H.-S.+Taeauthor=Y.+Chuauthor=T.+Jiangauthor=D.+J.+Adamsauthor=R.+Yu&title=Medicinal+chemistry%2C+pharmacology%2C+and+therapeutic+potential+of+%CE%B1-conotoxins+antagonizing+the+%CE%B19%CE%B110+nicotinic+acetylcholine+receptor&doi=10.1016%2Fj.pharmthera.2020.107792"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2020.107792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2020.107792%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DChu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DYu%26aufirst%3DR.%26atitle%3DMedicinal%2520chemistry%252C%2520pharmacology%252C%2520and%2520therapeutic%2520potential%2520of%2520%25CE%25B1-conotoxins%2520antagonizing%2520the%2520%25CE%25B19%25CE%25B110%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DPharmacol.%2520Therapeut.%26date%3D2021%26volume%3D222%26spage%3D107792%26doi%3D10.1016%2Fj.pharmthera.2020.107792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">Counting on Natural Products for Drug Design</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchem.2479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fnchem.2479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=27219696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=531-541&author=T.+Rodriguesauthor=D.+Rekerauthor=P.+Schneiderauthor=G.+Schneider&title=Counting+on+Natural+Products+for+Drug+Design&doi=10.1038%2Fnchem.2479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Counting on natural products for drug design</span></div><div class="casAuthors">Rodrigues, Tiago; Reker, Daniel; Schneider, Petra; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their mol. frameworks have a long tradition as valuable starting points for medicinal chem. and drug discovery.  Recently, there has been a revitalization of interest in the inclusion of these chemotypes in compd. collections for screening and achieving selective target modulation.  Here the authors discuss natural-product-inspired drug discovery with a focus on recent advances in the design of synthetically tractable small mols. that mimic nature's chem.  The authors highlight the potential of innovative computational tools in processing structurally complex natural products to predict their macromol. targets and attempt to forecast the role that natural-product-derived fragments and fragment-like natural products will play in next-generation drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNR16z66-NgLVg90H21EOLACvtfcHk0liPMu-NmmMKYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D&md5=3f6391192d648de2a54524afafd6203a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2479%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DReker%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DCounting%2520on%2520Natural%2520Products%2520for%2520Drug%2520Design%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D531%26epage%3D541%26doi%3D10.1038%2Fnchem.2479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patridge, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareiss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinch, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, D.</span></span> <span> </span><span class="NLM_article-title">An Analysis of FDA-approved Drugs: Natural Products and Their Derivatives</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.drudis.2015.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=25617672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ejt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=204-207&author=E.+Patridgeauthor=P.+Gareissauthor=M.+S.+Kinchauthor=D.+Hoyer&title=An+Analysis+of+FDA-approved+Drugs%3A+Natural+Products+and+Their+Derivatives&doi=10.1016%2Fj.drudis.2015.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of FDA-approved drugs: natural products and their derivatives</span></div><div class="casAuthors">Patridge, Eric; Gareiss, Peter; Kinch, Michael S.; Hoyer, Denton</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">204-207</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Natural products contribute greatly to the history and landscape of new mol. entities (NMEs).  An assessment of all FDA-approved NMEs reveals that natural products and their derivs. represent over one-third of all NMEs.  Nearly one-half of these are derived from mammals, one-quarter from microbes and one-quarter from plants.  Since the 1930s, the total fraction of natural products has diminished, whereas semisynthetic and synthetic natural product derivs. have increased.  Over time, this fraction has also become enriched with microbial natural products, which represent a significant portion of approved antibiotics, including more than two-thirds of all antibacterial NMEs.  In recent years, the declining focus on natural products has impacted the pipeline of NMEs from specific classes, and this trend is likely to continue without specific investment in the pursuit of natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEdmXjG8extLVg90H21EOLACvtfcHk0lgTS1qJVVqI5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ejt70%253D&md5=fbe216c17b12f1d6769543344f5a4dbe</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DPatridge%26aufirst%3DE.%26aulast%3DGareiss%26aufirst%3DP.%26aulast%3DKinch%26aufirst%3DM.%2BS.%26aulast%3DHoyer%26aufirst%3DD.%26atitle%3DAn%2520Analysis%2520of%2520FDA-approved%2520Drugs%253A%2520Natural%2520Products%2520and%2520Their%2520Derivatives%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2016%26volume%3D21%26spage%3D204%26epage%3D207%26doi%3D10.1016%2Fj.drudis.2015.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjørn-Yoshimoto, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramiro, I. B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yandell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellgaard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safavi-Hemami, H.</span></span> <span> </span><span class="NLM_article-title">Curses or Cures: A Review of the Numerous Benefits Versus the Biosecurity Concerns of Conotoxin Research</span>. <i>Biomedicines</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">235</span>, <span class="refDoi"> DOI: 10.3390/biomedicines8080235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3390%2Fbiomedicines8080235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFyjsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=235&author=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=I.+B.+L.+Ramiroauthor=M.+Yandellauthor=J.+M.+McIntoshauthor=B.+M.+Oliveraauthor=L.+Ellgaardauthor=H.+Safavi-Hemami&title=Curses+or+Cures%3A+A+Review+of+the+Numerous+Benefits+Versus+the+Biosecurity+Concerns+of+Conotoxin+Research&doi=10.3390%2Fbiomedicines8080235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Curses or cures: a review of the numerous benefits versus the biosecurity concerns of conotoxin research</span></div><div class="casAuthors">Bjorn-Yoshimoto, Walden E.; Ramiro, Iris Bea L.; Yandell, Mark; McIntosh, J. Michael; Olivera, Baldomero M.; Ellgaard, Lars; Safavi-Hemami, Helena</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicines</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">235</span>CODEN:
                <span class="NLM_cas:coden">BIOMID</span>;
        ISSN:<span class="NLM_cas:issn">2227-9059</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Conotoxins form a diverse group of peptide toxins found in the venom of predatory marine cone snails.  Decades of conotoxin research have provided numerous measurable scientific and societal benefits.  These include their use as a drug, diagnostic agent, drug leads, and research tools in neuroscience, pharmacol., biochem., structural biol., and mol. evolution.  Human envenomations by cone snails are rare but can be fatal.  Death by envenomation is likely caused by a small set of toxins that induce muscle paralysis of the diaphragm, resulting in respiratory arrest.  The potency of these toxins led to concerns regarding the potential development and use of conotoxins as biol. weapons.  To address this, various regulatory measures have been introduced that limit the use and access of conotoxins within the research community.  Some of these regulations apply to all of the ≈200,000 conotoxins predicted to exist in nature of which less than 0.05% are estd. to have any significant toxicity in humans.  In this review we provide an overview of the many benefits of conotoxin research, and contrast these to the perceived biosecurity concerns of conotoxins and research thereof.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc87aev7p6s7Vg90H21EOLACvtfcHk0lgTS1qJVVqI5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFyjsbvE&md5=22837f29edc765ebda9a5ffdff298870</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2Fbiomedicines8080235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiomedicines8080235%26sid%3Dliteratum%253Aachs%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DRamiro%26aufirst%3DI.%2BB.%2BL.%26aulast%3DYandell%26aufirst%3DM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DEllgaard%26aufirst%3DL.%26aulast%3DSafavi-Hemami%26aufirst%3DH.%26atitle%3DCurses%2520or%2520Cures%253A%2520A%2520Review%2520of%2520the%2520Numerous%2520Benefits%2520Versus%2520the%2520Biosecurity%2520Concerns%2520of%2520Conotoxin%2520Research%26jtitle%3DBiomedicines%26date%3D2020%26volume%3D8%26spage%3D235%26doi%3D10.3390%2Fbiomedicines8080235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, M.</span></span> <span> </span><span class="NLM_article-title">Intrathecal Ziconotide: A Review of its Use in Patients with Chronic Pain Refractory to Other Systemic or Intrathecal Analgesics</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">989</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1007/s40263-013-0107-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1007%2Fs40263-013-0107-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=23999971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSms7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=989-1002&author=M.+Sanford&title=Intrathecal+Ziconotide%3A+A+Review+of+its+Use+in+Patients+with+Chronic+Pain+Refractory+to+Other+Systemic+or+Intrathecal+Analgesics&doi=10.1007%2Fs40263-013-0107-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Intrathecal Ziconotide: A Review of Its Use in Patients with Chronic Pain Refractory to Other Systemic or Intrathecal Analgesics</span></div><div class="casAuthors">Sanford, Mark</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">989-1002</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Ziconotide (Prialt) is a synthetic conopeptide analgesic that acts by selectively antagonizing N-type voltage-gated calcium channels.  Intrathecal ziconotide is the only non-opioid intrathecal analgesic that is FDA-approved for use in patients with treatment-refractory, chronic pain.  The efficacy of intrathecal ziconotide was demonstrated in randomized, double-blind, placebo-controlled trials in patients with treatment-refractory noncancer-related pain or cancer- or AIDS-related pain.  Across trials, ziconotide recipients had significantly greater redns. in pain intensity during ziconotide treatment than those receiving placebo (primary endpoint).  At the end of the titrn. period, approx. one-sixth to one-third of patients with noncancer chronic pain and one-half with cancer- or AIDS-related pain who received ziconotide reached a pain response threshold (≥30 % redn. in the pain intensity score).  In ziconotide responders, analgesic effects were enduring, with some patients continuing treatment over extended periods.  Across trials, the chief tolerability concerns in ziconotide recipients during the titrn. phase and during extended treatment were related to CNS adverse events.  These were mostly of mild to moderate intensity, although serious adverse events were commonly attributed to ziconotide treatment, esp. in trials with rapid ziconotide titrn. and that permitted higher dosages.  In general, clin. important non-CNS adverse events were infrequent, and during the ziconotide titrn. phase, relatively few patients discontinued treatment because of adverse events.  Ongoing research will assess various strategies for selecting patients for ziconotide treatment and for enhancing its efficacy and tolerability.  At the present time, intrathecal ziconotide provides a treatment option for patients with severe, unremitting pain who have failed to respond to other intensive analgesic regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4PdXB5eyBvbVg90H21EOLACvtfcHk0lgTS1qJVVqI5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSms7zI&md5=eeabdd33fad6e0329eb2c49d0d632be7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs40263-013-0107-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-013-0107-5%26sid%3Dliteratum%253Aachs%26aulast%3DSanford%26aufirst%3DM.%26atitle%3DIntrathecal%2520Ziconotide%253A%2520A%2520Review%2520of%2520its%2520Use%2520in%2520Patients%2520with%2520Chronic%2520Pain%2520Refractory%2520to%2520Other%2520Systemic%2520or%2520Intrathecal%2520Analgesics%26jtitle%3DCNS%2520Drugs%26date%3D2013%26volume%3D27%26spage%3D989%26epage%3D1002%26doi%3D10.1007%2Fs40263-013-0107-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wulff, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophersen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colussi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandy, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarov-Yarovoy, V.</span></span> <span> </span><span class="NLM_article-title">Antibodies and Venom Peptides: New Modalities for Ion Channels</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1038/s41573-019-0013-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fs41573-019-0013-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=30728472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFKhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=339-357&author=H.+Wulffauthor=P.+Christophersenauthor=P.+Colussiauthor=K.+G.+Chandyauthor=V.+Yarov-Yarovoy&title=Antibodies+and+Venom+Peptides%3A+New+Modalities+for+Ion+Channels&doi=10.1038%2Fs41573-019-0013-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Antibodies and venom peptides: new modalities for ion channels</span></div><div class="casAuthors">Wulff, Heike; Christophersen, Palle; Colussi, Paul; Chandy, K. George; Yarov-Yarovoy, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">339-357</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Ion channels play fundamental roles in both excitable and non-excitable tissues and therefore constitute attractive drug targets for myriad neurol., cardiovascular and metabolic diseases as well as for cancer and immunomodulation.  However, achieving selectivity for specific ion channel subtypes with small-mol. drugs has been challenging, and there currently is a growing trend to target ion channels with biologics.  One approach is to improve the pharmacokinetics of existing or novel venom-derived peptides.  In parallel, after initial studies with polyclonal antibodies demonstrated the tech. feasibility of inhibiting channel function with antibodies, multiple preclin. programs are now using the full spectrum of available technologies to generate conventional monoclonal and engineered antibodies or nanobodies against extracellular loops of ion channels.  After a summary of the current state of ion channel drug discovery, this Review discusses recent developments using the purinergic receptor channel P2X purinoceptor 7 (P2X7), the voltage-gated potassium channel KV1.3 and the voltage-gated sodium channel NaV1.7 as examples of targeting ion channels with biologics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRJ4SEEcSEHbVg90H21EOLACvtfcHk0lhKBpoZMyAwCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFKhtbY%253D&md5=db019a42430ea7d47d8250a7f313d73b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41573-019-0013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-019-0013-8%26sid%3Dliteratum%253Aachs%26aulast%3DWulff%26aufirst%3DH.%26aulast%3DChristophersen%26aufirst%3DP.%26aulast%3DColussi%26aufirst%3DP.%26aulast%3DChandy%26aufirst%3DK.%2BG.%26aulast%3DYarov-Yarovoy%26aufirst%3DV.%26atitle%3DAntibodies%2520and%2520Venom%2520Peptides%253A%2520New%2520Modalities%2520for%2520Ion%2520Channels%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2019%26volume%3D18%26spage%3D339%26epage%3D357%26doi%3D10.1038%2Fs41573-019-0013-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safavi-Hemami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogan, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span> <span> </span><span class="NLM_article-title">Pain Therapeutics from Cone Snail Venoms: From Ziconotide to Novel Non-opioid Pathways</span>. <i>J. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.jprot.2018.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.jprot.2018.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=29777871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKnsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2019&pages=12-20&author=H.+Safavi-Hemamiauthor=S.+E.+Broganauthor=B.+M.+Olivera&title=Pain+Therapeutics+from+Cone+Snail+Venoms%3A+From+Ziconotide+to+Novel+Non-opioid+Pathways&doi=10.1016%2Fj.jprot.2018.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways</span></div><div class="casAuthors">Safavi-Hemami, Helena; Brogan, Shane E.; Olivera, Baldomero M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteomics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12-20</span>CODEN:
                <span class="NLM_cas:coden">JPORFQ</span>;
        ISSN:<span class="NLM_cas:issn">1874-3919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There have been numerous attempts to develop non-opioid drugs for severe pain, but the vast majority of these efforts have failed.  A notable exception is Ziconotide (Prialt), approved by the FDA in 2004.  In this review, we summarize the present status of Ziconotide as a therapeutic drug and introduce a wider framework: the potential of venom peptides from cone snails as a resource providing a continuous pipeline for the discovery of non-opioid pain therapeutics.  An auxiliary theme that we hope to develop is that these venoms, already a validated starting point for non-opioid drug leads, should also provide an opportunity for identifying novel mol. targets for future pain drugs.  This review comprises several sections: the first focuses on Ziconotide as a therapeutic (including a historical retrospective and a clin. perspective); followed by sections on other promising Conus venom peptides that are either in clin. or pre-clin. development.  We conclude with a discussion on why the outlook for discovery appears exceptionally promising.  The combination of new technologies in diverse fields, including the development of novel high-content assays and revolutionary advancements in transcriptomics and proteomics, puts us at the cusp of providing a continuous pipeline of non-opioid drug innovations for pain.  The current opioid epidemic is the deadliest drug crisis in American history.  Thus, this review on the discovery of non-opioid pain therapeutics and pathways from cone snail venoms is significant and timely.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAZhjAqPfOdLVg90H21EOLACvtfcHk0lhKBpoZMyAwCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKnsbnI&md5=561f0da69d43609f1ed00bdd9ea47dfa</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2018.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DSafavi-Hemami%26aufirst%3DH.%26aulast%3DBrogan%26aufirst%3DS.%2BE.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26atitle%3DPain%2520Therapeutics%2520from%2520Cone%2520Snail%2520Venoms%253A%2520From%2520Ziconotide%2520to%2520Novel%2520Non-opioid%2520Pathways%26jtitle%3DJ.%2520Proteomics%26date%3D2019%26volume%3D190%26spage%3D12%26epage%3D20%26doi%3D10.1016%2Fj.jprot.2018.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Layer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J.</span></span> <span> </span><span class="NLM_article-title">Conotoxins: Therapeutic Potential and Application</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.3390/md403119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3390%2Fmd403119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlWnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=119-142&author=R.+Layerauthor=J.+McIntosh&title=Conotoxins%3A+Therapeutic+Potential+and+Application&doi=10.3390%2Fmd403119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Conotoxins: Therapeutic potential and application</span></div><div class="casAuthors">Layer, Richard T.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">119-142</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI Center</span>)
        </div><div class="casAbstract">A review.  The pharmacol. variety of conotoxins, diverse peptides found in the venoms of marine cone snails, is well recognized.  Venoms from each of the estd. 500 species of cone snails contain 50 to 200 distinct biol. active peptides.  Most conotoxins characterized to date target receptors and ion channels of excitable tissues, such as ligand-gated nicotinic acetylcholine, N-methyl-D-aspartate, and type 3 serotonin receptors, as well as voltage-gated calcium, sodium, and potassium channels, and G-protein-coupled receptors including α-adrenergic, neurotensin, and vasopressin receptors, and the norepinephrine transporter.  Several conotoxins have shown promise in preclin. models of pain, convulsive disorders, stroke, neuromuscular block, and cardioprotection.  The pharmacol. selectivity of the conotoxins, coupled with the safety and efficacy demonstrated in preclin. models, has led to their investigation as human therapeutic agents.  In the following review, we will survey the pharmacol. and therapeutic rationale of those conotoxins with potential clin. application, and discuss the unique challenges that each will face in the course of their transition from venom component to human therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWd2YfMEY6EbVg90H21EOLACvtfcHk0lhKBpoZMyAwCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlWnsbs%253D&md5=b7a072aa00d3540b23a323224b4e4336</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fmd403119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd403119%26sid%3Dliteratum%253Aachs%26aulast%3DLayer%26aufirst%3DR.%26aulast%3DMcIntosh%26aufirst%3DJ.%26atitle%3DConotoxins%253A%2520Therapeutic%2520Potential%2520and%2520Application%26jtitle%3DMar.%2520Drugs%26date%3D2006%26volume%3D4%26spage%3D119%26epage%3D142%26doi%3D10.3390%2Fmd403119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Livett, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandall, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keays, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Down, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gayler, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satkunanathan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalil, Z.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Applications of Conotoxins that Target the Neuronal Nicotinic Acetylcholine Receptor</span>. <i>Toxicon</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.1016/j.toxicon.2006.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.toxicon.2006.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=16979678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WnsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=810-829&author=B.+G.+Livettauthor=D.+W.+Sandallauthor=D.+Keaysauthor=J.+Downauthor=K.+R.+Gaylerauthor=N.+Satkunanathanauthor=Z.+Khalil&title=Therapeutic+Applications+of+Conotoxins+that+Target+the+Neuronal+Nicotinic+Acetylcholine+Receptor&doi=10.1016%2Fj.toxicon.2006.07.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor</span></div><div class="casAuthors">Livett, Bruce G.; Sandall, David W.; Keays, David; Down, John; Gayler, Ken R.; Satkunanathan, Narmatha; Khalil, Zeinab</div><div class="citationInfo"><span class="NLM_cas:title">Toxicon</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">810-829</span>CODEN:
                <span class="NLM_cas:coden">TOXIA6</span>;
        ISSN:<span class="NLM_cas:issn">0041-0101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Pain therapeutics discovered by mol. mining of the expressed genome of Australian predatory cone snails are providing lead compds. for the treatment of neurol. diseases such as multiple sclerosis, shingles, diabetic neuropathy and other painful neurol. conditions.  The high specificity exhibited by these novel compds. for neuronal receptors and ion channels in the brain and nervous system indicates the high degree of selectivity that this class of neuropeptides can be expected to show when used therapeutically in humans.  A lead compd., ACV1 (conotoxin Vc1.1 from Conus victoriae), has entered Phase II clin. trials and is being developed for the treatment for neuropathic pain.  ACV1 will be targeted initially for the treatment of sciatica, shingles and diabetic neuropathy.  The compd. is a 16 amino acid peptide an antagonist of neuronal nicotinic acetylcholine receptors.  It has potent analgesic activity following s.c. or i.m. administration in several preclin. animal models of human neuropathic pain.  ACV1 may act as an analgesic by decreasing ectopic excitation in sensory nerves.  In addn. ACV1 appears to accelerate the recovery of injured nerves and tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVetpG2UlDK7Vg90H21EOLACvtfcHk0lhKBpoZMyAwCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WnsLfN&md5=6b0e3d503f21e0e290266497af8dcba3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2006.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2006.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DLivett%26aufirst%3DB.%2BG.%26aulast%3DSandall%26aufirst%3DD.%2BW.%26aulast%3DKeays%26aufirst%3DD.%26aulast%3DDown%26aufirst%3DJ.%26aulast%3DGayler%26aufirst%3DK.%2BR.%26aulast%3DSatkunanathan%26aufirst%3DN.%26aulast%3DKhalil%26aufirst%3DZ.%26atitle%3DTherapeutic%2520Applications%2520of%2520Conotoxins%2520that%2520Target%2520the%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptor%26jtitle%3DToxicon%26date%3D2006%26volume%3D48%26spage%3D810%26epage%3D829%26doi%3D10.1016%2Fj.toxicon.2006.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akondi, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Discovery, Synthesis, and Structure-Activity Relationships of Conotoxins</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">5815</span>– <span class="NLM_lpage">5847</span>, <span class="refDoi"> DOI: 10.1021/cr400401e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400401e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVegt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=5815-5847&author=K.+B.+Akondiauthor=M.+Muttenthalerauthor=S.+Dutertreauthor=Q.+Kaasauthor=D.+J.+Craikauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Discovery%2C+Synthesis%2C+and+Structure-Activity+Relationships+of+Conotoxins&doi=10.1021%2Fcr400401e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Synthesis, and Structure-Activity Relationships of Conotoxins</span></div><div class="casAuthors">Akondi, Kalyana B.; Muttenthaler, Markus; Dutertre, Sebastien; Kaas, Quentin; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5815-5847</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Venom peptides, esp. conotoxins isolated from the venom of predatory marine snails, hold enormous promise for the development of peptide-based drugs.  Conotoxin classification, nomenclature, synthesis, structure activity relationships, and as candidates for drugs are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBcE_sYX4b2LVg90H21EOLACvtfcHk0lhOflhHTADwjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVegt78%253D&md5=02f1253f5605757259436d2ecefd42a6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcr400401e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400401e%26sid%3Dliteratum%253Aachs%26aulast%3DAkondi%26aufirst%3DK.%2BB.%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DDiscovery%252C%2520Synthesis%252C%2520and%2520Structure-Activity%2520Relationships%2520of%2520Conotoxins%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D5815%26epage%3D5847%26doi%3D10.1021%2Fcr400401e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, A.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himaya, S. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Conotoxins: Chemistry and Biology</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">11510</span>– <span class="NLM_lpage">11549</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.9b00207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.9b00207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFymurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=11510-11549&author=A.-H.+Jinauthor=M.+Muttenthalerauthor=S.+Dutertreauthor=S.+W.+A.+Himayaauthor=Q.+Kaasauthor=D.+J.+Craikauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Conotoxins%3A+Chemistry+and+Biology&doi=10.1021%2Facs.chemrev.9b00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Conotoxins: Chemistry and Biology</span></div><div class="casAuthors">Jin, Ai-Hua; Muttenthaler, Markus; Dutertre, Sebastien; Himaya, S. W. A.; Kaas, Quentin; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">11510-11549</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The venom of the marine predatory cone snails (genus Conus) has evolved for prey capture and defense, providing the basis for survival and rapid diversification of the now estd. 750+ species.  A typical Conus venom contains hundreds to thousands of bioactive peptides known as conotoxins.  These mostly disulfide-rich and well-structured peptides act on a wide range of targets such as ion channels, G protein-coupled receptors, transporters and enzymes.  Conotoxins are of interest to neuroscientists as well as drug developers due to their exquisite potency and selectivity, not just against prey but also mammalian targets, thereby providing a rich source of mol. probes and therapeutic leads.  The rise of integrated venomics has accelerated conotoxin discovery with now well over 10,000 conotoxin sequences published.  However, their structural and pharmacol. characterization lags considerably behind.  In this review, the authors highlight the diversity of new conotoxins uncovered since 2014, their three-dimensional structures and folds, novel chem. approaches to their syntheses, and their value as pharmacol. tools to unravel complex biol.  Addnl., the authors discuss challenges and future directions for the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs3xqwJjTyX7Vg90H21EOLACvtfcHk0lhOflhHTADwjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFymurjJ&md5=9827551d941322ef8dee8a1f12576c6f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.9b00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.9b00207%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DA.-H.%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DHimaya%26aufirst%3DS.%2BW.%2BA.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DConotoxins%253A%2520Chemistry%2520and%2520Biology%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D11510%26epage%3D11549%26doi%3D10.1021%2Facs.chemrev.9b00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Q.</span></span> <span> </span><span class="NLM_article-title">Targeting of N-Type Calcium Channels via GABAB-Receptor Activation by α-Conotoxin Vc1.1 Variants Displaying Improved Analgesic Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10198</span>– <span class="NLM_lpage">10205</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01343</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01343" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvF2mt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10198-10205&author=F.+Caiauthor=N.+Xuauthor=Z.+Liuauthor=R.+Dingauthor=S.+Yuauthor=M.+Dongauthor=S.+Wangauthor=J.+Shenauthor=H.-S.+Taeauthor=D.+J.+Adamsauthor=X.+Zhangauthor=Q.+Dai&title=Targeting+of+N-Type+Calcium+Channels+via+GABAB-Receptor+Activation+by+%CE%B1-Conotoxin+Vc1.1+Variants+Displaying+Improved+Analgesic+Activity&doi=10.1021%2Facs.jmedchem.8b01343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of N-Type Calcium Channels via GABAB-Receptor Activation by α-Conotoxin Vc1.1 Variants Displaying Improved Analgesic Activity</span></div><div class="casAuthors">Cai, Fengtao; Xu, Ning; Liu, Zhuguo; Ding, Rong; Yu, Shuo; Dong, Mingxin; Wang, Shuo; Shen, Jintao; Tae, Han-Shen; Adams, David J.; Zhang, Xuerong; Dai, Qiuyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10198-10205</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxins exhibiting analgesic activity, such as Vc1.1, have been shown to inhibit α9α10 nicotinic acetylcholine receptors (nAChRs) and GABAB-receptor (GABABR) coupled N-type (CaV2.2) calcium channels.  Here, the authors report two Vc1.1 variants, Vc1.1[N9R] and benzoyl-Vc1.1[N9R], that selectively inhibit CaV2.2 channels via GABABR activation but exhibit reduced inhibitory activity at α9α10 and other neuronal nAChR subtypes compared with Vc1.1.  Surprisingly, the analgesic activity of Vc1.1[N9R] and benzoyl-Vc1.1[N9R] was more potent than that of Vc1.1 when tested in partial sciatic nerve ligation injury and chronic constriction injury models.  Vc1.1[N9R] and benzoyl-Vc1.1[N9R] exhibited either similar or tenfold higher activity of GABABR-mediated CaV2.2 inhibition but no activity at CaV2.2 alone; however, the mechanism of increased analgesic activity is unknown.  The effects on analgesic activity and α9α10 nAChR of other Vc1.1 variations at position 9 and the N-terminus were also detd.  The findings provide new insights for designing potent inhibitors for GABABR-coupled N-type (CaV2.2) calcium channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjJ9Opc3kw8bVg90H21EOLACvtfcHk0li6QHrvcHKl-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvF2mt7rL&md5=1b002766288bf578f5cb7a5e6339310e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01343%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DQ.%26atitle%3DTargeting%2520of%2520N-Type%2520Calcium%2520Channels%2520via%2520GABAB-Receptor%2520Activation%2520by%2520%25CE%25B1-Conotoxin%2520Vc1.1%2520Variants%2520Displaying%2520Improved%2520Analgesic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10198%26epage%3D10205%26doi%3D10.1021%2Facs.jmedchem.8b01343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iadonato, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercado, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E1825</span>– <span class="NLM_lpage">E1832</span>, <span class="refDoi"> DOI: 10.1073/pnas.1621433114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1073%2Fpnas.1621433114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28223528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E1825-E1832&author=H.+K.+Romeroauthor=S.+B.+Christensenauthor=L.+Di+Cesare+Mannelliauthor=J.+Gajewiakauthor=R.+Ramachandraauthor=K.+S.+Elmslieauthor=D.+E.+Vetterauthor=C.+Ghelardiniauthor=S.+P.+Iadonatoauthor=J.+L.+Mercadoauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Inhibition+of+%CE%B19%CE%B110+nicotinic+acetylcholine+receptors+prevents+chemotherapy-induced+neuropathic+pain&doi=10.1073%2Fpnas.1621433114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain</span></div><div class="casAuthors">Romero, Haylie K.; Christensen, Sean B.; Di Cesare Mannelli, Lorenzo; Gajewiak, Joanna; Ramachandra, Renuka; Elmslie, Keith S.; Vetter, Douglas E.; Ghelardini, Carla; Iadonato, Shawn P.; Mercado, Jose L.; Olivera, Baldomera M.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">E1825-E1832</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Opioids are first-line drugs for moderate to severe acute pain and cancer pain.  However, these medications are assocd. with severe side effects, and whether they are efficacious in treatment of chronic nonmalignant pain remains controversial.  Medications that act through alternative mol. mechanisms are critically needed.  Antagonists of α9α10 nicotinic acetylcholine receptors (nAChRs) have been proposed as an important nonopioid mechanism based on studies demonstrating prevention of neuropathol. after trauma-induced nerve injury.  However, the key α9α10 ligands characterized to date are at least two orders of magnitude less potent on human vs. rodent nAChRs, limiting their translational application.  Furthermore, an alternative proposal that these ligands achieve their beneficial effects by acting as agonists of GABAB receptors has caused confusion over whether blockade of α9α10 nAChRs is the fundamental underlying mechanism.  To address these issues definitively, we developed RgIA4, a peptide that exhibits high potency for both human and rodent α9α10 nAChRs, and was at least 1,000-fold more selective for α9α10 nAChRs vs. all other mol. targets tested, including opioid and GABAB receptors.  A daily s.c. dose of RgIA4 prevented chemotherapy-induced neuropathic pain in rats.  In wild-type mice, oxaliplatin treatment produced cold allodynia that could be prevented by RgIA4.  Addnl., in α9 KO mice, chemotherapy-induced development of cold allodynia was attenuated and the milder, temporary cold allodynia was not relieved by RgIA4.  These findings establish blockade of α9-contg. nAChRs as the basis for the efficacy of RgIA4, and that α9-contg. nAChRs are a crit. target for prevention of chronic cancer chemotherapy-induced neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_cYkcGhDBrVg90H21EOLACvtfcHk0li6QHrvcHKl-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kiu7s%253D&md5=2372b9f813b9c628cef156f7d114c7c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1621433114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1621433114%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DH.%2BK.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DRamachandra%26aufirst%3DR.%26aulast%3DElmslie%26aufirst%3DK.%2BS.%26aulast%3DVetter%26aufirst%3DD.%2BE.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DIadonato%26aufirst%3DS.%2BP.%26aulast%3DMercado%26aufirst%3DJ.%2BL.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520%25CE%25B19%25CE%25B110%2520nicotinic%2520acetylcholine%2520receptors%2520prevents%2520chemotherapy-induced%2520neuropathic%2520pain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3DE1825%26epage%3DE1832%26doi%3D10.1073%2Fpnas.1621433114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniazeff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glowatzki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">219</span>, <span class="refDoi"> DOI: 10.3389/fncel.2017.00219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3389%2Ffncel.2017.00219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28785206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2lsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=219&author=S.+B.+Christensenauthor=A.+J.+Honeauthor=I.+Rouxauthor=J.+Kniazeffauthor=J.-P.+Pinauthor=G.+Upertauthor=D.+Serventauthor=E.+Glowatzkiauthor=J.+M.+McIntosh&title=RgIA4+Potently+Blocks+Mouse+%CE%B19%CE%B110+nAChRs+and+Provides+Long+Lasting+Protection+against+Oxaliplatin-Induced+Cold+Allodynia&doi=10.3389%2Ffncel.2017.00219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">RgIA4 potently blocks mouse α9α10 nAChRs and provides long lasting protection against oxaliplatin-induced cold allodynia</span></div><div class="casAuthors">Christensen, Sean B.; Hone, Arik J.; Roux, Isabelle; Kniazeff, Julie; Pin, Jean-Philippe; Upert, Gregory; Servent, Denis; Glowatzki, Elisabeth; McIntosh, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219/1-219/12</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Transcripts for α9 and α10 nicotinic acetylcholine receptor (nAChR) subunits are found in diverse tissues.  The function of α9α10 nAChRs is best known in mechanosensory cochlear hair cells, but elsewhere their roles are less well-understood. α9α10 nAChRs have been implicated as analgesic targets and α-conotoxins that block α9α10 nAChRs produce analgesia.  However, some of these peptides show large potency differences between species.  Addnl. several studies have indicated that these conotoxins may also activate GABAB receptors (GABABRs).  To further address these issues, we cloned the cDNAs of mouse α9 and α10 nAChR subunits.  When heterologously expressed in Xenopus oocytes, the resulting α9α10 nAChRs had the expected pharmacol. of being activated by acetylcholine and choline but not by nicotine.  A conotoxin analog, RgIA4, potently, and selectively blocked mouse α9α10 nAChRs with low nanomolar affinity indicating that RgIA4 may be effectively used to study murine α9α10 nAChR function.  Previous reports indicated that RgIA4 attenuates chemotherapy-induced cold allodynia.  Here we demonstrate that RgIA4 analgesic effects following oxaliplatin treatment are sustained for 21 days after last RgIA4 administration indicating that RgIA4 may provide enduring protection against nerve damage.  RgIA4 lacks activity at GABAB receptors; a bioluminescence resonance energy transfer assay was used to demonstrate that two other analgesic α-conotoxins, Vc1.1 and AuIB, also do not activate GABABRs expressed in HEK cells.  Together these findings further support the targeting of α9α10 nAChRs in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC52uM4hSfIrVg90H21EOLACvtfcHk0lhQ7-XR5kzE7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2lsrbP&md5=c8180032785db70ebccb97bbbf24cb1c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2017.00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2017.00219%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DRoux%26aufirst%3DI.%26aulast%3DKniazeff%26aufirst%3DJ.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DUpert%26aufirst%3DG.%26aulast%3DServent%26aufirst%3DD.%26aulast%3DGlowatzki%26aufirst%3DE.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DRgIA4%2520Potently%2520Blocks%2520Mouse%2520%25CE%25B19%25CE%25B110%2520nAChRs%2520and%2520Provides%2520Long%2520Lasting%2520Protection%2520against%2520Oxaliplatin-Induced%2520Cold%2520Allodynia%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2017%26volume%3D11%26spage%3D219%26doi%3D10.3389%2Ffncel.2017.00219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuvelis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.3390/md18010012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3390%2Fmd18010012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=12&author=P.+N.+Huynhauthor=D.+Giuvelisauthor=S.+Christensenauthor=K.+L.+Tuckerauthor=J.+M.+McIntosh&title=RgIA4+Accelerates+Recovery+from+Paclitaxel-Induced+Neuropathic+Pain+in+Rats&doi=10.3390%2Fmd18010012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3390%2Fmd18010012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd18010012%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DP.%2BN.%26aulast%3DGiuvelis%26aufirst%3DD.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DTucker%26aufirst%3DK.%2BL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DRgIA4%2520Accelerates%2520Recovery%2520from%2520Paclitaxel-Induced%2520Neuropathic%2520Pain%2520in%2520Rats%26jtitle%3DMar.%2520Drugs%26date%3D2019%26volume%3D18%26spage%3D12%26doi%3D10.3390%2Fmd18010012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberlandt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Casati, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elgoyhen, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span> <span> </span><span class="NLM_article-title">α-RgIA: A Novel Conotoxin That Specifically and Potently Blocks the α9α10 nAChR†,‡</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1511</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1021/bi0520129</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0520129" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=1511-1517&author=M.+Ellisonauthor=C.+Haberlandtauthor=M.+E.+Gomez-Casatiauthor=M.+Watkinsauthor=A.+B.+Elgoyhenauthor=J.+M.+McIntoshauthor=B.+M.+Olivera&title=%CE%B1-RgIA%3A+A+Novel+Conotoxin+That+Specifically+and+Potently+Blocks+the+%CE%B19%CE%B110+nAChR%E2%80%A0%2C%E2%80%A1&doi=10.1021%2Fbi0520129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">α-RgIA: a novel conotoxin that specifically and potently blocks the α9α10 nAChR</span></div><div class="casAuthors">Ellison, Michael; Haberlandt, Christian; Gomez-Casati, Maria Eugenia; Watkins, Maren; Elgoyhen, A. Belen; McIntosh, J. Michael; Olivera, Baldomero M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1511-1517</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The α9 and α10 nicotinic acetylcholine receptor (nAChR) subunits assemble to form the α9α10 nAChR subtype.  This receptor is believed to mediate cholinergic synaptic transmission between efferent olivocochlear fibers and the hair cells of the cochlea.  In addn. α9 and/or α10 expression has been described in dorsal root ganglion neurons, lymphocytes, skin keratinocytes, and the pars tuberalis of the pituitary.  Specific antagonists that selectively block the α9α10 channel could be valuable tools for elucidating its role in these diverse tissues.  This study describes a novel α-conotoxin from the Western Atlantic species Conus regius, α-conotoxin RgIA (α-RgIA), that is a subtype specific blocker of the α9α10 nAChR.  Alpha-RgIA belongs to the α4/3 subfamily of the α-conotoxin family; sequence and subtype specificity comparisons between α-RgIA and previously characterized α4/3 toxins indicate that the amino acids in the C-terminal half of α-RgIA are responsible for its preferential inhibition of the α9α10 nAChR subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfx5hn1KHxALVg90H21EOLACvtfcHk0lhQ7-XR5kzE7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCjtQ%253D%253D&md5=991411e171ed4bf786cb3e7979c01f9d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi0520129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0520129%26sid%3Dliteratum%253Aachs%26aulast%3DEllison%26aufirst%3DM.%26aulast%3DHaberlandt%26aufirst%3DC.%26aulast%3DGomez-Casati%26aufirst%3DM.%2BE.%26aulast%3DWatkins%26aufirst%3DM.%26aulast%3DElgoyhen%26aufirst%3DA.%2BB.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26atitle%3D%25CE%25B1-RgIA%253A%2520A%2520Novel%2520Conotoxin%2520That%2520Specifically%2520and%2520Potently%2520Blocks%2520the%2520%25CE%25B19%25CE%25B110%2520nAChR%25E2%2580%25A0%252C%25E2%2580%25A1%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D1511%26epage%3D1517%26doi%3D10.1021%2Fbi0520129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulaj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span> <span> </span><span class="NLM_article-title">Folding of Conotoxins: Formation of the Native Disulfide Bridges During Chemical Synthesis and Biosynthesis ofConusPeptides</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1089/ars.2007.1856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1089%2Fars.2007.1856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=17961068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=141-156&author=G.+Bulajauthor=B.+M.+Olivera&title=Folding+of+Conotoxins%3A+Formation+of+the+Native+Disulfide+Bridges+During+Chemical+Synthesis+and+Biosynthesis+ofConusPeptides&doi=10.1089%2Fars.2007.1856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Folding of conotoxins: Formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides</span></div><div class="casAuthors">Bulaj, Grzegorz; Olivera, Baldomero M.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-156</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Conopeptides from >700 species of predatory marine Conus snails provide an impressive mol. diversity of cysteine-rich peptides.  Most of the estd. 50,000-100,000 distinct conopeptides are in the size range of 10-50 amino acid residues, often with multiple post-translational modifications.  The great majority contain 2-4 disulfide bridges.  As the biosynthetic and chem. prodn. of this impressive repertoire of disulfide-rich peptides has been investigated, particularly the formation of native disulfide bridges, differences between in vivo and in vitro oxidative folding have become increasingly evident.  Here, the authors provide an overview of the mol. diversity of conotoxins with an emphasis on the Cys residue patterns and disulfide frameworks.  The conotoxin folding studies reviewed include regioselective and direct oxidn. strategies, recombinant expression, optimization of folding methods, mechanisms of in vitro folding, and preliminary data on the biosynthesis of conotoxins in venom ducts.  Despite these studies, how the cone snails efficiently produce properly folded conotoxins remains unanswered.  As chemists continue to master oxidative folding techniques, insights gleaned from how conotoxins are folded in vivo will likely lead to the development of the new folding methods, as well as shed some light on fundamental mechanisms relevant to the protein folding problem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2k-lcrOMc1LVg90H21EOLACvtfcHk0lgRNBfj3uzgKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajs7rF&md5=9bad6a5fe0ac141fd6663a7886e26f5b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1856%26sid%3Dliteratum%253Aachs%26aulast%3DBulaj%26aufirst%3DG.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26atitle%3DFolding%2520of%2520Conotoxins%253A%2520Formation%2520of%2520the%2520Native%2520Disulfide%2520Bridges%2520During%2520Chemical%2520Synthesis%2520and%2520Biosynthesis%2520ofConusPeptides%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2008%26volume%3D10%26spage%3D141%26epage%3D156%26doi%3D10.1089%2Fars.2007.1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinaldi, S.</span></span> <span> </span><span class="NLM_article-title">Disulfide Bond Mimetics: Strategies and Challenges</span>. <i>Chem.—Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">14987</span>– <span class="NLM_lpage">14995</span>, <span class="refDoi"> DOI: 10.1002/chem.201703199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fchem.201703199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28749012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOktbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=14987-14995&author=A.+Goriauthor=P.+Gagniauthor=S.+Rinaldi&title=Disulfide+Bond+Mimetics%3A+Strategies+and+Challenges&doi=10.1002%2Fchem.201703199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfide Bond Mimetics: Strategies and Challenges</span></div><div class="casAuthors">Gori, Alessandro; Gagni, Paola; Rinaldi, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">60</span>),
    <span class="NLM_cas:pages">14987-14995</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The activity profile of many biol. relevant proteins and peptides often relies on a precise 3D structural organization.  In this context, disulfide bonds are natural covalent constraints that play a key role in driving and stabilizing the folding pattern of these mols.  Despite its prominent significance as structural motif, the disulfide bond itself is inherently unstable under physiol. conditions, posing a major limit to the use and development of disulfide-rich peptides and proteins as mol. tools and drug lead compds.  To tackle this restriction, disulfide engineering with stable functional analogs has arisen a considerable interest.  Here, the most popular approaches to disulfide replacement are reviewed and discussed with particular emphasis on advantages and limitations under both functional and synthetic perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7IExEgpIpDLVg90H21EOLACvtfcHk0lgbKsIXK013kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOktbbJ&md5=66c0d1b0d42d1d360ada07ee83111106</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703199%26sid%3Dliteratum%253Aachs%26aulast%3DGori%26aufirst%3DA.%26aulast%3DGagni%26aufirst%3DP.%26aulast%3DRinaldi%26aufirst%3DS.%26atitle%3DDisulfide%2520Bond%2520Mimetics%253A%2520Strategies%2520and%2520Challenges%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D14987%26epage%3D14995%26doi%3D10.1002%2Fchem.201703199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belgi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartels, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Lierop, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kompella, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, R. S.</span></span> <span> </span><span class="NLM_article-title">Dicarba Analogues of α-Conotoxin RgIA. Structure, Stability, and Activity at Potential Pain Targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9933</span>– <span class="NLM_lpage">9944</span>, <span class="refDoi"> DOI: 10.1021/jm501126u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501126u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWns7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9933-9944&author=S.+Chhabraauthor=A.+Belgiauthor=P.+Bartelsauthor=B.+J.+van+Lieropauthor=S.+D.+Robinsonauthor=S.+N.+Kompellaauthor=A.+Hungauthor=B.+P.+Callaghanauthor=D.+J.+Adamsauthor=A.+J.+Robinsonauthor=R.+S.+Norton&title=Dicarba+Analogues+of+%CE%B1-Conotoxin+RgIA.+Structure%2C+Stability%2C+and+Activity+at+Potential+Pain+Targets&doi=10.1021%2Fjm501126u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Dicarba Analogues of α-Conotoxin RgIA. Structure, Stability, and Activity at Potential Pain Targets</span></div><div class="casAuthors">Chhabra, Sandeep; Belgi, Alessia; Bartels, Peter; van Lierop, Bianca J.; Robinson, Samuel D.; Kompella, Shiva N.; Hung, Andrew; Callaghan, Brid P.; Adams, David J.; Robinson, Andrea J.; Norton, Raymond S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9933-9944</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxin RgIA is both an antagonist of the α9α10 nicotinic acetylcholine receptor (nAChR) subtype and an inhibitor of high-voltage-activated N-type calcium channel currents.  RgIA has therapeutic potential for the treatment of pain, but redn. of the disulfide bond framework under physiol. conditions represents a potential liability for clin. applications.  We synthesized four RgIA analogs that replaced native disulfide pairs with nonreducible dicarba bridges.  Soln. structures were detd. by NMR, activity assessed against biol. targets, and stability evaluated in human serum. [3,12]-Dicarba analogs retained inhibition of ACh-evoked currents at α9α10 nAChRs but not N-type calcium channel currents, whereas [2,8]-dicarba analogs displayed the opposite pattern of selectivity.  The [2,8]-dicarba RgIA analogs were effective in HEK293 cells stably expressing human Cav2.2 channels and transfected with human GABAB receptors.  The analogs also exhibited improved serum stability over the native peptide.  These selectively acting dicarba analogs may represent mechanistic probes to explore analgesia-related biol. receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1oDBKbBxsarVg90H21EOLACvtfcHk0lgbKsIXK013kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWns7fI&md5=9984b05b87c74f53c3c8c2c3a1aac66e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm501126u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501126u%26sid%3Dliteratum%253Aachs%26aulast%3DChhabra%26aufirst%3DS.%26aulast%3DBelgi%26aufirst%3DA.%26aulast%3DBartels%26aufirst%3DP.%26aulast%3Dvan%2BLierop%26aufirst%3DB.%2BJ.%26aulast%3DRobinson%26aufirst%3DS.%2BD.%26aulast%3DKompella%26aufirst%3DS.%2BN.%26aulast%3DHung%26aufirst%3DA.%26aulast%3DCallaghan%26aufirst%3DB.%2BP.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DRobinson%26aufirst%3DA.%2BJ.%26aulast%3DNorton%26aufirst%3DR.%2BS.%26atitle%3DDicarba%2520Analogues%2520of%2520%25CE%25B1-Conotoxin%2520RgIA.%2520Structure%252C%2520Stability%252C%2520and%2520Activity%2520at%2520Potential%2520Pain%2520Targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9933%26epage%3D9944%26doi%3D10.1021%2Fjm501126u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacRaild, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illesinghe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lierop, B. J. v.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chebib, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livett, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, R. S.</span></span> <span> </span><span class="NLM_article-title">Structure and Activity of (2,8)-Dicarba-(3,12)-cystino α-ImI, an α-Conotoxin Containing a Nonreducible Cystine Analogue</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1021/jm8011504</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8011504" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=755-762&author=C.+A.+MacRaildauthor=J.+Illesingheauthor=B.+J.+v.+Lieropauthor=A.+L.+Townsendauthor=M.+Chebibauthor=B.+G.+Livettauthor=A.+J.+Robinsonauthor=R.+S.+Norton&title=Structure+and+Activity+of+%282%2C8%29-Dicarba-%283%2C12%29-cystino+%CE%B1-ImI%2C+an+%CE%B1-Conotoxin+Containing+a+Nonreducible+Cystine+Analogue&doi=10.1021%2Fjm8011504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and Activity of (2,8)-Dicarba-(3,12)-cystino α-ImI, an α-Conotoxin Containing a Nonreducible Cystine Analogue</span></div><div class="casAuthors">MacRaild, Christopher A.; Illesinghe, Jayamini; van Lierop, Bianca J.; Townsend, Amanda L.; Chebib, Mary; Livett, Bruce G.; Robinson, Andrea J.; Norton, Raymond S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">755-762</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The α-conotoxins are potent and selective antagonists of nicotinic acetylcholine receptors (nAChR).  Exploitation of these and other peptides in research and clin. settings has been hampered by the lability of the disulfide bridges that are essential for toxin structure and activity.  One soln. to this problem is replacement of cystine bridges with non-reducible dicarba linkages.  We explore this approach by detg. the soln. structure and functional characteristics of a dicarba analog of the α-conotoxin α-ImI, (2,8)-dicarba-(3,12)-cystino α-ImI.  The structure of the dicarba analog was similar to that of native α-ImI, with differences attributable to the different covalent geometry of the disulfide and dicarba bridges.  Dicarba-α-ImI maintained inhibitory activity of nAChR comparable to that of native α-ImI in two in vitro assays.  These findings confirm the potential of the dicarba linkage to improve stability while maintaining α-conotoxin function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeo5yfSaiDCrVg90H21EOLACvtfcHk0ljX_-nf8s55Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVOhsQ%253D%253D&md5=257f9dbe0dc09ba9f2b0b31ac51d5654</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm8011504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8011504%26sid%3Dliteratum%253Aachs%26aulast%3DMacRaild%26aufirst%3DC.%2BA.%26aulast%3DIllesinghe%26aufirst%3DJ.%26aulast%3DLierop%26aufirst%3DB.%2BJ.%2Bv.%26aulast%3DTownsend%26aufirst%3DA.%2BL.%26aulast%3DChebib%26aufirst%3DM.%26aulast%3DLivett%26aufirst%3DB.%2BG.%26aulast%3DRobinson%26aufirst%3DA.%2BJ.%26aulast%3DNorton%26aufirst%3DR.%2BS.%26atitle%3DStructure%2520and%2520Activity%2520of%2520%25282%252C8%2529-Dicarba-%25283%252C12%2529-cystino%2520%25CE%25B1-ImI%252C%2520an%2520%25CE%25B1-Conotoxin%2520Containing%2520a%2520Nonreducible%2520Cystine%2520Analogue%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D755%26epage%3D762%26doi%3D10.1021%2Fjm8011504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belgi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnley, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRaild, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elnahriry, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooding, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartels, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spanswick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, A. J.</span></span> <span> </span><span class="NLM_article-title">Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">3222</span>– <span class="NLM_lpage">3233</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c02151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c02151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3MXmtlKks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2021&pages=3222-3233&author=A.+Belgiauthor=J.+V.+Burnleyauthor=C.+A.+MacRaildauthor=S.+Chhabraauthor=K.+A.+Elnahriryauthor=S.+D.+Robinsonauthor=S.+G.+Goodingauthor=H.-S.+Taeauthor=P.+Bartelsauthor=M.+Sadeghiauthor=F.-Y.+Zhaoauthor=H.+Weiauthor=D.+Spanswickauthor=D.+J.+Adamsauthor=R.+S.+Nortonauthor=A.+J.+Robinson&title=Alkyne-Bridged+%CE%B1-Conotoxin+Vc1.1+Potently+Reverses+Mechanical+Allodynia+in+Neuropathic+Pain+Models&doi=10.1021%2Facs.jmedchem.0c02151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models</span></div><div class="casAuthors">Belgi, Alessia; Burnley, James V.; MacRaild, Christopher A.; Chhabra, Sandeep; Elnahriry, Khaled A.; Robinson, Samuel D.; Gooding, Simon G.; Tae, Han-Shen; Bartels, Peter; Sadeghi, Mahsa; Zhao, Fei-Yue; Wei, Haifeng; Spanswick, David; Adams, David J.; Norton, Raymond S.; Robinson, Andrea J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3222-3233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several Conus-derived venom peptides are promising lead compds. for the management of neuropathic pain, with α-conotoxins being of particular interest.  Modification of the interlocked disulfide framework of α-conotoxin Vc1.1 has been achieved using on-resin alkyne metathesis.  Although introduction of a metabolically stable alkyne motif significantly disrupts backbone topog., the structural modification generates a potent and selective GABAB receptor agonist that inhibits Cav2.2 channels and exhibits dose-dependent reversal of mech. allodynia in a behavioral rat model of neuropathic pain.  The findings herein support the hypothesis that analgesia can be achieved via activation of GABABRs expressed in dorsal root ganglion (DRG) sensory neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmOHPYOoE1bVg90H21EOLACvtfcHk0ljX_-nf8s55Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXmtlKks7c%253D&md5=d419fea64e0aefc9b66d8f7c85733da9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c02151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c02151%26sid%3Dliteratum%253Aachs%26aulast%3DBelgi%26aufirst%3DA.%26aulast%3DBurnley%26aufirst%3DJ.%2BV.%26aulast%3DMacRaild%26aufirst%3DC.%2BA.%26aulast%3DChhabra%26aufirst%3DS.%26aulast%3DElnahriry%26aufirst%3DK.%2BA.%26aulast%3DRobinson%26aufirst%3DS.%2BD.%26aulast%3DGooding%26aufirst%3DS.%2BG.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DBartels%26aufirst%3DP.%26aulast%3DSadeghi%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DF.-Y.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DSpanswick%26aufirst%3DD.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DNorton%26aufirst%3DR.%2BS.%26aulast%3DRobinson%26aufirst%3DA.%2BJ.%26atitle%3DAlkyne-Bridged%2520%25CE%25B1-Conotoxin%2520Vc1.1%2520Potently%2520Reverses%2520Mechanical%2520Allodynia%2520in%2520Neuropathic%2520Pain%2520Models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2021%26volume%3D64%26spage%3D3222%26epage%3D3233%26doi%3D10.1021%2Facs.jmedchem.0c02151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Disulfide Surrogate Peptides Incorporating Large-Span Surrogate Bridges Through a Native-Chemical-Ligation-Assisted Diaminodiacid Strategy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6037</span>– <span class="NLM_lpage">6045</span>, <span class="refDoi"> DOI: 10.1002/anie.201915358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fanie.201915358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvF2rtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=6037-6045&author=Q.+Quauthor=S.+Gaoauthor=F.+Wuauthor=M.+G.+Zhangauthor=Y.+Liauthor=L.+H.+Zhangauthor=D.+Biererauthor=C.+L.+Tianauthor=J.+S.+Zhengauthor=L.+Liu&title=Synthesis+of+Disulfide+Surrogate+Peptides+Incorporating+Large-Span+Surrogate+Bridges+Through+a+Native-Chemical-Ligation-Assisted+Diaminodiacid+Strategy&doi=10.1002%2Fanie.201915358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of disulfide surrogate peptides incorporating large-span surrogate bridges through a native-chemical-ligation-assisted diaminodiacid strategy</span></div><div class="casAuthors">Qu, Qian; Gao, Shuai; Wu, Fangming; Zhang, Meng-Ge; Li, Ying; Zhang, Long-Hua; Bierer, Donald; Tian, Chang-Lin; Zheng, Ji-Shen; Liu, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6037-6045</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The use of synthetic bridges as surrogates for disulfide bonds has emerged as a practical strategy to obviate the poor stability of some disulfide-contg. peptides.  However, peptides incorporating large-span synthetic bridges are still beyond the reach of existing methods.  Herein, we report a native chem. ligation (NCL)-assisted diaminodiacid (DADA) strategy that enables the robust generation of disulfide surrogate peptides incorporating surrogate bridges up to 50 amino acids in length.  This strategy provides access to some highly desirable but otherwise impossible-to-obtain disulfide surrogates of bioactive peptide.  The bioactivities and structures of the synthetic disulfide surrogates were verified by voltage clamp assays, NMR, and X-ray crystallog.; and stability studies established that the disulfide replacements effectively overcame the problems of disulfide redn. and scrambling that often plague these pharmacol. important peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSuugH6oosD7Vg90H21EOLACvtfcHk0lhfrk4vSIlwjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvF2rtr8%253D&md5=603982e70a802b7d5bd94d7fc72b8a1c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fanie.201915358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201915358%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DM.%2BG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%2BH.%26aulast%3DBierer%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DC.%2BL.%26aulast%3DZheng%26aufirst%3DJ.%2BS.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DSynthesis%2520of%2520Disulfide%2520Surrogate%2520Peptides%2520Incorporating%2520Large-Span%2520Surrogate%2520Bridges%2520Through%2520a%2520Native-Chemical-Ligation-Assisted%2520Diaminodiacid%2520Strategy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2020%26volume%3D59%26spage%3D6037%26epage%3D6045%26doi%3D10.1002%2Fanie.201915358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-M.</span></span> <span> </span><span class="NLM_article-title">Chemical Synthesis and Biological Activity of Peptides Incorporating an Ether Bridge as a Surrogate for a Disulfide Bond</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">7927</span>– <span class="NLM_lpage">7932</span>, <span class="refDoi"> DOI: 10.1039/d0sc02374d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1039%2FD0SC02374D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=34094161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlentb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=7927-7932&author=R.+Zhaoauthor=P.+Shiauthor=J.+Chenauthor=S.+Sunauthor=J.+Chenauthor=J.+Cuiauthor=F.+Wuauthor=G.+Fangauthor=C.+Tianauthor=J.+Shiauthor=D.+Biererauthor=L.+Liuauthor=Y.-M.+Li&title=Chemical+Synthesis+and+Biological+Activity+of+Peptides+Incorporating+an+Ether+Bridge+as+a+Surrogate+for+a+Disulfide+Bond&doi=10.1039%2Fd0sc02374d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical synthesis and biological activity of peptides incorporating an ether bridge as a surrogate for a disulfide bond</span></div><div class="casAuthors">Zhao, Rui; Shi, Pan; Chen, Junyou; Sun, Shuaishuai; Chen, Jingnan; Cui, Jibin; Wu, Fangming; Fang, Gemin; Tian, Changlin; Shi, Jing; Bierer, Donald; Liu, Lei; Li, Yi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7927-7932</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Disulfide bridges contribute to the definition and rigidity of polypeptides, but they are inherently unstable in reducing environments and in the presence of isomerases and nucleophiles.  Strategies to address these deficiencies, ideally without significantly perturbing the structure of the polypeptide, would be of great interest.  One possible surrogate for the disulfide bridge is a simple thioether, but these are susceptible to oxidn.  We report the introduction of an ether linkage into the biol. active, disulfide-rich peptides oxytocin, tachyplesin I, and conotoxin α-ImI, using an ether-contg. diaminodiacid as the key building block, obtained by the stereoselective ring-opening addn. reaction of an aziridine skeleton with a hydroxy group.  NMR studies indicated that the derivs. with an ether surrogate bridge exhibited very small change of their three-dimensional structures.  The analogs obtained using this novel substitution strategy were found to be more stable than the original peptide in oxidative and reductive conditions; without a loss of bioactivity.  This strategy is therefore proposed as a practical and versatile soln. to the stability problems assocd. with cysteine-rich peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeIaXSdaqNNLVg90H21EOLACvtfcHk0lhfrk4vSIlwjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlentb3K&md5=9115f34ffe09e44040649a566b28eec0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2FD0SC02374D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0SC02374D%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DTian%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DBierer%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DChemical%2520Synthesis%2520and%2520Biological%2520Activity%2520of%2520Peptides%2520Incorporating%2520an%2520Ether%2520Bridge%2520as%2520a%2520Surrogate%2520for%2520a%2520Disulfide%2520Bond%26jtitle%3DChem.%2520Sci.%26date%3D2020%26volume%3D11%26spage%3D7927%26epage%3D7932%26doi%3D10.1039%2Fd0sc02374d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dekan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">α-Conotoxin ImI Incorporating Stable Cystathionine Bridges Maintains Full Potency and Identical Three-Dimensional Structure</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">15866</span>– <span class="NLM_lpage">15869</span>, <span class="refDoi"> DOI: 10.1021/ja206408q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja206408q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOqu73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=15866-15869&author=Z.+Dekanauthor=I.+Vetterauthor=N.+L.+Dalyauthor=D.+J.+Craikauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=%CE%B1-Conotoxin+ImI+Incorporating+Stable+Cystathionine+Bridges+Maintains+Full+Potency+and+Identical+Three-Dimensional+Structure&doi=10.1021%2Fja206408q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin ImI incorporating stable cystathionine bridges maintains full potency and identical three-dimensional structure</span></div><div class="casAuthors">Dekan, Zoltan; Vetter, Irina; Daly, Norelle L.; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">15866-15869</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two disulfide bonds of α-conotoxin ImI, a peptide antagonist of the α7 nicotinic acetylcholine receptor (nAChR), were systematically replaced with isosteric redox-stable cystathionine thioethers.  Regioselective thioether formation was accomplished on solid support through substitution of a γ-chlorohomoalanine by an intramol. cysteine thiol to produce hybrid thioether/disulfide analogs (I) (X = CH2, S; Y = S, CH2) as well as a dual cystathionine analog I (X = Y = CH2) that were found to be structurally homologous to α-conotoxin ImI by 1H NMR.  The antagonistic activity at the α7 nAChR of cystathionine analog I (X = S, Y = CH2) (pIC50 = 6.41 ± 0.09) was identical to that of α-conotoxin ImI I (X = Y = S), (pIC50 = 6.41 ± 0.09), whereas those of I (X = CH2, Y = S), (pIC50 = 5.96 ± 0.09) and I (X = Y = CH2), (pIC50 = 5.89 ± 0.09) showed a modest decrease.  The effect of oxidn. of the thioethers to sulfoxides was also investigated, with significant changes in the biol. activities obsd. ranging from a > 30-fold redn. (2S=O) to a 3-fold increase (3S=OB) in potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCs0VVHBEL-bVg90H21EOLACvtfcHk0lhfrk4vSIlwjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOqu73O&md5=4005d271f1c027f04249b1dcb0a1a7d8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja206408q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206408q%26sid%3Dliteratum%253Aachs%26aulast%3DDekan%26aufirst%3DZ.%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3D%25CE%25B1-Conotoxin%2520ImI%2520Incorporating%2520Stable%2520Cystathionine%2520Bridges%2520Maintains%2520Full%2520Potency%2520and%2520Identical%2520Three-Dimensional%2520Structure%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D15866%26epage%3D15869%26doi%3D10.1021%2Fja206408q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevin, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choy, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armishaw, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noakes, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Solving the α-Conotoxin Folding Problem: Efficient Selenium-Directed On-Resin Generation of More Potent and Stable Nicotinic Acetylcholine Receptor Antagonists</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">3514</span>– <span class="NLM_lpage">3522</span>, <span class="refDoi"> DOI: 10.1021/ja910602h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja910602h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=3514-3522&author=M.+Muttenthalerauthor=S.+T.+Nevinauthor=A.+A.+Grishinauthor=S.+T.+Ngoauthor=P.+T.+Choyauthor=N.+L.+Dalyauthor=S.-H.+Huauthor=C.+J.+Armishawauthor=C.-I.+A.+Wangauthor=R.+J.+Lewisauthor=J.+L.+Martinauthor=P.+G.+Noakesauthor=D.+J.+Craikauthor=D.+J.+Adamsauthor=P.+F.+Alewood&title=Solving+the+%CE%B1-Conotoxin+Folding+Problem%3A+Efficient+Selenium-Directed+On-Resin+Generation+of+More+Potent+and+Stable+Nicotinic+Acetylcholine+Receptor+Antagonists&doi=10.1021%2Fja910602h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Solving the α-Conotoxin Folding Problem: Efficient Selenium-Directed On-Resin Generation of More Potent and Stable Nicotinic Acetylcholine Receptor Antagonists</span></div><div class="casAuthors">Muttenthaler, Markus; Nevin, Simon T.; Grishin, Anton A.; Ngo, Shyuan. T.; Choy, Peng T.; Daly, Norelle L.; Hu, Shu-Hong; Armishaw, Christopher J.; Wang, Ching-I. A.; Lewis, Richard J.; Martin, Jennifer L.; Noakes, Peter G.; Craik, David J.; Adams, David J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3514-3522</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxins are tightly folded miniproteins that antagonize nicotinic acetylcholine receptors (nAChR) with high specificity for diverse subtypes.  Here we report the use of selenocysteine in a supported phase method to direct native folding and produce α-conotoxins efficiently with improved biophys. properties.  By replacing complementary cysteine pairs with selenocysteine pairs on an amphiphilic resin, we were able to chem. direct all five structural subclasses of α-conotoxins exclusively into their native folds.  X-ray anal. at 1.4 Å resoln. of α-selenoconotoxin PnIA confirmed the isosteric character of the diselenide bond and the integrity of the α-conotoxin fold.  The α-selenoconotoxins exhibited similar or improved potency at rat diaphragm muscle and α3β4, α7, and α1β1δγ nAChRs expressed in Xenopus oocytes plus improved disulfide bond scrambling stability in plasma.  Together, these results underpin the development of more stable and potent nicotinic antagonists suitable for new drug therapies, and highlight the application of selenocysteine technol. more broadly to disulfide-bonded peptides and proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWotv-TI362bVg90H21EOLACvtfcHk0lg1XeqG7ito8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2gsb8%253D&md5=f085a8347a2b83293731ce9eb3752f5d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja910602h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja910602h%26sid%3Dliteratum%253Aachs%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DNevin%26aufirst%3DS.%2BT.%26aulast%3DGrishin%26aufirst%3DA.%2BA.%26aulast%3DNgo%26aufirst%3DS.%2BT.%26aulast%3DChoy%26aufirst%3DP.%2BT.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DHu%26aufirst%3DS.-H.%26aulast%3DArmishaw%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DC.-I.%2BA.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DJ.%2BL.%26aulast%3DNoakes%26aufirst%3DP.%2BG.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DSolving%2520the%2520%25CE%25B1-Conotoxin%2520Folding%2520Problem%253A%2520Efficient%2520Selenium-Directed%2520On-Resin%2520Generation%2520of%2520More%2520Potent%2520and%2520Stable%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D3514%26epage%3D3522%26doi%3D10.1021%2Fja910602h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalicky, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulaj, G.</span></span> <span> </span><span class="NLM_article-title">Integrated Oxidative Folding of Cysteine/Selenocysteine Containing Peptides: Improving Chemical Synthesis of Conotoxins</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2224</span>, <span class="refDoi"> DOI: 10.1002/anie.200806085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fanie.200806085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2221-2224&author=A.+Walewskaauthor=M.-M.+Zhangauthor=J.+J.+Skalickyauthor=D.+Yoshikamiauthor=B.+M.+Oliveraauthor=G.+Bulaj&title=Integrated+Oxidative+Folding+of+Cysteine%2FSelenocysteine+Containing+Peptides%3A+Improving+Chemical+Synthesis+of+Conotoxins&doi=10.1002%2Fanie.200806085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated oxidative folding of cysteine/selenocysteine containing peptides: improving chemical synthesis of conotoxins</span></div><div class="casAuthors">Walewska, Aleksandra; Zhang, Min-min; Skalicky, Jack J.; Yoshikami, Doju; Olivera, Baldomero M.; Bulaj, Grzegorz</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2221-2224</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The use of diselenide and selectively (15N/13C)-labeled disulfide bridges is combined to give improvements in oxidative folding and disulfide mapping.  Conotoxin analogs, each with a pair of selenocysteines and 15N/13C-labeled cysteines, exhibited significantly improved folding and the labeled cysteines allow correctly folded species to be rapidly identified by NMR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYyryjjZwfTLVg90H21EOLACvtfcHk0lg1XeqG7ito8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFemsbY%253D&md5=d32fdf537ed6e3aed6b8f980f94fb34a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.200806085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200806085%26sid%3Dliteratum%253Aachs%26aulast%3DWalewska%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.-M.%26aulast%3DSkalicky%26aufirst%3DJ.%2BJ.%26aulast%3DYoshikami%26aufirst%3DD.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DBulaj%26aufirst%3DG.%26atitle%3DIntegrated%2520Oxidative%2520Folding%2520of%2520Cysteine%252FSelenocysteine%2520Containing%2520Peptides%253A%2520Improving%2520Chemical%2520Synthesis%2520of%2520Conotoxins%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D2221%26epage%3D2224%26doi%3D10.1002%2Fanie.200806085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knuhtsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitmore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhinnie, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDougall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timperley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinnear, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, A. G.</span></span> <span> </span><span class="NLM_article-title">α-Conotoxin GI triazole-peptidomimetics: potent and stable blockers of a human acetylcholine receptor</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1671</span>– <span class="NLM_lpage">1676</span>, <span class="refDoi"> DOI: 10.1039/c8sc04198a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1039%2FC8SC04198A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit12ksL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1671-1676&author=A.+Knuhtsenauthor=C.+Whitmoreauthor=F.+S.+McWhinnieauthor=L.+McDougallauthor=R.+Whitingauthor=B.+O.+Smithauthor=C.+M.+Timperleyauthor=A.+C.+Greenauthor=K.+I.+Kinnearauthor=A.+G.+Jamieson&title=%CE%B1-Conotoxin+GI+triazole-peptidomimetics%3A+potent+and+stable+blockers+of+a+human+acetylcholine+receptor&doi=10.1039%2Fc8sc04198a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin GI triazole-peptidomimetics: Potent and stable blockers of a human acetylcholine receptor</span></div><div class="casAuthors">Knuhtsen, Astrid; Whitmore, Charlotte; McWhinnie, Fergus S.; McDougall, Laura; Whiting, Rachel; Smith, Brian O.; Timperley, Christopher M.; Green, A. Christopher; Kinnear, Kenneth I.; Jamieson, Andrew G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1671-1676</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The potency and selectivity of conotoxin peptides for neuropathic receptors has made them attractive lead compds. in the development of new therapeutics.  Specifically, α-conotoxin GI has been shown to be an unparalleled antagonist of the nicotinic acetylcholine receptor (nAChR).  However, as with other peptidic leads, poor protease resistance and the redox instability of the conotoxin scaffold limit bioactivity.  To counter this, we have employed the underutilized 1,5-disubstituted 1,2,3-triazole to act as a structural surrogate of the native disulfide bonds.  Using an efficient, on-resin ruthenium azide-alkyne cycloaddn. (RuAAC), each disulfide bond was replaced in turn and the biol. activities quantified.  One of the mimetic isomers exhibited a comparable activity to the native toxin, while the other showed no biol. effect.  The active mimetic isomer 11 was an order of magnitude more stable in plasma than the native GI.  The NMR soln. structure of the mimetic overlays extremely well with the structure for the native GI demonstrating that the triazole bridge is an exceptional surrogate for the disulfide bridge.  Development of this potent and stable mimetic of GI leads us to believe that this strategy will yield many other new conotoxin-inspired probes and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7IF9GIvxXrVg90H21EOLACvtfcHk0lhgSdNGmbcOKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit12ksL7N&md5=269352a2d12961ff69140f3c53b9fdb3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC8SC04198A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC04198A%26sid%3Dliteratum%253Aachs%26aulast%3DKnuhtsen%26aufirst%3DA.%26aulast%3DWhitmore%26aufirst%3DC.%26aulast%3DMcWhinnie%26aufirst%3DF.%2BS.%26aulast%3DMcDougall%26aufirst%3DL.%26aulast%3DWhiting%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DB.%2BO.%26aulast%3DTimperley%26aufirst%3DC.%2BM.%26aulast%3DGreen%26aufirst%3DA.%2BC.%26aulast%3DKinnear%26aufirst%3DK.%2BI.%26aulast%3DJamieson%26aufirst%3DA.%2BG.%26atitle%3D%25CE%25B1-Conotoxin%2520GI%2520triazole-peptidomimetics%253A%2520potent%2520and%2520stable%2520blockers%2520of%2520a%2520human%2520acetylcholine%2520receptor%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26spage%3D1671%26epage%3D1676%26doi%3D10.1039%2Fc8sc04198a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosengren, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhola, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longhi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, A.</span></span> <span> </span><span class="NLM_article-title">Stabilization of the Cysteine-rich Conotoxin MrIA by Using a 1,2,3-Triazole as a Disulfide Bond Mimetic</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1361</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.1002/anie.201409678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fanie.201409678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVChsrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1361-1364&author=A.+Goriauthor=C.-I.+A.+Wangauthor=P.+J.+Harveyauthor=K.+J.+Rosengrenauthor=R.+F.+Bholaauthor=M.+L.+Gelmiauthor=R.+Longhiauthor=M.+J.+Christieauthor=R.+J.+Lewisauthor=P.+F.+Alewoodauthor=A.+Brust&title=Stabilization+of+the+Cysteine-rich+Conotoxin+MrIA+by+Using+a+1%2C2%2C3-Triazole+as+a+Disulfide+Bond+Mimetic&doi=10.1002%2Fanie.201409678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of the cysteine-rich conotoxin MrIA by using a 1,2,3-triazole as a disulfide bond mimetic</span></div><div class="casAuthors">Gori, Alessandro; Wang, Ching-I. A.; Harvey, Peta J.; Rosengren, K. Johan; Bhola, Rebecca F.; Gelmi, Maria L.; Longhi, Renato; Christie, Macdonald J.; Lewis, Richard J.; Alewood, Paul F.; Brust, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1361-1364</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The design of disulfide bond mimetics is an important strategy for optimizing cysteine-rich peptides in drug development.  Mimetics of the drug lead conotoxin MrIA, in which one disulfide bond is selectively replaced of by a 1,4-disubstituted-1,2,3-triazole bridge, are described.  Sequential copper-catalyzed azide-alkyne cycloaddn. (CuAAC; click reaction) followed by disulfide formation resulted in the regioselective syntheses of triazole-disulfide hybrid MrIA analogs.  Mimetics with a triazole replacing the Cys4-Cys13 disulfide bond retained tertiary structure and full in vitro and in vivo activity as norepinephrine reuptake inhibitors.  Importantly, these mimetics are resistant to redn. in the presence of glutathione, thus resulting in improved plasma stability and increased suitability for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQHz-plupvKrVg90H21EOLACvtfcHk0lhgSdNGmbcOKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVChsrnE&md5=0eeb125a320ddf437ef60aa70b1194cc</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fanie.201409678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201409678%26sid%3Dliteratum%253Aachs%26aulast%3DGori%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DC.-I.%2BA.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRosengren%26aufirst%3DK.%2BJ.%26aulast%3DBhola%26aufirst%3DR.%2BF.%26aulast%3DGelmi%26aufirst%3DM.%2BL.%26aulast%3DLonghi%26aufirst%3DR.%26aulast%3DChristie%26aufirst%3DM.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26aulast%3DBrust%26aufirst%3DA.%26atitle%3DStabilization%2520of%2520the%2520Cysteine-rich%2520Conotoxin%2520MrIA%2520by%2520Using%2520a%25201%252C2%252C3-Triazole%2520as%2520a%2520Disulfide%2520Bond%2520Mimetic%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1361%26epage%3D1364%26doi%3D10.1002%2Fanie.201409678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span>; <span class="NLM_string-name">Christensen, S. B.</span>; <span class="NLM_string-name">Dowell, C.</span>; <span class="NLM_string-name">Hararah, F.</span>; <span class="NLM_string-name">Fisher, F.</span>; <span class="NLM_string-name">Huynh, P. N.</span>; <span class="NLM_string-name">Olivera, B. M.</span>; <span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts Through a Non-Opioid Based Mechanism</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>, in press <span class="refDoi"> DOI: 10.1021/acs.jmedchem.1c00512</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.1c00512" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=J.+Gajewiak&author=S.+B.+Christensen&author=C.+Dowell&author=F.+Hararah&author=F.+Fisher&author=P.+N.+Huynh&author=B.+M.+Olivera&author=J.+M.+McIntosh&title=Selective+Penicillamine+Substitution+Enables+Development+of+a+Potent+Analgesic+Peptide+that+Acts+Through+a+Non-Opioid+Based+Mechanism&doi=10.1021%2Facs.jmedchem.1c00512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.1c00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.1c00512%26sid%3Dliteratum%253Aachs%26aulast%3DGajewiak%26aufirst%3DJ.%26atitle%3DSelective%2520Penicillamine%2520Substitution%2520Enables%2520Development%2520of%2520a%2520Potent%2520Analgesic%2520Peptide%2520that%2520Acts%2520Through%2520a%2520Non-Opioid%2520Based%2520Mechanism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2021%26doi%3D10.1021%2Facs.jmedchem.1c00512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanathan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Peptides: Technological Advances Driving Peptides into Development</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2006.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.copbio.2006.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=17049837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=638-642&author=A.+K.+Satoauthor=M.+Viswanathanauthor=R.+B.+Kentauthor=C.+R.+Wood&title=Therapeutic+Peptides%3A+Technological+Advances+Driving+Peptides+into+Development&doi=10.1016%2Fj.copbio.2006.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic peptides: Technological advances driving peptides into development</span></div><div class="casAuthors">Sato, Aaron K.; Viswanathan, Malini; Kent, Rachel B.; Wood, Clive R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">638-642</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  As potential therapeutics, peptides offer several advantages over small mols. (increased specificity) and antibodies (small size).  Nevertheless, a no. of key issues have hampered their use as drug candidates.  A series of new technologies have recently been developed that allow peptides to be viable drug candidates in areas usually restricted to protein therapeutics, such as monoclonal antibodies.  These include the development of various types of peptide-conjugates that have lower rates of clearance and hence the potential to increase the exposure of peptide drug candidates in chronic diseases.  Structural addns. were also made to peptides, including the use of unnatural amino acids, main-chain modifications, and other novel substitutions, which have helped to improve peptide stability and further their therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiwe4yE4GqUbVg90H21EOLACvtfcHk0lgo29B2mGphog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zL&md5=c29eae8a5bbf2e0bb5fb3c67211be0d5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2006.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2006.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DA.%2BK.%26aulast%3DViswanathan%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DR.%2BB.%26aulast%3DWood%26aufirst%3DC.%2BR.%26atitle%3DTherapeutic%2520Peptides%253A%2520Technological%2520Advances%2520Driving%2520Peptides%2520into%2520Development%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2006%26volume%3D17%26spage%3D638%26epage%3D642%26doi%3D10.1016%2Fj.copbio.2006.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">Designing Macrocyclic Disulfide-rich Peptides for Biotechnological Applications</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1038/s41589-018-0039-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fs41589-018-0039-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=29662187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=417-427&author=C.+K.+Wangauthor=D.+J.+Craik&title=Designing+Macrocyclic+Disulfide-rich+Peptides+for+Biotechnological+Applications&doi=10.1038%2Fs41589-018-0039-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Designing macrocyclic disulfide-rich peptides for biotechnological applications</span></div><div class="casAuthors">Wang, Conan K.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">417-427</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Bioactive peptides have potential as drug leads, but turning them into drugs is a challenge because of their typically poor metabolic stability.  Mol. grafting is one approach to stabilizing and constraining peptides and involves melding a bioactive peptide sequence onto a suitable mol. scaffold.  This method has the benefit of improving the stability of the bioactive peptide lead and potentially expanding its functionality.  Here we step through the mol. grafting process and describe its successes and limitations.  So far, mol. grafting has been successfully used to improve the stability of peptide drug leads, to enhance conformational rigidity, to facilitate delivery to intracellular targets, and in some cases to increase efficacy in oral administration.  Although applications of mol. grafting have focused mainly on therapeutic applications, including those for pain, metabolic disease, and cancer, its potential uses are much broader, and we hope this Perspective will inspire wider applications of this mol. design tool in biotechnol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryR7gPEIiVjLVg90H21EOLACvtfcHk0lgo29B2mGphog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFGlsrg%253D&md5=fa4153afd28759780e69338cddfe1645</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs41589-018-0039-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-018-0039-y%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BK.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DDesigning%2520Macrocyclic%2520Disulfide-rich%2520Peptides%2520for%2520Biotechnological%2520Applications%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D417%26epage%3D427%26doi%3D10.1038%2Fs41589-018-0039-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armishaw, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balle, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, K. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sørensen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strømgaard, K.</span></span> <span> </span><span class="NLM_article-title">Improving the Stability of α-Conotoxin AuIB Through N-to-C Cyclization: The Effect of Linker Length on Stability and Activity at Nicotinic Acetylcholine Receptors</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1089%2Fars.2010.3458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=20649464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyntbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=65-76&author=C.+J.+Armishawauthor=A.+A.+Jensenauthor=L.+D.+Balleauthor=K.+C.+M.+Scottauthor=L.+S%C3%B8rensenauthor=K.+Str%C3%B8mgaard&title=Improving+the+Stability+of+%CE%B1-Conotoxin+AuIB+Through+N-to-C+Cyclization%3A+The+Effect+of+Linker+Length+on+Stability+and+Activity+at+Nicotinic+Acetylcholine+Receptors&doi=10.1089%2Fars.2010.3458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Stability of α-Conotoxin AuIB Through N-to-C Cyclization: The Effect of Linker Length on Stability and Activity at Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Armishaw, Christopher J.; Jensen, Anders A.; Balle, Lena D.; Scott, Krystle C. M.; Sorensen, Lena; Stromgaard, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-76</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Modification of α-conotoxin frameworks through cyclization via an oligopeptide linker has previously been shown as an effective strategy for improving in vivo stability.  We have extended this strategy by investigating cyclic analogs of α-conotoxin AuIB, a selective α3β4 nicotinic acetylcholine receptor (nAChR) antagonist, to examine a range of oligopeptide linker lengths on the oxidative formation of disulfide bonds, activity at nAChRs, and stability to degrdn. by chymotrypsin.  Upon nondirected random oxidn., the ribbon isomer formed preferentially with the globular isomer occurring as a minor byproduct.  Therefore, a regioselective disulfide bond forming strategy was used to prep. the cAuIB-2 globular isomer in high yield and purity.  The cAuIB-2 globular isomer exhibited a threefold decrease in activity for the α3β4 nAChR compared to wild-type-AuIB, although it was selective for α3β4 over α7 and α4β2 subtypes.  On the other hand, the cAuIB-2 ribbon isomer was shown to be inactive at all three nAChR subtypes.  Nonetheless, all of the cyclic analogs were found to be significantly more stable to degrdn. by chymotrypsin than wild-type AuIB.  As such, the cAuIB-2 globular isomer could constitute a useful probe for studying the role of the α3β4 nAChR in a range of in vivo exptl. paradigms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbKHviNVhe7LVg90H21EOLACvtfcHk0lhRTwNEgRfFEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyntbnJ&md5=49c64b25c25d5bed5f73852b82d41537</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3458%26sid%3Dliteratum%253Aachs%26aulast%3DArmishaw%26aufirst%3DC.%2BJ.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBalle%26aufirst%3DL.%2BD.%26aulast%3DScott%26aufirst%3DK.%2BC.%2BM.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DL.%26aulast%3DStr%25C3%25B8mgaard%26aufirst%3DK.%26atitle%3DImproving%2520the%2520Stability%2520of%2520%25CE%25B1-Conotoxin%2520AuIB%2520Through%2520N-to-C%2520Cyclization%253A%2520The%2520Effect%2520of%2520Linker%2520Length%2520on%2520Stability%2520and%2520Activity%2520at%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2011%26volume%3D14%26spage%3D65%26epage%3D76%26doi%3D10.1089%2Fars.2010.3458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giribaldi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haufe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, E. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucherre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moha Ou Maati, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjalbal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molgó, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span> <span> </span><span class="NLM_article-title">Backbone Cyclization Turns a Venom Peptide into a Stable and Equipotent Ligand at Both Muscle and Neuronal Nicotinic Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">12682</span>– <span class="NLM_lpage">12692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00957</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00957" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVOjs7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=12682-12692&author=J.+Giribaldiauthor=Y.+Haufeauthor=E.+R.+J.+Evansauthor=M.+Amarauthor=A.+Durnerauthor=C.+Schmidtauthor=A.+Faucherreauthor=H.+Moha+Ou+Maatiauthor=C.+Enjalbalauthor=J.+Molg%C3%B3author=D.+Serventauthor=D.+T.+Wilsonauthor=N.+L.+Dalyauthor=A.+Nickeauthor=S.+Dutertre&title=Backbone+Cyclization+Turns+a+Venom+Peptide+into+a+Stable+and+Equipotent+Ligand+at+Both+Muscle+and+Neuronal+Nicotinic+Receptors&doi=10.1021%2Facs.jmedchem.0c00957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Backbone Cyclization Turns a Venom Peptide into a Stable and Equipotent Ligand at Both Muscle and Neuronal Nicotinic Receptors</span></div><div class="casAuthors">Giribaldi, Julien; Haufe, Yves; Evans, Edward R. J.; Amar, Muriel; Durner, Anna; Schmidt, Casey; Faucherre, Adele; Moha Ou Maati, Hamid; Enjalbal, Christine; Molgo, Jordi; Servent, Denis; Wilson, David T.; Daly, Norelle L.; Nicke, Annette; Dutertre, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12682-12692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Venom peptides are promising drug leads, but their therapeutic use is often limited by stability and bioavailability issues.  In this study, we designed cyclic analogs of α-conotoxin CIA, a potent muscle nicotinic acetylcholine receptor (nAChR) blocker with a significantly lower affinity at the neuronal α3β2 subtype.  Remarkably, all analogs retained the low nanomolar activity of native CIA toward muscle-type nAChRs but showed greatly improved resistance to degrdn. in human serum and, surprisingly, displayed up to 52-fold higher potency for the α3β2 neuronal nAChR subtype (IC50 1.3 nM).  Comparison of NMR-derived structures revealed some differences that might explain the gain of potency at α3β2 nAChRs.  All peptides were highly paralytic when injected into adult zebrafish and bath-applied to zebrafish larvae, suggesting barrier-crossing capabilities and efficient uptake.  Finally, these cyclic CIA analogs were shown to be unique pharmacol. tools to investigate the contribution of the presynaptic α3β2 nAChR subtype to the train-of-four fade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8pf_cJ_5OrVg90H21EOLACvtfcHk0lhRTwNEgRfFEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVOjs7jJ&md5=118316f3605c5e76281d71f11b9ee002</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00957%26sid%3Dliteratum%253Aachs%26aulast%3DGiribaldi%26aufirst%3DJ.%26aulast%3DHaufe%26aufirst%3DY.%26aulast%3DEvans%26aufirst%3DE.%2BR.%2BJ.%26aulast%3DAmar%26aufirst%3DM.%26aulast%3DDurner%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DC.%26aulast%3DFaucherre%26aufirst%3DA.%26aulast%3DMoha%2BOu%2BMaati%26aufirst%3DH.%26aulast%3DEnjalbal%26aufirst%3DC.%26aulast%3DMolg%25C3%25B3%26aufirst%3DJ.%26aulast%3DServent%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DD.%2BT.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DNicke%26aufirst%3DA.%26aulast%3DDutertre%26aufirst%3DS.%26atitle%3DBackbone%2520Cyclization%2520Turns%2520a%2520Venom%2520Peptide%2520into%2520a%2520Stable%2520and%2520Equipotent%2520Ligand%2520at%2520Both%2520Muscle%2520and%2520Neuronal%2520Nicotinic%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D12682%26epage%3D12692%26doi%3D10.1021%2Facs.jmedchem.0c00957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempster, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosengren, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevin, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the -conotoxin MII</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">13767</span>– <span class="NLM_lpage">13772</span>, <span class="refDoi"> DOI: 10.1073/pnas.0504613102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1073%2Fpnas.0504613102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=16162671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13767-13772&author=R.+J.+Clarkauthor=H.+Fischerauthor=L.+Dempsterauthor=N.+L.+Dalyauthor=K.+J.+Rosengrenauthor=S.+T.+Nevinauthor=F.+A.+Meunierauthor=D.+J.+Adamsauthor=D.+J.+Craik&title=Engineering+stable+peptide+toxins+by+means+of+backbone+cyclization%3A+Stabilization+of+the+-conotoxin+MII&doi=10.1073%2Fpnas.0504613102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the α-conotoxin MII</span></div><div class="casAuthors">Clark, Richard J.; Fischer, Harald; Dempster, Louise; Daly, Norelle L.; Rosengren, K. Johan; Nevin, Simon T.; Meunier, Frederic A.; Adams, David J.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13767-13772</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Conotoxins (CTXs), with their exquisite specificity and potency, have recently created much excitement as drug leads.  However, like most peptides, their beneficial activities may potentially be undermined by susceptibility to proteolysis in vivo.  By cyclizing the α-CTX MII by using a range of linkers, we have engineered peptides that preserve their full activity but have greatly improved resistance to proteolytic degrdn.  The cyclic MII analog contg. a seven-residue linker joining the N and C termini was as active and selective as the native peptide for native and recombinant neuronal nicotinic acetylcholine receptor subtypes present in bovine chromaffin cells and expressed in Xenopus oocytes, resp.  Furthermore, its resistance to proteolysis against a specific protease and in human plasma was significantly improved.  More generally, to our knowledge, this report is the first on the cyclization of disulfide-rich toxins.  Cyclization strategies represent an approach for stabilizing bioactive peptides while keeping their full potencies and should boost applications of peptide-based drugs in human medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp68B2NbOQcFLVg90H21EOLACvtfcHk0lhRTwNEgRfFEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqsb3K&md5=0eba4880941c8c0132856e54cd8c42f7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504613102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504613102%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DDempster%26aufirst%3DL.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DRosengren%26aufirst%3DK.%2BJ.%26aulast%3DNevin%26aufirst%3DS.%2BT.%26aulast%3DMeunier%26aufirst%3DF.%2BA.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DEngineering%2520stable%2520peptide%2520toxins%2520by%2520means%2520of%2520backbone%2520cyclization%253A%2520Stabilization%2520of%2520the%2520-conotoxin%2520MII%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D13767%26epage%3D13772%26doi%3D10.1073%2Fpnas.0504613102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">Effects of Cyclization on Stability, Structure, and Activity of α-Conotoxin RgIA at the α9α10 Nicotinic Acetylcholine Receptor and GABABReceptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6984</span>– <span class="NLM_lpage">6992</span>, <span class="refDoi"> DOI: 10.1021/jm201060r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201060r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOqu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6984-6992&author=R.+Halaiauthor=B.+Callaghanauthor=N.+L.+Dalyauthor=R.+J.+Clarkauthor=D.+J.+Adamsauthor=D.+J.+Craik&title=Effects+of+Cyclization+on+Stability%2C+Structure%2C+and+Activity+of+%CE%B1-Conotoxin+RgIA+at+the+%CE%B19%CE%B110+Nicotinic+Acetylcholine+Receptor+and+GABABReceptor&doi=10.1021%2Fjm201060r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Cyclization on Stability, Structure, and Activity of α-Conotoxin RgIA at the α9α10 Nicotinic Acetylcholine Receptor and GABAB Receptor</span></div><div class="casAuthors">Halai, Reena; Callaghan, Brid; Daly, Norelle L.; Clark, Richard J.; Adams, David J.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6984-6992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxin RgIA is of interest as a lead in the development of drugs for neuropathic pain.  It modulates the α9α10 nicotinic acetylcholine receptor (nAChR) and the GABAB receptor, both of which are implicated in antinociception.  However, because of its peptidic nature, RgIA is potentially susceptible to generic problems encountered by peptide-based drugs of poor oral bioavailability, short biol. half-life, and low stability.  Here, we improved the biopharmaceutical properties of RgIA by backbone cyclization using 3-7 residue peptidic linkers.  Cyclization with a six-residue linker does not perturb the overall structure of RgIA, improves selectivity for the GABAB receptor over the α9α10 nAChR, and improves stability in human serum.  The results provide insights to further improve the therapeutic properties of RgIA and other conotoxins being considered as drug leads and confirm that cyclization is a readily applicable strategy to improve the stability of peptides with proximate N- and C-termini.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAcHnWBqQbFbVg90H21EOLACvtfcHk0lgAe5gTRKbCFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOqu73P&md5=3512eadb771719a549c0350601897049</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm201060r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201060r%26sid%3Dliteratum%253Aachs%26aulast%3DHalai%26aufirst%3DR.%26aulast%3DCallaghan%26aufirst%3DB.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DEffects%2520of%2520Cyclization%2520on%2520Stability%252C%2520Structure%252C%2520and%2520Activity%2520of%2520%25CE%25B1-Conotoxin%2520RgIA%2520at%2520the%2520%25CE%25B19%25CE%25B110%2520Nicotinic%2520Acetylcholine%2520Receptor%2520and%2520GABABReceptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6984%26epage%3D6992%26doi%3D10.1021%2Fjm201060r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carstens, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brierley, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by α-Conotoxin Vc1.1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1577</span>– <span class="NLM_lpage">1587</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00190</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00190" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1Ggu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1577-1587&author=M.+Sadeghiauthor=B.+B.+Carstensauthor=B.+P.+Callaghanauthor=J.+T.+Danielauthor=H.-S.+Taeauthor=T.+O%E2%80%99Donnellauthor=J.+Castroauthor=S.+M.+Brierleyauthor=D.+J.+Adamsauthor=D.+J.+Craikauthor=R.+J.+Clark&title=Structure-Activity+Studies+Reveal+the+Molecular+Basis+for+GABAB-Receptor+Mediated+Inhibition+of+High+Voltage-Activated+Calcium+Channels+by+%CE%B1-Conotoxin+Vc1.1&doi=10.1021%2Facschembio.8b00190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by α-Conotoxin Vc1.1</span></div><div class="casAuthors">Sadeghi, Mahsa; Carstens, Bodil B.; Callaghan, Brid P.; Daniel, James T.; Tae, Han-Shen; O'Donnell, Tracey; Castro, Joel; Brierley, Stuart M.; Adams, David J.; Craik, David J.; Clark, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1577-1587</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxins are disulfide-bonded peptides from cone snail venoms and are characterized by their affinity for nicotinic acetylcholine receptors (nAChR).  Several α-conotoxins with distinct selectivity for nAChR subtypes have been identified as potent analgesics in animal models of chronic pain.  However, a no. of α-conotoxins have been shown to inhibit N-type calcium channel currents in rodent dissocd. dorsal root ganglion (DRG) neurons via activation of G protein-coupled GABAB receptors (GABABR).  Therefore, it is unclear whether activation of GABABR or inhibition of α9α10 nAChRs is the analgesic mechanism.  To investigate the mechanisms by which α-conotoxins provide analgesia, we synthesized a suite of Vc1.1 analogs where all residues, except the conserved cysteines, in Vc1.1 were individually replaced by alanine (A), lysine (K), and aspartic acid (D).  Our results show that the amino acids in the first loop play an important role in binding of the peptide to the receptor, whereas those in the second loop play an important role for the selectivity of the peptide for the GABABR over α9α10 nAChRs.  We designed a cVc1.1 analog that is >8000-fold selective for GABABR-mediated inhibition of high voltage-activated (HVA) calcium channels over α9α10 nAChRs and show that it is analgesic in a mouse model of chronic visceral hypersensitivity (CVH).  CVc1.1[D11A,E14A] caused dose-dependent inhibition of colonic nociceptors with greater efficacy in ex vivo CVH colonic nociceptors relative to healthy colonic nociceptors.  These findings suggest that selectively targeting GABABR-mediated HVA calcium channel inhibition by α-conotoxins could be effective for the treatment of chronic visceral pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrud0O9nAa327Vg90H21EOLACvtfcHk0lgAe5gTRKbCFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1Ggu7g%253D&md5=467204089f9301a9ea0fdd16ff19fe85</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00190%26sid%3Dliteratum%253Aachs%26aulast%3DSadeghi%26aufirst%3DM.%26aulast%3DCarstens%26aufirst%3DB.%2BB.%26aulast%3DCallaghan%26aufirst%3DB.%2BP.%26aulast%3DDaniel%26aufirst%3DJ.%2BT.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DT.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DBrierley%26aufirst%3DS.%2BM.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DClark%26aufirst%3DR.%2BJ.%26atitle%3DStructure-Activity%2520Studies%2520Reveal%2520the%2520Molecular%2520Basis%2520for%2520GABAB-Receptor%2520Mediated%2520Inhibition%2520of%2520High%2520Voltage-Activated%2520Calcium%2520Channels%2520by%2520%25CE%25B1-Conotoxin%2520Vc1.1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D1577%26epage%3D1587%26doi%3D10.1021%2Facschembio.8b00190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevin, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6545</span>– <span class="NLM_lpage">6548</span>, <span class="refDoi"> DOI: 10.1002/anie.201000620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fanie.201000620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6545-6548&author=R.+J.+Clarkauthor=J.+Jensenauthor=S.+T.+Nevinauthor=B.+P.+Callaghanauthor=D.+J.+Adamsauthor=D.+J.+Craik&title=The+Engineering+of+an+Orally+Active+Conotoxin+for+the+Treatment+of+Neuropathic+Pain&doi=10.1002%2Fanie.201000620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain</span></div><div class="casAuthors">Clark, Richard J.; Jensen, Jonas; Nevin, Simon T.; Callaghan, Brid P.; Adams, David J.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">6545-6548, S6545/1-S6545/33</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors prepd. a cyclized α-conotoxin Vc1.1 from the cone snail Conus victoriae and demonstrated its oral activity.  Vc1.1 is an effective analgesic in several rat models of neuropathic pain and therefore has attracted considerable interest as a potential treatment for this condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxI6y6jJXrCbVg90H21EOLACvtfcHk0lgAe5gTRKbCFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamur3N&md5=da52aa3e3d1747f2910d0105aa05f3ab</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fanie.201000620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201000620%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DJensen%26aufirst%3DJ.%26aulast%3DNevin%26aufirst%3DS.%2BT.%26aulast%3DCallaghan%26aufirst%3DB.%2BP.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Engineering%2520of%2520an%2520Orally%2520Active%2520Conotoxin%2520for%2520the%2520Treatment%2520of%2520Neuropathic%2520Pain%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6545%26epage%3D6548%26doi%3D10.1002%2Fanie.201000620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kourra, C. M. B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, N.</span></span> <span> </span><span class="NLM_article-title">Converting Disulfide Bridges in Native Peptides to Stable Methylene Thioacetals</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">7007</span>– <span class="NLM_lpage">7012</span>, <span class="refDoi"> DOI: 10.1039/c6sc02285e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1039%2FC6SC02285E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28451136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Crt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=7007-7012&author=C.+M.+B.+K.+Kourraauthor=N.+Cramer&title=Converting+Disulfide+Bridges+in+Native+Peptides+to+Stable+Methylene+Thioacetals&doi=10.1039%2Fc6sc02285e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Converting disulfide bridges in native peptides to stable methylene thioacetals</span></div><div class="casAuthors">Kourra, C. M. B. K.; Cramer, N.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7007-7012</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Disulfide bridges play a crucial role in defining and rigidifying the three-dimensional structure of peptides.  However, disulfides are inherently unstable in reducing environments.  Consequently, the development of strategies aiming to circumvent these deficiencies - ideally with little structural disturbance - are highly sought after.  Herein, we report a simple protocol converting the disulfide bond of peptides into highly stable methylene thioacetal.  The transformation occurs under mild, biocompatible conditions, enabling the conversion of unprotected native peptides into analogs with enhanced stability.  The developed protocol is applicable to a range of peptides and selective in the presence of a multitude of potentially reactive functional groups.  The thioacetal modification annihilates the reductive lability and increases the serum, pH and temp. stability of the important peptide hormone oxytocin.  Moreover, it is shown that the biol. activities for oxytocin are retained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNUJLTzqWREbVg90H21EOLACvtfcHk0lj13V5wlxue6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Crt7bO&md5=a91a7082858d171b9f5c3e07e30f7c61</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2FC6SC02285E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02285E%26sid%3Dliteratum%253Aachs%26aulast%3DKourra%26aufirst%3DC.%2BM.%2BB.%2BK.%26aulast%3DCramer%26aufirst%3DN.%26atitle%3DConverting%2520Disulfide%2520Bridges%2520in%2520Native%2520Peptides%2520to%2520Stable%2520Methylene%2520Thioacetals%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D7007%26epage%3D7012%26doi%3D10.1039%2Fc6sc02285e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metanis, N.</span></span> <span> </span><span class="NLM_article-title">BPTI Folding Revisited: Switching a Disulfide into Methylene Thioacetal Reveals a Previously Hidden Path</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4814</span>– <span class="NLM_lpage">4820</span>, <span class="refDoi"> DOI: 10.1039/c8sc01110a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1039%2FC8SC01110A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=29910933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Ont7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4814-4820&author=R.+Mousaauthor=S.+Lanskyauthor=G.+Shohamauthor=N.+Metanis&title=BPTI+Folding+Revisited%3A+Switching+a+Disulfide+into+Methylene+Thioacetal+Reveals+a+Previously+Hidden+Path&doi=10.1039%2Fc8sc01110a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">BPTI folding revisited: switching a disulfide into methylene thioacetal reveals a previously hidden path</span></div><div class="casAuthors">Mousa, Reem; Lansky, Shifra; Shoham, Gil; Metanis, Norman</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4814-4820</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Bovine pancreatic trypsin inhibitor (BPTI) is a 58-residue protein that is stabilized by three disulfide bonds at positions 5-55, 14-38 and 30-51.  Widely studied for about 50 years, BPTI represents a folding model for many disulfide-rich proteins.  In the study described below, we replaced the solvent exposed 14-38 disulfide bond with a methylene thioacetal bridge in an attempt to arrest the folding pathway of the protein at its two well-known intermediates, N' and N*.  The modified protein was expected to be unable to undergo the rate-detg. step in the widely accepted BPTI folding mechanism: the opening of the 14-38 disulfide bond followed by rearrangements that leads to the native state, N.  Surprisingly, instead of halting BPTI folding at N' and N*, we uncovered a hidden pathway involving a direct reaction between the N* intermediate and the oxidizing reagent glutathione (GSSG) to form the disulfide-mixed intermediate N*-SG, which spontaneously folds into N.  On the other hand, N' was unable to fold into N.  In addn., we found that the methylene thioacetal bridge enhances BPTI stability while fully maintaining its structure and biol. function.  These findings suggest a general strategy for enhancing protein stability without compromising on function or structure, suggesting potential applications for future therapeutic protein prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoukKNyBbIZ-7Vg90H21EOLACvtfcHk0lj13V5wlxue6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Ont7s%253D&md5=f10b27b9f55106b425c5b3e8e1b2d978</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC8SC01110A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC01110A%26sid%3Dliteratum%253Aachs%26aulast%3DMousa%26aufirst%3DR.%26aulast%3DLansky%26aufirst%3DS.%26aulast%3DShoham%26aufirst%3DG.%26aulast%3DMetanis%26aufirst%3DN.%26atitle%3DBPTI%2520Folding%2520Revisited%253A%2520Switching%2520a%2520Disulfide%2520into%2520Methylene%2520Thioacetal%2520Reveals%2520a%2520Previously%2520Hidden%2520Path%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D4814%26epage%3D4820%26doi%3D10.1039%2Fc8sc01110a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schönauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Els-Heindl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koebberling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Adrenomedullin Disulfide Bond Mimetics Uncover Structural Requirements for AM1 Receptor Activation</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>, <span class="NLM_elocation-id">e3147</span> <span class="refDoi"> DOI: 10.1002/psc.3147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fpsc.3147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=30680847" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&author=J.-P.+Fischerauthor=R.+Sch%C3%B6nauerauthor=S.+Els-Heindlauthor=D.+Biererauthor=J.+Koebberlingauthor=B.+Riedlauthor=A.+G.+Beck-Sickinger&title=Adrenomedullin+Disulfide+Bond+Mimetics+Uncover+Structural+Requirements+for+AM1+Receptor+Activation&doi=10.1002%2Fpsc.3147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fpsc.3147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.3147%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DJ.-P.%26aulast%3DSch%25C3%25B6nauer%26aufirst%3DR.%26aulast%3DEls-Heindl%26aufirst%3DS.%26aulast%3DBierer%26aufirst%3DD.%26aulast%3DKoebberling%26aufirst%3DJ.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DAdrenomedullin%2520Disulfide%2520Bond%2520Mimetics%2520Uncover%2520Structural%2520Requirements%2520for%2520AM1%2520Receptor%2520Activation%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2019%26volume%3D25%26doi%3D10.1002%2Fpsc.3147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VandenBerg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D. H.-C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Characterization of an A6-A11 Methylene Thioacetal Human Insulin Analogue with Enhanced Stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11437</span>– <span class="NLM_lpage">11443</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlWktrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11437-11443&author=N.+Zhengauthor=P.+Karraauthor=M.+A.+VandenBergauthor=J.+H.+Kimauthor=M.+J.+Webberauthor=W.+L.+Hollandauthor=D.+H.-C.+Chou&title=Synthesis+and+Characterization+of+an+A6-A11+Methylene+Thioacetal+Human+Insulin+Analogue+with+Enhanced+Stability&doi=10.1021%2Facs.jmedchem.9b01589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of an A6-A11 Methylene Thioacetal Human Insulin Analogue with Enhanced Stability</span></div><div class="casAuthors">Zheng, Nan; Karra, Prasoona; VandenBerg, Michael A.; Kim, Jin Hwan; Webber, Matthew J.; Holland, William L.; Chou, Danny Hung-Chieh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11437-11443</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Insulin has been a life-saving drug for millions of people with diabetes.  However, several challenges exist which limit therapeutic benefits and reduce patient convenience.  One key challenge is the fibrillation propensity, which necessitates refrigeration for storage.  To address this limitation, we chem. synthesized and evaluated a methylene thioacetal human insulin analog (SCS-Ins).  The synthesized SCS-Ins showed enhanced serum stability and aggregation resistance while retaining bioactivity compared with native insulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4aVEmx5w-irVg90H21EOLACvtfcHk0lhtBgsvamqZZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlWktrvF&md5=02eef5155c8b68531ea321813fee36fc</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01589%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DKarra%26aufirst%3DP.%26aulast%3DVandenBerg%26aufirst%3DM.%2BA.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DWebber%26aufirst%3DM.%2BJ.%26aulast%3DHolland%26aufirst%3DW.%2BL.%26aulast%3DChou%26aufirst%3DD.%2BH.-C.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520an%2520A6-A11%2520Methylene%2520Thioacetal%2520Human%2520Insulin%2520Analogue%2520with%2520Enhanced%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11437%26epage%3D11443%26doi%3D10.1021%2Facs.jmedchem.9b01589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haythornthwaite, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berecki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span> <span> </span><span class="NLM_article-title">Analgesic -Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">10943</span>– <span class="NLM_lpage">10951</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3594-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1523%2FJNEUROSCI.3594-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=18945902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWnsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=10943-10951&author=B.+Callaghanauthor=A.+Haythornthwaiteauthor=G.+Bereckiauthor=R.+J.+Clarkauthor=D.+J.+Craikauthor=D.+J.+Adams&title=Analgesic+-Conotoxins+Vc1.1+and+Rg1A+Inhibit+N-Type+Calcium+Channels+in+Rat+Sensory+Neurons+via+GABAB+Receptor+Activation&doi=10.1523%2Fjneurosci.3594-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic α-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation</span></div><div class="casAuthors">Callaghan, Brid; Haythornthwaite, Alison; Berecki, Geza; Clark, Richard J.; Craik, David J.; Adams, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10943-10951</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">α-Conotoxins Vc1.1 and Rg1A are peptides from the venom of marine Conus snails that are currently in development as a treatment for neuropathic pain.  Here we report that the α9α10 nicotinic acetylcholine receptor-selective conotoxins Vc1.1 and Rg1A potently and selectively inhibit high-voltage-activated (HVA) calcium channel currents in dissocd. DRG neurons in a concn.-dependent manner.  The post-translationally modified peptides vc1a and [P6O]Vc1.1 were inactive, as were all other α-conotoxins tested.  Vc1.1 inhibited the ω-conotoxin-sensitive HVA currents in DRG neurons but not those recorded from Xenopus oocytes expressing Cav2.2, Cav2.1, Cav2.3, or Cav1.2 channels.  Inhibition of HVA currents by Vc1.1 was not reversed by depolarizing prepulses but was abolished by pertussis toxin (PTX), intracellular GDPβS, or a selective inhibitor of pp60c-src tyrosine kinase.  These data indicate that Vc1.1 does not interact with N-type calcium channels directly but inhibits them via a voltage-independent mechanism involving a PTX-sensitive, G-protein-coupled receptor.  Preincubation with a variety of selective receptor antagonists demonstrated that only the GABAB receptor antagonists, [S-(R*,R*)][-3-[[1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxy propyl]([3,4]-cyclohexylmethyl) phosphinic acid hydrochloride (2S)-3[[(1S)-1-(3,4-dichlorophenyl)-ethyl]amino-2-hydroxypropyl] (phenylmethyl) phosphinic acid and phaclofen, blocked the effect of Vc1.1 and Rg1A on Ca2+ channel currents.  Together, the results identify Cav2.2 as a target of Vc1.1 and Rg1A, potentially mediating their analgesic actions.  We propose a novel mechanism by which α-conotoxins Vc1.1 and Rg1A modulate native N-type (Cav2.2) Ca2+ channel currents, namely acting as agonists via G-protein-coupled GABAB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIKcaVA5_WirVg90H21EOLACvtfcHk0liW5Yu4kY_Vcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWnsLzE&md5=4ddeed6a3d2184cc682580564639890c</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3594-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3594-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DCallaghan%26aufirst%3DB.%26aulast%3DHaythornthwaite%26aufirst%3DA.%26aulast%3DBerecki%26aufirst%3DG.%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26atitle%3DAnalgesic%2520-Conotoxins%2520Vc1.1%2520and%2520Rg1A%2520Inhibit%2520N-Type%2520Calcium%2520Channels%2520in%2520Rat%2520Sensory%2520Neurons%2520via%2520GABAB%2520Receptor%2520Activation%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D10943%26epage%3D10951%26doi%3D10.1523%2Fjneurosci.3594-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Faoite, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berecki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span> <span> </span><span class="NLM_article-title">γ-Aminobutyric Acid Type B (GABAB) Receptor Expression Is Needed for Inhibition of N-type (Cav2.2) Calcium Channels by Analgesic α-Conotoxins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">23948</span>– <span class="NLM_lpage">23957</span>, <span class="refDoi"> DOI: 10.1074/jbc.m112.342998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1074%2Fjbc.M112.342998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=22613715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVeju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=23948-23957&author=H.+Cunyauthor=A.+de+Faoiteauthor=T.+G.+Huynhauthor=T.+Yasudaauthor=G.+Bereckiauthor=D.+J.+Adams&title=%CE%B3-Aminobutyric+Acid+Type+B+%28GABAB%29+Receptor+Expression+Is+Needed+for+Inhibition+of+N-type+%28Cav2.2%29+Calcium+Channels+by+Analgesic+%CE%B1-Conotoxins&doi=10.1074%2Fjbc.m112.342998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Aminobutyric Acid Type B (GABAB) Receptor Expression Is Needed for Inhibition of N-type (Cav2.2) Calcium Channels by Analgesic α-Conotoxins</span></div><div class="casAuthors">Cuny, Hartmut; de Faoite, Andrew; Huynh, Thuan G.; Yasuda, Takahiro; Berecki, Geza; Adams, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">23948-23957</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">α-Conotoxins Vc1.1 and RgIA are small peptides isolated from the venom of marine cone snails.  They have effective anti-nociceptive actions in rat models of neuropathic pain.  Pharmacol. studies in rodent dorsal root ganglion (DRG) show their analgesic effect is mediated by inhibition of N-type (Cav2.2) calcium channels via a pathway involving γ-aminobutyric acid type B (GABAB) receptor.  However, there is no direct demonstration that functional GABAB receptors are needed for inhibition of the Cav2.2 channel by analgesic α-conotoxins.  This study examd. the effect of the GABAB agonist baclofen and α-conotoxins Vc1.1 and RgIA on calcium channel currents after transient knockdown of the GABAB receptor using RNA interference.  Isolated rat DRG neurons were transfected with small interfering RNAs (siRNA) targeting GABAB subunits R1 and R2.  Efficient knockdown of GABAB receptor expression at mRNA and protein levels was confirmed by quant. real time PCR (qRT-PCR) and immunocytochem. anal., resp.  Whole-cell patch clamp recordings conducted 2-4 days after transfection showed that inhibition of N-type calcium channels in response to baclofen, Vc1.1 and RgIA was significantly reduced in GABAB receptor knockdown DRG neurons.  In contrast, neurons transfected with a scrambled nontargeting siRNA were indistinguishable from untransfected neurons.  In the HEK 293 cell heterologous expression system, Vc1.1 and RgIA inhibition of Cav2.2 channels needed functional expression of both human GABAB receptor subunits.  Together, these results confirm that GABAB receptors must be activated for the modulation of N-type (Cav2.2) calcium channels by analgesic α-conotoxins Vc1.1 and RgIA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrva98Z3TvRtLVg90H21EOLACvtfcHk0liW5Yu4kY_Vcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVeju7Y%253D&md5=9b52259a7bd451d1299bbfec657c643a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.342998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.342998%26sid%3Dliteratum%253Aachs%26aulast%3DCuny%26aufirst%3DH.%26aulast%3Dde%2BFaoite%26aufirst%3DA.%26aulast%3DHuynh%26aufirst%3DT.%2BG.%26aulast%3DYasuda%26aufirst%3DT.%26aulast%3DBerecki%26aufirst%3DG.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26atitle%3D%25CE%25B3-Aminobutyric%2520Acid%2520Type%2520B%2520%2528GABAB%2529%2520Receptor%2520Expression%2520Is%2520Needed%2520for%2520Inhibition%2520of%2520N-type%2520%2528Cav2.2%2529%2520Calcium%2520Channels%2520by%2520Analgesic%2520%25CE%25B1-Conotoxins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D23948%26epage%3D23957%26doi%3D10.1074%2Fjbc.m112.342998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slesinger, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span> <span> </span><span class="NLM_article-title">Novel Mechanism of Voltage-Gated N-type (Cav2.2) Calcium Channel Inhibition Revealed through α-Conotoxin Vc1.1 Activation of the GABAB Receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1124/mol.114.096156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1124%2Fmol.114.096156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=25425625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Whtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=240-250&author=T.+G.+Huynhauthor=H.+Cunyauthor=P.+A.+Slesingerauthor=D.+J.+Adams&title=Novel+Mechanism+of+Voltage-Gated+N-type+%28Cav2.2%29+Calcium+Channel+Inhibition+Revealed+through+%CE%B1-Conotoxin+Vc1.1+Activation+of+the+GABAB+Receptor&doi=10.1124%2Fmol.114.096156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mechanism of voltage-gated N-type (Cav2.2) calcium channel inhibition revealed through α-conotoxin Vc1.1 activation of the GABAB receptor</span></div><div class="casAuthors">Huynh, Thuan G.; Cuny, Hartmut; Slesinger, Paul A.; Adams, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-250/1-240-250/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal voltage-gated N-type (Cav2.2) calcium channels are expressed throughout the nervous system and regulate neurotransmitter release and hence synaptic transmission.  They are predominantly modulated via G protein-coupled receptor activated pathways, and the well characterized Gβ γ subunits inhibit Cav2.2 currents.  Analgesic α-conotoxin Vc1.1, a peptide from predatory marine cone snail venom, inhibits Cav2.2 channels by activating pertussis toxin-sensitive Gi/o proteins via the GABAB receptor (GABABR) and potently suppresses pain in rat models.  Using a heterologous GABABR expression system, electrophysiol., and mutagenesis, we showed a-conotoxin Vc1.1 modulates Cav2.2 via a different pathway from that of the GABABR agonists GABA and baclofen.  In contrast to GABA and baclofen, Vc1.1 changes Cav2.2 channel kinetics by increasing the rate of activation and shifting its half max. inactivation to a more hyperpolarized potential.  We then systematically truncated the GABAB1a C terminus and discovered that removing the proximal carboxyl terminus of the GABAB1a subunit significantly reduced Vc1.1 inhibition of Cav2.2 currents.  We propose a novel mechanism by which Vc1.1 activates GABABR and requires the GABAB1a proximal carboxyl terminus domain to inhibit Cav2.2 channels.  These findings provide important insights into how GABABRs mediate Cav2.2 channel inhibition and alter nociceptive transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq859YS8L8ua7Vg90H21EOLACvtfcHk0liW5Yu4kY_Vcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Whtr0%253D&md5=c1ac5bd9b41e983007a8e967f1d69c3a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.096156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.096156%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DT.%2BG.%26aulast%3DCuny%26aufirst%3DH.%26aulast%3DSlesinger%26aufirst%3DP.%2BA.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26atitle%3DNovel%2520Mechanism%2520of%2520Voltage-Gated%2520N-type%2520%2528Cav2.2%2529%2520Calcium%2520Channel%2520Inhibition%2520Revealed%2520through%2520%25CE%25B1-Conotoxin%2520Vc1.1%2520Activation%2520of%2520the%2520GABAB%2520Receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D87%26spage%3D240%26epage%3D250%26doi%3D10.1124%2Fmol.114.096156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsetlin, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E4026</span>– <span class="NLM_lpage">E4035</span>, <span class="refDoi"> DOI: 10.1073/pnas.1503617112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1073%2Fpnas.1503617112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=26170295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGktr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E4026-E4035&author=S.+Luoauthor=D.+Zhangsunauthor=P.+J.+Harveyauthor=Q.+Kaasauthor=Y.+Wuauthor=X.+Zhuauthor=Y.+Huauthor=X.+Liauthor=V.+I.+Tsetlinauthor=S.+Christensenauthor=H.+K.+Romeroauthor=M.+McIntyreauthor=C.+Dowellauthor=J.+C.+Baxterauthor=K.+S.+Elmslieauthor=D.+J.+Craikauthor=J.+M.+McIntosh&title=Cloning%2C+synthesis%2C+and+characterization+of+%CE%B1O-conotoxin+GeXIVA%2C+a+potent+%CE%B19%CE%B110+nicotinic+acetylcholine+receptor+antagonist&doi=10.1073%2Fpnas.1503617112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist</span></div><div class="casAuthors">Luo, Sulan; Zhangsun, Dongting; Harvey, Peta J.; Kaas, Quentin; Wu, Yong; Zhu, Xiaopeng; Hu, Yuanyan; Li, Xiaodan; Tsetlin, Victor I.; Christensen, Sean; Romero, Haylie K.; McIntyre, Melissa; Dowell, Cheryl; Baxter, James C.; Elmslie, Keith S.; Craik, David J.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">E4026-E4035</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The authors identified a previously unidentified conotoxin gene from Conus generalis whose precursor signal sequence has high similarity to the O1-gene conotoxin superfamily.  The predicted mature peptide, αO-conotoxin GeXIVA, has four Cys residues, and its three disulfide isomers were synthesized.  Previously pharmacol. characterized O1-superfamily peptides, exemplified by the US Food and Drug Administration-approved pain medication, ziconotide, contain six Cys residues and are calcium, sodium, or potassium channel antagonists.  However, GeXIVA did not inhibit calcium channels but antagonized nicotinic AChRs (nAChRs), most potently on the α9α10 nAChR subtype (IC50 = 4.6 nM).  Toxin blockade was voltage-dependent, and kinetic anal. of toxin dissocn. indicated that the binding site of GeXIVA does not overlap with the binding site of the competitive antagonist α-conotoxin RgIA.  Surprisingly, the most active disulfide isomer of GeXIVA is the bead isomer, comprising, according to NMR anal., two well-resolved but uncoupled disulfide-restrained loops.  The ribbon isomer is almost as potent but has a more rigid structure built around a short 310-helix.  In contrast to most α-conotoxins, the globular isomer is the least potent and has a flexible, multiconformational nature.  GeXIVA reduced mech. hyperalgesia in the rat chronic constriction injury model of neuropathic pain but had no effect on motor performance, warranting its further investigation as a possible therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2OSEOMMXArVg90H21EOLACvtfcHk0lgUWubEMbs-XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGktr3F&md5=abbe5165fbe0eb66fbe342f30f55d1d6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1503617112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1503617112%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DZhangsun%26aufirst%3DD.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTsetlin%26aufirst%3DV.%2BI.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DH.%2BK.%26aulast%3DMcIntyre%26aufirst%3DM.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DBaxter%26aufirst%3DJ.%2BC.%26aulast%3DElmslie%26aufirst%3DK.%2BS.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DCloning%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520%25CE%25B1O-conotoxin%2520GeXIVA%252C%2520a%2520potent%2520%25CE%25B19%25CE%25B110%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3DE4026%26epage%3DE4035%26doi%3D10.1073%2Fpnas.1503617112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael
McIntosh, J.</span></span> <span> </span><span class="NLM_article-title">Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">114124</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2020.114124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.bcp.2020.114124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=32593612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtleksbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=114124&author=P.+N.+Huynhauthor=P.+J.+Harveyauthor=J.+Gajewiakauthor=D.+J.+Craikauthor=J.+Michael%0AMcIntosh&title=Critical+residue+properties+for+potency+and+selectivity+of+%CE%B1-Conotoxin+RgIA+towards+%CE%B19%CE%B110+nicotinic+acetylcholine+receptors&doi=10.1016%2Fj.bcp.2020.114124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Huynh, Peter N.; Harvey, Peta J.; Gajewiak, Joanna; Craik, David J.; Michael McIntosh, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114124</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The α9α10 nicotinic acetylcholine receptor (nAChR) has been characterized as an effective anti-pain target that functions through a non-opioid mechanism.  However, as a pentameric ion channel comprised of two different subunits, the specific targeting of α9α10 nAChRs has proven challenging.  Previously the 13-amino-acid peptide, RgIA, was shown to block α9α10 nAChRs with high potency and specificity.  This peptide, characterized from the venom of the carnivorous marine snail, Conus regius, produced analgesia in several rodent models of chronic pain.  Despite promising pre-clin. data in behavioral assays, the no. of specific α9α10 nAChR antagonists remains small and the physiol. mechanisms of analgesia remain cryptic.  In this study, we implement amino-acid substitutions to definitively characterize the chem. properties of RgIA that contribute to its activity against α9α10 nAChRs.  Using this mutational approach, we detd. the vital role of biochem. side-chain properties and amino acids in the second loop that are amenable to substitutions to further engineer next-generation analogs for the blockade of α9α10 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoToSjfA_ToLVg90H21EOLACvtfcHk0lgUWubEMbs-XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtleksbfF&md5=20a65a5077d56ca1ad4032c2a2f200d5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2020.114124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2020.114124%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DP.%2BN.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMichael%2BMcIntosh%26aufirst%3DJ.%26atitle%3DCritical%2520residue%2520properties%2520for%2520potency%2520and%2520selectivity%2520of%2520%25CE%25B1-Conotoxin%2520RgIA%2520towards%2520%25CE%25B19%25CE%25B110%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2020%26volume%3D181%26spage%3D114124%26doi%3D10.1016%2Fj.bcp.2020.114124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tabassum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span> <span> </span><span class="NLM_article-title">Role of CysI-CysIIIDisulfide Bond on the Structure and Activity of α-Conotoxins at Human Neuronal Nicotinic Acetylcholine Receptors</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">4621</span>– <span class="NLM_lpage">4631</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b00639</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b00639" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtleltbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=4621-4631&author=N.+Tabassumauthor=H.-S.+Taeauthor=X.+Jiaauthor=Q.+Kaasauthor=T.+Jiangauthor=D.+J.+Adamsauthor=R.+Yu&title=Role+of+CysI-CysIIIDisulfide+Bond+on+the+Structure+and+Activity+of+%CE%B1-Conotoxins+at+Human+Neuronal+Nicotinic+Acetylcholine+Receptors&doi=10.1021%2Facsomega.7b00639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CysI-CysIII Disulfide Bond on the Structure and Activity of α-Conotoxins at Human Neuronal Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Tabassum, Nargis; Tae, Han-Shen; Jia, Xinying; Kaas, Quentin; Jiang, Tao; Adams, David J.; Yu, Rilei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4621-4631</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxins preferentially antagonize muscle and neuronal nicotinic acetylcholine receptors (nAChRs).  Native α-conotoxins have two disulfide links, CI-CIII and CII-CIV, and due to the inherent properties of disulfide bonds, α-conotoxins have been systematically engineered to improve their chem. and biol. properties.  In this study, we explored the possibility of simplifying the disulfide framework of α-conotoxins Vc1.1, BuIA, ImI and AuIB, by introducing [C2H,C8F] modification to the CI-CIII bond.  We therefore explore the possibility of using hydrophobic packing of std. amino acid side chains to replace disulfide bonds as an alternative strategy to non-natural amino acid crosslinks.  The impact of CI-CIII disulfide bond replacement on the conformation of the α-conotoxins was investigated using mol. dynamic simulations and NMR chem. shift indexes study.  Two-electrode voltage clamp techniques and mol. dynamics simulations were used to study the impact of disulfide bond deletion on the activities of these peptides at human neuronal nAChRs.  All disulfide-deleted variants except ImI[C2H,C8F] had reduced potency for inhibiting nAChRs.  Our results suggest that the CI-CIII disulfide bond is important to stabilize the secondary structure of α-conotoxins as well as their interaction with neuronal nAChR targets.  Results from this study enrich our understanding on the function of the CI-CIII disulfide bond and are useful in guiding future structural engineering of the α-conotoxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCvFZMGGWB7Vg90H21EOLACvtfcHk0lgUWubEMbs-XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtleltbrL&md5=b327bf5302033866dd73b08ee6aca6d2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b00639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b00639%26sid%3Dliteratum%253Aachs%26aulast%3DTabassum%26aufirst%3DN.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DYu%26aufirst%3DR.%26atitle%3DRole%2520of%2520CysI-CysIIIDisulfide%2520Bond%2520on%2520the%2520Structure%2520and%2520Activity%2520of%2520%25CE%25B1-Conotoxins%2520at%2520Human%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26spage%3D4621%26epage%3D4631%26doi%3D10.1021%2Facsomega.7b00639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staff, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisold, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisold, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windebank, A. J.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy-induced Peripheral Neuropathy: A Current Review</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">781</span>, <span class="refDoi"> DOI: 10.1002/ana.24951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fana.24951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28486769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKisbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2017&pages=772-781&author=N.+P.+Staffauthor=A.+Grisoldauthor=W.+Grisoldauthor=A.+J.+Windebank&title=Chemotherapy-induced+Peripheral+Neuropathy%3A+A+Current+Review&doi=10.1002%2Fana.24951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy-induced peripheral neuropathy: A current review</span></div><div class="casAuthors">Staff, Nathan P.; Grisold, Anna; Grisold, Wolfgang; Windebank, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">772-781</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect experienced by patients receiving treatment for cancer.  Approx. 30 to 40% of patients treated with neurotoxic chemotherapy will develop CIPN, and there is considerable variability in its severity between patients.  It is often sensory-predominant with pain and can lead to long-term morbidity in survivors.  The prevalence and burden of CIPN late effects will likely increase as cancer survival rates continue to improve.  In this review, we discuss the approach to peripheral neuropathy in patients with cancer and address the clin. phenotypes and pathomechanisms of specific neurotoxic chemotherapeutic agents.  Ann Neurol 2017;81:772-781.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8ISXxlGByRbVg90H21EOLACvtfcHk0lh_V1hoWM2NBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKisbrN&md5=9d471056039e27cbb5adf6c43ea15743</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fana.24951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24951%26sid%3Dliteratum%253Aachs%26aulast%3DStaff%26aufirst%3DN.%2BP.%26aulast%3DGrisold%26aufirst%3DA.%26aulast%3DGrisold%26aufirst%3DW.%26aulast%3DWindebank%26aufirst%3DA.%2BJ.%26atitle%3DChemotherapy-induced%2520Peripheral%2520Neuropathy%253A%2520A%2520Current%2520Review%26jtitle%3DAnn.%2520Neurol.%26date%3D2017%26volume%3D81%26spage%3D772%26epage%3D781%26doi%3D10.1002%2Fana.24951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Noord, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eijgelsheim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stricker, B. H. C.</span></span> <span> </span><span class="NLM_article-title">Drug- and Non-drug-associated QT Interval Prolongation</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.2010.03660.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1111%2Fj.1365-2125.2010.03660.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=20642543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1emsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=16-23&author=C.+van%0ANoordauthor=M.+Eijgelsheimauthor=B.+H.+C.+Stricker&title=Drug-+and+Non-drug-associated+QT+Interval+Prolongation&doi=10.1111%2Fj.1365-2125.2010.03660.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Drug- and non-drug-associated QT interval prolongation</span></div><div class="casAuthors">van Noord, Charlotte; Eijgelsheim, Mark; Stricker, Bruno H. Ch.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-23</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Sudden cardiac death is among the most common causes of cardiovascular death in developed countries.  The majority of sudden cardiac deaths are caused by acute ventricular arrhythmia following repolarization disturbances.  An important risk factor for repolarization disturbances is use of QT prolonging drugs, probably partly explained by gene-drug interactions.  In this review, we will summarize QT interval physiol., known risk factors for QT prolongation, including drugs and the contribution of pharmacogenetics.  The long QT syndrome can be congenital or acquired.  The congenital long QT syndrome is caused by mutations in ion channel subunits or regulatory protein coding genes and is a rare monogenic disorder with a mendelian pattern of inheritance.  Apart from that, several common genetic variants that are assocd. with QT interval duration have been identified.  Acquired QT prolongation is more prevalent than the congenital form.  Several risk factors have been identified with use of QT prolonging drugs as the most frequent cause.  Most drugs that prolong the QT interval act by blocking hERG-encoded potassium channels, although some drugs mainly modify sodium channels.  Both pharmacodynamic as well as pharmacokinetic mechanisms may be responsible for QT prolongation.  Pharmacokinetic interactions often involve drugs that are metabolized by cytochrome P 450 enzymes.  Pharmacodynamic gene-drug interactions are due to genetic variants that potentiate the QT prolonging effect of drugs.  QT prolongation, often due to use of QT prolonging drugs, is a major public health issue.  Recently, common genetic variants assocd. with QT prolongation have been identified.  Few pharmacogenetic studies have been performed to establish the genetic background of acquired QT prolongation but addnl. studies in this newly developing field are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzyy2JTFkqQLVg90H21EOLACvtfcHk0lh_V1hoWM2NBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1emsrg%253D&md5=784c2dbd68ad4514fb606f58623c100a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2010.03660.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2010.03660.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNoord%26aufirst%3DC.%26aulast%3DEijgelsheim%26aufirst%3DM.%26aulast%3DStricker%26aufirst%3DB.%2BH.%2BC.%26atitle%3DDrug-%2520and%2520Non-drug-associated%2520QT%2520Interval%2520Prolongation%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D70%26spage%3D16%26epage%3D23%26doi%3D10.1111%2Fj.1365-2125.2010.03660.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, R. S.</span></span> <span> </span><span class="NLM_article-title">α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding Residues</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">1216</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.01.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.jmb.2008.01.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=18295795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1WhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=1216-1227&author=M.+Ellisonauthor=Z.-P.+Fengauthor=A.+J.+Parkauthor=X.+Zhangauthor=B.+M.+Oliveraauthor=J.+M.+McIntoshauthor=R.+S.+Norton&title=%CE%B1-RgIA%2C+a+Novel+Conotoxin+That+Blocks+the+%CE%B19%CE%B110+nAChR%3A+Structure+and+Identification+of+Key+Receptor-Binding+Residues&doi=10.1016%2Fj.jmb.2008.01.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding Residues</span></div><div class="casAuthors">Ellison, Michael; Feng, Zhi-Ping; Park, Anthony J.; Zhang, Xuecheng; Olivera, Baldomero M.; McIntosh, J. Michael; Norton, Raymond S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1216-1227</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">α-Conotoxins are small disulfide-constrained peptides from cone snails that act as antagonists at specific subtypes of nicotinic acetylcholine receptors (nAChRs).  The 13-residue peptide α-conotoxin RgIA (α-RgIA) is a member of the α-4,3 family of α-conotoxins and selectively blocks the α9α10 nAChR subtype, in contrast to another well-characterized member of this family, α-conotoxin ImI (α-ImI), which is a potent inhibitor of the α7 and α3β2 nAChR subtypes.  In this study, we have altered side chains in both the four-residue and the three-residue loops of α-RgIA, and have modified its C-terminus.  The effects of these changes on activity against α9α10 and α7 nAChRs were measured; the soln. structures of α-RgIA and its Y10W, D5E, and P6V analogs were detd. from NMR data; and resonance assignments were made for α-RgIA [R9A].  The structures for α-RgIA and its three analogs were well defined, except at the chain termini.  Comparison of these structures with reported structures of α-ImI reveals a common two-loop backbone architecture within the α-4,3 family, but with variations in side-chain solvent accessibility and orientation.  Asp5, Pro6, and Arg7 in loop 1 are crit. for blockade of both the α9α10 and the α7 subtypes.  In loop 2, α-RgIA [Y10W] had activity near that of wild-type α-RgIA, with high potency for α9α10 and low potency for α7, and had a structure similar to that of wild type.  By contrast, Arg9 in loop 2 is crit. for specific binding to the α9α10 subtype, probably because it is larger and more solvent accessible than Ala9 in α-ImI.  Our findings contribute to a better understanding of the mol. basis for antagonism of the α9α10 nAChR subtype, which is a target for the development of analgesics for the treatment of chronic neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9If5Ur8ivy7Vg90H21EOLACvtfcHk0lh_V1hoWM2NBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1WhsLs%253D&md5=d3a1c974279538a3071de3eabed150b1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.01.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.01.082%26sid%3Dliteratum%253Aachs%26aulast%3DEllison%26aufirst%3DM.%26aulast%3DFeng%26aufirst%3DZ.-P.%26aulast%3DPark%26aufirst%3DA.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DNorton%26aufirst%3DR.%2BS.%26atitle%3D%25CE%25B1-RgIA%252C%2520a%2520Novel%2520Conotoxin%2520That%2520Blocks%2520the%2520%25CE%25B19%25CE%25B110%2520nAChR%253A%2520Structure%2520and%2520Identification%2520of%2520Key%2520Receptor-Binding%2520Residues%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D377%26spage%3D1216%26epage%3D1227%26doi%3D10.1016%2Fj.jmb.2008.01.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zouridakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papakyriakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasheverov, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsetlin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzartos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giastas, P.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">474</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3389%2Ffphar.2019.00474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=31118896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGksb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=474&author=M.+Zouridakisauthor=A.+Papakyriakouauthor=I.+A.+Ivanovauthor=I.+E.+Kasheverovauthor=V.+Tsetlinauthor=S.+Tzartosauthor=P.+Giastas&title=Crystal+Structure+of+the+Monomeric+Extracellular+Domain+of+%CE%B19+Nicotinic+Receptor+Subunit+in+Complex+With+%CE%B1-Conotoxin+RgIA%3A+Molecular+Dynamics+Insights+Into+RgIA+Binding+to+%CE%B19%CE%B110+Nicotinic+Receptors&doi=10.3389%2Ffphar.2019.00474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the monomeric extracellular domain of α9 nicotinic receptor subunit in complex with α-conotoxin RgIA: molecular dynamics insights into rgia binding to α9α10 nicotinic receptors</span></div><div class="casAuthors">Zouridakis, Marios; Papakyriakou, Athanasios; Ivanov, Igor A.; Kasheverov, Igor E.; Tsetlin, Victor; Tzartos, Socrates; Giastas, Petros</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">474</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The α9 subunit of nicotinic acetylcholine receptors (nAChRs) exists mainly in heteropentameric assemblies with α10.  Accumulating data indicate the presence of three different binding sites in α9α10 nAChRs: the α9(+)/α9(-), the α9(+)/α10(-), and the α10(+)/α9(-).  The major role of the principal (+) side of the extracellular domain (ECD) of α9 subunit in binding of the antagonists methyllylcaconitine and α-bungarotoxin was shown previously by the crystal structures of the monomeric α9-ECD with these mols.  Here we present the 2.26-Å resoln. crystal structure of α9-ECD in complex with α-conotoxin (α-Ctx) RgIA, a potential drug for chronic pain, the first structure reported for a complex between an nAChR domain and an α-Ctx.  Superposition of this structure with those of other α-Ctxs bound to the homologous pentameric acetylcholine binding proteins revealed significant similarities in the orientation of bound conotoxins, despite the monomeric state of the α9-ECD.  In addn., ligand-binding studies calcd. a binding affinity of RgIA to the α9-ECD at the low micromolar range.  Given the high identity between α9 and α10 ECDs, particularly at their (+) sides, the presented structure was used as template for mol. dynamics simulations of the ECDs of the human α9 α10 nAChR in pentameric assemblies.  Our results support a favorable binding of RgIA at α9(+)/α9(-) or α10(+)/α9(-) rather than the α9(+)/α10(-) interface, in accordance with previous mutational and functional data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhljrV1Ab-CbVg90H21EOLACvtfcHk0ligO1KBtzKaPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGksb7P&md5=2301c1de59b08ba6994b3d3e5c8631d3</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00474%26sid%3Dliteratum%253Aachs%26aulast%3DZouridakis%26aufirst%3DM.%26aulast%3DPapakyriakou%26aufirst%3DA.%26aulast%3DIvanov%26aufirst%3DI.%2BA.%26aulast%3DKasheverov%26aufirst%3DI.%2BE.%26aulast%3DTsetlin%26aufirst%3DV.%26aulast%3DTzartos%26aufirst%3DS.%26aulast%3DGiastas%26aufirst%3DP.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Monomeric%2520Extracellular%2520Domain%2520of%2520%25CE%25B19%2520Nicotinic%2520Receptor%2520Subunit%2520in%2520Complex%2520With%2520%25CE%25B1-Conotoxin%2520RgIA%253A%2520Molecular%2520Dynamics%2520Insights%2520Into%2520RgIA%2520Binding%2520to%2520%25CE%25B19%25CE%25B110%2520Nicotinic%2520Receptors%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D474%26doi%3D10.3389%2Ffphar.2019.00474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakely, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purushottam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D. H.-C.</span></span> <span> </span><span class="NLM_article-title">Development of Conformationally Constrained α-RgIA Analogues as Stable Peptide Antagonists of Human α9α10 Nicotinic Acetylcholine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8380</span>– <span class="NLM_lpage">8387</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1ynurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8380-8387&author=N.+Zhengauthor=S.+B.+Christensenauthor=A.+Blakelyauthor=C.+Dowellauthor=L.+Purushottamauthor=J.+M.+McIntoshauthor=D.+H.-C.+Chou&title=Development+of+Conformationally+Constrained+%CE%B1-RgIA+Analogues+as+Stable+Peptide+Antagonists+of+Human+%CE%B19%CE%B110+Nicotinic+Acetylcholine+Receptors&doi=10.1021%2Facs.jmedchem.0c00613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Conformationally Constrained α-RgIAAnalogues as Stable Peptide Antagonists of Human α9α10Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Zheng, Nan; Christensen, Sean B.; Blakely, Alan; Dowell, Cheryl; Purushottam, Landa; McIntosh, J. Michael; Chou, Danny Hung-Chieh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8380-8387</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Non-opioid therapeutics for the treatment of neuropathic pain are urgently needed to address the ongoing opioid crisis.  Peptides from cone snail venoms have served as invaluable mols. to target key pain-related receptors but can suffer from unfavorable physicochem. properties, which limit their therapeutic potential.  In this work,we developed conformationally constrained α-RgIA analogs with high potency, receptor selectivity, and enhanced human serum stability to target the human α9α10 nicotinic acetylcholine receptor.The key lactam linkage introduced in α-RgIA fixed the favored globular conformation and suppressed disulfide scrambling.  The NMRstructure of the macrocyclic peptide overlays well with that of α-RgIA4,demonstrating that the cyclization does not perturb the overall conformation of backbone and key side-chain residues.  Finally, a mol. docking model was used to rationalize the selective binding between a macrocyclicanalogue and the α9α10 nicotinic acetylcholine receptor.These conformationally constrained antagonists are therefore promising candidates for antinociceptive therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs0xJyW0BFtbVg90H21EOLACvtfcHk0ligO1KBtzKaPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1ynurnN&md5=71a82089eaf4123fc1c8a08328ef0188</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00613%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DBlakely%26aufirst%3DA.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DPurushottam%26aufirst%3DL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DChou%26aufirst%3DD.%2BH.-C.%26atitle%3DDevelopment%2520of%2520Conformationally%2520Constrained%2520%25CE%25B1-RgIA%2520Analogues%2520as%2520Stable%2520Peptide%2520Antagonists%2520of%2520Human%2520%25CE%25B19%25CE%25B110%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8380%26epage%3D8387%26doi%3D10.1021%2Facs.jmedchem.0c00613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Góngora-Benítez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulla-Puche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">926</span>, <span class="refDoi"> DOI: 10.1021/cr400031z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400031z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=901-926&author=M.+G%C3%B3ngora-Ben%C3%ADtezauthor=J.+Tulla-Pucheauthor=F.+Albericio&title=Multifaceted+Roles+of+Disulfide+Bonds.+Peptides+as+Therapeutics&doi=10.1021%2Fcr400031z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics</span></div><div class="casAuthors">Gongora-Benitez, Miriam; Tulla-Puche, Judit; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">901-926</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present review, we have focused our attention on disulfide bonds as constrained elements and their further implications in the development of peptide-based therapeutics.  Thus, the versatile roles of the disulfide bonds formed between Cys residues in therapeutic peptides have been covered.  First, the biol. relevance of these covalent linkages in the oxidative folding process and the contribution of these structural elements to the 3D conformational stability of polypeptides have been discussed.  In addn., the capacity of these linkages to modulate the pharmacodynamic and pharmacokinetic properties of the peptide has been fully disclosed.  Overall, peptide cyclization through the incorporation of disulfide bridges not only may allow the improvement of diverse pharmacol. features, but may also provide valuable information about biol. processes and that is relevant for the further design of peptide analogs and peptidomimetics.  Here we have referred to several studies in which the insertion of a disulfide bond has endowed peptides enhanced pharmacol. properties, including bioactivity, selectivity and resistance to proteases. ,many other studies have demonstrated that these constrained elements are potentially capable of stabilizing secondary structure elements involved in widespread mol. surface recognition processes.  Moreover, disulfide bonds are being applied as reversible covalent bonds for the construction of peptide conjugates that comprise a drug delivery carrier for enhancing cell permeability.  In this regard, the early development of bioactive peptides linked to drug delivery systems is gaining relevance, and this tendency has been progressively implemented in many pharmaceutical companies.  In particular, CPPs may allow a large no. of peptide drugs to enter the market, and they are expected to contribute to accelerating the research performed in both the industrial sector and in the academic world.  The next generation of CPPs is expected to combine both targeting and internalization advantages.  On the other hand, of special interest are small disulfide-rich peptides,which have also been discussed as valuable therapeutic agents.  In general, these privileged mols. show extraordinary chem. and biol. stability and, given their highly constrained architecture, many of them and analogs thereof are currently undergoing preclin. studies or are in clin. trials.  Together with the increasing significance of these constrained peptides as drugs themselves, some of these rigid structures have been used as scaffolds for peptide engineering.  Thus, by taking advantages of the privileged pharmacokinetic properties of some of these extremely rigid architectures, this novel approach is emerging as an extremely valuable tool for peptide drug discovery.  Furthermore, of relevance, owing to their special topol. and cyclic backbone, some small cyclicdisulfide-rich peptides have the capacity to cross the cell membrane.  These peptides constitute a new family of CPPs that are referred to as cyclic cell-penetrating peptides(CCPPs).  These mols. ofer several advantages over linear CPPs, including greater stability and bioavailability, and therefore, they are promising mols. for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYp3zST79N7Vg90H21EOLACvtfcHk0ligO1KBtzKaPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7nJ&md5=903478ec86d15479bf1987d142cccf58</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fcr400031z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400031z%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B3ngora-Ben%25C3%25ADtez%26aufirst%3DM.%26aulast%3DTulla-Puche%26aufirst%3DJ.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DMultifaceted%2520Roles%2520of%2520Disulfide%2520Bonds.%2520Peptides%2520as%2520Therapeutics%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D901%26epage%3D926%26doi%3D10.1021%2Fcr400031z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Amino acid sequence alignments of α-Ctx RgIA, ImI, Vc1.1, PeIA, MII, and PnIA. Disulfide connectivity is Cys<sup>I</sup>–Cys<sup>III</sup> (loop I) and Cys<sup>II</sup>–Cys<sup>IV</sup> (loop II). # = C-terminal amide; ̂ = C-terminal carboxylate acid. (B) Binding surface of RgIA bound to the α9 nAChR subunit crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HY7">6HY7</a>). Key binding residues (Ser4, Asp5, Arg7, and Arg9) are labeled in black font and shown as stick representation with oxygen, nitrogen, and sulfur atoms in red, blue, and yellow, respectively. (C) Chemical structures of native disulfide and developed disulfide mimetics. Pen = <span class="smallcaps smallerCapital">l</span>-penicillamine. (D) Chemical syntheses of methylene thioacetal RgIA analogues in this study. All linear peptides were synthesized through Fmoc-SPPS on the automated synthesizer. Fully folded peptides were obtained <i>via</i> a two-step procedure. Reaction conditions (a) TCEP·HCl, K<sub>2</sub>CO<sub>3</sub>, and H<sub>2</sub>O and then Et<sub>3</sub>N, CH<sub>2</sub>I<sub>2</sub>, and THF. (b) I<sub>2</sub>, AcOH, and H<sub>2</sub>O.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Amino acid sequences and potencies of synthesized methylene thioacetal RgIA analogues on hα9α10 nAChRs. <sup><i>a</i></sup>Bond connectivity is C<sup>I</sup>–C<sup>III</sup> (loop I) and C<sup>II</sup>–C<sup>IV</sup> (loop II) or their corresponding methylene thioacetal surrogates X<sup>I</sup>–X<sup>III</sup> and X<sup>II</sup>–X<sup>IV</sup>. X represents methylene thioacetal replacement; ̂ represents C-terminal carboxylic acid; Cit = <span class="smallcaps smallerCapital">l</span>-citrulline; iY = L-3-iodo-tyrosine; bA = β-alanine; bhY = <span class="smallcaps smallerCapital">l</span>-β-homotyrosine. <sup><i>b</i></sup>Calculated from concentration–response curves. Numbers in parenthesis are 95% confidence intervals. (B) Concentration–response analysis for inhibition of human α9α10 nAChR by synthesized peptides on blocking ACh-induced current on human nAChR currents expressed in <i>X. laevis</i> oocytes. (C) IC<sub>50</sub> for inhibition of nAChR subtypes by RgIA-5524 and RgIA-5533 on blocking ACh-induced current on human nAChR currents expressed in <i>X. laevis</i> oocytes. (D) Concentration–response analysis for inhibition of hα9α10 <i>vs</i> hα7 nAChR by RgIA-5524 and RgIA-5533. Data points represent the mean ± SEM from three to four independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vivo</i> pain-relieving effects of RgIA-5524 in chronic chemotherapy-induced neuropathic pain. RgIA-5524 relieves pain induced by repeated oxaliplatin dosing. Mice were injected once per day, 5 days per week with the chemotherapeutic agent oxaliplatin (3.5 mg/kg, i.p.) over a three-week period. On the days of oxaliplatin injection, mice also received either saline or RgIA-5524 (40 μg/kg). Once per week, 24 h after last RgIA-5524 injection, mice were assessed for cold allodynia using a cold plate as described in the Experimental Section. Allodynia reached statistical significance by day 21 and was effectively reversed by RgIA-5524. Statistical evaluations of the data were performed by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. Data are expressed as means ± SEM, <i>n</i> = eight mice per group. <sup>xxx</sup><i>P</i> < 0.001 for a significant difference from Ox/Sal <i>vs</i> Sal/Sal-treated mice; ***<i>P</i> < 0.001 for a significant difference from Ox/Sal <i>vs</i> Ox/RgIA-5524-treated mice. Ox, oxaliplatin; Sal, 0.9% saline; s, seconds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. α9 nAChR subunit is required for analgesic effects of RgIA-5524. (A, B) On day 1, a single dose of oxaliplatin 5 mg/kg i.p. was given along with either RgIA 5524 (40 μg/kg, s.c.) or 0.9% saline. Mice were assessed for cold allodynia on day 5. RgIA-5524 prevented the development of allodynia in (A) wild-type mice but not in (B) α9-subunit null mice (<i>n</i> = 12 mice/group). (C,D) On day 1, mice were administered a higher dose of oxaliplatin (10 mg/kg i.p.) and either RgIA-5524 (40 μg/kg s.c.) or saline. Oxaliplatin-induced cold allodynia was prevented by the single dose of RgIA-5524 administered on day 1 in (C) wild-type mice but not in (D) α9-subunit null mice (n = 8 mice/group). Statistical evaluations of the data were performed by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. All results are expressed as means ± SEM. *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 for a significant difference from Sal/Sal-treated mice. <sup>o</sup><i>P</i> <0.05, <sup>oo</sup><i>P</i> <0.01, and <sup>ooo</sup><i>P</i> < 0.001 for a significant difference from oxaliplatin/RgIA-5524-treated mice. Ox, oxaliplatin; Sal, 0.9% saline; s, seconds; α9<sup>–/–</sup>, α9 knockout mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Binding activity of RgIA-5524 on other pain-related ion channels and receptors at 10 μM. <sup><i>a</i></sup>Each experiment was conducted with duplicate wells. Binding was calculated as % inhibition of the binding of a radioactively labeled ligand specific for each target, and the enzyme inhibition effect was calculated as % inhibition of control enzyme activity. A secondary, concentration–response analysis was conducted when the primary screening assay indicated ≥50% inhibition. <sup><i>b</i></sup>Nicotinic neuronal type. <sup><i>c</i></sup>Strychnine-sensitive. <sup><i>d</i></sup>Strychnine-insensitive; AR, adenosine receptor; AT, angiotensin; BK<sub>2</sub>, bradykinin receptor; CB, cannabinoid receptor; CCK, cholecystokinin receptor; CRF, corticotropin-releasing factor; D, dopamine; ET, endothelin receptor; GABA, γ-aminobutyric acid; GAL, galanin receptor; mGluR, metabotropic glutamate receptor; GlyR, glycine receptor (strychnine-sensitive); H, histamine receptor; CysLT, cysteinyl leukotriene; M, muscarinic acetylcholine receptor; NK, neurokinin receptor; DOP, δ-opioid receptor; KOP, κ-opioid receptor; MOP, μ-opioid receptor; NOP, nociceptin/orphanin FQ receptor; GR, glucocorticoid receptor; ER, estrogen receptor; AR, androgen receptor; PAFR, platelet-activating factor receptor; TRH1, thyrotropin-releasing hormone; VPAC, vasoactive intestinal peptide receptor; V, vasopressin receptor; LTCC, L-type Ca<sup>2+</sup> channel; NTCC, N-type Ca<sup>2+</sup> channel; BZD, benzodiazepine; PCP, phencyclidine. (B) Functional activity of RgIA-5524 on GABA<sub>B</sub> receptors and the hERG K<sup>+</sup> channel. <sup><i>e</i></sup>Two separate experiments were conducted with duplicate wells for the IC<sub>50</sub> and EC<sub>50</sub> studies. Cellular agonist and antagonist effects were calculated as % of control response and % inhibition to a known reference agonist or antagonist, respectively; <sup><i>f</i></sup>Measured at 100 μM RgIA-5524. (C) Enzyme and uptake assays of RgIA-5524. <sup><i>g</i></sup>Each experiment was conducted with duplicate wells. The antagonist effect was calculated as % inhibition to the measured component. TXA<sub>2</sub> synthetase, thromboxane A2 synthetase; constitutive NOS, constitutive NO synthase; MAO, monoamine oxidase. Concentration–response analysis of the (D) agonist and (E) antagonist effect of RgIA-5524 on GABA<sub>B</sub> receptors. (F) Concentration–response analysis of RgIA-5524 on the hERG K<sup>+</sup> channel measured by tail current inhibition. (G) Inhibition of CYP enzyme isoforms by RgIA-5524 at 100 nM and 10 μM. Duplicated experiments were conducted for each concentration, and data are expressed as means ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Overlay of the secondary chemical shifts of RgIA (black), RgIA4 (gray), RgIA-5617 (pink), RgIA-5533 (green), and RgIA-5524 (blue). The <i>x</i>-axis shows the peptide sequences with the substituted residue for the mutant at residues 4, 9, 10, 13, and 14 calculated based on their corresponding standard chemical shifts. Representative NMR structures and distance measurements (Å) between Cα in two intramolecular bridges. (B) RgIA bound to the hα9 nAChR subunit crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HY7">6HY7</a>); representative NMR solution structures of (C) RgIA (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JUQ">2JUQ</a>), (D) RgIA4, (E) RgIA-5533, (F) RgIA-5617, and (G) RgIA-5524. Structures are shown as stick representation with atom oxygen, nitrogen, sulfur, and iodine colored in red, blue, yellow, and purple, respectively. Cα distances were measured using PyMOL program.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/medium/jm1c00802_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. RgIA-5524 shows greatly improved stability compared with RgIA4. (A) Complete disulfide scrambling prevention was observed indicated by HPLC traces at certain time points post peptide incubation in 90% human serum at 37 °C. The front peak in the left panel is the scrambled ribbon isomer RgIA4[1,4]. (B) Stability assay of RgIA-5524 and RgIA-5533 <i>vs</i> RgIA4 in human serum. Peptides were incubated in the 90% human serum AB type (0.1 mg/mL) at 37 °C. (C) Reductive stability assay of RgIA-5524 <i>vs</i> RgIA4. Peptide samples were dissolved at 0.1 mg/mL in the presence of reduced GSH (10 equiv.) in pH 7.4 PBS and incubated at 37 °C. Statistical evaluations of the data were performed by Student’s <i>t</i> (unpaired) test. All results are expressed as means ± SD (<i>n</i> = 3), **<i>P</i> < 0.01, ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00802/20210629/images/large/jm1c00802_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00802&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colloca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhassira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickenson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarnitsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccleston, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, S. N.</span></span> <span> </span><span class="NLM_article-title">Neuropathic pain</span>. <i>Nat. Rev. Dis. Primers.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17002</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2017.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fnrdp.2017.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28205574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A280%3ADC%252BC1c3nsFWqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=17002&author=L.+Collocaauthor=T.+Ludmanauthor=D.+Bouhassiraauthor=R.+Baronauthor=A.+H.+Dickensonauthor=D.+Yarnitskyauthor=R.+Freemanauthor=A.+Truiniauthor=N.+Attalauthor=N.+B.+Finnerupauthor=C.+Ecclestonauthor=E.+Kalsoauthor=D.+L.+Bennettauthor=R.+H.+Dworkinauthor=S.+N.+Raja&title=Neuropathic+pain&doi=10.1038%2Fnrdp.2017.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain</span></div><div class="casAuthors">Colloca Luana; Ludman Taylor; Bouhassira Didier; Baron Ralf; Dickenson Anthony H; Yarnitsky David; Freeman Roy; Truini Andrea; Attal Nadine; Finnerup Nanna B; Eccleston Christopher; Eccleston Christopher; Kalso Eija; Bennett David L; Dworkin Robert H; Raja Srinivasa N</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7-10% of the general population.  Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the ageing global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy.  Indeed, imbalances between excitatory and inhibitory somatosensory signalling, alterations in ion channels and variability in the way that pain messages are modulated in the central nervous system all have been implicated in neuropathic pain.  The burden of chronic neuropathic pain seems to be related to the complexity of neuropathic symptoms, poor outcomes and difficult treatment decisions.  Importantly, quality of life is impaired in patients with neuropathic pain owing to increased drug prescriptions and visits to health care providers, as well as the morbidity from the pain itself and the inciting disease.  Despite challenges, progress in the understanding of the pathophysiology of neuropathic pain is spurring the development of new diagnostic procedures and personalized interventions, which emphasize the need for a multidisciplinary approach to the management of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtG6bfcFGVpLJzI8owOhpDfW6udTcc2eYcpbe9jjJWCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3nsFWqsQ%253D%253D&md5=003498925636e0a417267ad96d446782</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2017.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2017.2%26sid%3Dliteratum%253Aachs%26aulast%3DColloca%26aufirst%3DL.%26aulast%3DLudman%26aufirst%3DT.%26aulast%3DBouhassira%26aufirst%3DD.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26aulast%3DYarnitsky%26aufirst%3DD.%26aulast%3DFreeman%26aufirst%3DR.%26aulast%3DTruini%26aufirst%3DA.%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DEccleston%26aufirst%3DC.%26aulast%3DKalso%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26atitle%3DNeuropathic%2520pain%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers.%26date%3D2017%26volume%3D3%26spage%3D17002%26doi%3D10.1038%2Fnrdp.2017.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murnion, B. P.</span></span> <span> </span><span class="NLM_article-title">Neuropathic Pain: Current Definition and Review of Drug Treatment</span>. <i>Aust. Prescr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.18773/austprescr.2018.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.18773%2Faustprescr.2018.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=29921999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A280%3ADC%252BC1Mbpt1Knsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=60-63&author=B.+P.+Murnion&title=Neuropathic+Pain%3A+Current+Definition+and+Review+of+Drug+Treatment&doi=10.18773%2Faustprescr.2018.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain: current definition and review of drug treatment</span></div><div class="casAuthors">Murnion Bridin P</div><div class="citationInfo"><span class="NLM_cas:title">Australian prescriber</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">60-63</span>
        ISSN:<span class="NLM_cas:issn">0312-8008</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtGXiLlyciwZZoeNcnHOQ9fW6udTcc2ebxKw-FdR9SDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mbpt1Knsg%253D%253D&md5=542c0155bcea11e8420f9906d4a7ca03</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.18773%2Faustprescr.2018.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18773%252Faustprescr.2018.022%26sid%3Dliteratum%253Aachs%26aulast%3DMurnion%26aufirst%3DB.%2BP.%26atitle%3DNeuropathic%2520Pain%253A%2520Current%2520Definition%2520and%2520Review%2520of%2520Drug%2520Treatment%26jtitle%3DAust.%2520Prescr.%26date%3D2018%26volume%3D41%26spage%3D60%26epage%3D63%26doi%3D10.18773%2Faustprescr.2018.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brady, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Back, S. E.</span></span> <span> </span><span class="NLM_article-title">Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update</span>. <i>Am. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1176/appi.ajp.2015.15020262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1176%2Fappi.ajp.2015.15020262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=26337039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A280%3ADC%252BC287ptVensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=18-26&author=K.+T.+Bradyauthor=J.+L.+McCauleyauthor=S.+E.+Back&title=Prescription+Opioid+Misuse%2C+Abuse%2C+and+Treatment+in+the+United+States%3A+An+Update&doi=10.1176%2Fappi.ajp.2015.15020262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update</span></div><div class="casAuthors">Brady Kathleen T; McCauley Jenna L; Back Sudie E</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Prescription opioid abuse and dependence have escalated rapidly in the United States over the past 20 years, leading to high rates of overdose deaths and a dramatic increase in the number of people seeking treatment for opioid dependence.  The authors review the scope of the abuse and overdose epidemic, prescription practices, and the assessment, treatment, and prevention of prescription opioid misuse and dependence.  METHOD:  The authors provide an overview of the literature from 2006 to the present, with the twin goals of highlighting advances in prevention and treatment and identifying remaining gaps in the science.  RESULTS:  A number of policy and educational initiatives at the state and federal government level have been undertaken in the past 5 years to help providers and consumers, respectively, prescribe and use opioids more responsibly.  Initial reports suggest that diversion and abuse levels have begun to plateau, likely as a result of these initiatives.  While there is a large body of research suggesting that opioid substitution coupled with psychosocial interventions is the best treatment option for heroin dependence, there is limited research focusing specifically on the treatment of prescription opioid dependence.  In particular, the treatment of chronic pain in individuals with prescription opioid use disorders is underexplored.  CONCLUSIONS:  While policy and educational initiatives appear to be effective in decreasing prescription opioid abuse and misuse, research focusing on the development and evaluation of treatments specific to prescription opioid dependence and its common comorbidities (e.g., chronic pain, depression) is critically needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvfVgf-x3X7NHxxy173TfNfW6udTcc2ebxKw-FdR9SDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ptVensw%253D%253D&md5=ab766e00ee16e8a1ceaf763c59128d9d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2015.15020262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2015.15020262%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DK.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BL.%26aulast%3DBack%26aufirst%3DS.%2BE.%26atitle%3DPrescription%2520Opioid%2520Misuse%252C%2520Abuse%252C%2520and%2520Treatment%2520in%2520the%2520United%2520States%253A%2520An%2520Update%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2016%26volume%3D173%26spage%3D18%26epage%3D26%26doi%3D10.1176%2Fappi.ajp.2015.15020262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burke, D. S.</span></span> <span> </span><span class="NLM_article-title">Forecasting the Opioid Epidemic</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">529</span>, <span class="refDoi"> DOI: 10.1126/science.aal2943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1126%2Fscience.aal2943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=27811241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCmsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2016&pages=529&author=D.+S.+Burke&title=Forecasting+the+Opioid+Epidemic&doi=10.1126%2Fscience.aal2943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Forecasting the opioid epidemic</span></div><div class="casAuthors">Burke, Donald S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">6312</span>),
    <span class="NLM_cas:pages">529</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXwaOiXEwDCLVg90H21EOLACvtfcHk0lhHfsQVtfj3ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCmsr%252FM&md5=883cf8ce5827e2e45af8d71235298696</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.aal2943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aal2943%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DD.%2BS.%26atitle%3DForecasting%2520the%2520Opioid%2520Epidemic%26jtitle%3DScience%26date%3D2016%26volume%3D354%26spage%3D529%26doi%3D10.1126%2Fscience.aal2943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span> <span> </span><span class="NLM_article-title">The Opioid Epidemic: Crisis and Solutions</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-010617-052534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1146%2Fannurev-pharmtox-010617-052534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28968188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsF2hurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2018&pages=143-159&author=P.+Skolnick&title=The+Opioid+Epidemic%3A+Crisis+and+Solutions&doi=10.1146%2Fannurev-pharmtox-010617-052534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Opioid Epidemic: Crisis and Solutions</span></div><div class="casAuthors">Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-159</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">The widespread abuse of prescription opioids and a dramatic increase in the availability of illicit opioids have created what is commonly referred to as the opioid epidemic.  The magnitude of this epidemic is startling: About 4% of the adult US population misuses prescription opioids, and in 2015, more than 33,000 deaths were attributable to overdose with licit and illicit opioids.  Increasing the availability of medication-assisted treatments (such as buprenorphine and naltrexone), the use of abuse-deterrent formulations, and the adoption of US Centers for Disease Control and Prevention prescribing guidelines all constitute short-term approaches to quell this epidemic.  However, with more than 125 million Americans suffering from either acute or chronic pain, the development of effective alternatives to opioids, enabled at least in part by a fuller understanding of the neurobiol. bases of pain, offers the best long-term soln. for controlling and ultimately eradicating this epidemic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfFMgljpaLo7Vg90H21EOLACvtfcHk0lhHfsQVtfj3ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2hurzP&md5=af8d4dfe44cab36c82163e4e06e9ac61</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010617-052534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010617-052534%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DThe%2520Opioid%2520Epidemic%253A%2520Crisis%2520and%2520Solutions%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2018%26volume%3D58%26spage%3D143%26epage%3D159%26doi%3D10.1146%2Fannurev-pharmtox-010617-052534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1016/j.nurt.2009.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.nurt.2009.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=19789073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=693-702&author=L.-J.+Wuauthor=M.+Zhuo&title=Targeting+the+NMDA+Receptor+Subunit+NR2B+for+the+Treatment+of+Neuropathic+Pain&doi=10.1016%2Fj.nurt.2009.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain</span></div><div class="casAuthors">Wu, Long-Jun; Zhuo, Min</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-702</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1933-7213</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain is generally defined as a chronic pain state resulting from peripheral or central nerve injury, or both.  An effective treatment for neuropathic pain is still lacking.  The NMDA receptor, one type of the ionotropic glutamate receptors, is known to be important for triggering long-lasting changes in synapses.  NMDA receptor-dependent synaptic plasticity plays roles not only in physiol. functions such as learning and memory, but also in unwanted pathol. conditions such as chronic pain.  This review addresses recent progress on NMDA receptors in neuropathic pain, with particular emphasis on the NR2B-subunit-contg. receptors.  The expression and function of NMDA receptors in synaptic plasticity in the pain transmission pathway from dorsal root ganglia to the anterior cingulate cortex is reviewed, and preclin. and clin. investigations of selective NMDA receptor in neuropathic pain are discussed.  The NMDA receptors, in particular NR2B-contg. NMDA receptors, serve as promising targets for treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJj_EcDQHnR7Vg90H21EOLACvtfcHk0lgfLRiAnxcEdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKqu7g%253D&md5=b68285897a56e8c4e2b02233cf2c8de7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.nurt.2009.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nurt.2009.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.-J.%26aulast%3DZhuo%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520NMDA%2520Receptor%2520Subunit%2520NR2B%2520for%2520the%2520Treatment%2520of%2520Neuropathic%2520Pain%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D693%26epage%3D702%26doi%3D10.1016%2Fj.nurt.2009.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidders, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skerratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Ion Channels as Therapeutic Targets: A Drug Discovery Perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1021/jm3011433</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3011433" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=593-624&author=S.+K.+Bagalauthor=A.+D.+Brownauthor=P.+J.+Coxauthor=K.+Omotoauthor=R.+M.+Owenauthor=D.+C.+Prydeauthor=B.+Siddersauthor=S.+E.+Skerrattauthor=E.+B.+Stevensauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Ion+Channels+as+Therapeutic+Targets%3A+A+Drug+Discovery+Perspective&doi=10.1021%2Fjm3011433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ion Channels as Therapeutic Targets: A Drug Discovery Perspective</span></div><div class="casAuthors">Bagal, Sharan K.; Brown, Alan D.; Cox, Peter J.; Omoto, Kiyoyuki; Owen, Robert M.; Pryde, David C.; Sidders, Benjamin; Skerratt, Sarah E.; Stevens, Edward B.; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">593-624</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Ion channels are membrane proteins expressed in almost all living cells.  The sequencing of the human genome has identified more than 400 putative ion channels, but only a fraction of these have been cloned and functionally tested.  The widespread tissue distribution of ion channels, coupled with the plethora of physiol. consequences of their opening and closing, makes ion-channel-targeted drug discovery highly compelling.  However, despite some important drugs in clin. use today, as a class, ion channels remain underexploited in drug discovery and many existing drugs are poorly selective with significant toxicities or suboptimal efficacy.  This Perspective seeks to review the ion channel family, its structural and functional features, and the diseases that are known to be modulated by members of the family.  In particular, we will explore the structure and properties of known ligands and consider the future prospects for drug discovery in this challenging but high potential area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4sRMpezV_yLVg90H21EOLACvtfcHk0lgfLRiAnxcEdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsbbN&md5=aa6f69a2a48003055d10bd75d4575ee4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm3011433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3011433%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DOwen%26aufirst%3DR.%2BM.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DSidders%26aufirst%3DB.%26aulast%3DSkerratt%26aufirst%3DS.%2BE.%26aulast%3DStevens%26aufirst%3DE.%2BB.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DIon%2520Channels%2520as%2520Therapeutic%2520Targets%253A%2520A%2520Drug%2520Discovery%2520Perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D593%26epage%3D624%26doi%3D10.1021%2Fjm3011433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de%0ALera+Ruizauthor=R.+L.+Kraus&title=Voltage-Gated+Sodium+Channels%3A+Structure%2C+Function%2C+Pharmacology%2C+and+Clinical+Indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0lh-UtEv4QmgIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-Gated%2520Sodium%2520Channels%253A%2520Structure%252C%2520Function%252C%2520Pharmacology%252C%2520and%2520Clinical%2520Indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajouhesh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckley, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delwig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Bois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, J. C.</span></span> <span> </span><span class="NLM_article-title">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8695</span>– <span class="NLM_lpage">8710</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01906</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8695-8710&author=J.+V.+Mulcahyauthor=H.+Pajouheshauthor=J.+T.+Beckleyauthor=A.+Delwigauthor=J.+Du+Boisauthor=J.+C.+Hunter&title=Challenges+and+Opportunities+for+Therapeutics+Targeting+the+Voltage-Gated+Sodium+Channel+Isoform+NaV1.7&doi=10.1021%2Facs.jmedchem.8b01906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7</span></div><div class="casAuthors">Mulcahy, John V.; Pajouhesh, Hassan; Beckley, Jacob T.; Delwig, Anton; Du Bois, J.; Hunter, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8695-8710</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium ion channel subtype 1.7 (NaV1.7) is a high interest target for the discovery of non-opioid analgesics.  Compelling evidence from human genetic data, particularly the finding that persons lacking functional NaV1.7 are insensitive to pain, has spurred considerable effort to develop selective inhibitors of this Na+ ion channel target as analgesic medicines.  Recent clin. setbacks and disappointing performance of preclin. compds. in animal pain models, however, have led to skepticism around the potential of selective NaV1.7 inhibitors as human therapeutics.  In this Perspective, we discuss the attributes and limitations of recently disclosed investigational drugs targeting NaV1.7, and review evidence that, by better understanding the requirements for selectivity and target engagement, the opportunity to deliver effective analgesic medicines targeting NaV1.7 endures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLRid0FL5Uk7Vg90H21EOLACvtfcHk0lh-UtEv4QmgIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFCiurw%253D&md5=414a1a2ba5f68684ae8a6fbba812b1f5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01906%26sid%3Dliteratum%253Aachs%26aulast%3DMulcahy%26aufirst%3DJ.%2BV.%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DBeckley%26aufirst%3DJ.%2BT.%26aulast%3DDelwig%26aufirst%3DA.%26aulast%3DDu%2BBois%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DChallenges%2520and%2520Opportunities%2520for%2520Therapeutics%2520Targeting%2520the%2520Voltage-Gated%2520Sodium%2520Channel%2520Isoform%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8695%26epage%3D8710%26doi%3D10.1021%2Facs.jmedchem.8b01906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortright, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eid, S. R.</span></span> <span> </span><span class="NLM_article-title">The Vanilloid Receptor TRPV1: 10 Years from Channel Cloning to Antagonist Proof-of-Concept</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1038/nrd2280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fnrd2280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=17464295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslyiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=357-372&author=A.+Szallasiauthor=D.+N.+Cortrightauthor=C.+A.+Blumauthor=S.+R.+Eid&title=The+Vanilloid+Receptor+TRPV1%3A+10+Years+from+Channel+Cloning+to+Antagonist+Proof-of-Concept&doi=10.1038%2Fnrd2280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept</span></div><div class="casAuthors">Szallasi, Arpad; Cortright, Daniel N.; Blum, Charles A.; Eid, Samer R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-372</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The clin. use of TRPV1 (transient receptor potential vanilloid subfamily, member 1; also known as VR1) antagonists is based on the concept that endogenous agonists acting on TRPV1 might provide a major contribution to certain pain conditions.  Indeed, a no. of small-mol. TRPV1 antagonists are already undergoing Phase I/II clin. trials for the indications of chronic inflammatory pain and migraine.  Moreover, animal models suggest a therapeutic value for TRPV1 antagonists in the treatment of other types of pain, including pain from cancer.  We argue that TRPV1 antagonists alone or in conjunction with other analgesics will improve the quality of life of people with migraine, chronic intractable pain secondary to cancer, AIDS or diabetes.  Moreover, emerging data indicate that TRPV1 antagonists could also be useful in treating disorders other than pain, such as urinary urge incontinence, chronic cough and irritable bowel syndrome.  The lack of effective drugs for treating many of these conditions highlights the need for further investigation into the therapeutic potential of TRPV1 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUDqlPg9Oh7Vg90H21EOLACvtfcHk0liZp2b_KlfI8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslyiu7Y%253D&md5=6ddc7988d2b5924320b46cd89196b9d8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd2280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2280%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26aulast%3DCortright%26aufirst%3DD.%2BN.%26aulast%3DBlum%26aufirst%3DC.%2BA.%26aulast%3DEid%26aufirst%3DS.%2BR.%26atitle%3DThe%2520Vanilloid%2520Receptor%2520TRPV1%253A%252010%2520Years%2520from%2520Channel%2520Cloning%2520to%2520Antagonist%2520Proof-of-Concept%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2007%26volume%3D6%26spage%3D357%26epage%3D372%26doi%3D10.1038%2Fnrd2280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, E. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, E. F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkondon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, S. W.</span></span> <span> </span><span class="NLM_article-title">Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1152/physrev.00015.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1152%2Fphysrev.00015.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=19126755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Cqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=73-120&author=E.+X.+Albuquerqueauthor=E.+F.+R.+Pereiraauthor=M.+Alkondonauthor=S.+W.+Rogers&title=Mammalian+Nicotinic+Acetylcholine+Receptors%3A+From+Structure+to+Function&doi=10.1152%2Fphysrev.00015.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian nicotinic acetylcholine receptors: from structure to function</span></div><div class="casAuthors">Albuquerque, Edson X.; Pereira, Edna F. R.; Alkondon, Manickavasagom; Rogers, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-120</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The classical studies of nicotine by Langley at the turn of the 20th century introduced the concept of a "receptive substance," from which the idea of a "receptor" came to light.  Subsequent studies aided by the Torpedo elec. organ, a rich source of muscle-type nicotinic receptors (nAChRs), and the discovery of α-bungarotoxin, a snake toxin that binds pseudo-irreversibly to the muscle nAChR, resulted in the muscle nAChR being the best characterized ligand-gated ion channel hitherto.  With the advancement of functional and genetic studies in the late 1980s, the existence of nAChRs in the mammalian brain was confirmed and the realization that the numerous nAChR subtypes contribute to the psychoactive properties of nicotine and other drugs of abuse and to the neuropathol. of various diseases, including Alzheimer's, Parkinson's, and schizophrenia, has since emerged.  This review provides a comprehensive overview of these findings and the more recent revelations of the impact that the rich diversity in function and expression of this receptor family has on neuronal and nonneuronal cells throughout the body.  Despite these numerous developments, our understanding of the contributions of specific neuronal nAChR subtypes to the many facets of physiol. throughout the body remains in its infancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5h0p4UKbZkbVg90H21EOLACvtfcHk0lgUTSoGSRsESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Cqtrw%253D&md5=aa33a8cc5ac9736725840588b9fc191c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00015.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00015.2008%26sid%3Dliteratum%253Aachs%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DPereira%26aufirst%3DE.%2BF.%2BR.%26aulast%3DAlkondon%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DS.%2BW.%26atitle%3DMammalian%2520Nicotinic%2520Acetylcholine%2520Receptors%253A%2520From%2520Structure%2520to%2520Function%26jtitle%3DPhysiol.%2520Rev.%26date%3D2009%26volume%3D89%26spage%3D73%26epage%3D120%26doi%3D10.1152%2Fphysrev.00015.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lester, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lummis, S. C. R.</span></span> <span> </span><span class="NLM_article-title">The Structural Basis of Function in Cys-loop Receptors</span>. <i>Q. Rev. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1017/s0033583510000168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1017%2FS0033583510000168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=20849671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGitbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2010&pages=449-499&author=A.+J.+Thompsonauthor=H.+A.+Lesterauthor=S.+C.+R.+Lummis&title=The+Structural+Basis+of+Function+in+Cys-loop+Receptors&doi=10.1017%2Fs0033583510000168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The structural basis of function in Cys-loop receptors</span></div><div class="casAuthors">Thompson, Andrew J.; Lester, Henry A.; Lummis, Sarah C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Quarterly Reviews of Biophysics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-499</span>CODEN:
                <span class="NLM_cas:coden">QURBAW</span>;
        ISSN:<span class="NLM_cas:issn">0033-5835</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  Cys-loop receptors are membrane-spanning neurotransmitter-gated ion channels that are responsible for fast excitatory and inhibitory transmission in the peripheral and central nervous systems.  The best studied members of the Cys-loop family are nACh, 5-HT3, GABAA and glycine receptors.  All these receptors share a common structure of five subunits, pseudo-sym. arranged to form a rosette with a central ion-conducting pore.  Some are cation selective (e.g. nACh and 5-HT3) and some are anion selective (e.g. GABAA and glycine).  Each receptor has an extracellular domain (ECD) that contains the ligand-binding sites, a transmembrane domain (TMD) that allows ions to pass across the membrane, and an intracellular domain (ICD) that plays a role in channel conductance and receptor modulation.  Cys-loop receptors are the targets for many currently used clin. relevant drugs (e.g. benzodiazepines and anesthetics).  Understanding the mol. mechanisms of these receptors could therefore provide the catalyst for further development in this field, as well as promoting the development of exptl. techniques for other areas of neuro-science.In this review, we present our current understanding of Cys-loop receptor structure and function.  The ECD has been extensively studied.  Research in this area has been stimulated in recent years by the publication of high-resoln. structures of nACh receptors and related proteins, which have permitted the creation of many Cys loop receptor homol. models of this region.  Here, using the 5-HT3 receptor as a typical member of the family, we describe how homol. modeling and ligand docking can provide useful but not definitive information about ligand interactions.  We briefly consider some of the many Cys-loop receptors modulators.  We discuss the current understanding of the structure of the TMD, and how this links to the ECD to allow channel gating, and consider the roles of the ICD, whose structure is poorly understood.  We also describe some of the current methods that are beginning to reveal the differences between different receptor states, and may ultimately show structural details of transitions between them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVJDk3Q9tLCbVg90H21EOLACvtfcHk0lgUTSoGSRsESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGitbfL&md5=4cc49b8ab933a4a53af023c525b64578</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1017%2FS0033583510000168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0033583510000168%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DLummis%26aufirst%3DS.%2BC.%2BR.%26atitle%3DThe%2520Structural%2520Basis%2520of%2520Function%2520in%2520Cys-loop%2520Receptors%26jtitle%3DQ.%2520Rev.%2520Biophys.%26date%3D2010%26volume%3D43%26spage%3D449%26epage%3D499%26doi%3D10.1017%2Fs0033583510000168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anand, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span> <span> </span><span class="NLM_article-title">Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes have a Pentameric Quaternary Structure</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">11192</span>– <span class="NLM_lpage">11198</span>, <span class="refDoi"> DOI: 10.1016/s0021-9258(18)99147-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2FS0021-9258%2818%2999147-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=2040627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADyaK3MXks1Ort74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=11192-11198&author=R.+Anandauthor=W.+G.+Conroyauthor=R.+Schoepferauthor=P.+Whitingauthor=J.+Lindstrom&title=Neuronal+Nicotinic+Acetylcholine+Receptors+Expressed+in+Xenopus+Oocytes+have+a+Pentameric+Quaternary+Structure&doi=10.1016%2Fs0021-9258%2818%2999147-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure</span></div><div class="casAuthors">Anand, Rene; Conroy, William G.; Schoepfer, Ralf; Whiting, Paul; Lindstrom, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">11192-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The subunit stoichiometry of chicken neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes was detd. by quantitation of the amt. of radioactivity in individual subunits of [35S]methionine-labeled receptors.  The chicken neuronal nicotinic acetylcholine receptor appears to be a pentamer of 2α4 acetylcholine-binding subunits and 3β2 structural subunits.  These expressed receptors bind L-[3H]nicotine with high affinity, are transposed to the surface of the oocyte outer membrane, and cosediment on sucrose gradients with acetylcholine receptors isolated from chicken brain.  By using this unique and generally applicable method of detg. subunit stoichiometry of receptors expressed in oocytes, the expected (α1)2β1γδ stoichiometry was obtained for muscle-type acetylcholine receptors assembled from coexpression of either Torpedo α1 or human α1 subunits, with Torpedo β1, γ, and δ subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqZD5fdhaDBbVg90H21EOLACvtfcHk0lgUTSoGSRsESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXks1Ort74%253D&md5=9dd5b2c1e749ffa366b85e75b9381ba6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2999147-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252999147-7%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DConroy%26aufirst%3DW.%2BG.%26aulast%3DSchoepfer%26aufirst%3DR.%26aulast%3DWhiting%26aufirst%3DP.%26aulast%3DLindstrom%26aufirst%3DJ.%26atitle%3DNeuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%2520Expressed%2520in%2520Xenopus%2520Oocytes%2520have%2520a%2520Pentameric%2520Quaternary%2520Structure%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D11192%26epage%3D11198%26doi%3D10.1016%2Fs0021-9258%2818%2999147-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umana, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGehee, D. S.</span></span> <span> </span><span class="NLM_article-title">Neuronal Nicotinic Receptors as Analgesic Targets: It’s a Winding Road</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1208</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2013.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.bcp.2013.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=23948066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGrurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=1208-1214&author=I.+C.+Umanaauthor=C.+A.+Danieleauthor=D.+S.+McGehee&title=Neuronal+Nicotinic+Receptors+as+Analgesic+Targets%3A+It%E2%80%99s+a+Winding+Road&doi=10.1016%2Fj.bcp.2013.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors as analgesic targets: It's a winding road</span></div><div class="casAuthors">Umana, Iboro C.; Daniele, Claire A.; McGehee, Daniel S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1208-1214</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Along with their well known role in nicotine addiction and autonomic physiol., neuronal nicotinic receptors (nAChRs) also have profound analgesic effects in animal models and humans.  This is not a new idea, even in the early 1500s, soon after tobacco was introduced to the new world, its proponents listed pain relief among the beneficial properties of smoking.  In recent years, analgesics that target specific nAChR subtypes have shown highly efficacious antinociceptive properties in acute and chronic pain models.  To date, the side effects of these drugs have precluded their advancement to the clinic.  This review summarizes the recent efforts to identify novel analgesics that target nAChRs, and outlines some of the key neural substrates that contribute to these physiol. effects.  There remain many unanswered mechanistic questions in this field, and there are still compelling reasons to explore neuronal nAChRs as targets for the relief of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotPcztI6nLt7Vg90H21EOLACvtfcHk0liNSnooHRp71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGrurzJ&md5=23c9429a6a857df03ee6ce9b67e7928e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DUmana%26aufirst%3DI.%2BC.%26aulast%3DDaniele%26aufirst%3DC.%2BA.%26aulast%3DMcGehee%26aufirst%3DD.%2BS.%26atitle%3DNeuronal%2520Nicotinic%2520Receptors%2520as%2520Analgesic%2520Targets%253A%2520It%25E2%2580%2599s%2520a%2520Winding%2520Road%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26spage%3D1208%26epage%3D1214%26doi%3D10.1016%2Fj.bcp.2013.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincler, M.</span></span> <span> </span><span class="NLM_article-title">Neuronal Nicotinic Receptors as Targets for Novel Analgesics</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1191</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1517/13543784.14.10.1191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1517%2F13543784.14.10.1191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=16185161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVehsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1191-1198&author=M.+Vincler&title=Neuronal+Nicotinic+Receptors+as+Targets+for+Novel+Analgesics&doi=10.1517%2F13543784.14.10.1191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors as targets for novel analgesics</span></div><div class="casAuthors">Vincler, Michelle</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1191-1198</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The potential use of nicotinic acetylcholine receptor agonists has been the subject of a no. of recent reviews.  Despite the promises of better things to come, few new compds. have been identified that circumvent the issues hindering the widespread use of the previously described nicotinic analgesics, mainly a narrow therapeutic window between analgesic efficacy and toxicity, and a lack of knowledge of native nicotinic acetylcholine receptor expression.  However, several recent developments have potentially opened new windows of opportunity in the use of nicotinic agents for analgesia.  A small no. of labs. have reported that peripheral nerve injury alters the pharmacol. of nicotinic receptors, resulting in a leftward shift of analgesic potency but not of toxicity.  Another important development in the pathophysiol. of neuropathic pain is the reliance of nerve injury-induced behavioral hypersensitivity on both peripheral and central neural immune interactions.  Finally, the reported neuroprotective effects of nicotine following spinal cord injury may provide an opportunity for the development of selective nicotinic agonists that are capable of attenuating chronic pain.  The current review will attempt to highlight these recent developments and outline key findings that demonstrate further opportunity for the development of nicotinic agonists as novel analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOi3sjgoNqS7Vg90H21EOLACvtfcHk0liNSnooHRp71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVehsLbP&md5=ad045b7017465e4aeaeb7a015f2744d9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.10.1191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.10.1191%26sid%3Dliteratum%253Aachs%26aulast%3DVincler%26aufirst%3DM.%26atitle%3DNeuronal%2520Nicotinic%2520Receptors%2520as%2520Targets%2520for%2520Novel%2520Analgesics%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1191%26epage%3D1198%26doi%3D10.1517%2F13543784.14.10.1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Absalom, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chebib, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elgoyhen, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincler, M.</span></span> <span> </span><span class="NLM_article-title">Alpha9 nicotinic acetylcholine receptors and the treatment of pain</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.bcp.2009.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=19477168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSmsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=693-702&author=J.+M.+McIntoshauthor=N.+Absalomauthor=M.+Chebibauthor=A.+B.+Elgoyhenauthor=M.+Vincler&title=Alpha9+nicotinic+acetylcholine+receptors+and+the+treatment+of+pain&doi=10.1016%2Fj.bcp.2009.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Alpha9 nicotinic acetylcholine receptors and the treatment of pain</span></div><div class="casAuthors">McIntosh, J. Michael; Absalom, Nathan; Chebib, Mary; Elgoyhen, Ana Belen; Vincler, Michelle</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">693-702</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronic pain is a vexing worldwide problem that causes substantial disability and consumes significant medical resources.  Although there are numerous analgesic medications, these work through a small set of mol. mechanisms.  Even when these medications are used in combination, substantial amts. of pain often remain.  It is therefore highly desirable to develop treatments that work through distinct mechanisms of action.  While agonists of nicotinic acetylcholine receptors (nAChRs) have been intensively studied, new data suggest a role for selective antagonists of nAChRs. α-Conotoxins are small peptides used offensively by carnivorous marine snails known as Conus.  A subset of these peptides known as α-conotoxins RgIA and Vc1.1 produces both acute and long lasting analgesia.  In addn., these peptides appear to accelerate the recovery of function after nerve injury, possibly through immune mediated mechanisms.  Pharmacol. anal. indicates that RgIA and Vc1.1 are selective antagonists of α9α10 nAChRs.  A recent study also reported that these α9α10 antagonists are also potent GABA-B agonists.  In the current study, we were unable to detect RgIA or Vc1.1 binding to or action on cloned GABA-B receptors expressed in HEK cells or Xenopus oocytes.  We review the background, findings and implications of use of compds. that act on α9* nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_JL-Oz_qm7Vg90H21EOLACvtfcHk0lh92IBOkogMJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSmsLjP&md5=6c280aabb216d07a17a6f066686a215f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DAbsalom%26aufirst%3DN.%26aulast%3DChebib%26aufirst%3DM.%26aulast%3DElgoyhen%26aufirst%3DA.%2BB.%26aulast%3DVincler%26aufirst%3DM.%26atitle%3DAlpha9%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520the%2520treatment%2520of%2520pain%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D693%26epage%3D702%26doi%3D10.1016%2Fj.bcp.2009.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">α9-containing nicotinic acetylcholine receptors and the modulation of pain</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">1927</span>, <span class="refDoi"> DOI: 10.1111/bph.13931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1111%2Fbph.13931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28662295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1CjsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=1915-1927&author=A.+J.+Honeauthor=D.+Serventauthor=J.+M.+McIntosh&title=%CE%B19-containing+nicotinic+acetylcholine+receptors+and+the+modulation+of+pain&doi=10.1111%2Fbph.13931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">α9-containing nicotinic acetylcholine receptors and the modulation of pain</span></div><div class="casAuthors">Hone, Arik J.; Servent, Denis; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1915-1927</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Neuropathic pain is a complex and debilitating syndrome for which there are few effective pharmacol. treatments.  Opioid-based medications are initially effective for acute pain, but tolerance to their analgesic effects quickly develops, and long-term use often leads to phys. dependence and addiction.  Furthermore, neuropathic pain is generally resistant to non-steroidal anti-inflammatory drugs.  Other classes of medications including antidepressants, antiepileptics and voltage-gated calcium channel inhibitors are only partially effective in most patients, may be assocd. with significant side effects and have few disease-modifying effects on the underlying pathol.  Medications that act through new mechanisms of action, and particularly ones that have disease-modifying properties, would be highly desirable.  In the last decade, a potential new target for the treatment of neuropathic pain has emerged: the α9-contg. nicotinic acetylcholine receptor (nAChR).  Recent studies indicate that antagonists of α9-contg. nAChRs are analgesic in animal models of neuropathic pain.  These nerve injury models include chronic constriction injury, partial sciatic nerve ligation, streptozotocin-induced diabetic neuropathy and chemotherapeutic-induced neuropathy.  This review details the history and state of the field regarding the role that α9-contg. nAChRs may play in neuropathic pain.  An alternative hypothesis that α-conotoxins exert their therapeutic effect through blocking N-type calcium channels via activation of GABAB receptors is also reviewed.  Understanding how antagonists of α9-contg. nAChRs exert their therapeutic effects may ultimately result in the development of medications that not only treat but also prevent the development of neuropathic pain states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3vMYRgMOCarVg90H21EOLACvtfcHk0lh92IBOkogMJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1CjsrnI&md5=fee4ba72b136e684770c221feefbf4b1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fbph.13931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13931%26sid%3Dliteratum%253Aachs%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DServent%26aufirst%3DD.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3D%25CE%25B19-containing%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520the%2520modulation%2520of%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D1915%26epage%3D1927%26doi%3D10.1111%2Fbph.13931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor</span>. <i>Pharmacol. Therapeut.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>222</i></span>,  <span class="NLM_fpage">107792</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2020.107792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.pharmthera.2020.107792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=33309557" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2021&pages=107792&author=X.+Liauthor=H.-S.+Taeauthor=Y.+Chuauthor=T.+Jiangauthor=D.+J.+Adamsauthor=R.+Yu&title=Medicinal+chemistry%2C+pharmacology%2C+and+therapeutic+potential+of+%CE%B1-conotoxins+antagonizing+the+%CE%B19%CE%B110+nicotinic+acetylcholine+receptor&doi=10.1016%2Fj.pharmthera.2020.107792"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2020.107792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2020.107792%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DChu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DYu%26aufirst%3DR.%26atitle%3DMedicinal%2520chemistry%252C%2520pharmacology%252C%2520and%2520therapeutic%2520potential%2520of%2520%25CE%25B1-conotoxins%2520antagonizing%2520the%2520%25CE%25B19%25CE%25B110%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DPharmacol.%2520Therapeut.%26date%3D2021%26volume%3D222%26spage%3D107792%26doi%3D10.1016%2Fj.pharmthera.2020.107792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">Counting on Natural Products for Drug Design</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchem.2479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fnchem.2479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=27219696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=531-541&author=T.+Rodriguesauthor=D.+Rekerauthor=P.+Schneiderauthor=G.+Schneider&title=Counting+on+Natural+Products+for+Drug+Design&doi=10.1038%2Fnchem.2479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Counting on natural products for drug design</span></div><div class="casAuthors">Rodrigues, Tiago; Reker, Daniel; Schneider, Petra; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their mol. frameworks have a long tradition as valuable starting points for medicinal chem. and drug discovery.  Recently, there has been a revitalization of interest in the inclusion of these chemotypes in compd. collections for screening and achieving selective target modulation.  Here the authors discuss natural-product-inspired drug discovery with a focus on recent advances in the design of synthetically tractable small mols. that mimic nature's chem.  The authors highlight the potential of innovative computational tools in processing structurally complex natural products to predict their macromol. targets and attempt to forecast the role that natural-product-derived fragments and fragment-like natural products will play in next-generation drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNR16z66-NgLVg90H21EOLACvtfcHk0ljvVQ5WXRoBww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D&md5=3f6391192d648de2a54524afafd6203a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2479%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DReker%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DCounting%2520on%2520Natural%2520Products%2520for%2520Drug%2520Design%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D531%26epage%3D541%26doi%3D10.1038%2Fnchem.2479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patridge, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareiss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinch, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, D.</span></span> <span> </span><span class="NLM_article-title">An Analysis of FDA-approved Drugs: Natural Products and Their Derivatives</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.drudis.2015.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=25617672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ejt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=204-207&author=E.+Patridgeauthor=P.+Gareissauthor=M.+S.+Kinchauthor=D.+Hoyer&title=An+Analysis+of+FDA-approved+Drugs%3A+Natural+Products+and+Their+Derivatives&doi=10.1016%2Fj.drudis.2015.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of FDA-approved drugs: natural products and their derivatives</span></div><div class="casAuthors">Patridge, Eric; Gareiss, Peter; Kinch, Michael S.; Hoyer, Denton</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">204-207</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Natural products contribute greatly to the history and landscape of new mol. entities (NMEs).  An assessment of all FDA-approved NMEs reveals that natural products and their derivs. represent over one-third of all NMEs.  Nearly one-half of these are derived from mammals, one-quarter from microbes and one-quarter from plants.  Since the 1930s, the total fraction of natural products has diminished, whereas semisynthetic and synthetic natural product derivs. have increased.  Over time, this fraction has also become enriched with microbial natural products, which represent a significant portion of approved antibiotics, including more than two-thirds of all antibacterial NMEs.  In recent years, the declining focus on natural products has impacted the pipeline of NMEs from specific classes, and this trend is likely to continue without specific investment in the pursuit of natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEdmXjG8extLVg90H21EOLACvtfcHk0ljvVQ5WXRoBww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ejt70%253D&md5=fbe216c17b12f1d6769543344f5a4dbe</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DPatridge%26aufirst%3DE.%26aulast%3DGareiss%26aufirst%3DP.%26aulast%3DKinch%26aufirst%3DM.%2BS.%26aulast%3DHoyer%26aufirst%3DD.%26atitle%3DAn%2520Analysis%2520of%2520FDA-approved%2520Drugs%253A%2520Natural%2520Products%2520and%2520Their%2520Derivatives%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2016%26volume%3D21%26spage%3D204%26epage%3D207%26doi%3D10.1016%2Fj.drudis.2015.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjørn-Yoshimoto, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramiro, I. B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yandell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellgaard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safavi-Hemami, H.</span></span> <span> </span><span class="NLM_article-title">Curses or Cures: A Review of the Numerous Benefits Versus the Biosecurity Concerns of Conotoxin Research</span>. <i>Biomedicines</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">235</span>, <span class="refDoi"> DOI: 10.3390/biomedicines8080235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3390%2Fbiomedicines8080235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFyjsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=235&author=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=I.+B.+L.+Ramiroauthor=M.+Yandellauthor=J.+M.+McIntoshauthor=B.+M.+Oliveraauthor=L.+Ellgaardauthor=H.+Safavi-Hemami&title=Curses+or+Cures%3A+A+Review+of+the+Numerous+Benefits+Versus+the+Biosecurity+Concerns+of+Conotoxin+Research&doi=10.3390%2Fbiomedicines8080235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Curses or cures: a review of the numerous benefits versus the biosecurity concerns of conotoxin research</span></div><div class="casAuthors">Bjorn-Yoshimoto, Walden E.; Ramiro, Iris Bea L.; Yandell, Mark; McIntosh, J. Michael; Olivera, Baldomero M.; Ellgaard, Lars; Safavi-Hemami, Helena</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicines</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">235</span>CODEN:
                <span class="NLM_cas:coden">BIOMID</span>;
        ISSN:<span class="NLM_cas:issn">2227-9059</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Conotoxins form a diverse group of peptide toxins found in the venom of predatory marine cone snails.  Decades of conotoxin research have provided numerous measurable scientific and societal benefits.  These include their use as a drug, diagnostic agent, drug leads, and research tools in neuroscience, pharmacol., biochem., structural biol., and mol. evolution.  Human envenomations by cone snails are rare but can be fatal.  Death by envenomation is likely caused by a small set of toxins that induce muscle paralysis of the diaphragm, resulting in respiratory arrest.  The potency of these toxins led to concerns regarding the potential development and use of conotoxins as biol. weapons.  To address this, various regulatory measures have been introduced that limit the use and access of conotoxins within the research community.  Some of these regulations apply to all of the ≈200,000 conotoxins predicted to exist in nature of which less than 0.05% are estd. to have any significant toxicity in humans.  In this review we provide an overview of the many benefits of conotoxin research, and contrast these to the perceived biosecurity concerns of conotoxins and research thereof.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc87aev7p6s7Vg90H21EOLACvtfcHk0lg9_5u5DfCxJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFyjsbvE&md5=22837f29edc765ebda9a5ffdff298870</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2Fbiomedicines8080235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiomedicines8080235%26sid%3Dliteratum%253Aachs%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DRamiro%26aufirst%3DI.%2BB.%2BL.%26aulast%3DYandell%26aufirst%3DM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DEllgaard%26aufirst%3DL.%26aulast%3DSafavi-Hemami%26aufirst%3DH.%26atitle%3DCurses%2520or%2520Cures%253A%2520A%2520Review%2520of%2520the%2520Numerous%2520Benefits%2520Versus%2520the%2520Biosecurity%2520Concerns%2520of%2520Conotoxin%2520Research%26jtitle%3DBiomedicines%26date%3D2020%26volume%3D8%26spage%3D235%26doi%3D10.3390%2Fbiomedicines8080235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, M.</span></span> <span> </span><span class="NLM_article-title">Intrathecal Ziconotide: A Review of its Use in Patients with Chronic Pain Refractory to Other Systemic or Intrathecal Analgesics</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">989</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1007/s40263-013-0107-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1007%2Fs40263-013-0107-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=23999971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSms7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=989-1002&author=M.+Sanford&title=Intrathecal+Ziconotide%3A+A+Review+of+its+Use+in+Patients+with+Chronic+Pain+Refractory+to+Other+Systemic+or+Intrathecal+Analgesics&doi=10.1007%2Fs40263-013-0107-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Intrathecal Ziconotide: A Review of Its Use in Patients with Chronic Pain Refractory to Other Systemic or Intrathecal Analgesics</span></div><div class="casAuthors">Sanford, Mark</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">989-1002</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Ziconotide (Prialt) is a synthetic conopeptide analgesic that acts by selectively antagonizing N-type voltage-gated calcium channels.  Intrathecal ziconotide is the only non-opioid intrathecal analgesic that is FDA-approved for use in patients with treatment-refractory, chronic pain.  The efficacy of intrathecal ziconotide was demonstrated in randomized, double-blind, placebo-controlled trials in patients with treatment-refractory noncancer-related pain or cancer- or AIDS-related pain.  Across trials, ziconotide recipients had significantly greater redns. in pain intensity during ziconotide treatment than those receiving placebo (primary endpoint).  At the end of the titrn. period, approx. one-sixth to one-third of patients with noncancer chronic pain and one-half with cancer- or AIDS-related pain who received ziconotide reached a pain response threshold (≥30 % redn. in the pain intensity score).  In ziconotide responders, analgesic effects were enduring, with some patients continuing treatment over extended periods.  Across trials, the chief tolerability concerns in ziconotide recipients during the titrn. phase and during extended treatment were related to CNS adverse events.  These were mostly of mild to moderate intensity, although serious adverse events were commonly attributed to ziconotide treatment, esp. in trials with rapid ziconotide titrn. and that permitted higher dosages.  In general, clin. important non-CNS adverse events were infrequent, and during the ziconotide titrn. phase, relatively few patients discontinued treatment because of adverse events.  Ongoing research will assess various strategies for selecting patients for ziconotide treatment and for enhancing its efficacy and tolerability.  At the present time, intrathecal ziconotide provides a treatment option for patients with severe, unremitting pain who have failed to respond to other intensive analgesic regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4PdXB5eyBvbVg90H21EOLACvtfcHk0lg9_5u5DfCxJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSms7zI&md5=eeabdd33fad6e0329eb2c49d0d632be7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs40263-013-0107-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-013-0107-5%26sid%3Dliteratum%253Aachs%26aulast%3DSanford%26aufirst%3DM.%26atitle%3DIntrathecal%2520Ziconotide%253A%2520A%2520Review%2520of%2520its%2520Use%2520in%2520Patients%2520with%2520Chronic%2520Pain%2520Refractory%2520to%2520Other%2520Systemic%2520or%2520Intrathecal%2520Analgesics%26jtitle%3DCNS%2520Drugs%26date%3D2013%26volume%3D27%26spage%3D989%26epage%3D1002%26doi%3D10.1007%2Fs40263-013-0107-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wulff, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophersen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colussi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandy, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarov-Yarovoy, V.</span></span> <span> </span><span class="NLM_article-title">Antibodies and Venom Peptides: New Modalities for Ion Channels</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1038/s41573-019-0013-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fs41573-019-0013-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=30728472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFKhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=339-357&author=H.+Wulffauthor=P.+Christophersenauthor=P.+Colussiauthor=K.+G.+Chandyauthor=V.+Yarov-Yarovoy&title=Antibodies+and+Venom+Peptides%3A+New+Modalities+for+Ion+Channels&doi=10.1038%2Fs41573-019-0013-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Antibodies and venom peptides: new modalities for ion channels</span></div><div class="casAuthors">Wulff, Heike; Christophersen, Palle; Colussi, Paul; Chandy, K. George; Yarov-Yarovoy, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">339-357</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Ion channels play fundamental roles in both excitable and non-excitable tissues and therefore constitute attractive drug targets for myriad neurol., cardiovascular and metabolic diseases as well as for cancer and immunomodulation.  However, achieving selectivity for specific ion channel subtypes with small-mol. drugs has been challenging, and there currently is a growing trend to target ion channels with biologics.  One approach is to improve the pharmacokinetics of existing or novel venom-derived peptides.  In parallel, after initial studies with polyclonal antibodies demonstrated the tech. feasibility of inhibiting channel function with antibodies, multiple preclin. programs are now using the full spectrum of available technologies to generate conventional monoclonal and engineered antibodies or nanobodies against extracellular loops of ion channels.  After a summary of the current state of ion channel drug discovery, this Review discusses recent developments using the purinergic receptor channel P2X purinoceptor 7 (P2X7), the voltage-gated potassium channel KV1.3 and the voltage-gated sodium channel NaV1.7 as examples of targeting ion channels with biologics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRJ4SEEcSEHbVg90H21EOLACvtfcHk0lgvDMuSGRU1sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFKhtbY%253D&md5=db019a42430ea7d47d8250a7f313d73b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41573-019-0013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-019-0013-8%26sid%3Dliteratum%253Aachs%26aulast%3DWulff%26aufirst%3DH.%26aulast%3DChristophersen%26aufirst%3DP.%26aulast%3DColussi%26aufirst%3DP.%26aulast%3DChandy%26aufirst%3DK.%2BG.%26aulast%3DYarov-Yarovoy%26aufirst%3DV.%26atitle%3DAntibodies%2520and%2520Venom%2520Peptides%253A%2520New%2520Modalities%2520for%2520Ion%2520Channels%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2019%26volume%3D18%26spage%3D339%26epage%3D357%26doi%3D10.1038%2Fs41573-019-0013-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safavi-Hemami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogan, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span> <span> </span><span class="NLM_article-title">Pain Therapeutics from Cone Snail Venoms: From Ziconotide to Novel Non-opioid Pathways</span>. <i>J. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.jprot.2018.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.jprot.2018.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=29777871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKnsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2019&pages=12-20&author=H.+Safavi-Hemamiauthor=S.+E.+Broganauthor=B.+M.+Olivera&title=Pain+Therapeutics+from+Cone+Snail+Venoms%3A+From+Ziconotide+to+Novel+Non-opioid+Pathways&doi=10.1016%2Fj.jprot.2018.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways</span></div><div class="casAuthors">Safavi-Hemami, Helena; Brogan, Shane E.; Olivera, Baldomero M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteomics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12-20</span>CODEN:
                <span class="NLM_cas:coden">JPORFQ</span>;
        ISSN:<span class="NLM_cas:issn">1874-3919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There have been numerous attempts to develop non-opioid drugs for severe pain, but the vast majority of these efforts have failed.  A notable exception is Ziconotide (Prialt), approved by the FDA in 2004.  In this review, we summarize the present status of Ziconotide as a therapeutic drug and introduce a wider framework: the potential of venom peptides from cone snails as a resource providing a continuous pipeline for the discovery of non-opioid pain therapeutics.  An auxiliary theme that we hope to develop is that these venoms, already a validated starting point for non-opioid drug leads, should also provide an opportunity for identifying novel mol. targets for future pain drugs.  This review comprises several sections: the first focuses on Ziconotide as a therapeutic (including a historical retrospective and a clin. perspective); followed by sections on other promising Conus venom peptides that are either in clin. or pre-clin. development.  We conclude with a discussion on why the outlook for discovery appears exceptionally promising.  The combination of new technologies in diverse fields, including the development of novel high-content assays and revolutionary advancements in transcriptomics and proteomics, puts us at the cusp of providing a continuous pipeline of non-opioid drug innovations for pain.  The current opioid epidemic is the deadliest drug crisis in American history.  Thus, this review on the discovery of non-opioid pain therapeutics and pathways from cone snail venoms is significant and timely.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAZhjAqPfOdLVg90H21EOLACvtfcHk0lgvDMuSGRU1sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKnsbnI&md5=561f0da69d43609f1ed00bdd9ea47dfa</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2018.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DSafavi-Hemami%26aufirst%3DH.%26aulast%3DBrogan%26aufirst%3DS.%2BE.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26atitle%3DPain%2520Therapeutics%2520from%2520Cone%2520Snail%2520Venoms%253A%2520From%2520Ziconotide%2520to%2520Novel%2520Non-opioid%2520Pathways%26jtitle%3DJ.%2520Proteomics%26date%3D2019%26volume%3D190%26spage%3D12%26epage%3D20%26doi%3D10.1016%2Fj.jprot.2018.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Layer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J.</span></span> <span> </span><span class="NLM_article-title">Conotoxins: Therapeutic Potential and Application</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.3390/md403119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3390%2Fmd403119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlWnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=119-142&author=R.+Layerauthor=J.+McIntosh&title=Conotoxins%3A+Therapeutic+Potential+and+Application&doi=10.3390%2Fmd403119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Conotoxins: Therapeutic potential and application</span></div><div class="casAuthors">Layer, Richard T.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">119-142</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI Center</span>)
        </div><div class="casAbstract">A review.  The pharmacol. variety of conotoxins, diverse peptides found in the venoms of marine cone snails, is well recognized.  Venoms from each of the estd. 500 species of cone snails contain 50 to 200 distinct biol. active peptides.  Most conotoxins characterized to date target receptors and ion channels of excitable tissues, such as ligand-gated nicotinic acetylcholine, N-methyl-D-aspartate, and type 3 serotonin receptors, as well as voltage-gated calcium, sodium, and potassium channels, and G-protein-coupled receptors including α-adrenergic, neurotensin, and vasopressin receptors, and the norepinephrine transporter.  Several conotoxins have shown promise in preclin. models of pain, convulsive disorders, stroke, neuromuscular block, and cardioprotection.  The pharmacol. selectivity of the conotoxins, coupled with the safety and efficacy demonstrated in preclin. models, has led to their investigation as human therapeutic agents.  In the following review, we will survey the pharmacol. and therapeutic rationale of those conotoxins with potential clin. application, and discuss the unique challenges that each will face in the course of their transition from venom component to human therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWd2YfMEY6EbVg90H21EOLACvtfcHk0lgvDMuSGRU1sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlWnsbs%253D&md5=b7a072aa00d3540b23a323224b4e4336</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fmd403119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd403119%26sid%3Dliteratum%253Aachs%26aulast%3DLayer%26aufirst%3DR.%26aulast%3DMcIntosh%26aufirst%3DJ.%26atitle%3DConotoxins%253A%2520Therapeutic%2520Potential%2520and%2520Application%26jtitle%3DMar.%2520Drugs%26date%3D2006%26volume%3D4%26spage%3D119%26epage%3D142%26doi%3D10.3390%2Fmd403119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Livett, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandall, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keays, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Down, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gayler, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satkunanathan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalil, Z.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Applications of Conotoxins that Target the Neuronal Nicotinic Acetylcholine Receptor</span>. <i>Toxicon</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.1016/j.toxicon.2006.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.toxicon.2006.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=16979678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WnsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=810-829&author=B.+G.+Livettauthor=D.+W.+Sandallauthor=D.+Keaysauthor=J.+Downauthor=K.+R.+Gaylerauthor=N.+Satkunanathanauthor=Z.+Khalil&title=Therapeutic+Applications+of+Conotoxins+that+Target+the+Neuronal+Nicotinic+Acetylcholine+Receptor&doi=10.1016%2Fj.toxicon.2006.07.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor</span></div><div class="casAuthors">Livett, Bruce G.; Sandall, David W.; Keays, David; Down, John; Gayler, Ken R.; Satkunanathan, Narmatha; Khalil, Zeinab</div><div class="citationInfo"><span class="NLM_cas:title">Toxicon</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">810-829</span>CODEN:
                <span class="NLM_cas:coden">TOXIA6</span>;
        ISSN:<span class="NLM_cas:issn">0041-0101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Pain therapeutics discovered by mol. mining of the expressed genome of Australian predatory cone snails are providing lead compds. for the treatment of neurol. diseases such as multiple sclerosis, shingles, diabetic neuropathy and other painful neurol. conditions.  The high specificity exhibited by these novel compds. for neuronal receptors and ion channels in the brain and nervous system indicates the high degree of selectivity that this class of neuropeptides can be expected to show when used therapeutically in humans.  A lead compd., ACV1 (conotoxin Vc1.1 from Conus victoriae), has entered Phase II clin. trials and is being developed for the treatment for neuropathic pain.  ACV1 will be targeted initially for the treatment of sciatica, shingles and diabetic neuropathy.  The compd. is a 16 amino acid peptide an antagonist of neuronal nicotinic acetylcholine receptors.  It has potent analgesic activity following s.c. or i.m. administration in several preclin. animal models of human neuropathic pain.  ACV1 may act as an analgesic by decreasing ectopic excitation in sensory nerves.  In addn. ACV1 appears to accelerate the recovery of injured nerves and tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVetpG2UlDK7Vg90H21EOLACvtfcHk0licxqKKES_sWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WnsLfN&md5=6b0e3d503f21e0e290266497af8dcba3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2006.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2006.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DLivett%26aufirst%3DB.%2BG.%26aulast%3DSandall%26aufirst%3DD.%2BW.%26aulast%3DKeays%26aufirst%3DD.%26aulast%3DDown%26aufirst%3DJ.%26aulast%3DGayler%26aufirst%3DK.%2BR.%26aulast%3DSatkunanathan%26aufirst%3DN.%26aulast%3DKhalil%26aufirst%3DZ.%26atitle%3DTherapeutic%2520Applications%2520of%2520Conotoxins%2520that%2520Target%2520the%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptor%26jtitle%3DToxicon%26date%3D2006%26volume%3D48%26spage%3D810%26epage%3D829%26doi%3D10.1016%2Fj.toxicon.2006.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akondi, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Discovery, Synthesis, and Structure-Activity Relationships of Conotoxins</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">5815</span>– <span class="NLM_lpage">5847</span>, <span class="refDoi"> DOI: 10.1021/cr400401e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400401e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVegt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=5815-5847&author=K.+B.+Akondiauthor=M.+Muttenthalerauthor=S.+Dutertreauthor=Q.+Kaasauthor=D.+J.+Craikauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Discovery%2C+Synthesis%2C+and+Structure-Activity+Relationships+of+Conotoxins&doi=10.1021%2Fcr400401e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Synthesis, and Structure-Activity Relationships of Conotoxins</span></div><div class="casAuthors">Akondi, Kalyana B.; Muttenthaler, Markus; Dutertre, Sebastien; Kaas, Quentin; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5815-5847</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Venom peptides, esp. conotoxins isolated from the venom of predatory marine snails, hold enormous promise for the development of peptide-based drugs.  Conotoxin classification, nomenclature, synthesis, structure activity relationships, and as candidates for drugs are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBcE_sYX4b2LVg90H21EOLACvtfcHk0licxqKKES_sWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVegt78%253D&md5=02f1253f5605757259436d2ecefd42a6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcr400401e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400401e%26sid%3Dliteratum%253Aachs%26aulast%3DAkondi%26aufirst%3DK.%2BB.%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DDiscovery%252C%2520Synthesis%252C%2520and%2520Structure-Activity%2520Relationships%2520of%2520Conotoxins%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D5815%26epage%3D5847%26doi%3D10.1021%2Fcr400401e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, A.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himaya, S. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Conotoxins: Chemistry and Biology</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">11510</span>– <span class="NLM_lpage">11549</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.9b00207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.9b00207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFymurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=11510-11549&author=A.-H.+Jinauthor=M.+Muttenthalerauthor=S.+Dutertreauthor=S.+W.+A.+Himayaauthor=Q.+Kaasauthor=D.+J.+Craikauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Conotoxins%3A+Chemistry+and+Biology&doi=10.1021%2Facs.chemrev.9b00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Conotoxins: Chemistry and Biology</span></div><div class="casAuthors">Jin, Ai-Hua; Muttenthaler, Markus; Dutertre, Sebastien; Himaya, S. W. A.; Kaas, Quentin; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">11510-11549</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The venom of the marine predatory cone snails (genus Conus) has evolved for prey capture and defense, providing the basis for survival and rapid diversification of the now estd. 750+ species.  A typical Conus venom contains hundreds to thousands of bioactive peptides known as conotoxins.  These mostly disulfide-rich and well-structured peptides act on a wide range of targets such as ion channels, G protein-coupled receptors, transporters and enzymes.  Conotoxins are of interest to neuroscientists as well as drug developers due to their exquisite potency and selectivity, not just against prey but also mammalian targets, thereby providing a rich source of mol. probes and therapeutic leads.  The rise of integrated venomics has accelerated conotoxin discovery with now well over 10,000 conotoxin sequences published.  However, their structural and pharmacol. characterization lags considerably behind.  In this review, the authors highlight the diversity of new conotoxins uncovered since 2014, their three-dimensional structures and folds, novel chem. approaches to their syntheses, and their value as pharmacol. tools to unravel complex biol.  Addnl., the authors discuss challenges and future directions for the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs3xqwJjTyX7Vg90H21EOLACvtfcHk0lgKeLIuQLP9rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFymurjJ&md5=9827551d941322ef8dee8a1f12576c6f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.9b00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.9b00207%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DA.-H.%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DHimaya%26aufirst%3DS.%2BW.%2BA.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DConotoxins%253A%2520Chemistry%2520and%2520Biology%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D11510%26epage%3D11549%26doi%3D10.1021%2Facs.chemrev.9b00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Q.</span></span> <span> </span><span class="NLM_article-title">Targeting of N-Type Calcium Channels via GABAB-Receptor Activation by α-Conotoxin Vc1.1 Variants Displaying Improved Analgesic Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10198</span>– <span class="NLM_lpage">10205</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01343</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01343" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvF2mt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10198-10205&author=F.+Caiauthor=N.+Xuauthor=Z.+Liuauthor=R.+Dingauthor=S.+Yuauthor=M.+Dongauthor=S.+Wangauthor=J.+Shenauthor=H.-S.+Taeauthor=D.+J.+Adamsauthor=X.+Zhangauthor=Q.+Dai&title=Targeting+of+N-Type+Calcium+Channels+via+GABAB-Receptor+Activation+by+%CE%B1-Conotoxin+Vc1.1+Variants+Displaying+Improved+Analgesic+Activity&doi=10.1021%2Facs.jmedchem.8b01343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of N-Type Calcium Channels via GABAB-Receptor Activation by α-Conotoxin Vc1.1 Variants Displaying Improved Analgesic Activity</span></div><div class="casAuthors">Cai, Fengtao; Xu, Ning; Liu, Zhuguo; Ding, Rong; Yu, Shuo; Dong, Mingxin; Wang, Shuo; Shen, Jintao; Tae, Han-Shen; Adams, David J.; Zhang, Xuerong; Dai, Qiuyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10198-10205</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxins exhibiting analgesic activity, such as Vc1.1, have been shown to inhibit α9α10 nicotinic acetylcholine receptors (nAChRs) and GABAB-receptor (GABABR) coupled N-type (CaV2.2) calcium channels.  Here, the authors report two Vc1.1 variants, Vc1.1[N9R] and benzoyl-Vc1.1[N9R], that selectively inhibit CaV2.2 channels via GABABR activation but exhibit reduced inhibitory activity at α9α10 and other neuronal nAChR subtypes compared with Vc1.1.  Surprisingly, the analgesic activity of Vc1.1[N9R] and benzoyl-Vc1.1[N9R] was more potent than that of Vc1.1 when tested in partial sciatic nerve ligation injury and chronic constriction injury models.  Vc1.1[N9R] and benzoyl-Vc1.1[N9R] exhibited either similar or tenfold higher activity of GABABR-mediated CaV2.2 inhibition but no activity at CaV2.2 alone; however, the mechanism of increased analgesic activity is unknown.  The effects on analgesic activity and α9α10 nAChR of other Vc1.1 variations at position 9 and the N-terminus were also detd.  The findings provide new insights for designing potent inhibitors for GABABR-coupled N-type (CaV2.2) calcium channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjJ9Opc3kw8bVg90H21EOLACvtfcHk0lgKeLIuQLP9rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvF2mt7rL&md5=1b002766288bf578f5cb7a5e6339310e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01343%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DQ.%26atitle%3DTargeting%2520of%2520N-Type%2520Calcium%2520Channels%2520via%2520GABAB-Receptor%2520Activation%2520by%2520%25CE%25B1-Conotoxin%2520Vc1.1%2520Variants%2520Displaying%2520Improved%2520Analgesic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10198%26epage%3D10205%26doi%3D10.1021%2Facs.jmedchem.8b01343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iadonato, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercado, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E1825</span>– <span class="NLM_lpage">E1832</span>, <span class="refDoi"> DOI: 10.1073/pnas.1621433114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1073%2Fpnas.1621433114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28223528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E1825-E1832&author=H.+K.+Romeroauthor=S.+B.+Christensenauthor=L.+Di+Cesare+Mannelliauthor=J.+Gajewiakauthor=R.+Ramachandraauthor=K.+S.+Elmslieauthor=D.+E.+Vetterauthor=C.+Ghelardiniauthor=S.+P.+Iadonatoauthor=J.+L.+Mercadoauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Inhibition+of+%CE%B19%CE%B110+nicotinic+acetylcholine+receptors+prevents+chemotherapy-induced+neuropathic+pain&doi=10.1073%2Fpnas.1621433114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain</span></div><div class="casAuthors">Romero, Haylie K.; Christensen, Sean B.; Di Cesare Mannelli, Lorenzo; Gajewiak, Joanna; Ramachandra, Renuka; Elmslie, Keith S.; Vetter, Douglas E.; Ghelardini, Carla; Iadonato, Shawn P.; Mercado, Jose L.; Olivera, Baldomera M.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">E1825-E1832</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Opioids are first-line drugs for moderate to severe acute pain and cancer pain.  However, these medications are assocd. with severe side effects, and whether they are efficacious in treatment of chronic nonmalignant pain remains controversial.  Medications that act through alternative mol. mechanisms are critically needed.  Antagonists of α9α10 nicotinic acetylcholine receptors (nAChRs) have been proposed as an important nonopioid mechanism based on studies demonstrating prevention of neuropathol. after trauma-induced nerve injury.  However, the key α9α10 ligands characterized to date are at least two orders of magnitude less potent on human vs. rodent nAChRs, limiting their translational application.  Furthermore, an alternative proposal that these ligands achieve their beneficial effects by acting as agonists of GABAB receptors has caused confusion over whether blockade of α9α10 nAChRs is the fundamental underlying mechanism.  To address these issues definitively, we developed RgIA4, a peptide that exhibits high potency for both human and rodent α9α10 nAChRs, and was at least 1,000-fold more selective for α9α10 nAChRs vs. all other mol. targets tested, including opioid and GABAB receptors.  A daily s.c. dose of RgIA4 prevented chemotherapy-induced neuropathic pain in rats.  In wild-type mice, oxaliplatin treatment produced cold allodynia that could be prevented by RgIA4.  Addnl., in α9 KO mice, chemotherapy-induced development of cold allodynia was attenuated and the milder, temporary cold allodynia was not relieved by RgIA4.  These findings establish blockade of α9-contg. nAChRs as the basis for the efficacy of RgIA4, and that α9-contg. nAChRs are a crit. target for prevention of chronic cancer chemotherapy-induced neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_cYkcGhDBrVg90H21EOLACvtfcHk0ljcgaHhTre3mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kiu7s%253D&md5=2372b9f813b9c628cef156f7d114c7c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1621433114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1621433114%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DH.%2BK.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DRamachandra%26aufirst%3DR.%26aulast%3DElmslie%26aufirst%3DK.%2BS.%26aulast%3DVetter%26aufirst%3DD.%2BE.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DIadonato%26aufirst%3DS.%2BP.%26aulast%3DMercado%26aufirst%3DJ.%2BL.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520%25CE%25B19%25CE%25B110%2520nicotinic%2520acetylcholine%2520receptors%2520prevents%2520chemotherapy-induced%2520neuropathic%2520pain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3DE1825%26epage%3DE1832%26doi%3D10.1073%2Fpnas.1621433114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniazeff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glowatzki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">219</span>, <span class="refDoi"> DOI: 10.3389/fncel.2017.00219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3389%2Ffncel.2017.00219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28785206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2lsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=219&author=S.+B.+Christensenauthor=A.+J.+Honeauthor=I.+Rouxauthor=J.+Kniazeffauthor=J.-P.+Pinauthor=G.+Upertauthor=D.+Serventauthor=E.+Glowatzkiauthor=J.+M.+McIntosh&title=RgIA4+Potently+Blocks+Mouse+%CE%B19%CE%B110+nAChRs+and+Provides+Long+Lasting+Protection+against+Oxaliplatin-Induced+Cold+Allodynia&doi=10.3389%2Ffncel.2017.00219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">RgIA4 potently blocks mouse α9α10 nAChRs and provides long lasting protection against oxaliplatin-induced cold allodynia</span></div><div class="casAuthors">Christensen, Sean B.; Hone, Arik J.; Roux, Isabelle; Kniazeff, Julie; Pin, Jean-Philippe; Upert, Gregory; Servent, Denis; Glowatzki, Elisabeth; McIntosh, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219/1-219/12</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Transcripts for α9 and α10 nicotinic acetylcholine receptor (nAChR) subunits are found in diverse tissues.  The function of α9α10 nAChRs is best known in mechanosensory cochlear hair cells, but elsewhere their roles are less well-understood. α9α10 nAChRs have been implicated as analgesic targets and α-conotoxins that block α9α10 nAChRs produce analgesia.  However, some of these peptides show large potency differences between species.  Addnl. several studies have indicated that these conotoxins may also activate GABAB receptors (GABABRs).  To further address these issues, we cloned the cDNAs of mouse α9 and α10 nAChR subunits.  When heterologously expressed in Xenopus oocytes, the resulting α9α10 nAChRs had the expected pharmacol. of being activated by acetylcholine and choline but not by nicotine.  A conotoxin analog, RgIA4, potently, and selectively blocked mouse α9α10 nAChRs with low nanomolar affinity indicating that RgIA4 may be effectively used to study murine α9α10 nAChR function.  Previous reports indicated that RgIA4 attenuates chemotherapy-induced cold allodynia.  Here we demonstrate that RgIA4 analgesic effects following oxaliplatin treatment are sustained for 21 days after last RgIA4 administration indicating that RgIA4 may provide enduring protection against nerve damage.  RgIA4 lacks activity at GABAB receptors; a bioluminescence resonance energy transfer assay was used to demonstrate that two other analgesic α-conotoxins, Vc1.1 and AuIB, also do not activate GABABRs expressed in HEK cells.  Together these findings further support the targeting of α9α10 nAChRs in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC52uM4hSfIrVg90H21EOLACvtfcHk0ljcgaHhTre3mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2lsrbP&md5=c8180032785db70ebccb97bbbf24cb1c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2017.00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2017.00219%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DHone%26aufirst%3DA.%2BJ.%26aulast%3DRoux%26aufirst%3DI.%26aulast%3DKniazeff%26aufirst%3DJ.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DUpert%26aufirst%3DG.%26aulast%3DServent%26aufirst%3DD.%26aulast%3DGlowatzki%26aufirst%3DE.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DRgIA4%2520Potently%2520Blocks%2520Mouse%2520%25CE%25B19%25CE%25B110%2520nAChRs%2520and%2520Provides%2520Long%2520Lasting%2520Protection%2520against%2520Oxaliplatin-Induced%2520Cold%2520Allodynia%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2017%26volume%3D11%26spage%3D219%26doi%3D10.3389%2Ffncel.2017.00219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuvelis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.3390/md18010012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3390%2Fmd18010012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=12&author=P.+N.+Huynhauthor=D.+Giuvelisauthor=S.+Christensenauthor=K.+L.+Tuckerauthor=J.+M.+McIntosh&title=RgIA4+Accelerates+Recovery+from+Paclitaxel-Induced+Neuropathic+Pain+in+Rats&doi=10.3390%2Fmd18010012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3390%2Fmd18010012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd18010012%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DP.%2BN.%26aulast%3DGiuvelis%26aufirst%3DD.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DTucker%26aufirst%3DK.%2BL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DRgIA4%2520Accelerates%2520Recovery%2520from%2520Paclitaxel-Induced%2520Neuropathic%2520Pain%2520in%2520Rats%26jtitle%3DMar.%2520Drugs%26date%3D2019%26volume%3D18%26spage%3D12%26doi%3D10.3390%2Fmd18010012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberlandt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Casati, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elgoyhen, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span> <span> </span><span class="NLM_article-title">α-RgIA: A Novel Conotoxin That Specifically and Potently Blocks the α9α10 nAChR†,‡</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1511</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1021/bi0520129</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0520129" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=1511-1517&author=M.+Ellisonauthor=C.+Haberlandtauthor=M.+E.+Gomez-Casatiauthor=M.+Watkinsauthor=A.+B.+Elgoyhenauthor=J.+M.+McIntoshauthor=B.+M.+Olivera&title=%CE%B1-RgIA%3A+A+Novel+Conotoxin+That+Specifically+and+Potently+Blocks+the+%CE%B19%CE%B110+nAChR%E2%80%A0%2C%E2%80%A1&doi=10.1021%2Fbi0520129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">α-RgIA: a novel conotoxin that specifically and potently blocks the α9α10 nAChR</span></div><div class="casAuthors">Ellison, Michael; Haberlandt, Christian; Gomez-Casati, Maria Eugenia; Watkins, Maren; Elgoyhen, A. Belen; McIntosh, J. Michael; Olivera, Baldomero M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1511-1517</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The α9 and α10 nicotinic acetylcholine receptor (nAChR) subunits assemble to form the α9α10 nAChR subtype.  This receptor is believed to mediate cholinergic synaptic transmission between efferent olivocochlear fibers and the hair cells of the cochlea.  In addn. α9 and/or α10 expression has been described in dorsal root ganglion neurons, lymphocytes, skin keratinocytes, and the pars tuberalis of the pituitary.  Specific antagonists that selectively block the α9α10 channel could be valuable tools for elucidating its role in these diverse tissues.  This study describes a novel α-conotoxin from the Western Atlantic species Conus regius, α-conotoxin RgIA (α-RgIA), that is a subtype specific blocker of the α9α10 nAChR.  Alpha-RgIA belongs to the α4/3 subfamily of the α-conotoxin family; sequence and subtype specificity comparisons between α-RgIA and previously characterized α4/3 toxins indicate that the amino acids in the C-terminal half of α-RgIA are responsible for its preferential inhibition of the α9α10 nAChR subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfx5hn1KHxALVg90H21EOLACvtfcHk0lh6vzS8civEGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCjtQ%253D%253D&md5=991411e171ed4bf786cb3e7979c01f9d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi0520129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0520129%26sid%3Dliteratum%253Aachs%26aulast%3DEllison%26aufirst%3DM.%26aulast%3DHaberlandt%26aufirst%3DC.%26aulast%3DGomez-Casati%26aufirst%3DM.%2BE.%26aulast%3DWatkins%26aufirst%3DM.%26aulast%3DElgoyhen%26aufirst%3DA.%2BB.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26atitle%3D%25CE%25B1-RgIA%253A%2520A%2520Novel%2520Conotoxin%2520That%2520Specifically%2520and%2520Potently%2520Blocks%2520the%2520%25CE%25B19%25CE%25B110%2520nAChR%25E2%2580%25A0%252C%25E2%2580%25A1%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D1511%26epage%3D1517%26doi%3D10.1021%2Fbi0520129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulaj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span> <span> </span><span class="NLM_article-title">Folding of Conotoxins: Formation of the Native Disulfide Bridges During Chemical Synthesis and Biosynthesis ofConusPeptides</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1089/ars.2007.1856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1089%2Fars.2007.1856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=17961068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=141-156&author=G.+Bulajauthor=B.+M.+Olivera&title=Folding+of+Conotoxins%3A+Formation+of+the+Native+Disulfide+Bridges+During+Chemical+Synthesis+and+Biosynthesis+ofConusPeptides&doi=10.1089%2Fars.2007.1856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Folding of conotoxins: Formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides</span></div><div class="casAuthors">Bulaj, Grzegorz; Olivera, Baldomero M.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-156</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Conopeptides from >700 species of predatory marine Conus snails provide an impressive mol. diversity of cysteine-rich peptides.  Most of the estd. 50,000-100,000 distinct conopeptides are in the size range of 10-50 amino acid residues, often with multiple post-translational modifications.  The great majority contain 2-4 disulfide bridges.  As the biosynthetic and chem. prodn. of this impressive repertoire of disulfide-rich peptides has been investigated, particularly the formation of native disulfide bridges, differences between in vivo and in vitro oxidative folding have become increasingly evident.  Here, the authors provide an overview of the mol. diversity of conotoxins with an emphasis on the Cys residue patterns and disulfide frameworks.  The conotoxin folding studies reviewed include regioselective and direct oxidn. strategies, recombinant expression, optimization of folding methods, mechanisms of in vitro folding, and preliminary data on the biosynthesis of conotoxins in venom ducts.  Despite these studies, how the cone snails efficiently produce properly folded conotoxins remains unanswered.  As chemists continue to master oxidative folding techniques, insights gleaned from how conotoxins are folded in vivo will likely lead to the development of the new folding methods, as well as shed some light on fundamental mechanisms relevant to the protein folding problem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2k-lcrOMc1LVg90H21EOLACvtfcHk0lh6vzS8civEGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajs7rF&md5=9bad6a5fe0ac141fd6663a7886e26f5b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1856%26sid%3Dliteratum%253Aachs%26aulast%3DBulaj%26aufirst%3DG.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26atitle%3DFolding%2520of%2520Conotoxins%253A%2520Formation%2520of%2520the%2520Native%2520Disulfide%2520Bridges%2520During%2520Chemical%2520Synthesis%2520and%2520Biosynthesis%2520ofConusPeptides%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2008%26volume%3D10%26spage%3D141%26epage%3D156%26doi%3D10.1089%2Fars.2007.1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinaldi, S.</span></span> <span> </span><span class="NLM_article-title">Disulfide Bond Mimetics: Strategies and Challenges</span>. <i>Chem.—Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">14987</span>– <span class="NLM_lpage">14995</span>, <span class="refDoi"> DOI: 10.1002/chem.201703199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fchem.201703199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28749012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOktbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=14987-14995&author=A.+Goriauthor=P.+Gagniauthor=S.+Rinaldi&title=Disulfide+Bond+Mimetics%3A+Strategies+and+Challenges&doi=10.1002%2Fchem.201703199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfide Bond Mimetics: Strategies and Challenges</span></div><div class="casAuthors">Gori, Alessandro; Gagni, Paola; Rinaldi, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">60</span>),
    <span class="NLM_cas:pages">14987-14995</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The activity profile of many biol. relevant proteins and peptides often relies on a precise 3D structural organization.  In this context, disulfide bonds are natural covalent constraints that play a key role in driving and stabilizing the folding pattern of these mols.  Despite its prominent significance as structural motif, the disulfide bond itself is inherently unstable under physiol. conditions, posing a major limit to the use and development of disulfide-rich peptides and proteins as mol. tools and drug lead compds.  To tackle this restriction, disulfide engineering with stable functional analogs has arisen a considerable interest.  Here, the most popular approaches to disulfide replacement are reviewed and discussed with particular emphasis on advantages and limitations under both functional and synthetic perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7IExEgpIpDLVg90H21EOLACvtfcHk0lj_jt3N-GjCgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOktbbJ&md5=66c0d1b0d42d1d360ada07ee83111106</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703199%26sid%3Dliteratum%253Aachs%26aulast%3DGori%26aufirst%3DA.%26aulast%3DGagni%26aufirst%3DP.%26aulast%3DRinaldi%26aufirst%3DS.%26atitle%3DDisulfide%2520Bond%2520Mimetics%253A%2520Strategies%2520and%2520Challenges%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D14987%26epage%3D14995%26doi%3D10.1002%2Fchem.201703199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belgi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartels, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Lierop, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kompella, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, R. S.</span></span> <span> </span><span class="NLM_article-title">Dicarba Analogues of α-Conotoxin RgIA. Structure, Stability, and Activity at Potential Pain Targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9933</span>– <span class="NLM_lpage">9944</span>, <span class="refDoi"> DOI: 10.1021/jm501126u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501126u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWns7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9933-9944&author=S.+Chhabraauthor=A.+Belgiauthor=P.+Bartelsauthor=B.+J.+van+Lieropauthor=S.+D.+Robinsonauthor=S.+N.+Kompellaauthor=A.+Hungauthor=B.+P.+Callaghanauthor=D.+J.+Adamsauthor=A.+J.+Robinsonauthor=R.+S.+Norton&title=Dicarba+Analogues+of+%CE%B1-Conotoxin+RgIA.+Structure%2C+Stability%2C+and+Activity+at+Potential+Pain+Targets&doi=10.1021%2Fjm501126u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Dicarba Analogues of α-Conotoxin RgIA. Structure, Stability, and Activity at Potential Pain Targets</span></div><div class="casAuthors">Chhabra, Sandeep; Belgi, Alessia; Bartels, Peter; van Lierop, Bianca J.; Robinson, Samuel D.; Kompella, Shiva N.; Hung, Andrew; Callaghan, Brid P.; Adams, David J.; Robinson, Andrea J.; Norton, Raymond S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9933-9944</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxin RgIA is both an antagonist of the α9α10 nicotinic acetylcholine receptor (nAChR) subtype and an inhibitor of high-voltage-activated N-type calcium channel currents.  RgIA has therapeutic potential for the treatment of pain, but redn. of the disulfide bond framework under physiol. conditions represents a potential liability for clin. applications.  We synthesized four RgIA analogs that replaced native disulfide pairs with nonreducible dicarba bridges.  Soln. structures were detd. by NMR, activity assessed against biol. targets, and stability evaluated in human serum. [3,12]-Dicarba analogs retained inhibition of ACh-evoked currents at α9α10 nAChRs but not N-type calcium channel currents, whereas [2,8]-dicarba analogs displayed the opposite pattern of selectivity.  The [2,8]-dicarba RgIA analogs were effective in HEK293 cells stably expressing human Cav2.2 channels and transfected with human GABAB receptors.  The analogs also exhibited improved serum stability over the native peptide.  These selectively acting dicarba analogs may represent mechanistic probes to explore analgesia-related biol. receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1oDBKbBxsarVg90H21EOLACvtfcHk0lj_jt3N-GjCgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWns7fI&md5=9984b05b87c74f53c3c8c2c3a1aac66e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm501126u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501126u%26sid%3Dliteratum%253Aachs%26aulast%3DChhabra%26aufirst%3DS.%26aulast%3DBelgi%26aufirst%3DA.%26aulast%3DBartels%26aufirst%3DP.%26aulast%3Dvan%2BLierop%26aufirst%3DB.%2BJ.%26aulast%3DRobinson%26aufirst%3DS.%2BD.%26aulast%3DKompella%26aufirst%3DS.%2BN.%26aulast%3DHung%26aufirst%3DA.%26aulast%3DCallaghan%26aufirst%3DB.%2BP.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DRobinson%26aufirst%3DA.%2BJ.%26aulast%3DNorton%26aufirst%3DR.%2BS.%26atitle%3DDicarba%2520Analogues%2520of%2520%25CE%25B1-Conotoxin%2520RgIA.%2520Structure%252C%2520Stability%252C%2520and%2520Activity%2520at%2520Potential%2520Pain%2520Targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9933%26epage%3D9944%26doi%3D10.1021%2Fjm501126u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacRaild, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illesinghe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lierop, B. J. v.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chebib, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livett, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, R. S.</span></span> <span> </span><span class="NLM_article-title">Structure and Activity of (2,8)-Dicarba-(3,12)-cystino α-ImI, an α-Conotoxin Containing a Nonreducible Cystine Analogue</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1021/jm8011504</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8011504" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=755-762&author=C.+A.+MacRaildauthor=J.+Illesingheauthor=B.+J.+v.+Lieropauthor=A.+L.+Townsendauthor=M.+Chebibauthor=B.+G.+Livettauthor=A.+J.+Robinsonauthor=R.+S.+Norton&title=Structure+and+Activity+of+%282%2C8%29-Dicarba-%283%2C12%29-cystino+%CE%B1-ImI%2C+an+%CE%B1-Conotoxin+Containing+a+Nonreducible+Cystine+Analogue&doi=10.1021%2Fjm8011504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and Activity of (2,8)-Dicarba-(3,12)-cystino α-ImI, an α-Conotoxin Containing a Nonreducible Cystine Analogue</span></div><div class="casAuthors">MacRaild, Christopher A.; Illesinghe, Jayamini; van Lierop, Bianca J.; Townsend, Amanda L.; Chebib, Mary; Livett, Bruce G.; Robinson, Andrea J.; Norton, Raymond S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">755-762</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The α-conotoxins are potent and selective antagonists of nicotinic acetylcholine receptors (nAChR).  Exploitation of these and other peptides in research and clin. settings has been hampered by the lability of the disulfide bridges that are essential for toxin structure and activity.  One soln. to this problem is replacement of cystine bridges with non-reducible dicarba linkages.  We explore this approach by detg. the soln. structure and functional characteristics of a dicarba analog of the α-conotoxin α-ImI, (2,8)-dicarba-(3,12)-cystino α-ImI.  The structure of the dicarba analog was similar to that of native α-ImI, with differences attributable to the different covalent geometry of the disulfide and dicarba bridges.  Dicarba-α-ImI maintained inhibitory activity of nAChR comparable to that of native α-ImI in two in vitro assays.  These findings confirm the potential of the dicarba linkage to improve stability while maintaining α-conotoxin function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeo5yfSaiDCrVg90H21EOLACvtfcHk0lhRkpKiaknOPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVOhsQ%253D%253D&md5=257f9dbe0dc09ba9f2b0b31ac51d5654</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm8011504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8011504%26sid%3Dliteratum%253Aachs%26aulast%3DMacRaild%26aufirst%3DC.%2BA.%26aulast%3DIllesinghe%26aufirst%3DJ.%26aulast%3DLierop%26aufirst%3DB.%2BJ.%2Bv.%26aulast%3DTownsend%26aufirst%3DA.%2BL.%26aulast%3DChebib%26aufirst%3DM.%26aulast%3DLivett%26aufirst%3DB.%2BG.%26aulast%3DRobinson%26aufirst%3DA.%2BJ.%26aulast%3DNorton%26aufirst%3DR.%2BS.%26atitle%3DStructure%2520and%2520Activity%2520of%2520%25282%252C8%2529-Dicarba-%25283%252C12%2529-cystino%2520%25CE%25B1-ImI%252C%2520an%2520%25CE%25B1-Conotoxin%2520Containing%2520a%2520Nonreducible%2520Cystine%2520Analogue%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D755%26epage%3D762%26doi%3D10.1021%2Fjm8011504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belgi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnley, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRaild, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elnahriry, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooding, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartels, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spanswick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, A. J.</span></span> <span> </span><span class="NLM_article-title">Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">3222</span>– <span class="NLM_lpage">3233</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c02151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c02151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3MXmtlKks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2021&pages=3222-3233&author=A.+Belgiauthor=J.+V.+Burnleyauthor=C.+A.+MacRaildauthor=S.+Chhabraauthor=K.+A.+Elnahriryauthor=S.+D.+Robinsonauthor=S.+G.+Goodingauthor=H.-S.+Taeauthor=P.+Bartelsauthor=M.+Sadeghiauthor=F.-Y.+Zhaoauthor=H.+Weiauthor=D.+Spanswickauthor=D.+J.+Adamsauthor=R.+S.+Nortonauthor=A.+J.+Robinson&title=Alkyne-Bridged+%CE%B1-Conotoxin+Vc1.1+Potently+Reverses+Mechanical+Allodynia+in+Neuropathic+Pain+Models&doi=10.1021%2Facs.jmedchem.0c02151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models</span></div><div class="casAuthors">Belgi, Alessia; Burnley, James V.; MacRaild, Christopher A.; Chhabra, Sandeep; Elnahriry, Khaled A.; Robinson, Samuel D.; Gooding, Simon G.; Tae, Han-Shen; Bartels, Peter; Sadeghi, Mahsa; Zhao, Fei-Yue; Wei, Haifeng; Spanswick, David; Adams, David J.; Norton, Raymond S.; Robinson, Andrea J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3222-3233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several Conus-derived venom peptides are promising lead compds. for the management of neuropathic pain, with α-conotoxins being of particular interest.  Modification of the interlocked disulfide framework of α-conotoxin Vc1.1 has been achieved using on-resin alkyne metathesis.  Although introduction of a metabolically stable alkyne motif significantly disrupts backbone topog., the structural modification generates a potent and selective GABAB receptor agonist that inhibits Cav2.2 channels and exhibits dose-dependent reversal of mech. allodynia in a behavioral rat model of neuropathic pain.  The findings herein support the hypothesis that analgesia can be achieved via activation of GABABRs expressed in dorsal root ganglion (DRG) sensory neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmOHPYOoE1bVg90H21EOLACvtfcHk0lhRkpKiaknOPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXmtlKks7c%253D&md5=d419fea64e0aefc9b66d8f7c85733da9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c02151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c02151%26sid%3Dliteratum%253Aachs%26aulast%3DBelgi%26aufirst%3DA.%26aulast%3DBurnley%26aufirst%3DJ.%2BV.%26aulast%3DMacRaild%26aufirst%3DC.%2BA.%26aulast%3DChhabra%26aufirst%3DS.%26aulast%3DElnahriry%26aufirst%3DK.%2BA.%26aulast%3DRobinson%26aufirst%3DS.%2BD.%26aulast%3DGooding%26aufirst%3DS.%2BG.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DBartels%26aufirst%3DP.%26aulast%3DSadeghi%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DF.-Y.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DSpanswick%26aufirst%3DD.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DNorton%26aufirst%3DR.%2BS.%26aulast%3DRobinson%26aufirst%3DA.%2BJ.%26atitle%3DAlkyne-Bridged%2520%25CE%25B1-Conotoxin%2520Vc1.1%2520Potently%2520Reverses%2520Mechanical%2520Allodynia%2520in%2520Neuropathic%2520Pain%2520Models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2021%26volume%3D64%26spage%3D3222%26epage%3D3233%26doi%3D10.1021%2Facs.jmedchem.0c02151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Disulfide Surrogate Peptides Incorporating Large-Span Surrogate Bridges Through a Native-Chemical-Ligation-Assisted Diaminodiacid Strategy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6037</span>– <span class="NLM_lpage">6045</span>, <span class="refDoi"> DOI: 10.1002/anie.201915358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fanie.201915358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvF2rtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=6037-6045&author=Q.+Quauthor=S.+Gaoauthor=F.+Wuauthor=M.+G.+Zhangauthor=Y.+Liauthor=L.+H.+Zhangauthor=D.+Biererauthor=C.+L.+Tianauthor=J.+S.+Zhengauthor=L.+Liu&title=Synthesis+of+Disulfide+Surrogate+Peptides+Incorporating+Large-Span+Surrogate+Bridges+Through+a+Native-Chemical-Ligation-Assisted+Diaminodiacid+Strategy&doi=10.1002%2Fanie.201915358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of disulfide surrogate peptides incorporating large-span surrogate bridges through a native-chemical-ligation-assisted diaminodiacid strategy</span></div><div class="casAuthors">Qu, Qian; Gao, Shuai; Wu, Fangming; Zhang, Meng-Ge; Li, Ying; Zhang, Long-Hua; Bierer, Donald; Tian, Chang-Lin; Zheng, Ji-Shen; Liu, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6037-6045</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The use of synthetic bridges as surrogates for disulfide bonds has emerged as a practical strategy to obviate the poor stability of some disulfide-contg. peptides.  However, peptides incorporating large-span synthetic bridges are still beyond the reach of existing methods.  Herein, we report a native chem. ligation (NCL)-assisted diaminodiacid (DADA) strategy that enables the robust generation of disulfide surrogate peptides incorporating surrogate bridges up to 50 amino acids in length.  This strategy provides access to some highly desirable but otherwise impossible-to-obtain disulfide surrogates of bioactive peptide.  The bioactivities and structures of the synthetic disulfide surrogates were verified by voltage clamp assays, NMR, and X-ray crystallog.; and stability studies established that the disulfide replacements effectively overcame the problems of disulfide redn. and scrambling that often plague these pharmacol. important peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSuugH6oosD7Vg90H21EOLACvtfcHk0liZaBPADCiTdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvF2rtr8%253D&md5=603982e70a802b7d5bd94d7fc72b8a1c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fanie.201915358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201915358%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DM.%2BG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%2BH.%26aulast%3DBierer%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DC.%2BL.%26aulast%3DZheng%26aufirst%3DJ.%2BS.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DSynthesis%2520of%2520Disulfide%2520Surrogate%2520Peptides%2520Incorporating%2520Large-Span%2520Surrogate%2520Bridges%2520Through%2520a%2520Native-Chemical-Ligation-Assisted%2520Diaminodiacid%2520Strategy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2020%26volume%3D59%26spage%3D6037%26epage%3D6045%26doi%3D10.1002%2Fanie.201915358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-M.</span></span> <span> </span><span class="NLM_article-title">Chemical Synthesis and Biological Activity of Peptides Incorporating an Ether Bridge as a Surrogate for a Disulfide Bond</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">7927</span>– <span class="NLM_lpage">7932</span>, <span class="refDoi"> DOI: 10.1039/d0sc02374d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1039%2FD0SC02374D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=34094161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlentb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=7927-7932&author=R.+Zhaoauthor=P.+Shiauthor=J.+Chenauthor=S.+Sunauthor=J.+Chenauthor=J.+Cuiauthor=F.+Wuauthor=G.+Fangauthor=C.+Tianauthor=J.+Shiauthor=D.+Biererauthor=L.+Liuauthor=Y.-M.+Li&title=Chemical+Synthesis+and+Biological+Activity+of+Peptides+Incorporating+an+Ether+Bridge+as+a+Surrogate+for+a+Disulfide+Bond&doi=10.1039%2Fd0sc02374d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical synthesis and biological activity of peptides incorporating an ether bridge as a surrogate for a disulfide bond</span></div><div class="casAuthors">Zhao, Rui; Shi, Pan; Chen, Junyou; Sun, Shuaishuai; Chen, Jingnan; Cui, Jibin; Wu, Fangming; Fang, Gemin; Tian, Changlin; Shi, Jing; Bierer, Donald; Liu, Lei; Li, Yi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7927-7932</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Disulfide bridges contribute to the definition and rigidity of polypeptides, but they are inherently unstable in reducing environments and in the presence of isomerases and nucleophiles.  Strategies to address these deficiencies, ideally without significantly perturbing the structure of the polypeptide, would be of great interest.  One possible surrogate for the disulfide bridge is a simple thioether, but these are susceptible to oxidn.  We report the introduction of an ether linkage into the biol. active, disulfide-rich peptides oxytocin, tachyplesin I, and conotoxin α-ImI, using an ether-contg. diaminodiacid as the key building block, obtained by the stereoselective ring-opening addn. reaction of an aziridine skeleton with a hydroxy group.  NMR studies indicated that the derivs. with an ether surrogate bridge exhibited very small change of their three-dimensional structures.  The analogs obtained using this novel substitution strategy were found to be more stable than the original peptide in oxidative and reductive conditions; without a loss of bioactivity.  This strategy is therefore proposed as a practical and versatile soln. to the stability problems assocd. with cysteine-rich peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeIaXSdaqNNLVg90H21EOLACvtfcHk0liZaBPADCiTdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlentb3K&md5=9115f34ffe09e44040649a566b28eec0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2FD0SC02374D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0SC02374D%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DTian%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DBierer%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DChemical%2520Synthesis%2520and%2520Biological%2520Activity%2520of%2520Peptides%2520Incorporating%2520an%2520Ether%2520Bridge%2520as%2520a%2520Surrogate%2520for%2520a%2520Disulfide%2520Bond%26jtitle%3DChem.%2520Sci.%26date%3D2020%26volume%3D11%26spage%3D7927%26epage%3D7932%26doi%3D10.1039%2Fd0sc02374d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dekan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">α-Conotoxin ImI Incorporating Stable Cystathionine Bridges Maintains Full Potency and Identical Three-Dimensional Structure</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">15866</span>– <span class="NLM_lpage">15869</span>, <span class="refDoi"> DOI: 10.1021/ja206408q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja206408q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOqu73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=15866-15869&author=Z.+Dekanauthor=I.+Vetterauthor=N.+L.+Dalyauthor=D.+J.+Craikauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=%CE%B1-Conotoxin+ImI+Incorporating+Stable+Cystathionine+Bridges+Maintains+Full+Potency+and+Identical+Three-Dimensional+Structure&doi=10.1021%2Fja206408q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin ImI incorporating stable cystathionine bridges maintains full potency and identical three-dimensional structure</span></div><div class="casAuthors">Dekan, Zoltan; Vetter, Irina; Daly, Norelle L.; Craik, David J.; Lewis, Richard J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">15866-15869</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two disulfide bonds of α-conotoxin ImI, a peptide antagonist of the α7 nicotinic acetylcholine receptor (nAChR), were systematically replaced with isosteric redox-stable cystathionine thioethers.  Regioselective thioether formation was accomplished on solid support through substitution of a γ-chlorohomoalanine by an intramol. cysteine thiol to produce hybrid thioether/disulfide analogs (I) (X = CH2, S; Y = S, CH2) as well as a dual cystathionine analog I (X = Y = CH2) that were found to be structurally homologous to α-conotoxin ImI by 1H NMR.  The antagonistic activity at the α7 nAChR of cystathionine analog I (X = S, Y = CH2) (pIC50 = 6.41 ± 0.09) was identical to that of α-conotoxin ImI I (X = Y = S), (pIC50 = 6.41 ± 0.09), whereas those of I (X = CH2, Y = S), (pIC50 = 5.96 ± 0.09) and I (X = Y = CH2), (pIC50 = 5.89 ± 0.09) showed a modest decrease.  The effect of oxidn. of the thioethers to sulfoxides was also investigated, with significant changes in the biol. activities obsd. ranging from a > 30-fold redn. (2S=O) to a 3-fold increase (3S=OB) in potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCs0VVHBEL-bVg90H21EOLACvtfcHk0lh_lSCqDVCuIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOqu73O&md5=4005d271f1c027f04249b1dcb0a1a7d8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja206408q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206408q%26sid%3Dliteratum%253Aachs%26aulast%3DDekan%26aufirst%3DZ.%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3D%25CE%25B1-Conotoxin%2520ImI%2520Incorporating%2520Stable%2520Cystathionine%2520Bridges%2520Maintains%2520Full%2520Potency%2520and%2520Identical%2520Three-Dimensional%2520Structure%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D15866%26epage%3D15869%26doi%3D10.1021%2Fja206408q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevin, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choy, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armishaw, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noakes, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Solving the α-Conotoxin Folding Problem: Efficient Selenium-Directed On-Resin Generation of More Potent and Stable Nicotinic Acetylcholine Receptor Antagonists</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">3514</span>– <span class="NLM_lpage">3522</span>, <span class="refDoi"> DOI: 10.1021/ja910602h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja910602h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=3514-3522&author=M.+Muttenthalerauthor=S.+T.+Nevinauthor=A.+A.+Grishinauthor=S.+T.+Ngoauthor=P.+T.+Choyauthor=N.+L.+Dalyauthor=S.-H.+Huauthor=C.+J.+Armishawauthor=C.-I.+A.+Wangauthor=R.+J.+Lewisauthor=J.+L.+Martinauthor=P.+G.+Noakesauthor=D.+J.+Craikauthor=D.+J.+Adamsauthor=P.+F.+Alewood&title=Solving+the+%CE%B1-Conotoxin+Folding+Problem%3A+Efficient+Selenium-Directed+On-Resin+Generation+of+More+Potent+and+Stable+Nicotinic+Acetylcholine+Receptor+Antagonists&doi=10.1021%2Fja910602h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Solving the α-Conotoxin Folding Problem: Efficient Selenium-Directed On-Resin Generation of More Potent and Stable Nicotinic Acetylcholine Receptor Antagonists</span></div><div class="casAuthors">Muttenthaler, Markus; Nevin, Simon T.; Grishin, Anton A.; Ngo, Shyuan. T.; Choy, Peng T.; Daly, Norelle L.; Hu, Shu-Hong; Armishaw, Christopher J.; Wang, Ching-I. A.; Lewis, Richard J.; Martin, Jennifer L.; Noakes, Peter G.; Craik, David J.; Adams, David J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3514-3522</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxins are tightly folded miniproteins that antagonize nicotinic acetylcholine receptors (nAChR) with high specificity for diverse subtypes.  Here we report the use of selenocysteine in a supported phase method to direct native folding and produce α-conotoxins efficiently with improved biophys. properties.  By replacing complementary cysteine pairs with selenocysteine pairs on an amphiphilic resin, we were able to chem. direct all five structural subclasses of α-conotoxins exclusively into their native folds.  X-ray anal. at 1.4 Å resoln. of α-selenoconotoxin PnIA confirmed the isosteric character of the diselenide bond and the integrity of the α-conotoxin fold.  The α-selenoconotoxins exhibited similar or improved potency at rat diaphragm muscle and α3β4, α7, and α1β1δγ nAChRs expressed in Xenopus oocytes plus improved disulfide bond scrambling stability in plasma.  Together, these results underpin the development of more stable and potent nicotinic antagonists suitable for new drug therapies, and highlight the application of selenocysteine technol. more broadly to disulfide-bonded peptides and proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWotv-TI362bVg90H21EOLACvtfcHk0lh_lSCqDVCuIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2gsb8%253D&md5=f085a8347a2b83293731ce9eb3752f5d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja910602h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja910602h%26sid%3Dliteratum%253Aachs%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DNevin%26aufirst%3DS.%2BT.%26aulast%3DGrishin%26aufirst%3DA.%2BA.%26aulast%3DNgo%26aufirst%3DS.%2BT.%26aulast%3DChoy%26aufirst%3DP.%2BT.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DHu%26aufirst%3DS.-H.%26aulast%3DArmishaw%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DC.-I.%2BA.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DJ.%2BL.%26aulast%3DNoakes%26aufirst%3DP.%2BG.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DSolving%2520the%2520%25CE%25B1-Conotoxin%2520Folding%2520Problem%253A%2520Efficient%2520Selenium-Directed%2520On-Resin%2520Generation%2520of%2520More%2520Potent%2520and%2520Stable%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D3514%26epage%3D3522%26doi%3D10.1021%2Fja910602h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalicky, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulaj, G.</span></span> <span> </span><span class="NLM_article-title">Integrated Oxidative Folding of Cysteine/Selenocysteine Containing Peptides: Improving Chemical Synthesis of Conotoxins</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2224</span>, <span class="refDoi"> DOI: 10.1002/anie.200806085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fanie.200806085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2221-2224&author=A.+Walewskaauthor=M.-M.+Zhangauthor=J.+J.+Skalickyauthor=D.+Yoshikamiauthor=B.+M.+Oliveraauthor=G.+Bulaj&title=Integrated+Oxidative+Folding+of+Cysteine%2FSelenocysteine+Containing+Peptides%3A+Improving+Chemical+Synthesis+of+Conotoxins&doi=10.1002%2Fanie.200806085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated oxidative folding of cysteine/selenocysteine containing peptides: improving chemical synthesis of conotoxins</span></div><div class="casAuthors">Walewska, Aleksandra; Zhang, Min-min; Skalicky, Jack J.; Yoshikami, Doju; Olivera, Baldomero M.; Bulaj, Grzegorz</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2221-2224</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The use of diselenide and selectively (15N/13C)-labeled disulfide bridges is combined to give improvements in oxidative folding and disulfide mapping.  Conotoxin analogs, each with a pair of selenocysteines and 15N/13C-labeled cysteines, exhibited significantly improved folding and the labeled cysteines allow correctly folded species to be rapidly identified by NMR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYyryjjZwfTLVg90H21EOLACvtfcHk0lh_lSCqDVCuIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFemsbY%253D&md5=d32fdf537ed6e3aed6b8f980f94fb34a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.200806085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200806085%26sid%3Dliteratum%253Aachs%26aulast%3DWalewska%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.-M.%26aulast%3DSkalicky%26aufirst%3DJ.%2BJ.%26aulast%3DYoshikami%26aufirst%3DD.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DBulaj%26aufirst%3DG.%26atitle%3DIntegrated%2520Oxidative%2520Folding%2520of%2520Cysteine%252FSelenocysteine%2520Containing%2520Peptides%253A%2520Improving%2520Chemical%2520Synthesis%2520of%2520Conotoxins%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D2221%26epage%3D2224%26doi%3D10.1002%2Fanie.200806085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knuhtsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitmore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhinnie, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDougall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timperley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinnear, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, A. G.</span></span> <span> </span><span class="NLM_article-title">α-Conotoxin GI triazole-peptidomimetics: potent and stable blockers of a human acetylcholine receptor</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1671</span>– <span class="NLM_lpage">1676</span>, <span class="refDoi"> DOI: 10.1039/c8sc04198a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1039%2FC8SC04198A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit12ksL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1671-1676&author=A.+Knuhtsenauthor=C.+Whitmoreauthor=F.+S.+McWhinnieauthor=L.+McDougallauthor=R.+Whitingauthor=B.+O.+Smithauthor=C.+M.+Timperleyauthor=A.+C.+Greenauthor=K.+I.+Kinnearauthor=A.+G.+Jamieson&title=%CE%B1-Conotoxin+GI+triazole-peptidomimetics%3A+potent+and+stable+blockers+of+a+human+acetylcholine+receptor&doi=10.1039%2Fc8sc04198a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">α-Conotoxin GI triazole-peptidomimetics: Potent and stable blockers of a human acetylcholine receptor</span></div><div class="casAuthors">Knuhtsen, Astrid; Whitmore, Charlotte; McWhinnie, Fergus S.; McDougall, Laura; Whiting, Rachel; Smith, Brian O.; Timperley, Christopher M.; Green, A. Christopher; Kinnear, Kenneth I.; Jamieson, Andrew G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1671-1676</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The potency and selectivity of conotoxin peptides for neuropathic receptors has made them attractive lead compds. in the development of new therapeutics.  Specifically, α-conotoxin GI has been shown to be an unparalleled antagonist of the nicotinic acetylcholine receptor (nAChR).  However, as with other peptidic leads, poor protease resistance and the redox instability of the conotoxin scaffold limit bioactivity.  To counter this, we have employed the underutilized 1,5-disubstituted 1,2,3-triazole to act as a structural surrogate of the native disulfide bonds.  Using an efficient, on-resin ruthenium azide-alkyne cycloaddn. (RuAAC), each disulfide bond was replaced in turn and the biol. activities quantified.  One of the mimetic isomers exhibited a comparable activity to the native toxin, while the other showed no biol. effect.  The active mimetic isomer 11 was an order of magnitude more stable in plasma than the native GI.  The NMR soln. structure of the mimetic overlays extremely well with the structure for the native GI demonstrating that the triazole bridge is an exceptional surrogate for the disulfide bridge.  Development of this potent and stable mimetic of GI leads us to believe that this strategy will yield many other new conotoxin-inspired probes and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7IF9GIvxXrVg90H21EOLACvtfcHk0ljlc0HSCuZOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit12ksL7N&md5=269352a2d12961ff69140f3c53b9fdb3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC8SC04198A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC04198A%26sid%3Dliteratum%253Aachs%26aulast%3DKnuhtsen%26aufirst%3DA.%26aulast%3DWhitmore%26aufirst%3DC.%26aulast%3DMcWhinnie%26aufirst%3DF.%2BS.%26aulast%3DMcDougall%26aufirst%3DL.%26aulast%3DWhiting%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DB.%2BO.%26aulast%3DTimperley%26aufirst%3DC.%2BM.%26aulast%3DGreen%26aufirst%3DA.%2BC.%26aulast%3DKinnear%26aufirst%3DK.%2BI.%26aulast%3DJamieson%26aufirst%3DA.%2BG.%26atitle%3D%25CE%25B1-Conotoxin%2520GI%2520triazole-peptidomimetics%253A%2520potent%2520and%2520stable%2520blockers%2520of%2520a%2520human%2520acetylcholine%2520receptor%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26spage%3D1671%26epage%3D1676%26doi%3D10.1039%2Fc8sc04198a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosengren, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhola, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longhi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, A.</span></span> <span> </span><span class="NLM_article-title">Stabilization of the Cysteine-rich Conotoxin MrIA by Using a 1,2,3-Triazole as a Disulfide Bond Mimetic</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1361</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.1002/anie.201409678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fanie.201409678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVChsrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1361-1364&author=A.+Goriauthor=C.-I.+A.+Wangauthor=P.+J.+Harveyauthor=K.+J.+Rosengrenauthor=R.+F.+Bholaauthor=M.+L.+Gelmiauthor=R.+Longhiauthor=M.+J.+Christieauthor=R.+J.+Lewisauthor=P.+F.+Alewoodauthor=A.+Brust&title=Stabilization+of+the+Cysteine-rich+Conotoxin+MrIA+by+Using+a+1%2C2%2C3-Triazole+as+a+Disulfide+Bond+Mimetic&doi=10.1002%2Fanie.201409678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of the cysteine-rich conotoxin MrIA by using a 1,2,3-triazole as a disulfide bond mimetic</span></div><div class="casAuthors">Gori, Alessandro; Wang, Ching-I. A.; Harvey, Peta J.; Rosengren, K. Johan; Bhola, Rebecca F.; Gelmi, Maria L.; Longhi, Renato; Christie, Macdonald J.; Lewis, Richard J.; Alewood, Paul F.; Brust, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1361-1364</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The design of disulfide bond mimetics is an important strategy for optimizing cysteine-rich peptides in drug development.  Mimetics of the drug lead conotoxin MrIA, in which one disulfide bond is selectively replaced of by a 1,4-disubstituted-1,2,3-triazole bridge, are described.  Sequential copper-catalyzed azide-alkyne cycloaddn. (CuAAC; click reaction) followed by disulfide formation resulted in the regioselective syntheses of triazole-disulfide hybrid MrIA analogs.  Mimetics with a triazole replacing the Cys4-Cys13 disulfide bond retained tertiary structure and full in vitro and in vivo activity as norepinephrine reuptake inhibitors.  Importantly, these mimetics are resistant to redn. in the presence of glutathione, thus resulting in improved plasma stability and increased suitability for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQHz-plupvKrVg90H21EOLACvtfcHk0ljlc0HSCuZOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVChsrnE&md5=0eeb125a320ddf437ef60aa70b1194cc</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fanie.201409678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201409678%26sid%3Dliteratum%253Aachs%26aulast%3DGori%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DC.-I.%2BA.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRosengren%26aufirst%3DK.%2BJ.%26aulast%3DBhola%26aufirst%3DR.%2BF.%26aulast%3DGelmi%26aufirst%3DM.%2BL.%26aulast%3DLonghi%26aufirst%3DR.%26aulast%3DChristie%26aufirst%3DM.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26aulast%3DBrust%26aufirst%3DA.%26atitle%3DStabilization%2520of%2520the%2520Cysteine-rich%2520Conotoxin%2520MrIA%2520by%2520Using%2520a%25201%252C2%252C3-Triazole%2520as%2520a%2520Disulfide%2520Bond%2520Mimetic%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1361%26epage%3D1364%26doi%3D10.1002%2Fanie.201409678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span>; <span class="NLM_string-name">Christensen, S. B.</span>; <span class="NLM_string-name">Dowell, C.</span>; <span class="NLM_string-name">Hararah, F.</span>; <span class="NLM_string-name">Fisher, F.</span>; <span class="NLM_string-name">Huynh, P. N.</span>; <span class="NLM_string-name">Olivera, B. M.</span>; <span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts Through a Non-Opioid Based Mechanism</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>, in press <span class="refDoi"> DOI: 10.1021/acs.jmedchem.1c00512</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.1c00512" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=J.+Gajewiak&author=S.+B.+Christensen&author=C.+Dowell&author=F.+Hararah&author=F.+Fisher&author=P.+N.+Huynh&author=B.+M.+Olivera&author=J.+M.+McIntosh&title=Selective+Penicillamine+Substitution+Enables+Development+of+a+Potent+Analgesic+Peptide+that+Acts+Through+a+Non-Opioid+Based+Mechanism&doi=10.1021%2Facs.jmedchem.1c00512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.1c00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.1c00512%26sid%3Dliteratum%253Aachs%26aulast%3DGajewiak%26aufirst%3DJ.%26atitle%3DSelective%2520Penicillamine%2520Substitution%2520Enables%2520Development%2520of%2520a%2520Potent%2520Analgesic%2520Peptide%2520that%2520Acts%2520Through%2520a%2520Non-Opioid%2520Based%2520Mechanism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2021%26doi%3D10.1021%2Facs.jmedchem.1c00512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanathan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Peptides: Technological Advances Driving Peptides into Development</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2006.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.copbio.2006.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=17049837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=638-642&author=A.+K.+Satoauthor=M.+Viswanathanauthor=R.+B.+Kentauthor=C.+R.+Wood&title=Therapeutic+Peptides%3A+Technological+Advances+Driving+Peptides+into+Development&doi=10.1016%2Fj.copbio.2006.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic peptides: Technological advances driving peptides into development</span></div><div class="casAuthors">Sato, Aaron K.; Viswanathan, Malini; Kent, Rachel B.; Wood, Clive R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">638-642</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  As potential therapeutics, peptides offer several advantages over small mols. (increased specificity) and antibodies (small size).  Nevertheless, a no. of key issues have hampered their use as drug candidates.  A series of new technologies have recently been developed that allow peptides to be viable drug candidates in areas usually restricted to protein therapeutics, such as monoclonal antibodies.  These include the development of various types of peptide-conjugates that have lower rates of clearance and hence the potential to increase the exposure of peptide drug candidates in chronic diseases.  Structural addns. were also made to peptides, including the use of unnatural amino acids, main-chain modifications, and other novel substitutions, which have helped to improve peptide stability and further their therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiwe4yE4GqUbVg90H21EOLACvtfcHk0livOcV6ULI9xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zL&md5=c29eae8a5bbf2e0bb5fb3c67211be0d5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2006.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2006.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DA.%2BK.%26aulast%3DViswanathan%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DR.%2BB.%26aulast%3DWood%26aufirst%3DC.%2BR.%26atitle%3DTherapeutic%2520Peptides%253A%2520Technological%2520Advances%2520Driving%2520Peptides%2520into%2520Development%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2006%26volume%3D17%26spage%3D638%26epage%3D642%26doi%3D10.1016%2Fj.copbio.2006.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">Designing Macrocyclic Disulfide-rich Peptides for Biotechnological Applications</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1038/s41589-018-0039-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1038%2Fs41589-018-0039-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=29662187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=417-427&author=C.+K.+Wangauthor=D.+J.+Craik&title=Designing+Macrocyclic+Disulfide-rich+Peptides+for+Biotechnological+Applications&doi=10.1038%2Fs41589-018-0039-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Designing macrocyclic disulfide-rich peptides for biotechnological applications</span></div><div class="casAuthors">Wang, Conan K.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">417-427</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Bioactive peptides have potential as drug leads, but turning them into drugs is a challenge because of their typically poor metabolic stability.  Mol. grafting is one approach to stabilizing and constraining peptides and involves melding a bioactive peptide sequence onto a suitable mol. scaffold.  This method has the benefit of improving the stability of the bioactive peptide lead and potentially expanding its functionality.  Here we step through the mol. grafting process and describe its successes and limitations.  So far, mol. grafting has been successfully used to improve the stability of peptide drug leads, to enhance conformational rigidity, to facilitate delivery to intracellular targets, and in some cases to increase efficacy in oral administration.  Although applications of mol. grafting have focused mainly on therapeutic applications, including those for pain, metabolic disease, and cancer, its potential uses are much broader, and we hope this Perspective will inspire wider applications of this mol. design tool in biotechnol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryR7gPEIiVjLVg90H21EOLACvtfcHk0livOcV6ULI9xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFGlsrg%253D&md5=fa4153afd28759780e69338cddfe1645</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs41589-018-0039-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-018-0039-y%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BK.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DDesigning%2520Macrocyclic%2520Disulfide-rich%2520Peptides%2520for%2520Biotechnological%2520Applications%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D417%26epage%3D427%26doi%3D10.1038%2Fs41589-018-0039-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armishaw, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balle, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, K. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sørensen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strømgaard, K.</span></span> <span> </span><span class="NLM_article-title">Improving the Stability of α-Conotoxin AuIB Through N-to-C Cyclization: The Effect of Linker Length on Stability and Activity at Nicotinic Acetylcholine Receptors</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1089%2Fars.2010.3458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=20649464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyntbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=65-76&author=C.+J.+Armishawauthor=A.+A.+Jensenauthor=L.+D.+Balleauthor=K.+C.+M.+Scottauthor=L.+S%C3%B8rensenauthor=K.+Str%C3%B8mgaard&title=Improving+the+Stability+of+%CE%B1-Conotoxin+AuIB+Through+N-to-C+Cyclization%3A+The+Effect+of+Linker+Length+on+Stability+and+Activity+at+Nicotinic+Acetylcholine+Receptors&doi=10.1089%2Fars.2010.3458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Stability of α-Conotoxin AuIB Through N-to-C Cyclization: The Effect of Linker Length on Stability and Activity at Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Armishaw, Christopher J.; Jensen, Anders A.; Balle, Lena D.; Scott, Krystle C. M.; Sorensen, Lena; Stromgaard, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-76</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Modification of α-conotoxin frameworks through cyclization via an oligopeptide linker has previously been shown as an effective strategy for improving in vivo stability.  We have extended this strategy by investigating cyclic analogs of α-conotoxin AuIB, a selective α3β4 nicotinic acetylcholine receptor (nAChR) antagonist, to examine a range of oligopeptide linker lengths on the oxidative formation of disulfide bonds, activity at nAChRs, and stability to degrdn. by chymotrypsin.  Upon nondirected random oxidn., the ribbon isomer formed preferentially with the globular isomer occurring as a minor byproduct.  Therefore, a regioselective disulfide bond forming strategy was used to prep. the cAuIB-2 globular isomer in high yield and purity.  The cAuIB-2 globular isomer exhibited a threefold decrease in activity for the α3β4 nAChR compared to wild-type-AuIB, although it was selective for α3β4 over α7 and α4β2 subtypes.  On the other hand, the cAuIB-2 ribbon isomer was shown to be inactive at all three nAChR subtypes.  Nonetheless, all of the cyclic analogs were found to be significantly more stable to degrdn. by chymotrypsin than wild-type AuIB.  As such, the cAuIB-2 globular isomer could constitute a useful probe for studying the role of the α3β4 nAChR in a range of in vivo exptl. paradigms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbKHviNVhe7LVg90H21EOLACvtfcHk0livOcV6ULI9xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyntbnJ&md5=49c64b25c25d5bed5f73852b82d41537</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3458%26sid%3Dliteratum%253Aachs%26aulast%3DArmishaw%26aufirst%3DC.%2BJ.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBalle%26aufirst%3DL.%2BD.%26aulast%3DScott%26aufirst%3DK.%2BC.%2BM.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DL.%26aulast%3DStr%25C3%25B8mgaard%26aufirst%3DK.%26atitle%3DImproving%2520the%2520Stability%2520of%2520%25CE%25B1-Conotoxin%2520AuIB%2520Through%2520N-to-C%2520Cyclization%253A%2520The%2520Effect%2520of%2520Linker%2520Length%2520on%2520Stability%2520and%2520Activity%2520at%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2011%26volume%3D14%26spage%3D65%26epage%3D76%26doi%3D10.1089%2Fars.2010.3458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giribaldi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haufe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, E. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucherre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moha Ou Maati, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjalbal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molgó, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutertre, S.</span></span> <span> </span><span class="NLM_article-title">Backbone Cyclization Turns a Venom Peptide into a Stable and Equipotent Ligand at Both Muscle and Neuronal Nicotinic Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">12682</span>– <span class="NLM_lpage">12692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00957</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00957" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVOjs7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=12682-12692&author=J.+Giribaldiauthor=Y.+Haufeauthor=E.+R.+J.+Evansauthor=M.+Amarauthor=A.+Durnerauthor=C.+Schmidtauthor=A.+Faucherreauthor=H.+Moha+Ou+Maatiauthor=C.+Enjalbalauthor=J.+Molg%C3%B3author=D.+Serventauthor=D.+T.+Wilsonauthor=N.+L.+Dalyauthor=A.+Nickeauthor=S.+Dutertre&title=Backbone+Cyclization+Turns+a+Venom+Peptide+into+a+Stable+and+Equipotent+Ligand+at+Both+Muscle+and+Neuronal+Nicotinic+Receptors&doi=10.1021%2Facs.jmedchem.0c00957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Backbone Cyclization Turns a Venom Peptide into a Stable and Equipotent Ligand at Both Muscle and Neuronal Nicotinic Receptors</span></div><div class="casAuthors">Giribaldi, Julien; Haufe, Yves; Evans, Edward R. J.; Amar, Muriel; Durner, Anna; Schmidt, Casey; Faucherre, Adele; Moha Ou Maati, Hamid; Enjalbal, Christine; Molgo, Jordi; Servent, Denis; Wilson, David T.; Daly, Norelle L.; Nicke, Annette; Dutertre, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12682-12692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Venom peptides are promising drug leads, but their therapeutic use is often limited by stability and bioavailability issues.  In this study, we designed cyclic analogs of α-conotoxin CIA, a potent muscle nicotinic acetylcholine receptor (nAChR) blocker with a significantly lower affinity at the neuronal α3β2 subtype.  Remarkably, all analogs retained the low nanomolar activity of native CIA toward muscle-type nAChRs but showed greatly improved resistance to degrdn. in human serum and, surprisingly, displayed up to 52-fold higher potency for the α3β2 neuronal nAChR subtype (IC50 1.3 nM).  Comparison of NMR-derived structures revealed some differences that might explain the gain of potency at α3β2 nAChRs.  All peptides were highly paralytic when injected into adult zebrafish and bath-applied to zebrafish larvae, suggesting barrier-crossing capabilities and efficient uptake.  Finally, these cyclic CIA analogs were shown to be unique pharmacol. tools to investigate the contribution of the presynaptic α3β2 nAChR subtype to the train-of-four fade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8pf_cJ_5OrVg90H21EOLACvtfcHk0liAfF4Vn3YbEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVOjs7jJ&md5=118316f3605c5e76281d71f11b9ee002</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00957%26sid%3Dliteratum%253Aachs%26aulast%3DGiribaldi%26aufirst%3DJ.%26aulast%3DHaufe%26aufirst%3DY.%26aulast%3DEvans%26aufirst%3DE.%2BR.%2BJ.%26aulast%3DAmar%26aufirst%3DM.%26aulast%3DDurner%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DC.%26aulast%3DFaucherre%26aufirst%3DA.%26aulast%3DMoha%2BOu%2BMaati%26aufirst%3DH.%26aulast%3DEnjalbal%26aufirst%3DC.%26aulast%3DMolg%25C3%25B3%26aufirst%3DJ.%26aulast%3DServent%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DD.%2BT.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DNicke%26aufirst%3DA.%26aulast%3DDutertre%26aufirst%3DS.%26atitle%3DBackbone%2520Cyclization%2520Turns%2520a%2520Venom%2520Peptide%2520into%2520a%2520Stable%2520and%2520Equipotent%2520Ligand%2520at%2520Both%2520Muscle%2520and%2520Neuronal%2520Nicotinic%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D12682%26epage%3D12692%26doi%3D10.1021%2Facs.jmedchem.0c00957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempster, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosengren, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevin, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the -conotoxin MII</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">13767</span>– <span class="NLM_lpage">13772</span>, <span class="refDoi"> DOI: 10.1073/pnas.0504613102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1073%2Fpnas.0504613102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=16162671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13767-13772&author=R.+J.+Clarkauthor=H.+Fischerauthor=L.+Dempsterauthor=N.+L.+Dalyauthor=K.+J.+Rosengrenauthor=S.+T.+Nevinauthor=F.+A.+Meunierauthor=D.+J.+Adamsauthor=D.+J.+Craik&title=Engineering+stable+peptide+toxins+by+means+of+backbone+cyclization%3A+Stabilization+of+the+-conotoxin+MII&doi=10.1073%2Fpnas.0504613102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the α-conotoxin MII</span></div><div class="casAuthors">Clark, Richard J.; Fischer, Harald; Dempster, Louise; Daly, Norelle L.; Rosengren, K. Johan; Nevin, Simon T.; Meunier, Frederic A.; Adams, David J.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13767-13772</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Conotoxins (CTXs), with their exquisite specificity and potency, have recently created much excitement as drug leads.  However, like most peptides, their beneficial activities may potentially be undermined by susceptibility to proteolysis in vivo.  By cyclizing the α-CTX MII by using a range of linkers, we have engineered peptides that preserve their full activity but have greatly improved resistance to proteolytic degrdn.  The cyclic MII analog contg. a seven-residue linker joining the N and C termini was as active and selective as the native peptide for native and recombinant neuronal nicotinic acetylcholine receptor subtypes present in bovine chromaffin cells and expressed in Xenopus oocytes, resp.  Furthermore, its resistance to proteolysis against a specific protease and in human plasma was significantly improved.  More generally, to our knowledge, this report is the first on the cyclization of disulfide-rich toxins.  Cyclization strategies represent an approach for stabilizing bioactive peptides while keeping their full potencies and should boost applications of peptide-based drugs in human medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp68B2NbOQcFLVg90H21EOLACvtfcHk0liAfF4Vn3YbEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqsb3K&md5=0eba4880941c8c0132856e54cd8c42f7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504613102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504613102%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DDempster%26aufirst%3DL.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DRosengren%26aufirst%3DK.%2BJ.%26aulast%3DNevin%26aufirst%3DS.%2BT.%26aulast%3DMeunier%26aufirst%3DF.%2BA.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DEngineering%2520stable%2520peptide%2520toxins%2520by%2520means%2520of%2520backbone%2520cyclization%253A%2520Stabilization%2520of%2520the%2520-conotoxin%2520MII%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D13767%26epage%3D13772%26doi%3D10.1073%2Fpnas.0504613102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">Effects of Cyclization on Stability, Structure, and Activity of α-Conotoxin RgIA at the α9α10 Nicotinic Acetylcholine Receptor and GABABReceptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6984</span>– <span class="NLM_lpage">6992</span>, <span class="refDoi"> DOI: 10.1021/jm201060r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201060r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOqu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6984-6992&author=R.+Halaiauthor=B.+Callaghanauthor=N.+L.+Dalyauthor=R.+J.+Clarkauthor=D.+J.+Adamsauthor=D.+J.+Craik&title=Effects+of+Cyclization+on+Stability%2C+Structure%2C+and+Activity+of+%CE%B1-Conotoxin+RgIA+at+the+%CE%B19%CE%B110+Nicotinic+Acetylcholine+Receptor+and+GABABReceptor&doi=10.1021%2Fjm201060r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Cyclization on Stability, Structure, and Activity of α-Conotoxin RgIA at the α9α10 Nicotinic Acetylcholine Receptor and GABAB Receptor</span></div><div class="casAuthors">Halai, Reena; Callaghan, Brid; Daly, Norelle L.; Clark, Richard J.; Adams, David J.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6984-6992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxin RgIA is of interest as a lead in the development of drugs for neuropathic pain.  It modulates the α9α10 nicotinic acetylcholine receptor (nAChR) and the GABAB receptor, both of which are implicated in antinociception.  However, because of its peptidic nature, RgIA is potentially susceptible to generic problems encountered by peptide-based drugs of poor oral bioavailability, short biol. half-life, and low stability.  Here, we improved the biopharmaceutical properties of RgIA by backbone cyclization using 3-7 residue peptidic linkers.  Cyclization with a six-residue linker does not perturb the overall structure of RgIA, improves selectivity for the GABAB receptor over the α9α10 nAChR, and improves stability in human serum.  The results provide insights to further improve the therapeutic properties of RgIA and other conotoxins being considered as drug leads and confirm that cyclization is a readily applicable strategy to improve the stability of peptides with proximate N- and C-termini.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAcHnWBqQbFbVg90H21EOLACvtfcHk0liAfF4Vn3YbEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOqu73P&md5=3512eadb771719a549c0350601897049</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm201060r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201060r%26sid%3Dliteratum%253Aachs%26aulast%3DHalai%26aufirst%3DR.%26aulast%3DCallaghan%26aufirst%3DB.%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DEffects%2520of%2520Cyclization%2520on%2520Stability%252C%2520Structure%252C%2520and%2520Activity%2520of%2520%25CE%25B1-Conotoxin%2520RgIA%2520at%2520the%2520%25CE%25B19%25CE%25B110%2520Nicotinic%2520Acetylcholine%2520Receptor%2520and%2520GABABReceptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6984%26epage%3D6992%26doi%3D10.1021%2Fjm201060r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carstens, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brierley, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by α-Conotoxin Vc1.1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1577</span>– <span class="NLM_lpage">1587</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00190</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00190" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1Ggu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1577-1587&author=M.+Sadeghiauthor=B.+B.+Carstensauthor=B.+P.+Callaghanauthor=J.+T.+Danielauthor=H.-S.+Taeauthor=T.+O%E2%80%99Donnellauthor=J.+Castroauthor=S.+M.+Brierleyauthor=D.+J.+Adamsauthor=D.+J.+Craikauthor=R.+J.+Clark&title=Structure-Activity+Studies+Reveal+the+Molecular+Basis+for+GABAB-Receptor+Mediated+Inhibition+of+High+Voltage-Activated+Calcium+Channels+by+%CE%B1-Conotoxin+Vc1.1&doi=10.1021%2Facschembio.8b00190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by α-Conotoxin Vc1.1</span></div><div class="casAuthors">Sadeghi, Mahsa; Carstens, Bodil B.; Callaghan, Brid P.; Daniel, James T.; Tae, Han-Shen; O'Donnell, Tracey; Castro, Joel; Brierley, Stuart M.; Adams, David J.; Craik, David J.; Clark, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1577-1587</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxins are disulfide-bonded peptides from cone snail venoms and are characterized by their affinity for nicotinic acetylcholine receptors (nAChR).  Several α-conotoxins with distinct selectivity for nAChR subtypes have been identified as potent analgesics in animal models of chronic pain.  However, a no. of α-conotoxins have been shown to inhibit N-type calcium channel currents in rodent dissocd. dorsal root ganglion (DRG) neurons via activation of G protein-coupled GABAB receptors (GABABR).  Therefore, it is unclear whether activation of GABABR or inhibition of α9α10 nAChRs is the analgesic mechanism.  To investigate the mechanisms by which α-conotoxins provide analgesia, we synthesized a suite of Vc1.1 analogs where all residues, except the conserved cysteines, in Vc1.1 were individually replaced by alanine (A), lysine (K), and aspartic acid (D).  Our results show that the amino acids in the first loop play an important role in binding of the peptide to the receptor, whereas those in the second loop play an important role for the selectivity of the peptide for the GABABR over α9α10 nAChRs.  We designed a cVc1.1 analog that is >8000-fold selective for GABABR-mediated inhibition of high voltage-activated (HVA) calcium channels over α9α10 nAChRs and show that it is analgesic in a mouse model of chronic visceral hypersensitivity (CVH).  CVc1.1[D11A,E14A] caused dose-dependent inhibition of colonic nociceptors with greater efficacy in ex vivo CVH colonic nociceptors relative to healthy colonic nociceptors.  These findings suggest that selectively targeting GABABR-mediated HVA calcium channel inhibition by α-conotoxins could be effective for the treatment of chronic visceral pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrud0O9nAa327Vg90H21EOLACvtfcHk0lj4qjRS_TQc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1Ggu7g%253D&md5=467204089f9301a9ea0fdd16ff19fe85</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00190%26sid%3Dliteratum%253Aachs%26aulast%3DSadeghi%26aufirst%3DM.%26aulast%3DCarstens%26aufirst%3DB.%2BB.%26aulast%3DCallaghan%26aufirst%3DB.%2BP.%26aulast%3DDaniel%26aufirst%3DJ.%2BT.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DT.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DBrierley%26aufirst%3DS.%2BM.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DClark%26aufirst%3DR.%2BJ.%26atitle%3DStructure-Activity%2520Studies%2520Reveal%2520the%2520Molecular%2520Basis%2520for%2520GABAB-Receptor%2520Mediated%2520Inhibition%2520of%2520High%2520Voltage-Activated%2520Calcium%2520Channels%2520by%2520%25CE%25B1-Conotoxin%2520Vc1.1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D1577%26epage%3D1587%26doi%3D10.1021%2Facschembio.8b00190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevin, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6545</span>– <span class="NLM_lpage">6548</span>, <span class="refDoi"> DOI: 10.1002/anie.201000620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fanie.201000620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6545-6548&author=R.+J.+Clarkauthor=J.+Jensenauthor=S.+T.+Nevinauthor=B.+P.+Callaghanauthor=D.+J.+Adamsauthor=D.+J.+Craik&title=The+Engineering+of+an+Orally+Active+Conotoxin+for+the+Treatment+of+Neuropathic+Pain&doi=10.1002%2Fanie.201000620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain</span></div><div class="casAuthors">Clark, Richard J.; Jensen, Jonas; Nevin, Simon T.; Callaghan, Brid P.; Adams, David J.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">6545-6548, S6545/1-S6545/33</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors prepd. a cyclized α-conotoxin Vc1.1 from the cone snail Conus victoriae and demonstrated its oral activity.  Vc1.1 is an effective analgesic in several rat models of neuropathic pain and therefore has attracted considerable interest as a potential treatment for this condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxI6y6jJXrCbVg90H21EOLACvtfcHk0lj4qjRS_TQc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamur3N&md5=da52aa3e3d1747f2910d0105aa05f3ab</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fanie.201000620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201000620%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DJensen%26aufirst%3DJ.%26aulast%3DNevin%26aufirst%3DS.%2BT.%26aulast%3DCallaghan%26aufirst%3DB.%2BP.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Engineering%2520of%2520an%2520Orally%2520Active%2520Conotoxin%2520for%2520the%2520Treatment%2520of%2520Neuropathic%2520Pain%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6545%26epage%3D6548%26doi%3D10.1002%2Fanie.201000620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kourra, C. M. B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, N.</span></span> <span> </span><span class="NLM_article-title">Converting Disulfide Bridges in Native Peptides to Stable Methylene Thioacetals</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">7007</span>– <span class="NLM_lpage">7012</span>, <span class="refDoi"> DOI: 10.1039/c6sc02285e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1039%2FC6SC02285E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28451136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Crt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=7007-7012&author=C.+M.+B.+K.+Kourraauthor=N.+Cramer&title=Converting+Disulfide+Bridges+in+Native+Peptides+to+Stable+Methylene+Thioacetals&doi=10.1039%2Fc6sc02285e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Converting disulfide bridges in native peptides to stable methylene thioacetals</span></div><div class="casAuthors">Kourra, C. M. B. K.; Cramer, N.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7007-7012</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Disulfide bridges play a crucial role in defining and rigidifying the three-dimensional structure of peptides.  However, disulfides are inherently unstable in reducing environments.  Consequently, the development of strategies aiming to circumvent these deficiencies - ideally with little structural disturbance - are highly sought after.  Herein, we report a simple protocol converting the disulfide bond of peptides into highly stable methylene thioacetal.  The transformation occurs under mild, biocompatible conditions, enabling the conversion of unprotected native peptides into analogs with enhanced stability.  The developed protocol is applicable to a range of peptides and selective in the presence of a multitude of potentially reactive functional groups.  The thioacetal modification annihilates the reductive lability and increases the serum, pH and temp. stability of the important peptide hormone oxytocin.  Moreover, it is shown that the biol. activities for oxytocin are retained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNUJLTzqWREbVg90H21EOLACvtfcHk0lj4qjRS_TQc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Crt7bO&md5=a91a7082858d171b9f5c3e07e30f7c61</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2FC6SC02285E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02285E%26sid%3Dliteratum%253Aachs%26aulast%3DKourra%26aufirst%3DC.%2BM.%2BB.%2BK.%26aulast%3DCramer%26aufirst%3DN.%26atitle%3DConverting%2520Disulfide%2520Bridges%2520in%2520Native%2520Peptides%2520to%2520Stable%2520Methylene%2520Thioacetals%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D7007%26epage%3D7012%26doi%3D10.1039%2Fc6sc02285e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metanis, N.</span></span> <span> </span><span class="NLM_article-title">BPTI Folding Revisited: Switching a Disulfide into Methylene Thioacetal Reveals a Previously Hidden Path</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4814</span>– <span class="NLM_lpage">4820</span>, <span class="refDoi"> DOI: 10.1039/c8sc01110a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1039%2FC8SC01110A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=29910933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Ont7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4814-4820&author=R.+Mousaauthor=S.+Lanskyauthor=G.+Shohamauthor=N.+Metanis&title=BPTI+Folding+Revisited%3A+Switching+a+Disulfide+into+Methylene+Thioacetal+Reveals+a+Previously+Hidden+Path&doi=10.1039%2Fc8sc01110a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">BPTI folding revisited: switching a disulfide into methylene thioacetal reveals a previously hidden path</span></div><div class="casAuthors">Mousa, Reem; Lansky, Shifra; Shoham, Gil; Metanis, Norman</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4814-4820</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Bovine pancreatic trypsin inhibitor (BPTI) is a 58-residue protein that is stabilized by three disulfide bonds at positions 5-55, 14-38 and 30-51.  Widely studied for about 50 years, BPTI represents a folding model for many disulfide-rich proteins.  In the study described below, we replaced the solvent exposed 14-38 disulfide bond with a methylene thioacetal bridge in an attempt to arrest the folding pathway of the protein at its two well-known intermediates, N' and N*.  The modified protein was expected to be unable to undergo the rate-detg. step in the widely accepted BPTI folding mechanism: the opening of the 14-38 disulfide bond followed by rearrangements that leads to the native state, N.  Surprisingly, instead of halting BPTI folding at N' and N*, we uncovered a hidden pathway involving a direct reaction between the N* intermediate and the oxidizing reagent glutathione (GSSG) to form the disulfide-mixed intermediate N*-SG, which spontaneously folds into N.  On the other hand, N' was unable to fold into N.  In addn., we found that the methylene thioacetal bridge enhances BPTI stability while fully maintaining its structure and biol. function.  These findings suggest a general strategy for enhancing protein stability without compromising on function or structure, suggesting potential applications for future therapeutic protein prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoukKNyBbIZ-7Vg90H21EOLACvtfcHk0lj4qjRS_TQc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Ont7s%253D&md5=f10b27b9f55106b425c5b3e8e1b2d978</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC8SC01110A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC01110A%26sid%3Dliteratum%253Aachs%26aulast%3DMousa%26aufirst%3DR.%26aulast%3DLansky%26aufirst%3DS.%26aulast%3DShoham%26aufirst%3DG.%26aulast%3DMetanis%26aufirst%3DN.%26atitle%3DBPTI%2520Folding%2520Revisited%253A%2520Switching%2520a%2520Disulfide%2520into%2520Methylene%2520Thioacetal%2520Reveals%2520a%2520Previously%2520Hidden%2520Path%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D4814%26epage%3D4820%26doi%3D10.1039%2Fc8sc01110a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schönauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Els-Heindl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koebberling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Adrenomedullin Disulfide Bond Mimetics Uncover Structural Requirements for AM1 Receptor Activation</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>, <span class="NLM_elocation-id">e3147</span> <span class="refDoi"> DOI: 10.1002/psc.3147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fpsc.3147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=30680847" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&author=J.-P.+Fischerauthor=R.+Sch%C3%B6nauerauthor=S.+Els-Heindlauthor=D.+Biererauthor=J.+Koebberlingauthor=B.+Riedlauthor=A.+G.+Beck-Sickinger&title=Adrenomedullin+Disulfide+Bond+Mimetics+Uncover+Structural+Requirements+for+AM1+Receptor+Activation&doi=10.1002%2Fpsc.3147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fpsc.3147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.3147%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DJ.-P.%26aulast%3DSch%25C3%25B6nauer%26aufirst%3DR.%26aulast%3DEls-Heindl%26aufirst%3DS.%26aulast%3DBierer%26aufirst%3DD.%26aulast%3DKoebberling%26aufirst%3DJ.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DAdrenomedullin%2520Disulfide%2520Bond%2520Mimetics%2520Uncover%2520Structural%2520Requirements%2520for%2520AM1%2520Receptor%2520Activation%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2019%26volume%3D25%26doi%3D10.1002%2Fpsc.3147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VandenBerg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D. H.-C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Characterization of an A6-A11 Methylene Thioacetal Human Insulin Analogue with Enhanced Stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11437</span>– <span class="NLM_lpage">11443</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlWktrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11437-11443&author=N.+Zhengauthor=P.+Karraauthor=M.+A.+VandenBergauthor=J.+H.+Kimauthor=M.+J.+Webberauthor=W.+L.+Hollandauthor=D.+H.-C.+Chou&title=Synthesis+and+Characterization+of+an+A6-A11+Methylene+Thioacetal+Human+Insulin+Analogue+with+Enhanced+Stability&doi=10.1021%2Facs.jmedchem.9b01589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of an A6-A11 Methylene Thioacetal Human Insulin Analogue with Enhanced Stability</span></div><div class="casAuthors">Zheng, Nan; Karra, Prasoona; VandenBerg, Michael A.; Kim, Jin Hwan; Webber, Matthew J.; Holland, William L.; Chou, Danny Hung-Chieh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11437-11443</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Insulin has been a life-saving drug for millions of people with diabetes.  However, several challenges exist which limit therapeutic benefits and reduce patient convenience.  One key challenge is the fibrillation propensity, which necessitates refrigeration for storage.  To address this limitation, we chem. synthesized and evaluated a methylene thioacetal human insulin analog (SCS-Ins).  The synthesized SCS-Ins showed enhanced serum stability and aggregation resistance while retaining bioactivity compared with native insulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4aVEmx5w-irVg90H21EOLACvtfcHk0lhIduKwQnn1cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlWktrvF&md5=02eef5155c8b68531ea321813fee36fc</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01589%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DKarra%26aufirst%3DP.%26aulast%3DVandenBerg%26aufirst%3DM.%2BA.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DWebber%26aufirst%3DM.%2BJ.%26aulast%3DHolland%26aufirst%3DW.%2BL.%26aulast%3DChou%26aufirst%3DD.%2BH.-C.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520an%2520A6-A11%2520Methylene%2520Thioacetal%2520Human%2520Insulin%2520Analogue%2520with%2520Enhanced%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11437%26epage%3D11443%26doi%3D10.1021%2Facs.jmedchem.9b01589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haythornthwaite, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berecki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span> <span> </span><span class="NLM_article-title">Analgesic -Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">10943</span>– <span class="NLM_lpage">10951</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3594-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1523%2FJNEUROSCI.3594-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=18945902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWnsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=10943-10951&author=B.+Callaghanauthor=A.+Haythornthwaiteauthor=G.+Bereckiauthor=R.+J.+Clarkauthor=D.+J.+Craikauthor=D.+J.+Adams&title=Analgesic+-Conotoxins+Vc1.1+and+Rg1A+Inhibit+N-Type+Calcium+Channels+in+Rat+Sensory+Neurons+via+GABAB+Receptor+Activation&doi=10.1523%2Fjneurosci.3594-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic α-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation</span></div><div class="casAuthors">Callaghan, Brid; Haythornthwaite, Alison; Berecki, Geza; Clark, Richard J.; Craik, David J.; Adams, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10943-10951</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">α-Conotoxins Vc1.1 and Rg1A are peptides from the venom of marine Conus snails that are currently in development as a treatment for neuropathic pain.  Here we report that the α9α10 nicotinic acetylcholine receptor-selective conotoxins Vc1.1 and Rg1A potently and selectively inhibit high-voltage-activated (HVA) calcium channel currents in dissocd. DRG neurons in a concn.-dependent manner.  The post-translationally modified peptides vc1a and [P6O]Vc1.1 were inactive, as were all other α-conotoxins tested.  Vc1.1 inhibited the ω-conotoxin-sensitive HVA currents in DRG neurons but not those recorded from Xenopus oocytes expressing Cav2.2, Cav2.1, Cav2.3, or Cav1.2 channels.  Inhibition of HVA currents by Vc1.1 was not reversed by depolarizing prepulses but was abolished by pertussis toxin (PTX), intracellular GDPβS, or a selective inhibitor of pp60c-src tyrosine kinase.  These data indicate that Vc1.1 does not interact with N-type calcium channels directly but inhibits them via a voltage-independent mechanism involving a PTX-sensitive, G-protein-coupled receptor.  Preincubation with a variety of selective receptor antagonists demonstrated that only the GABAB receptor antagonists, [S-(R*,R*)][-3-[[1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxy propyl]([3,4]-cyclohexylmethyl) phosphinic acid hydrochloride (2S)-3[[(1S)-1-(3,4-dichlorophenyl)-ethyl]amino-2-hydroxypropyl] (phenylmethyl) phosphinic acid and phaclofen, blocked the effect of Vc1.1 and Rg1A on Ca2+ channel currents.  Together, the results identify Cav2.2 as a target of Vc1.1 and Rg1A, potentially mediating their analgesic actions.  We propose a novel mechanism by which α-conotoxins Vc1.1 and Rg1A modulate native N-type (Cav2.2) Ca2+ channel currents, namely acting as agonists via G-protein-coupled GABAB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIKcaVA5_WirVg90H21EOLACvtfcHk0lhIduKwQnn1cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWnsLzE&md5=4ddeed6a3d2184cc682580564639890c</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3594-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3594-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DCallaghan%26aufirst%3DB.%26aulast%3DHaythornthwaite%26aufirst%3DA.%26aulast%3DBerecki%26aufirst%3DG.%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26atitle%3DAnalgesic%2520-Conotoxins%2520Vc1.1%2520and%2520Rg1A%2520Inhibit%2520N-Type%2520Calcium%2520Channels%2520in%2520Rat%2520Sensory%2520Neurons%2520via%2520GABAB%2520Receptor%2520Activation%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D10943%26epage%3D10951%26doi%3D10.1523%2Fjneurosci.3594-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Faoite, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berecki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span> <span> </span><span class="NLM_article-title">γ-Aminobutyric Acid Type B (GABAB) Receptor Expression Is Needed for Inhibition of N-type (Cav2.2) Calcium Channels by Analgesic α-Conotoxins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">23948</span>– <span class="NLM_lpage">23957</span>, <span class="refDoi"> DOI: 10.1074/jbc.m112.342998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1074%2Fjbc.M112.342998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=22613715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVeju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=23948-23957&author=H.+Cunyauthor=A.+de+Faoiteauthor=T.+G.+Huynhauthor=T.+Yasudaauthor=G.+Bereckiauthor=D.+J.+Adams&title=%CE%B3-Aminobutyric+Acid+Type+B+%28GABAB%29+Receptor+Expression+Is+Needed+for+Inhibition+of+N-type+%28Cav2.2%29+Calcium+Channels+by+Analgesic+%CE%B1-Conotoxins&doi=10.1074%2Fjbc.m112.342998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Aminobutyric Acid Type B (GABAB) Receptor Expression Is Needed for Inhibition of N-type (Cav2.2) Calcium Channels by Analgesic α-Conotoxins</span></div><div class="casAuthors">Cuny, Hartmut; de Faoite, Andrew; Huynh, Thuan G.; Yasuda, Takahiro; Berecki, Geza; Adams, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">23948-23957</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">α-Conotoxins Vc1.1 and RgIA are small peptides isolated from the venom of marine cone snails.  They have effective anti-nociceptive actions in rat models of neuropathic pain.  Pharmacol. studies in rodent dorsal root ganglion (DRG) show their analgesic effect is mediated by inhibition of N-type (Cav2.2) calcium channels via a pathway involving γ-aminobutyric acid type B (GABAB) receptor.  However, there is no direct demonstration that functional GABAB receptors are needed for inhibition of the Cav2.2 channel by analgesic α-conotoxins.  This study examd. the effect of the GABAB agonist baclofen and α-conotoxins Vc1.1 and RgIA on calcium channel currents after transient knockdown of the GABAB receptor using RNA interference.  Isolated rat DRG neurons were transfected with small interfering RNAs (siRNA) targeting GABAB subunits R1 and R2.  Efficient knockdown of GABAB receptor expression at mRNA and protein levels was confirmed by quant. real time PCR (qRT-PCR) and immunocytochem. anal., resp.  Whole-cell patch clamp recordings conducted 2-4 days after transfection showed that inhibition of N-type calcium channels in response to baclofen, Vc1.1 and RgIA was significantly reduced in GABAB receptor knockdown DRG neurons.  In contrast, neurons transfected with a scrambled nontargeting siRNA were indistinguishable from untransfected neurons.  In the HEK 293 cell heterologous expression system, Vc1.1 and RgIA inhibition of Cav2.2 channels needed functional expression of both human GABAB receptor subunits.  Together, these results confirm that GABAB receptors must be activated for the modulation of N-type (Cav2.2) calcium channels by analgesic α-conotoxins Vc1.1 and RgIA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrva98Z3TvRtLVg90H21EOLACvtfcHk0lgFhv8YgMgG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVeju7Y%253D&md5=9b52259a7bd451d1299bbfec657c643a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.342998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.342998%26sid%3Dliteratum%253Aachs%26aulast%3DCuny%26aufirst%3DH.%26aulast%3Dde%2BFaoite%26aufirst%3DA.%26aulast%3DHuynh%26aufirst%3DT.%2BG.%26aulast%3DYasuda%26aufirst%3DT.%26aulast%3DBerecki%26aufirst%3DG.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26atitle%3D%25CE%25B3-Aminobutyric%2520Acid%2520Type%2520B%2520%2528GABAB%2529%2520Receptor%2520Expression%2520Is%2520Needed%2520for%2520Inhibition%2520of%2520N-type%2520%2528Cav2.2%2529%2520Calcium%2520Channels%2520by%2520Analgesic%2520%25CE%25B1-Conotoxins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D23948%26epage%3D23957%26doi%3D10.1074%2Fjbc.m112.342998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slesinger, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span> <span> </span><span class="NLM_article-title">Novel Mechanism of Voltage-Gated N-type (Cav2.2) Calcium Channel Inhibition Revealed through α-Conotoxin Vc1.1 Activation of the GABAB Receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1124/mol.114.096156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1124%2Fmol.114.096156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=25425625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Whtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=240-250&author=T.+G.+Huynhauthor=H.+Cunyauthor=P.+A.+Slesingerauthor=D.+J.+Adams&title=Novel+Mechanism+of+Voltage-Gated+N-type+%28Cav2.2%29+Calcium+Channel+Inhibition+Revealed+through+%CE%B1-Conotoxin+Vc1.1+Activation+of+the+GABAB+Receptor&doi=10.1124%2Fmol.114.096156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mechanism of voltage-gated N-type (Cav2.2) calcium channel inhibition revealed through α-conotoxin Vc1.1 activation of the GABAB receptor</span></div><div class="casAuthors">Huynh, Thuan G.; Cuny, Hartmut; Slesinger, Paul A.; Adams, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-250/1-240-250/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal voltage-gated N-type (Cav2.2) calcium channels are expressed throughout the nervous system and regulate neurotransmitter release and hence synaptic transmission.  They are predominantly modulated via G protein-coupled receptor activated pathways, and the well characterized Gβ γ subunits inhibit Cav2.2 currents.  Analgesic α-conotoxin Vc1.1, a peptide from predatory marine cone snail venom, inhibits Cav2.2 channels by activating pertussis toxin-sensitive Gi/o proteins via the GABAB receptor (GABABR) and potently suppresses pain in rat models.  Using a heterologous GABABR expression system, electrophysiol., and mutagenesis, we showed a-conotoxin Vc1.1 modulates Cav2.2 via a different pathway from that of the GABABR agonists GABA and baclofen.  In contrast to GABA and baclofen, Vc1.1 changes Cav2.2 channel kinetics by increasing the rate of activation and shifting its half max. inactivation to a more hyperpolarized potential.  We then systematically truncated the GABAB1a C terminus and discovered that removing the proximal carboxyl terminus of the GABAB1a subunit significantly reduced Vc1.1 inhibition of Cav2.2 currents.  We propose a novel mechanism by which Vc1.1 activates GABABR and requires the GABAB1a proximal carboxyl terminus domain to inhibit Cav2.2 channels.  These findings provide important insights into how GABABRs mediate Cav2.2 channel inhibition and alter nociceptive transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq859YS8L8ua7Vg90H21EOLACvtfcHk0lgFhv8YgMgG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Whtr0%253D&md5=c1ac5bd9b41e983007a8e967f1d69c3a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.096156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.096156%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DT.%2BG.%26aulast%3DCuny%26aufirst%3DH.%26aulast%3DSlesinger%26aufirst%3DP.%2BA.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26atitle%3DNovel%2520Mechanism%2520of%2520Voltage-Gated%2520N-type%2520%2528Cav2.2%2529%2520Calcium%2520Channel%2520Inhibition%2520Revealed%2520through%2520%25CE%25B1-Conotoxin%2520Vc1.1%2520Activation%2520of%2520the%2520GABAB%2520Receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D87%26spage%3D240%26epage%3D250%26doi%3D10.1124%2Fmol.114.096156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhangsun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsetlin, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span> <span> </span><span class="NLM_article-title">Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E4026</span>– <span class="NLM_lpage">E4035</span>, <span class="refDoi"> DOI: 10.1073/pnas.1503617112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1073%2Fpnas.1503617112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=26170295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGktr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E4026-E4035&author=S.+Luoauthor=D.+Zhangsunauthor=P.+J.+Harveyauthor=Q.+Kaasauthor=Y.+Wuauthor=X.+Zhuauthor=Y.+Huauthor=X.+Liauthor=V.+I.+Tsetlinauthor=S.+Christensenauthor=H.+K.+Romeroauthor=M.+McIntyreauthor=C.+Dowellauthor=J.+C.+Baxterauthor=K.+S.+Elmslieauthor=D.+J.+Craikauthor=J.+M.+McIntosh&title=Cloning%2C+synthesis%2C+and+characterization+of+%CE%B1O-conotoxin+GeXIVA%2C+a+potent+%CE%B19%CE%B110+nicotinic+acetylcholine+receptor+antagonist&doi=10.1073%2Fpnas.1503617112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist</span></div><div class="casAuthors">Luo, Sulan; Zhangsun, Dongting; Harvey, Peta J.; Kaas, Quentin; Wu, Yong; Zhu, Xiaopeng; Hu, Yuanyan; Li, Xiaodan; Tsetlin, Victor I.; Christensen, Sean; Romero, Haylie K.; McIntyre, Melissa; Dowell, Cheryl; Baxter, James C.; Elmslie, Keith S.; Craik, David J.; McIntosh, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">E4026-E4035</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The authors identified a previously unidentified conotoxin gene from Conus generalis whose precursor signal sequence has high similarity to the O1-gene conotoxin superfamily.  The predicted mature peptide, αO-conotoxin GeXIVA, has four Cys residues, and its three disulfide isomers were synthesized.  Previously pharmacol. characterized O1-superfamily peptides, exemplified by the US Food and Drug Administration-approved pain medication, ziconotide, contain six Cys residues and are calcium, sodium, or potassium channel antagonists.  However, GeXIVA did not inhibit calcium channels but antagonized nicotinic AChRs (nAChRs), most potently on the α9α10 nAChR subtype (IC50 = 4.6 nM).  Toxin blockade was voltage-dependent, and kinetic anal. of toxin dissocn. indicated that the binding site of GeXIVA does not overlap with the binding site of the competitive antagonist α-conotoxin RgIA.  Surprisingly, the most active disulfide isomer of GeXIVA is the bead isomer, comprising, according to NMR anal., two well-resolved but uncoupled disulfide-restrained loops.  The ribbon isomer is almost as potent but has a more rigid structure built around a short 310-helix.  In contrast to most α-conotoxins, the globular isomer is the least potent and has a flexible, multiconformational nature.  GeXIVA reduced mech. hyperalgesia in the rat chronic constriction injury model of neuropathic pain but had no effect on motor performance, warranting its further investigation as a possible therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2OSEOMMXArVg90H21EOLACvtfcHk0lgFhv8YgMgG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGktr3F&md5=abbe5165fbe0eb66fbe342f30f55d1d6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1503617112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1503617112%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DZhangsun%26aufirst%3DD.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTsetlin%26aufirst%3DV.%2BI.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DH.%2BK.%26aulast%3DMcIntyre%26aufirst%3DM.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DBaxter%26aufirst%3DJ.%2BC.%26aulast%3DElmslie%26aufirst%3DK.%2BS.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DCloning%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520%25CE%25B1O-conotoxin%2520GeXIVA%252C%2520a%2520potent%2520%25CE%25B19%25CE%25B110%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3DE4026%26epage%3DE4035%26doi%3D10.1073%2Fpnas.1503617112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael
McIntosh, J.</span></span> <span> </span><span class="NLM_article-title">Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">114124</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2020.114124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.bcp.2020.114124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=32593612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtleksbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=114124&author=P.+N.+Huynhauthor=P.+J.+Harveyauthor=J.+Gajewiakauthor=D.+J.+Craikauthor=J.+Michael%0AMcIntosh&title=Critical+residue+properties+for+potency+and+selectivity+of+%CE%B1-Conotoxin+RgIA+towards+%CE%B19%CE%B110+nicotinic+acetylcholine+receptors&doi=10.1016%2Fj.bcp.2020.114124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Huynh, Peter N.; Harvey, Peta J.; Gajewiak, Joanna; Craik, David J.; Michael McIntosh, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114124</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The α9α10 nicotinic acetylcholine receptor (nAChR) has been characterized as an effective anti-pain target that functions through a non-opioid mechanism.  However, as a pentameric ion channel comprised of two different subunits, the specific targeting of α9α10 nAChRs has proven challenging.  Previously the 13-amino-acid peptide, RgIA, was shown to block α9α10 nAChRs with high potency and specificity.  This peptide, characterized from the venom of the carnivorous marine snail, Conus regius, produced analgesia in several rodent models of chronic pain.  Despite promising pre-clin. data in behavioral assays, the no. of specific α9α10 nAChR antagonists remains small and the physiol. mechanisms of analgesia remain cryptic.  In this study, we implement amino-acid substitutions to definitively characterize the chem. properties of RgIA that contribute to its activity against α9α10 nAChRs.  Using this mutational approach, we detd. the vital role of biochem. side-chain properties and amino acids in the second loop that are amenable to substitutions to further engineer next-generation analogs for the blockade of α9α10 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoToSjfA_ToLVg90H21EOLACvtfcHk0lj1rxUg0h7yYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtleksbfF&md5=20a65a5077d56ca1ad4032c2a2f200d5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2020.114124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2020.114124%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DP.%2BN.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DMichael%2BMcIntosh%26aufirst%3DJ.%26atitle%3DCritical%2520residue%2520properties%2520for%2520potency%2520and%2520selectivity%2520of%2520%25CE%25B1-Conotoxin%2520RgIA%2520towards%2520%25CE%25B19%25CE%25B110%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2020%26volume%3D181%26spage%3D114124%26doi%3D10.1016%2Fj.bcp.2020.114124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tabassum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaas, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span> <span> </span><span class="NLM_article-title">Role of CysI-CysIIIDisulfide Bond on the Structure and Activity of α-Conotoxins at Human Neuronal Nicotinic Acetylcholine Receptors</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">4621</span>– <span class="NLM_lpage">4631</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b00639</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b00639" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtleltbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=4621-4631&author=N.+Tabassumauthor=H.-S.+Taeauthor=X.+Jiaauthor=Q.+Kaasauthor=T.+Jiangauthor=D.+J.+Adamsauthor=R.+Yu&title=Role+of+CysI-CysIIIDisulfide+Bond+on+the+Structure+and+Activity+of+%CE%B1-Conotoxins+at+Human+Neuronal+Nicotinic+Acetylcholine+Receptors&doi=10.1021%2Facsomega.7b00639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CysI-CysIII Disulfide Bond on the Structure and Activity of α-Conotoxins at Human Neuronal Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Tabassum, Nargis; Tae, Han-Shen; Jia, Xinying; Kaas, Quentin; Jiang, Tao; Adams, David J.; Yu, Rilei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4621-4631</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Conotoxins preferentially antagonize muscle and neuronal nicotinic acetylcholine receptors (nAChRs).  Native α-conotoxins have two disulfide links, CI-CIII and CII-CIV, and due to the inherent properties of disulfide bonds, α-conotoxins have been systematically engineered to improve their chem. and biol. properties.  In this study, we explored the possibility of simplifying the disulfide framework of α-conotoxins Vc1.1, BuIA, ImI and AuIB, by introducing [C2H,C8F] modification to the CI-CIII bond.  We therefore explore the possibility of using hydrophobic packing of std. amino acid side chains to replace disulfide bonds as an alternative strategy to non-natural amino acid crosslinks.  The impact of CI-CIII disulfide bond replacement on the conformation of the α-conotoxins was investigated using mol. dynamic simulations and NMR chem. shift indexes study.  Two-electrode voltage clamp techniques and mol. dynamics simulations were used to study the impact of disulfide bond deletion on the activities of these peptides at human neuronal nAChRs.  All disulfide-deleted variants except ImI[C2H,C8F] had reduced potency for inhibiting nAChRs.  Our results suggest that the CI-CIII disulfide bond is important to stabilize the secondary structure of α-conotoxins as well as their interaction with neuronal nAChR targets.  Results from this study enrich our understanding on the function of the CI-CIII disulfide bond and are useful in guiding future structural engineering of the α-conotoxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCvFZMGGWB7Vg90H21EOLACvtfcHk0lj1rxUg0h7yYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtleltbrL&md5=b327bf5302033866dd73b08ee6aca6d2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b00639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b00639%26sid%3Dliteratum%253Aachs%26aulast%3DTabassum%26aufirst%3DN.%26aulast%3DTae%26aufirst%3DH.-S.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DKaas%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DYu%26aufirst%3DR.%26atitle%3DRole%2520of%2520CysI-CysIIIDisulfide%2520Bond%2520on%2520the%2520Structure%2520and%2520Activity%2520of%2520%25CE%25B1-Conotoxins%2520at%2520Human%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26spage%3D4621%26epage%3D4631%26doi%3D10.1021%2Facsomega.7b00639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staff, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisold, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisold, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windebank, A. J.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy-induced Peripheral Neuropathy: A Current Review</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">781</span>, <span class="refDoi"> DOI: 10.1002/ana.24951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1002%2Fana.24951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=28486769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKisbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2017&pages=772-781&author=N.+P.+Staffauthor=A.+Grisoldauthor=W.+Grisoldauthor=A.+J.+Windebank&title=Chemotherapy-induced+Peripheral+Neuropathy%3A+A+Current+Review&doi=10.1002%2Fana.24951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy-induced peripheral neuropathy: A current review</span></div><div class="casAuthors">Staff, Nathan P.; Grisold, Anna; Grisold, Wolfgang; Windebank, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">772-781</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect experienced by patients receiving treatment for cancer.  Approx. 30 to 40% of patients treated with neurotoxic chemotherapy will develop CIPN, and there is considerable variability in its severity between patients.  It is often sensory-predominant with pain and can lead to long-term morbidity in survivors.  The prevalence and burden of CIPN late effects will likely increase as cancer survival rates continue to improve.  In this review, we discuss the approach to peripheral neuropathy in patients with cancer and address the clin. phenotypes and pathomechanisms of specific neurotoxic chemotherapeutic agents.  Ann Neurol 2017;81:772-781.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8ISXxlGByRbVg90H21EOLACvtfcHk0lj1rxUg0h7yYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKisbrN&md5=9d471056039e27cbb5adf6c43ea15743</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fana.24951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24951%26sid%3Dliteratum%253Aachs%26aulast%3DStaff%26aufirst%3DN.%2BP.%26aulast%3DGrisold%26aufirst%3DA.%26aulast%3DGrisold%26aufirst%3DW.%26aulast%3DWindebank%26aufirst%3DA.%2BJ.%26atitle%3DChemotherapy-induced%2520Peripheral%2520Neuropathy%253A%2520A%2520Current%2520Review%26jtitle%3DAnn.%2520Neurol.%26date%3D2017%26volume%3D81%26spage%3D772%26epage%3D781%26doi%3D10.1002%2Fana.24951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Noord, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eijgelsheim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stricker, B. H. C.</span></span> <span> </span><span class="NLM_article-title">Drug- and Non-drug-associated QT Interval Prolongation</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.2010.03660.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1111%2Fj.1365-2125.2010.03660.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=20642543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1emsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=16-23&author=C.+van%0ANoordauthor=M.+Eijgelsheimauthor=B.+H.+C.+Stricker&title=Drug-+and+Non-drug-associated+QT+Interval+Prolongation&doi=10.1111%2Fj.1365-2125.2010.03660.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Drug- and non-drug-associated QT interval prolongation</span></div><div class="casAuthors">van Noord, Charlotte; Eijgelsheim, Mark; Stricker, Bruno H. Ch.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-23</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Sudden cardiac death is among the most common causes of cardiovascular death in developed countries.  The majority of sudden cardiac deaths are caused by acute ventricular arrhythmia following repolarization disturbances.  An important risk factor for repolarization disturbances is use of QT prolonging drugs, probably partly explained by gene-drug interactions.  In this review, we will summarize QT interval physiol., known risk factors for QT prolongation, including drugs and the contribution of pharmacogenetics.  The long QT syndrome can be congenital or acquired.  The congenital long QT syndrome is caused by mutations in ion channel subunits or regulatory protein coding genes and is a rare monogenic disorder with a mendelian pattern of inheritance.  Apart from that, several common genetic variants that are assocd. with QT interval duration have been identified.  Acquired QT prolongation is more prevalent than the congenital form.  Several risk factors have been identified with use of QT prolonging drugs as the most frequent cause.  Most drugs that prolong the QT interval act by blocking hERG-encoded potassium channels, although some drugs mainly modify sodium channels.  Both pharmacodynamic as well as pharmacokinetic mechanisms may be responsible for QT prolongation.  Pharmacokinetic interactions often involve drugs that are metabolized by cytochrome P 450 enzymes.  Pharmacodynamic gene-drug interactions are due to genetic variants that potentiate the QT prolonging effect of drugs.  QT prolongation, often due to use of QT prolonging drugs, is a major public health issue.  Recently, common genetic variants assocd. with QT prolongation have been identified.  Few pharmacogenetic studies have been performed to establish the genetic background of acquired QT prolongation but addnl. studies in this newly developing field are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzyy2JTFkqQLVg90H21EOLACvtfcHk0lj1rxUg0h7yYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1emsrg%253D&md5=784c2dbd68ad4514fb606f58623c100a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2010.03660.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2010.03660.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNoord%26aufirst%3DC.%26aulast%3DEijgelsheim%26aufirst%3DM.%26aulast%3DStricker%26aufirst%3DB.%2BH.%2BC.%26atitle%3DDrug-%2520and%2520Non-drug-associated%2520QT%2520Interval%2520Prolongation%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D70%26spage%3D16%26epage%3D23%26doi%3D10.1111%2Fj.1365-2125.2010.03660.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, R. S.</span></span> <span> </span><span class="NLM_article-title">α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding Residues</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">1216</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.01.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.1016%2Fj.jmb.2008.01.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=18295795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1WhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=1216-1227&author=M.+Ellisonauthor=Z.-P.+Fengauthor=A.+J.+Parkauthor=X.+Zhangauthor=B.+M.+Oliveraauthor=J.+M.+McIntoshauthor=R.+S.+Norton&title=%CE%B1-RgIA%2C+a+Novel+Conotoxin+That+Blocks+the+%CE%B19%CE%B110+nAChR%3A+Structure+and+Identification+of+Key+Receptor-Binding+Residues&doi=10.1016%2Fj.jmb.2008.01.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding Residues</span></div><div class="casAuthors">Ellison, Michael; Feng, Zhi-Ping; Park, Anthony J.; Zhang, Xuecheng; Olivera, Baldomero M.; McIntosh, J. Michael; Norton, Raymond S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1216-1227</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">α-Conotoxins are small disulfide-constrained peptides from cone snails that act as antagonists at specific subtypes of nicotinic acetylcholine receptors (nAChRs).  The 13-residue peptide α-conotoxin RgIA (α-RgIA) is a member of the α-4,3 family of α-conotoxins and selectively blocks the α9α10 nAChR subtype, in contrast to another well-characterized member of this family, α-conotoxin ImI (α-ImI), which is a potent inhibitor of the α7 and α3β2 nAChR subtypes.  In this study, we have altered side chains in both the four-residue and the three-residue loops of α-RgIA, and have modified its C-terminus.  The effects of these changes on activity against α9α10 and α7 nAChRs were measured; the soln. structures of α-RgIA and its Y10W, D5E, and P6V analogs were detd. from NMR data; and resonance assignments were made for α-RgIA [R9A].  The structures for α-RgIA and its three analogs were well defined, except at the chain termini.  Comparison of these structures with reported structures of α-ImI reveals a common two-loop backbone architecture within the α-4,3 family, but with variations in side-chain solvent accessibility and orientation.  Asp5, Pro6, and Arg7 in loop 1 are crit. for blockade of both the α9α10 and the α7 subtypes.  In loop 2, α-RgIA [Y10W] had activity near that of wild-type α-RgIA, with high potency for α9α10 and low potency for α7, and had a structure similar to that of wild type.  By contrast, Arg9 in loop 2 is crit. for specific binding to the α9α10 subtype, probably because it is larger and more solvent accessible than Ala9 in α-ImI.  Our findings contribute to a better understanding of the mol. basis for antagonism of the α9α10 nAChR subtype, which is a target for the development of analgesics for the treatment of chronic neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9If5Ur8ivy7Vg90H21EOLACvtfcHk0lgrtyouiY8Byw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1WhsLs%253D&md5=d3a1c974279538a3071de3eabed150b1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.01.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.01.082%26sid%3Dliteratum%253Aachs%26aulast%3DEllison%26aufirst%3DM.%26aulast%3DFeng%26aufirst%3DZ.-P.%26aulast%3DPark%26aufirst%3DA.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DNorton%26aufirst%3DR.%2BS.%26atitle%3D%25CE%25B1-RgIA%252C%2520a%2520Novel%2520Conotoxin%2520That%2520Blocks%2520the%2520%25CE%25B19%25CE%25B110%2520nAChR%253A%2520Structure%2520and%2520Identification%2520of%2520Key%2520Receptor-Binding%2520Residues%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D377%26spage%3D1216%26epage%3D1227%26doi%3D10.1016%2Fj.jmb.2008.01.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zouridakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papakyriakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasheverov, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsetlin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzartos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giastas, P.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">474</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=10.3389%2Ffphar.2019.00474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=31118896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGksb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=474&author=M.+Zouridakisauthor=A.+Papakyriakouauthor=I.+A.+Ivanovauthor=I.+E.+Kasheverovauthor=V.+Tsetlinauthor=S.+Tzartosauthor=P.+Giastas&title=Crystal+Structure+of+the+Monomeric+Extracellular+Domain+of+%CE%B19+Nicotinic+Receptor+Subunit+in+Complex+With+%CE%B1-Conotoxin+RgIA%3A+Molecular+Dynamics+Insights+Into+RgIA+Binding+to+%CE%B19%CE%B110+Nicotinic+Receptors&doi=10.3389%2Ffphar.2019.00474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the monomeric extracellular domain of α9 nicotinic receptor subunit in complex with α-conotoxin RgIA: molecular dynamics insights into rgia binding to α9α10 nicotinic receptors</span></div><div class="casAuthors">Zouridakis, Marios; Papakyriakou, Athanasios; Ivanov, Igor A.; Kasheverov, Igor E.; Tsetlin, Victor; Tzartos, Socrates; Giastas, Petros</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">474</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The α9 subunit of nicotinic acetylcholine receptors (nAChRs) exists mainly in heteropentameric assemblies with α10.  Accumulating data indicate the presence of three different binding sites in α9α10 nAChRs: the α9(+)/α9(-), the α9(+)/α10(-), and the α10(+)/α9(-).  The major role of the principal (+) side of the extracellular domain (ECD) of α9 subunit in binding of the antagonists methyllylcaconitine and α-bungarotoxin was shown previously by the crystal structures of the monomeric α9-ECD with these mols.  Here we present the 2.26-Å resoln. crystal structure of α9-ECD in complex with α-conotoxin (α-Ctx) RgIA, a potential drug for chronic pain, the first structure reported for a complex between an nAChR domain and an α-Ctx.  Superposition of this structure with those of other α-Ctxs bound to the homologous pentameric acetylcholine binding proteins revealed significant similarities in the orientation of bound conotoxins, despite the monomeric state of the α9-ECD.  In addn., ligand-binding studies calcd. a binding affinity of RgIA to the α9-ECD at the low micromolar range.  Given the high identity between α9 and α10 ECDs, particularly at their (+) sides, the presented structure was used as template for mol. dynamics simulations of the ECDs of the human α9 α10 nAChR in pentameric assemblies.  Our results support a favorable binding of RgIA at α9(+)/α9(-) or α10(+)/α9(-) rather than the α9(+)/α10(-) interface, in accordance with previous mutational and functional data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhljrV1Ab-CbVg90H21EOLACvtfcHk0lgrtyouiY8Byw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGksb7P&md5=2301c1de59b08ba6994b3d3e5c8631d3</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00474%26sid%3Dliteratum%253Aachs%26aulast%3DZouridakis%26aufirst%3DM.%26aulast%3DPapakyriakou%26aufirst%3DA.%26aulast%3DIvanov%26aufirst%3DI.%2BA.%26aulast%3DKasheverov%26aufirst%3DI.%2BE.%26aulast%3DTsetlin%26aufirst%3DV.%26aulast%3DTzartos%26aufirst%3DS.%26aulast%3DGiastas%26aufirst%3DP.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Monomeric%2520Extracellular%2520Domain%2520of%2520%25CE%25B19%2520Nicotinic%2520Receptor%2520Subunit%2520in%2520Complex%2520With%2520%25CE%25B1-Conotoxin%2520RgIA%253A%2520Molecular%2520Dynamics%2520Insights%2520Into%2520RgIA%2520Binding%2520to%2520%25CE%25B19%25CE%25B110%2520Nicotinic%2520Receptors%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D474%26doi%3D10.3389%2Ffphar.2019.00474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakely, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purushottam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D. H.-C.</span></span> <span> </span><span class="NLM_article-title">Development of Conformationally Constrained α-RgIA Analogues as Stable Peptide Antagonists of Human α9α10 Nicotinic Acetylcholine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8380</span>– <span class="NLM_lpage">8387</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1ynurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8380-8387&author=N.+Zhengauthor=S.+B.+Christensenauthor=A.+Blakelyauthor=C.+Dowellauthor=L.+Purushottamauthor=J.+M.+McIntoshauthor=D.+H.-C.+Chou&title=Development+of+Conformationally+Constrained+%CE%B1-RgIA+Analogues+as+Stable+Peptide+Antagonists+of+Human+%CE%B19%CE%B110+Nicotinic+Acetylcholine+Receptors&doi=10.1021%2Facs.jmedchem.0c00613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Conformationally Constrained α-RgIAAnalogues as Stable Peptide Antagonists of Human α9α10Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Zheng, Nan; Christensen, Sean B.; Blakely, Alan; Dowell, Cheryl; Purushottam, Landa; McIntosh, J. Michael; Chou, Danny Hung-Chieh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8380-8387</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Non-opioid therapeutics for the treatment of neuropathic pain are urgently needed to address the ongoing opioid crisis.  Peptides from cone snail venoms have served as invaluable mols. to target key pain-related receptors but can suffer from unfavorable physicochem. properties, which limit their therapeutic potential.  In this work,we developed conformationally constrained α-RgIA analogs with high potency, receptor selectivity, and enhanced human serum stability to target the human α9α10 nicotinic acetylcholine receptor.The key lactam linkage introduced in α-RgIA fixed the favored globular conformation and suppressed disulfide scrambling.  The NMRstructure of the macrocyclic peptide overlays well with that of α-RgIA4,demonstrating that the cyclization does not perturb the overall conformation of backbone and key side-chain residues.  Finally, a mol. docking model was used to rationalize the selective binding between a macrocyclicanalogue and the α9α10 nicotinic acetylcholine receptor.These conformationally constrained antagonists are therefore promising candidates for antinociceptive therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs0xJyW0BFtbVg90H21EOLACvtfcHk0lgmJ8ObWPdBqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1ynurnN&md5=71a82089eaf4123fc1c8a08328ef0188</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00613%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DBlakely%26aufirst%3DA.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DPurushottam%26aufirst%3DL.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DChou%26aufirst%3DD.%2BH.-C.%26atitle%3DDevelopment%2520of%2520Conformationally%2520Constrained%2520%25CE%25B1-RgIA%2520Analogues%2520as%2520Stable%2520Peptide%2520Antagonists%2520of%2520Human%2520%25CE%25B19%25CE%25B110%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8380%26epage%3D8387%26doi%3D10.1021%2Facs.jmedchem.0c00613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Góngora-Benítez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulla-Puche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">926</span>, <span class="refDoi"> DOI: 10.1021/cr400031z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400031z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=901-926&author=M.+G%C3%B3ngora-Ben%C3%ADtezauthor=J.+Tulla-Pucheauthor=F.+Albericio&title=Multifaceted+Roles+of+Disulfide+Bonds.+Peptides+as+Therapeutics&doi=10.1021%2Fcr400031z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics</span></div><div class="casAuthors">Gongora-Benitez, Miriam; Tulla-Puche, Judit; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">901-926</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present review, we have focused our attention on disulfide bonds as constrained elements and their further implications in the development of peptide-based therapeutics.  Thus, the versatile roles of the disulfide bonds formed between Cys residues in therapeutic peptides have been covered.  First, the biol. relevance of these covalent linkages in the oxidative folding process and the contribution of these structural elements to the 3D conformational stability of polypeptides have been discussed.  In addn., the capacity of these linkages to modulate the pharmacodynamic and pharmacokinetic properties of the peptide has been fully disclosed.  Overall, peptide cyclization through the incorporation of disulfide bridges not only may allow the improvement of diverse pharmacol. features, but may also provide valuable information about biol. processes and that is relevant for the further design of peptide analogs and peptidomimetics.  Here we have referred to several studies in which the insertion of a disulfide bond has endowed peptides enhanced pharmacol. properties, including bioactivity, selectivity and resistance to proteases. ,many other studies have demonstrated that these constrained elements are potentially capable of stabilizing secondary structure elements involved in widespread mol. surface recognition processes.  Moreover, disulfide bonds are being applied as reversible covalent bonds for the construction of peptide conjugates that comprise a drug delivery carrier for enhancing cell permeability.  In this regard, the early development of bioactive peptides linked to drug delivery systems is gaining relevance, and this tendency has been progressively implemented in many pharmaceutical companies.  In particular, CPPs may allow a large no. of peptide drugs to enter the market, and they are expected to contribute to accelerating the research performed in both the industrial sector and in the academic world.  The next generation of CPPs is expected to combine both targeting and internalization advantages.  On the other hand, of special interest are small disulfide-rich peptides,which have also been discussed as valuable therapeutic agents.  In general, these privileged mols. show extraordinary chem. and biol. stability and, given their highly constrained architecture, many of them and analogs thereof are currently undergoing preclin. studies or are in clin. trials.  Together with the increasing significance of these constrained peptides as drugs themselves, some of these rigid structures have been used as scaffolds for peptide engineering.  Thus, by taking advantages of the privileged pharmacokinetic properties of some of these extremely rigid architectures, this novel approach is emerging as an extremely valuable tool for peptide drug discovery.  Furthermore, of relevance, owing to their special topol. and cyclic backbone, some small cyclicdisulfide-rich peptides have the capacity to cross the cell membrane.  These peptides constitute a new family of CPPs that are referred to as cyclic cell-penetrating peptides(CCPPs).  These mols. ofer several advantages over linear CPPs, including greater stability and bioavailability, and therefore, they are promising mols. for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYp3zST79N7Vg90H21EOLACvtfcHk0lgmJ8ObWPdBqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7nJ&md5=903478ec86d15479bf1987d142cccf58</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fcr400031z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400031z%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B3ngora-Ben%25C3%25ADtez%26aufirst%3DM.%26aulast%3DTulla-Puche%26aufirst%3DJ.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DMultifaceted%2520Roles%2520of%2520Disulfide%2520Bonds.%2520Peptides%2520as%2520Therapeutics%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D901%26epage%3D926%26doi%3D10.1021%2Fcr400031z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HY7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HY7','PDB','6HY7'); return false;">PDB: 6HY7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JUQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JUQ','PDB','2JUQ'); return false;">PDB: 2JUQ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i19"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00802">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_00640"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00802?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00802</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Twenty lowest energy states’ ensemble of NMR solution structures for RgIA-5533 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_001.pdb">PDB</a>)</p></li><li><p class="inline">Twenty lowest energy states’ ensemble of NMR solution structures for RgIA-5617 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Twenty lowest energy states’ ensemble of NMR solution structures for RgIA-5524 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Supporting figures and tables; LC-chromatogram and MS spectrum for purified peptides; NMR chemical shift assignments; NMR solution structure ensemble; and NMR spectra of compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_004.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_001.pdb">jm1c00802_si_001.pdb (294.24 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_002.pdb">jm1c00802_si_002.pdb (256.29 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_003.pdb">jm1c00802_si_003.pdb (256.29 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00802/suppl_file/jm1c00802_si_004.pdf">jm1c00802_si_004.pdf (1.32 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00802&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00802%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-13%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00802" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679993abbcdb3d76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
